Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

74265 208345 None 115 Human Functional pEC50 = 6 6.0 -2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
CHEMBL99384 208345 None 115 Human Functional pEC50 = 6 6.0 -2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 0 0 2 4.0 Cc1cnc2c(ccc3c(C)c(C)cnc32)c1C 10.1021/jm301121j
14434082 83781 None 17 Human Functional pEC50 = 5 5.0 -1 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
CHEMBL2205801 83781 None 17 Human Functional pEC50 = 5 5.0 -1 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 236 2 0 4 2.4 O=Cc1ccnc2c1ccc1c(C=O)ccnc12 10.1021/jm301121j
16726107 83487 None 2 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
CHEMBL220199 83487 None 2 Human Functional pEC50 = 6.0 6.0 - 1
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
14338 4366 None 124 Human Functional pEC50 = 5.0 5.0 -3 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4366 None 124 Human Functional pEC50 = 5.0 5.0 -3 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
14338 4366 None 124 Human Functional pEC50 = 4.9 4.9 -3 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
CHEMBL101165 4366 None 124 Human Functional pEC50 = 4.9 4.9 -3 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccnc(-c2cc(C)ccn2)c1 10.1021/jm301121j
16301115 83433 None 4 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 435 7 1 6 3.8 Cc1ccc(-n2c(C)nnc2SCC(=O)NC2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm061389p
CHEMBL219769 83433 None 4 Human Functional pEC50 = 4.9 4.9 - 1
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 435 7 1 6 3.8 Cc1ccc(-n2c(C)nnc2SCC(=O)NC2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm061389p
93149 107199 None 84 Human Functional pEC50 = 5.8 5.8 -16 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 107199 None 84 Human Functional pEC50 = 5.8 5.8 -16 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
3258407 84902 None 19 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
CHEMBL223686 84902 None 19 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
12987698 83788 None 4 Human Functional pEC50 = 5.7 5.7 2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83788 None 4 Human Functional pEC50 = 5.7 5.7 2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
1474 154397 None 142 Human Functional pEC50 = 4.7 4.7 -1 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 154397 None 142 Human Functional pEC50 = 4.7 4.7 -1 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
12987698 83788 None 4 Human Functional pEC50 = 5.7 5.7 2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
CHEMBL2205809 83788 None 4 Human Functional pEC50 = 5.7 5.7 2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1cnc2c(ccc3cc(C)cnc32)c1 10.1021/jm301121j
15783796 83790 None 1 Human Functional pEC50 = 5.7 5.7 -3 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83790 None 1 Human Functional pEC50 = 5.7 5.7 -3 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
93149 107199 None 84 Human Functional pEC50 = 5.7 5.7 -16 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 107199 None 84 Human Functional pEC50 = 5.7 5.7 -16 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
2733927 83787 None 97 Human Functional pEC50 = 4.7 4.7 -4 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83787 None 97 Human Functional pEC50 = 4.7 4.7 -4 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
1474 154397 None 142 Human Functional pEC50 = 4.7 4.7 -1 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 154397 None 142 Human Functional pEC50 = 4.7 4.7 -1 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
16728788 83434 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
CHEMBL219770 83434 None 0 Human Functional pEC50 = 5.7 5.7 - 1
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
15783796 83790 None 1 Human Functional pEC50 = 5.7 5.7 -3 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
CHEMBL2205810 83790 None 1 Human Functional pEC50 = 5.7 5.7 -3 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 194 0 0 2 3.1 Cc1cnc2c(ccc3cccnc32)c1 10.1021/jm301121j
2733927 83787 None 97 Human Functional pEC50 = 4.7 4.7 -4 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
CHEMBL2205808 83787 None 97 Human Functional pEC50 = 4.7 4.7 -4 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 216 3 0 4 2.2 COc1ccnc(-c2cc(OC)ccn2)c1 10.1021/jm301121j
15664 83786 None 101 Human Functional pEC50 = 5.6 5.6 2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83786 None 101 Human Functional pEC50 = 5.6 5.6 2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
137660245 159284 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 461 7 1 4 4.4 CC(C)CN1CC(C(=O)Nc2ccc(CN(C)C3CCOCC3)cc2)=Cc2ccccc2C1=O 10.1016/j.ejmech.2017.04.046
CHEMBL4099473 159284 None 0 Human Functional pEC50 = 5.6 5.6 - 1
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 461 7 1 4 4.4 CC(C)CN1CC(C(=O)Nc2ccc(CN(C)C3CCOCC3)cc2)=Cc2ccccc2C1=O 10.1016/j.ejmech.2017.04.046
15664 83786 None 101 Human Functional pEC50 = 5.6 5.6 2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
CHEMBL2205807 83786 None 101 Human Functional pEC50 = 5.6 5.6 2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 10.1021/jm301121j
72792 199721 None 84 Human Functional pEC50 = 5.6 5.6 -5 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 199721 None 84 Human Functional pEC50 = 5.6 5.6 -5 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
72792 199721 None 84 Human Functional pEC50 = 5.6 5.6 -5 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
CHEMBL593442 199721 None 84 Human Functional pEC50 = 5.6 5.6 -5 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccnc2c1ccc1c(C)ccnc12 10.1021/jm301121j
70848 206670 None 112 Human Functional pEC50 = 4.5 4.5 -5 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 206670 None 112 Human Functional pEC50 = 4.5 4.5 -5 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
1167892 83436 None 1 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
CHEMBL219781 83436 None 1 Human Functional pEC50 = 5.5 5.5 - 1
Agonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assayAgonist activity at CCR5 expressed in CHO-K1 cells in aqeuorin based assay
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
70848 206670 None 112 Human Functional pEC50 = 4.5 4.5 -5 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 206670 None 112 Human Functional pEC50 = 4.5 4.5 -5 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
10585 1078 None 1 Human Functional pEC50 = 8.4 8.4 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1078 None 1 Human Functional pEC50 = 8.4 8.4 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1078 None 1 Human Functional pEC50 = 8.4 8.4 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
12425 6 None 126 Human Functional pEC50 = 5.3 5.3 -4 4
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 None 126 Human Functional pEC50 = 5.3 5.3 -4 4
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 None 126 Human Functional pEC50 = 5.3 5.3 -4 4
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 None 126 Human Functional pEC50 = 5.3 5.3 -4 4
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
10585 1078 None 1 Human Functional pEC50 = 8.3 8.3 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1078 None 1 Human Functional pEC50 = 8.3 8.3 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1078 None 1 Human Functional pEC50 = 8.3 8.3 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
155491018 174081 None 1 Human Functional pEC50 = 8.3 8.3 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 174081 None 1 Human Functional pEC50 = 8.3 8.3 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
155491018 174081 None 1 Human Functional pEC50 = 8.3 8.3 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 174081 None 1 Human Functional pEC50 = 8.3 8.3 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 30 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
12425 6 None 126 Human Functional pEC50 = 5.3 5.3 -4 4
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 None 126 Human Functional pEC50 = 5.3 5.3 -4 4
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 None 126 Human Functional pEC50 = 5.3 5.3 -4 4
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 None 126 Human Functional pEC50 = 5.3 5.3 -4 4
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
155491018 174081 None 1 Human Functional pEC50 = 8.2 8.2 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 174081 None 1 Human Functional pEC50 = 8.2 8.2 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
155491018 174081 None 1 Human Functional pEC50 = 8.2 8.2 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 174081 None 1 Human Functional pEC50 = 8.2 8.2 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 100 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
65237 137622 None 105 Human Functional pEC50 = 4.2 4.2 -28 2
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 137622 None 105 Human Functional pEC50 = 4.2 4.2 -28 2
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
65237 137622 None 105 Human Functional pEC50 = 4.2 4.2 -28 2
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 137622 None 105 Human Functional pEC50 = 4.2 4.2 -28 2
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
183790 3740 None 11 Human Functional pEC50 = 8.2 8.2 -2 5
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
783 3740 None 11 Human Functional pEC50 = 8.2 8.2 -2 5
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
CHEMBL1178786 3740 None 11 Human Functional pEC50 = 8.2 8.2 -2 5
Positive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assayPositive allosteric modulation of human CCR5 expressed in HEK293T cells co-expressing CAMYEL assessed as increase in CCL4-induced inhibition of forskolin-stimulated cAMP accumulation after 10 mins by BRET assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
10585 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
10585 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
10585 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
155491018 174081 None 1 Human Functional pEC50 = 8.1 8.1 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 174081 None 1 Human Functional pEC50 = 8.1 8.1 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as pEC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 8.42 +/- 0.06 No_unit)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
10585 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1078 None 1 Human Functional pEC50 = 8.1 8.1 -1 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 1000 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
155491018 174081 None 1 Human Functional pEC50 = 8.1 8.1 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 174081 None 1 Human Functional pEC50 = 8.1 8.1 2 2
Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)Non-competitive insurmountable antagonist activity at human CCR5 expressed in human U2OS cell membranes assessed as EC50 for CCL3-stimulated [35S]GTPgammaS binding at 300 nM preincubated for 30 mins followed by [35S]GTPgammaS addition and measured after 90 mins (Rvb = 4 nM)
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
11151928 189485 None 0 Human Functional pED50 = 9.1 9.1 -10 4
Antagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assayAntagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assay
ChEMBL 338 11 2 2 4.3 CCCCCCCCCCC(C)(C)C(=O)N[C@H]1CCCCNC1=O 10.1021/jm900133w
CHEMBL513863 189485 None 0 Human Functional pED50 = 9.1 9.1 -10 4
Antagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assayAntagonist activity at CCR5 in human THP1 cells assessed as inhibition of CCL5-induced chemotaxis after 2 hrs by microtiter format trans-well migration assay
ChEMBL 338 11 2 2 4.3 CCCCCCCCCCC(C)(C)C(=O)N[C@H]1CCCCNC1=O 10.1021/jm900133w
15941255 81771 None 0 Human Functional pIC50 = 10.1 10.1 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 527 9 2 6 4.5 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2Cl)CC1 10.1021/ml2002604
CHEMBL2164207 81771 None 0 Human Functional pIC50 = 10.1 10.1 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 527 9 2 6 4.5 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2Cl)CC1 10.1021/ml2002604
57402801 69221 None 0 Human Functional pIC50 = 10.1 10.1 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 600 12 2 7 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C(=O)NC(C)C)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926899 69221 None 0 Human Functional pIC50 = 10.1 10.1 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 600 12 2 7 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C(=O)NC(C)C)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
50993591 57207 None 0 Human Functional pIC50 = 10 10.0 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3cccc(F)c3)c2C1 10.1021/jm100978n
CHEMBL1649924 57207 None 0 Human Functional pIC50 = 10 10.0 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3cccc(F)c3)c2C1 10.1021/jm100978n
15940800 81766 None 0 Human Functional pIC50 = 10 10.0 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 561 10 1 7 3.9 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CN2CCOC2=O)CC1 10.1021/ml2002604
CHEMBL2164202 81766 None 0 Human Functional pIC50 = 10 10.0 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 561 10 1 7 3.9 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CN2CCOC2=O)CC1 10.1021/ml2002604
15941086 81774 None 0 Human Functional pIC50 = 10 10.0 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 518 9 2 7 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2Cl)CC1 10.1021/ml2002604
CHEMBL2164210 81774 None 0 Human Functional pIC50 = 10 10.0 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 518 9 2 7 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2Cl)CC1 10.1021/ml2002604
11285792 878 None 34 Human Functional pIC50 = 10 10.0 -3 6
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 878 None 34 Human Functional pIC50 = 10 10.0 -3 6
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 878 None 34 Human Functional pIC50 = 10 10.0 -3 6
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 878 None 34 Human Functional pIC50 = 10 10.0 -3 6
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
62706107 81781 None 0 Human Functional pIC50 = 10.0 10.0 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 554 9 2 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)Nc2cccnc2)CC1 10.1021/ml2002604
CHEMBL2164217 81781 None 0 Human Functional pIC50 = 10.0 10.0 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 554 9 2 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)Nc2cccnc2)CC1 10.1021/ml2002604
11650548 103540 None 0 Human Functional pIC50 = 9.7 9.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085308 103540 None 0 Human Functional pIC50 = 9.7 9.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
15947119 69215 None 0 Human Functional pIC50 = 9.7 9.7 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926893 69215 None 0 Human Functional pIC50 = 9.7 9.7 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
3002977 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
803 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
806 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
CHEMBL256907 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
CHEMBL584744 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
DB04835 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm100978n
50993593 57209 None 0 Human Functional pIC50 = 9.7 9.7 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
CHEMBL1649926 57209 None 0 Human Functional pIC50 = 9.7 9.7 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 497 6 1 6 3.9 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
50992494 57210 None 0 Human Functional pIC50 = 9.7 9.7 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 6 1 7 4.1 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)OC)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
CHEMBL1649927 57210 None 0 Human Functional pIC50 = 9.7 9.7 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 6 1 7 4.1 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)OC)CC3)C2)c1cccc(F)c1 10.1021/jm100978n
3002977 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
803 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
806 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
CHEMBL256907 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
CHEMBL584744 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
DB04835 2458 None 71 Human Functional pIC50 = 9.7 9.7 2 4
Inhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assayInhibition of CCR5 in human TZM-bl cells infected with HIV1 Bal R5 assessed as antiviral activity by measuring reduction in viral infection pre-incubated with cells followed by viral infection measured after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.12.035
11285792 878 None 34 Human Functional pIC50 = 9.7 9.7 -3 6
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 878 None 34 Human Functional pIC50 = 9.7 9.7 -3 6
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 878 None 34 Human Functional pIC50 = 9.7 9.7 -3 6
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 878 None 34 Human Functional pIC50 = 9.7 9.7 -3 6
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
11513274 103541 None 0 Human Functional pIC50 = 9.7 9.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
CHEMBL3085309 103541 None 0 Human Functional pIC50 = 9.7 9.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
9810893 103539 None 0 Human Functional pIC50 = 9.6 9.6 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085307 103539 None 0 Human Functional pIC50 = 9.6 9.6 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
44511934 69218 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 10 1 6 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926896 69218 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 10 1 6 5.2 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44512090 69220 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 7 5.0 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926898 69220 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 7 5.0 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44512058 69229 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 10 1 8 4.5 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1927008 69229 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 10 1 8 4.5 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44511938 69230 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 10 1 7 5.3 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1927009 69230 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 10 1 7 5.3 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
50992641 57206 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
CHEMBL1649922 57206 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
62706110 81767 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 491 8 2 5 4.2 CNC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164203 81767 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 491 8 2 5 4.2 CNC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
15940799 81769 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 493 8 3 6 4.0 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NO)CC1 10.1021/ml2002604
CHEMBL2164205 81769 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 493 8 3 6 4.0 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NO)CC1 10.1021/ml2002604
57384005 81770 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 9 2 6 4.2 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164206 81770 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 9 2 6 4.2 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
57384006 81775 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 12 2 7 4.2 COCCONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164211 81775 None 0 Human Functional pIC50 = 9.5 9.5 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 12 2 7 4.2 COCCONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
50915506 19043 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
CHEMBL1288663 19043 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
44455217 95417 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assayAntagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 608 7 1 5 6.4 CC(=O)N1CCc2c(nc(C)n2[C@H]2C[C@@H]3CC[C@H](C2)N3CCCN(C(=O)Nc2ccc(C(F)(F)F)cc2)c2ccccc2)C1 10.1016/j.bmcl.2007.12.058
CHEMBL257000 95417 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assayAntagonist activity at CCR5 receptor by [35S]GTP-gamma-S binding assay
ChEMBL 608 7 1 5 6.4 CC(=O)N1CCc2c(nc(C)n2[C@H]2C[C@@H]3CC[C@H](C2)N3CCCN(C(=O)Nc2ccc(C(F)(F)F)cc2)c2ccccc2)C1 10.1016/j.bmcl.2007.12.058
50992577 57202 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 6 1 5 3.5 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649919 57202 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 6 1 5 3.5 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
50992639 57204 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 477 7 1 5 3.9 CCC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
CHEMBL1649920 57204 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 477 7 1 5 3.9 CCC(=O)N1CCc2nc(C)n([C@@H]3C[C@@H]4CC[C@H](C3)N4CC[C@H](NC(C)=O)c3ccccc3)c2C1 10.1021/jm100978n
50992640 57205 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 491 7 1 5 4.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649921 57205 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 491 7 1 5 4.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(=O)C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
59458228 81772 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 558 11 3 7 3.6 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C(=O)NC(C)C)nc2C)CC1 10.1021/ml2002604
CHEMBL2164208 81772 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 558 11 3 7 3.6 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C(=O)NC(C)C)nc2C)CC1 10.1021/ml2002604
59458061 81773 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 543 9 2 6 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)[n+]([O-])c2Cl)CC1 10.1021/ml2002604
CHEMBL2164209 81773 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 543 9 2 6 3.7 CONC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)[n+]([O-])c2Cl)CC1 10.1021/ml2002604
15941083 81783 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 506 10 1 6 4.1 COCC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164219 81783 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 506 10 1 6 4.1 COCC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
15940801 81784 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 501 9 1 6 4.3 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC#N)CC1 10.1021/ml2002604
CHEMBL2164220 81784 None 0 Human Functional pIC50 = 9.4 9.4 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 501 9 1 6 4.3 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC#N)CC1 10.1021/ml2002604
5275766 3736 None 40 Human Functional pIC50 = 9.4 9.4 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
800 3736 None 40 Human Functional pIC50 = 9.4 9.4 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
CHEMBL207004 3736 None 40 Human Functional pIC50 = 9.4 9.4 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
11700429 103543 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085311 103543 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
53325983 57196 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 416 6 1 4 4.8 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3ccccc31)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649913 57196 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 416 6 1 4 4.8 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3ccccc31)C2)c1ccccc1 10.1021/jm100978n
15940498 81776 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 611 11 3 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NCc2ccc(C(=O)O)cc2)CC1 10.1021/ml2002604
CHEMBL2164212 81776 None 0 Human Functional pIC50 = 9.3 9.3 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 611 11 3 6 5.5 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)NCc2ccc(C(=O)O)cc2)CC1 10.1021/ml2002604
457871 100721 None 1 Human Functional pIC50 = 9.3 9.3 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL292625 100721 None 1 Human Functional pIC50 = 9.3 9.3 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
44511935 69222 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 593 13 1 7 5.8 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926900 69222 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 593 13 1 7 5.8 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
50993592 57208 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649925 57208 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 479 6 1 6 3.8 COC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
3008904 199964 None 1 Human Functional pIC50 = 9.2 9.2 1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59511 199964 None 1 Human Functional pIC50 = 9.2 9.2 1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
11614352 550 None 1 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxis
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
7686 550 None 1 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxis
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
CHEMBL1951914 550 None 1 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in allo T cells assessed as inhibition of MIP-1beta-induced chemotaxis
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
57392303 69213 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926891 69213 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
44512001 69231 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 544 10 1 7 4.8 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1927010 69231 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 544 10 1 7 4.8 COc1ccc(N(Cc2cccc(C#N)n2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
62706106 81779 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 560 10 1 6 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
CHEMBL2164215 81779 None 0 Human Functional pIC50 = 9.2 9.2 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 560 10 1 6 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
3008917 202782 None 5 Human Functional pIC50 = 9.2 9.2 -6 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 202782 None 5 Human Functional pIC50 = 9.2 9.2 -6 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3002977 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
803 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
806 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL256907 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL584744 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
DB04835 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
44511871 69223 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 13 1 8 5.0 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926901 69223 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 13 1 8 5.0 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(C#N)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72711958 92653 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435864 92653 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711740 92698 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435909 92698 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
62706109 81765 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 10 1 7 4.5 Cc1cc(C#N)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
CHEMBL2164201 81765 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 551 10 1 7 4.5 Cc1cc(C#N)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)CC2CCOCC2)CC1 10.1021/ml2002604
3008909 199098 None 1 Human Functional pIC50 = 9.1 9.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL58897 199098 None 1 Human Functional pIC50 = 9.1 9.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
3013701 77092 None 1 Human Functional pIC50 = 9.1 9.1 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207487 77092 None 1 Human Functional pIC50 = 9.1 9.1 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
3002977 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
803 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
806 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
CHEMBL256907 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
CHEMBL584744 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
DB04835 2458 None 71 Human Functional pIC50 = 9.1 9.1 2 4
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00781
72711739 92696 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435907 92696 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
62706108 81782 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 476 8 1 5 4.4 CC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164218 81782 None 0 Human Functional pIC50 = 9.1 9.1 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 476 8 1 5 4.4 CC(=O)N(Cc1ccsc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
11636141 103542 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085310 103542 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
57402802 69226 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 12 2 8 3.8 Cc1ccncc1CN(c1ccc(OCC(N)=O)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926904 69226 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 12 2 8 3.8 Cc1ccncc1CN(c1ccc(OCC(N)=O)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
46225532 199671 None 0 Human Functional pIC50 = 9 9.0 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593042 199671 None 0 Human Functional pIC50 = 9 9.0 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008928 202655 None 1 Human Functional pIC50 = 9 9.0 -1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61424 202655 None 1 Human Functional pIC50 = 9 9.0 -1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3013575 75768 None 1 Human Functional pIC50 = 9 9.0 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL204821 75768 None 1 Human Functional pIC50 = 9 9.0 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
49798082 10818 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 579 9 1 5 5.5 C=CCN(C(=O)OCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172043 10818 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 579 9 1 5 5.5 C=CCN(C(=O)OCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
44194590 10823 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 612 9 2 4 5.4 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172048 10823 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 612 9 2 4 5.4 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
11353001 58806 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688239 58806 None 0 Human Functional pIC50 = 9.0 9.0 - 1
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
11597 673 None 5 Human Functional pIC50 = 9.0 9.0 -11 2
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
23725180 673 None 5 Human Functional pIC50 = 9.0 9.0 -11 2
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
CHEMBL4781426 673 None 5 Human Functional pIC50 = 9.0 9.0 -11 2
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
51039119 176215 None 33 Human Functional pIC50 = 9.0 9.0 1 3
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
CHEMBL4594419 176215 None 33 Human Functional pIC50 = 9.0 9.0 1 3
Antagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxisAntagonist activity at CCR5 in human peripheral T cells assessed as reduction in MIP-1beta-induced chemotaxis
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
3008927 198856 None 1 Human Functional pIC50 = 9.0 9.0 -2 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58387 198856 None 1 Human Functional pIC50 = 9.0 9.0 -2 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008909 199098 None 1 Human Functional pIC50 = 9.0 9.0 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL58897 199098 None 1 Human Functional pIC50 = 9.0 9.0 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
72711956 92651 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435862 92651 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
3009355 3987 None 26 Human Functional pIC50 = 8.9 8.9 -1 2
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
807 3987 None 26 Human Functional pIC50 = 8.9 8.9 -1 2
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
CHEMBL82301 3987 None 26 Human Functional pIC50 = 8.9 8.9 -1 2
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
DB06652 3987 None 26 Human Functional pIC50 = 8.9 8.9 -1 2
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
11605997 58808 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688240 58808 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
71458736 81777 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 10 1 7 4.8 COc1ccc(N(Cc2ccsc2)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
CHEMBL2164213 81777 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 507 10 1 7 4.8 COc1ccc(N(Cc2ccsc2)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
183790 3740 None 11 Human Functional pIC50 = 8.9 8.9 -2 5
Inhibition of chemotactic protein to CCR5Inhibition of chemotactic protein to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm010468s
783 3740 None 11 Human Functional pIC50 = 8.9 8.9 -2 5
Inhibition of chemotactic protein to CCR5Inhibition of chemotactic protein to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm010468s
CHEMBL1178786 3740 None 11 Human Functional pIC50 = 8.9 8.9 -2 5
Inhibition of chemotactic protein to CCR5Inhibition of chemotactic protein to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm010468s
44512349 69224 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 577 13 1 7 5.2 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926902 69224 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 577 13 1 7 5.2 COCCOc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72711742 92649 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435860 92649 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49864971 15781 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222769 15781 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
49768863 57195 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1021/jm100978n
CHEMBL1649912 57195 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1021/jm100978n
3008913 101974 None 1 Human Functional pIC50 = 8.9 8.9 -1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 101974 None 1 Human Functional pIC50 = 8.9 8.9 -1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
183790 3740 None 11 Human Functional pIC50 = 8.9 8.9 -2 5
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00347-4
783 3740 None 11 Human Functional pIC50 = 8.9 8.9 -2 5
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00347-4
CHEMBL1178786 3740 None 11 Human Functional pIC50 = 8.9 8.9 -2 5
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00347-4
183790 3740 None 11 Human Functional pIC50 = 8.9 8.9 -2 5
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
783 3740 None 11 Human Functional pIC50 = 8.9 8.9 -2 5
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
CHEMBL1178786 3740 None 11 Human Functional pIC50 = 8.9 8.9 -2 5
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
5275759 77114 None 1 Human Functional pIC50 = 8.9 8.9 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207630 77114 None 1 Human Functional pIC50 = 8.9 8.9 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
9810893 103539 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085307 103539 None 0 Human Functional pIC50 = 8.9 8.9 - 1
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL5084989 214939 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL None None None CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1021/acs.jmedchem.1c00781
57395817 69216 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926894 69216 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72714078 92674 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435885 92674 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72714079 92675 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435886 92675 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49871007 58811 None 13 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 assessed as inhibition of receptor internalizationAntagonist activity at CCR5 assessed as inhibition of receptor internalization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58811 None 13 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 assessed as inhibition of receptor internalizationAntagonist activity at CCR5 assessed as inhibition of receptor internalization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
44194588 10885 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 622 11 2 6 3.2 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172625 10885 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 622 11 2 6 3.2 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
57394057 69219 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 519 10 1 6 4.9 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926897 69219 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 519 10 1 6 4.9 COc1ccc(N(Cc2cccnc2)C2CCN([C@H](C)CCNC(=O)c3c(C)cc(F)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
49798089 10825 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)cc1F)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172050 10825 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)cc1F)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49798090 10826 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172051 10826 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 580 9 2 4 4.7 C=CCN(C(=O)NCc1ccc(F)c(F)c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
50915506 19043 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
CHEMBL1288663 19043 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 11 2 6 8.2 CC(C)(C)NS(=O)(=O)c1cc(C(=O)N2CCC(CCN3CCC(N(C(=O)NCc4ccc(C#N)cc4)c4cccc(F)c4)CC3)(c3cccc(F)c3)CC2)c(Cl)cc1F 10.1016/j.bmcl.2010.10.033
49798085 10820 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 562 9 2 4 4.5 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172045 10820 None 0 Human Functional pIC50 = 8.8 8.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 562 9 2 4 4.5 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
72711741 92648 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435859 92648 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
11505350 168785 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL437494 168785 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
46225515 199653 None 0 Human Functional pIC50 = 8 8.0 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592940 199653 None 0 Human Functional pIC50 = 8 8.0 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008904 199964 None 1 Human Functional pIC50 = 8.0 8.0 1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59511 199964 None 1 Human Functional pIC50 = 8.0 8.0 1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
118727180 117382 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 592 8 0 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCN(S(=O)(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397991 117382 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 592 8 0 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCN(S(=O)(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
44511967 69210 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926888 69210 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
44511967 69210 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
CHEMBL1926888 69210 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 516 10 1 7 4.5 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ncnc3C)CC2)cc1 10.1021/ml2002604
3008907 202665 None 1 Human Functional pIC50 = 7 7.0 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 405 4 1 3 4.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61465 202665 None 1 Human Functional pIC50 = 7 7.0 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 405 4 1 3 4.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccccc3)CC2)CC1 10.1021/jm031046g
505868 27777 None 1 Human Functional pIC50 = 7 7.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137072 27777 None 1 Human Functional pIC50 = 7 7.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44357072 98490 None 0 Human Functional pIC50 = 7 7.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL275998 98490 None 0 Human Functional pIC50 = 7 7.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
505878 119186 None 1 Human Functional pIC50 = 7 7.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343160 119186 None 1 Human Functional pIC50 = 7 7.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44356944 119217 None 1 Human Functional pIC50 = 7 7.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343366 119217 None 1 Human Functional pIC50 = 7 7.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44357078 119399 None 0 Human Functional pIC50 = 7 7.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344641 119399 None 0 Human Functional pIC50 = 7 7.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
46225346 200040 None 0 Human Functional pIC50 = 6 6.0 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595570 200040 None 0 Human Functional pIC50 = 6 6.0 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46837554 10666 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 516 9 1 4 5.6 COC(=O)C1(Cc2ccccc2)CCN(CC[C@H](NC(=O)C2CCC2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.ejmech.2010.03.003
CHEMBL1170529 10666 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 516 9 1 4 5.6 COC(=O)C1(Cc2ccccc2)CCN(CC[C@H](NC(=O)C2CCC2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.ejmech.2010.03.003
46837425 103404 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 547 7 1 5 6.8 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)c1ccc(F)cc1)c1cccc2ccccc12 10.1016/j.ejmech.2010.03.003
CHEMBL3084746 103404 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 547 7 1 5 6.8 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)c1ccc(F)cc1)c1cccc2ccccc12 10.1016/j.ejmech.2010.03.003
53389085 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817911 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852138 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057814 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
53389085 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1817911 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852138 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057814 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.ejmech.2012.07.049
46226118 14120 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 531 10 1 4 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198032 14120 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 531 10 1 4 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL593605 14120 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 531 10 1 4 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
44395365 124471 None 0 Human Functional pIC50 = 5 5.0 - 1
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
CHEMBL363999 124471 None 0 Human Functional pIC50 = 5 5.0 - 1
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
53389085 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817911 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852138 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057814 66464 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
54752873 77173 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057812 77173 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2078840 77173 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
54752873 77173 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057812 77173 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2078840 77173 None 0 Human Functional pIC50 = 5 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
46225343 200139 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596299 200139 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008911 100979 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
CHEMBL294271 100979 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
3008925 100912 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
CHEMBL293900 100912 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
90656325 111064 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 431 7 1 6 3.8 CC(C)Oc1ccc(N2CCN(Cc3ccccc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263023 111064 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 431 7 1 6 3.8 CC(C)Oc1ccc(N2CCN(Cc3ccccc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
70690766 77168 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2064266 77168 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2078746 77168 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
57397596 69202 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 646 12 2 6 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Oc3ccc(C(=O)O)cc3)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926878 69202 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 646 12 2 6 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Oc3ccc(C(=O)O)cc3)cc2)CC1 10.1016/j.bmcl.2011.09.133
49798132 10729 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 547 9 1 4 4.4 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171029 10729 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 547 9 1 4 4.4 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52948296 19074 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288924 19074 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
44357379 28136 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL137327 28136 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
505869 28264 None 1 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137419 28264 None 1 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44357375 116001 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL335562 116001 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
9914742 166633 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL428104 166633 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
3008927 198856 None 1 Human Functional pIC50 = 8.0 8.0 -2 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58387 198856 None 1 Human Functional pIC50 = 8.0 8.0 -2 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
53325460 58492 None 0 Human Functional pIC50 = 8.0 8.0 -2 2
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683190 58492 None 0 Human Functional pIC50 = 8.0 8.0 -2 2
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
3008934 198691 None 1 Human Functional pIC50 = 8.0 8.0 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58101 198691 None 1 Human Functional pIC50 = 8.0 8.0 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49864972 15782 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222770 15782 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
49864975 15785 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 695 11 2 6 4.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222773 15785 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 695 11 2 6 4.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
52943424 19063 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288913 19063 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
73346388 92667 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435878 92667 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
118727176 117378 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3cccc(F)c3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397987 117378 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3cccc(F)c3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
168279183 190909 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 541 9 1 8 5.2 COC(=O)C1CCC(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)CC1 10.1021/acs.jmedchem.2c01383
CHEMBL5185201 190909 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 541 9 1 8 5.2 COC(=O)C1CCC(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)CC1 10.1021/acs.jmedchem.2c01383
145967391 164247 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 589 7 0 5 6.9 Cc1nc2cnccc2n1C1CCN(CCC2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)Cc3ccccc3)C2)CC1 10.1021/acs.jmedchem.8b00180
CHEMBL4211358 164247 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 589 7 0 5 6.9 Cc1nc2cnccc2n1C1CCN(CCC2(c3ccc(Cl)c(Cl)c3)CCCN(C(=O)Cc3ccccc3)C2)CC1 10.1021/acs.jmedchem.8b00180
76327885 103401 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 418 6 0 6 4.3 COC(=O)[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3cccnc31)C2)c1ccccc1 10.1016/j.bmcl.2010.02.023
CHEMBL3084729 103401 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 418 6 0 6 4.3 COC(=O)[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3cccnc31)C2)c1ccccc1 10.1016/j.bmcl.2010.02.023
44194496 10816 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 587 9 1 8 4.3 C=CCN(C(=O)OCc1ccc2nonc2c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172041 10816 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 587 9 1 8 4.3 C=CCN(C(=O)OCc1ccc2nonc2c1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
57397595 69201 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 10 1 5 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(=O)N(C)C)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926877 69201 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 10 1 5 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(=O)N(C)C)cc2)CC1 10.1016/j.bmcl.2011.09.133
46225348 200170 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596519 200170 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008936 198694 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58109 198694 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
57401042 69209 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 9 1 6 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926887 69209 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 9 1 6 5.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
126567277 165639 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(Cl)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4243842 165639 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(Cl)s1 10.1021/acs.jmedchem.8b01077
3008930 198678 None 1 Human Functional pIC50 = 7.9 7.9 1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 198678 None 1 Human Functional pIC50 = 7.9 7.9 1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
11527582 76426 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205964 76426 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
505875 25973 None 1 Human Functional pIC50 = 7.9 7.9 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL135432 25973 None 1 Human Functional pIC50 = 7.9 7.9 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505873 27944 None 1 Human Functional pIC50 = 7.9 7.9 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137206 27944 None 1 Human Functional pIC50 = 7.9 7.9 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
3008913 101974 None 1 Human Functional pIC50 = 7.9 7.9 -1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 101974 None 1 Human Functional pIC50 = 7.9 7.9 -1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
57395816 69214 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3cnc(Cl)cc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926892 69214 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 10 1 6 5.4 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3cnc(Cl)cc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
72712159 92656 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435867 92656 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
73352463 92635 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
CHEMBL2435846 92635 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
491775 12875 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188807 12875 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL537424 12875 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
10117348 13925 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
CHEMBL1196455 13925 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
CHEMBL557015 13925 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
10117348 13925 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196455 13925 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL557015 13925 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmc.2010.05.057
10117348 13925 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1196455 13925 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL557015 13925 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1016/j.bmcl.2009.11.018
16728326 10813 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 9 1 7 4.5 C=CCN(C(=O)OCc1ccc2c(c1)OCO2)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172037 10813 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 9 1 7 4.5 C=CCN(C(=O)OCc1ccc2c(c1)OCO2)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
76317388 104590 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 614 11 0 4 5.8 CCN(CCc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104693 104590 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 614 11 0 4 5.8 CCN(CCc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL5071060 214249 None 0 Human Functional pIC50 = 6.9 6.9 -3 2
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL None None None Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1021/acs.jmedchem.1c00408
89702731 109394 None 0 Human Functional pIC50 = 6.9 6.9 -3 2
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
CHEMBL3219777 109394 None 0 Human Functional pIC50 = 6.9 6.9 -3 2
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
162650661 180147 None 0 Human Functional pIC50 = 6.9 6.9 -3 2
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4748891 180147 None 0 Human Functional pIC50 = 6.9 6.9 -3 2
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
89702731 109394 None 0 Human Functional pIC50 = 6.9 6.9 -3 2
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
CHEMBL3219777 109394 None 0 Human Functional pIC50 = 6.9 6.9 -3 2
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
CHEMBL5074037 214307 None 0 Human Functional pIC50 = 5.9 5.9 -1 2
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
3008936 198694 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58109 198694 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
122185609 122906 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 514 6 2 2 5.7 Cc1c(CNC(=O)c2ccc3ccccc3c2)c(C)[n+]2c(c1CNC(=O)c1ccc3ccccc3c1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604296 122906 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 514 6 2 2 5.7 Cc1c(CNC(=O)c2ccc3ccccc3c2)c(C)[n+]2c(c1CNC(=O)c1ccc3ccccc3c1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606029 122906 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 514 6 2 2 5.7 Cc1c(CNC(=O)c2ccc3ccccc3c2)c(C)[n+]2c(c1CNC(=O)c1ccc3ccccc3c1)CCC2 10.1016/j.bmcl.2015.06.029
162677279 183476 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1cccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1016/j.bmc.2016.09.059
CHEMBL4799343 183476 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1cccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1016/j.bmc.2016.09.059
46225344 200067 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595760 200067 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
122185613 122914 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 578 8 2 2 7.5 Cc1c(CNC(=O)c2ccc(C3CCCCC3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C3CCCCC3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604298 122914 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 578 8 2 2 7.5 Cc1c(CNC(=O)c2ccc(C3CCCCC3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C3CCCCC3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606076 122914 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 578 8 2 2 7.5 Cc1c(CNC(=O)c2ccc(C3CCCCC3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C3CCCCC3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
21064283 14330 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1170878 14330 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1200019 14330 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
21064283 14330 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170878 14330 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200019 14330 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226132 14117 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 575 11 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C(=O)O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198014 14117 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 575 11 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C(=O)O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL593205 14117 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 575 11 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C(=O)O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
3002977 2458 None 71 Human Functional pIC50 = 7.9 7.9 2 4
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
803 2458 None 71 Human Functional pIC50 = 7.9 7.9 2 4
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
806 2458 None 71 Human Functional pIC50 = 7.9 7.9 2 4
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 7.9 7.9 2 4
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
CHEMBL256907 2458 None 71 Human Functional pIC50 = 7.9 7.9 2 4
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
CHEMBL584744 2458 None 71 Human Functional pIC50 = 7.9 7.9 2 4
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
DB04835 2458 None 71 Human Functional pIC50 = 7.9 7.9 2 4
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2014.12.052
3008930 198678 None 1 Human Functional pIC50 = 7.9 7.9 1 2
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 198678 None 1 Human Functional pIC50 = 7.9 7.9 1 2
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
72713860 92702 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435913 92702 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
57395818 69225 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 548 10 1 7 4.2 Cc1ccncc1CN(c1ccc([S+](C)[O-])cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926903 69225 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 548 10 1 7 4.2 Cc1ccncc1CN(c1ccc([S+](C)[O-])cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1016/j.bmcl.2011.09.133
16728785 12828 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188408 12828 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536298 12828 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728785 12828 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188408 12828 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL536298 12828 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
21064293 14326 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 547 10 1 5 5.9 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170874 14326 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 547 10 1 5 5.9 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200015 14326 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 547 10 1 5 5.9 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226126 14114 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 561 11 1 5 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(OC)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198011 14114 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 561 11 1 5 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(OC)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL593177 14114 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 561 11 1 5 6.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(OC)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
23577409 66416 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813439 66416 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851891 66416 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
162660215 181210 None 0 Human Functional pIC50 = 5.9 5.9 -79 2
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)c1 10.1016/j.bmc.2016.09.059
CHEMBL4761273 181210 None 0 Human Functional pIC50 = 5.9 5.9 -79 2
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)c1 10.1016/j.bmc.2016.09.059
122185641 122920 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 414 6 2 2 3.4 Cc1c(CNC(=O)c2ccccc2)c(C)[n+]2c(c1CNC(=O)c1ccccc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604312 122920 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 414 6 2 2 3.4 Cc1c(CNC(=O)c2ccccc2)c(C)[n+]2c(c1CNC(=O)c1ccccc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606113 122920 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 414 6 2 2 3.4 Cc1c(CNC(=O)c2ccccc2)c(C)[n+]2c(c1CNC(=O)c1ccccc1)CCC2 10.1016/j.bmcl.2015.06.029
46225350 201156 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL603325 201156 None 0 Human Functional pIC50 = 6.9 6.9 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
70694942 77198 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2064263 77198 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079186 77198 None 0 Human Functional pIC50 = 4.9 4.9 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
168283795 190891 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 586 10 2 9 4.2 COc1ccc(S(N)(=O)=O)cc1C(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
CHEMBL5184978 190891 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 586 10 2 9 4.2 COc1ccc(S(N)(=O)=O)cc1C(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
90666578 109397 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
CHEMBL3219780 109397 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
112500049 132483 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
CHEMBL3697626 132483 None 0 Human Functional pIC50 = 7.9 7.9 - 1
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
71458737 81780 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 563 9 2 6 5.2 Cc1ccncc1CN(C(=O)Nc1cccnc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164216 81780 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 563 9 2 6 5.2 Cc1ccncc1CN(C(=O)Nc1cccnc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
49864974 15788 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222776 15788 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
76316949 103403 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 511 8 1 5 5.5 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](C(=O)NCc1ccc(F)cc1)c1ccccc1 10.1016/j.bmcl.2010.02.023
CHEMBL3084731 103403 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS bindingAntagonist activity at CCR5 receptor expressed in CHO cells assessed as inhibition of RANTES-induced [32S]GTPgammaS binding
ChEMBL 511 8 1 5 5.5 Cc1nc2cccnc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](C(=O)NCc1ccc(F)cc1)c1ccccc1 10.1016/j.bmcl.2010.02.023
3008913 101974 None 1 Human Functional pIC50 = 7.8 7.8 -1 2
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 101974 None 1 Human Functional pIC50 = 7.8 7.8 -1 2
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008917 202782 None 5 Human Functional pIC50 = 7.8 7.8 -6 2
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 202782 None 5 Human Functional pIC50 = 7.8 7.8 -6 2
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49798130 10866 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 559 10 1 5 4.3 C=CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172438 10866 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 559 10 1 5 4.3 C=CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3008902 202678 None 1 Human Functional pIC50 = 7.8 7.8 -1 2
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 202678 None 1 Human Functional pIC50 = 7.8 7.8 -1 2
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008902 202678 None 1 Human Functional pIC50 = 7.8 7.8 -1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 202678 None 1 Human Functional pIC50 = 7.8 7.8 -1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008905 198716 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58248 198716 None 1 Human Functional pIC50 = 6.9 6.9 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
23577386 66370 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813435 66370 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851672 66370 None 0 Human Functional pIC50 = 5.9 5.9 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
52944616 19064 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288914 19064 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
72714077 92673 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435884 92673 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
3008911 100979 None 1 Human Functional pIC50 = 6.8 6.8 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
CHEMBL294271 100979 None 1 Human Functional pIC50 = 6.8 6.8 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
49798157 10882 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 597 9 1 4 5.3 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172622 10882 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 597 9 1 4 5.3 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
72711281 92690 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
CHEMBL2435901 92690 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
72711048 92682 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435893 92682 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
52944586 19051 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288873 19051 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225347 200042 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595584 200042 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225530 199665 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592997 199665 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
122668134 190338 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 415 7 1 6 4.2 CC(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
CHEMBL5176665 190338 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 415 7 1 6 4.2 CC(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1 10.1021/acs.jmedchem.2c01383
118727172 117374 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 524 8 0 4 4.8 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397983 117374 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 524 8 0 4 4.8 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
72712373 92662 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
CHEMBL2435873 92662 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
3008917 202782 None 5 Human Functional pIC50 = 7.8 7.8 -6 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 202782 None 5 Human Functional pIC50 = 7.8 7.8 -6 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008935 202727 None 1 Human Functional pIC50 = 7.8 7.8 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61828 202727 None 1 Human Functional pIC50 = 7.8 7.8 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008914 201007 None 1 Human Functional pIC50 = 7.8 7.8 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL60225 201007 None 1 Human Functional pIC50 = 7.8 7.8 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
126567253 165510 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 537 8 1 6 6.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4240763 165510 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 537 8 1 6 6.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)s1 10.1021/acs.jmedchem.8b01077
72712597 92665 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
CHEMBL2435876 92665 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
122668182 190246 None 2 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 573 7 1 6 5.4 CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)C1 10.1021/acs.jmedchem.2c01383
CHEMBL5175220 190246 None 2 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 573 7 1 6 5.4 CC(=O)N1CCc2c(nc(C)n2[C@@H]2C[C@H]3CC[C@@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccsc2)C1 10.1021/acs.jmedchem.2c01383
52943426 19073 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 751 13 1 6 6.1 C=CCN(C(=O)CCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288923 19073 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 751 13 1 6 6.1 C=CCN(C(=O)CCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
16728786 13967 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196759 13967 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL558043 13967 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
76310165 104589 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 598 11 0 4 5.3 CCN(CCc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104692 104589 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 598 11 0 4 5.3 CCN(CCc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
56673134 66439 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817913 66439 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852005 66439 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057818 66439 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
56673134 66439 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817913 66439 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852005 66439 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057818 66439 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 442 18 0 0 9.3 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
72714319 92678 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
CHEMBL2435889 92678 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
72711050 92684 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435895 92684 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
90666579 109398 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 628 9 2 7 7.3 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)OC(C)(C)C)cc1 10.1039/c3md00080j
CHEMBL3219781 109398 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 628 9 2 7 7.3 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)OC(C)(C)C)cc1 10.1039/c3md00080j
57397603 69228 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 10 1 7 5.6 Cc1ccncc1CN(c1ccc(N2CCOCC2)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1927007 69228 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 10 1 7 5.6 Cc1ccncc1CN(c1ccc(N2CCOCC2)cc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1016/j.bmcl.2011.09.133
72712375 92664 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 514 6 0 3 6.5 Cc1ccccc1N1CCC(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435875 92664 None 0 Human Functional pIC50 = 5.8 5.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 514 6 0 3 6.5 Cc1ccccc1N1CCC(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
49871007 58811 None 13 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilizationAntagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58811 None 13 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilizationAntagonist activity at CCR5 assessed as inhibition of intracellular calcium mobilization
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
3008929 195635 None 1 Human Functional pIC50 = 7.8 7.8 -1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL556314 195635 None 1 Human Functional pIC50 = 7.8 7.8 -1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145983513 165558 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 457 8 1 6 5.2 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C(C)C)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4242034 165558 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 457 8 1 6 5.2 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C(C)C)s1 10.1021/acs.jmedchem.8b01077
10278617 95180 None 3 Human Functional pIC50 = 7.8 7.8 1 2
Antagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 95180 None 3 Human Functional pIC50 = 7.8 7.8 1 2
Antagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in L1.2 cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008931 202645 None 1 Human Functional pIC50 = 7.8 7.8 - 1
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 202645 None 1 Human Functional pIC50 = 7.8 7.8 - 1
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
464990 14383 None 1 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 2 4 4.5 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c[nH]c(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200254 14383 None 1 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 2 4 4.5 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c[nH]c(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL3216057 14383 None 1 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 2 4 4.5 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c[nH]c(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
46225343 200139 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596299 200139 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 521 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
118727191 117393 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 535 7 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3398002 117393 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 535 7 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
62707284 77187 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057807 77187 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2079027 77187 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
62707284 77187 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057807 77187 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079027 77187 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
70688700 77194 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2064264 77194 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079127 77194 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 288 9 0 0 5.2 CCCCCCCCCCc1c(C)cc2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
46225346 200040 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595570 200040 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 7 1 6 3.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)CO)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225529 199693 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593195 199693 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008912 201070 None 1 Human Functional pIC50 = 5.8 5.8 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
CHEMBL60279 201070 None 1 Human Functional pIC50 = 5.8 5.8 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
90656328 111065 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccccc3[N+](=O)[O-])CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263025 111065 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccccc3[N+](=O)[O-])CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
72712160 92658 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
CHEMBL2435869 92658 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
52943389 19054 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288876 19054 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46191233 199668 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 575 6 0 5 4.6 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593027 199668 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 575 6 0 5 4.6 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
118727184 117386 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 578 9 0 5 4.4 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(S(C)(=O)=O)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
CHEMBL3397995 117386 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 578 9 0 5 4.4 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(S(C)(=O)=O)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
15950679 92657 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435868 92657 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
49798156 10572 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 9 1 4 5.0 C=CCN(C(=O)Cc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1169819 10572 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 9 1 4 5.0 C=CCN(C(=O)Cc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
72712161 92659 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435870 92659 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
10280945 12838 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188557 12838 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL536743 12838 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
10277467 13082 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
CHEMBL1190217 13082 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
CHEMBL540366 13082 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
21064331 14375 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Sc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1172871 14375 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Sc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200224 14375 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Sc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226120 14144 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Sc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198114 14144 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Sc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL596165 14144 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Sc3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
122185611 122908 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 566 8 2 2 6.7 Cc1c(CNC(=O)c2ccc(-c3ccccc3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(-c3ccccc3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604297 122908 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 566 8 2 2 6.7 Cc1c(CNC(=O)c2ccc(-c3ccccc3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(-c3ccccc3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606030 122908 None 0 Human Functional pIC50 = 4.8 4.8 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 566 8 2 2 6.7 Cc1c(CNC(=O)c2ccc(-c3ccccc3)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(-c3ccccc3)cc1)CCC2 10.1016/j.bmcl.2015.06.029
52945865 19070 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288920 19070 None 0 Human Functional pIC50 = 7.8 7.8 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
168271219 190428 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 483 8 1 6 5.7 Cc1ccsc1[C@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCCC1 10.1021/acs.jmedchem.2c01383
CHEMBL5178121 190428 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 483 8 1 6 5.7 Cc1ccsc1[C@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCCC1 10.1021/acs.jmedchem.2c01383
11237537 192096 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 509 7 1 5 4.3 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5203084 192096 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 509 7 1 5 4.3 CC(=O)N[C@@H](CCN1C2CCC1CC(n1c(C)nc3c1CCN(C(=O)C(C)C)C3)C2)c1cccc(F)c1 10.1021/acs.jmedchem.2c01383
10277467 13082 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1190217 13082 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL540366 13082 None 0 Human Functional pIC50 = 6.8 6.8 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1016/j.bmcl.2009.11.018
53324598 60110 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668020 60110 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739382 60110 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
46225512 201598 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL605727 201598 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
122185639 122919 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 442 6 2 2 4.0 Cc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(C)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3604311 122919 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 442 6 2 2 4.0 Cc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(C)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606112 122919 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 442 6 2 2 4.0 Cc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(C)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
11466794 69199 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 9 1 5 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926875 69199 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 535 9 1 5 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C#N)cc2)CC1 10.1016/j.bmcl.2011.09.133
122185633 122916 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 506 8 2 4 4.8 CSc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(SC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3604308 122916 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 506 8 2 4 4.8 CSc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(SC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606102 122916 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 506 8 2 4 4.8 CSc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(SC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
46225428 199939 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594914 199939 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
76335572 104586 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 570 10 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104689 104586 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 570 10 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
90656340 111126 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 461 8 1 7 3.8 COc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263319 111126 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 461 8 1 7 3.8 COc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
57402800 69207 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 10 1 6 5.9 COc1ccc(N(Cc2cccc(C#N)c2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926885 69207 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 10 1 6 5.9 COc1ccc(N(Cc2cccc(C#N)c2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
53319405 57201 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 499 7 1 6 2.9 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(S(C)(=O)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649918 57201 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 499 7 1 6 2.9 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(S(C)(=O)=O)CC3)C2)c1ccccc1 10.1021/jm100978n
46191232 199672 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593046 199672 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008902 202678 None 1 Human Functional pIC50 = 8.7 8.7 -1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 202678 None 1 Human Functional pIC50 = 8.7 8.7 -1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008908 202666 None 1 Human Functional pIC50 = 8.7 8.7 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL61466 202666 None 1 Human Functional pIC50 = 8.7 8.7 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
11570778 140917 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL382252 140917 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
44194589 10884 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 608 10 2 6 2.9 C=CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172624 10884 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 608 10 2 6 2.9 C=CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3002977 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
803 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
806 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL256907 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL584744 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
DB04835 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
3013689 77039 None 1 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207190 77039 None 1 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
11700429 103543 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085311 103543 None 0 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
3002977 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
803 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
806 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL256907 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL584744 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
DB04835 2458 None 71 Human Functional pIC50 = 8.7 8.7 2 4
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
457871 100721 None 1 Human Functional pIC50 = 8.7 8.7 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL292625 100721 None 1 Human Functional pIC50 = 8.7 8.7 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
3008928 202655 None 1 Human Functional pIC50 = 8.7 8.7 -1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61424 202655 None 1 Human Functional pIC50 = 8.7 8.7 -1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
483407 166038 None 21 Human Functional pIC50 = 8.7 8.7 - 1
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
CHEMBL425618 166038 None 21 Human Functional pIC50 = 8.7 8.7 - 1
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
5275765 138232 None 1 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL377026 138232 None 1 Human Functional pIC50 = 8.7 8.7 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
145984727 165565 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4242114 165565 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
145986021 165795 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4248009 165795 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
59458103 92695 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435906 92695 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3008927 198856 None 1 Human Functional pIC50 = 8.6 8.6 -2 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58387 198856 None 1 Human Functional pIC50 = 8.6 8.6 -2 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008914 201007 None 1 Human Functional pIC50 = 8.6 8.6 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL60225 201007 None 1 Human Functional pIC50 = 8.6 8.6 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
11513274 103541 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
CHEMBL3085309 103541 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
57397598 69212 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926890 69212 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)ccnc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
59458247 92701 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435912 92701 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
3008923 198897 None 1 Human Functional pIC50 = 8.6 8.6 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
CHEMBL58441 198897 None 1 Human Functional pIC50 = 8.6 8.6 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
3008908 202666 None 1 Human Functional pIC50 = 8.6 8.6 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL61466 202666 None 1 Human Functional pIC50 = 8.6 8.6 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
168268916 190002 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 549 10 1 7 5.9 COCc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.2c01383
CHEMBL5171331 190002 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 549 10 1 7 5.9 COCc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.2c01383
122668213 165581 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.7 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4242489 165581 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 6 5.7 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCCC2)s1 10.1021/acs.jmedchem.8b01077
145984502 165601 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
CHEMBL4242913 165601 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
145984829 165816 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4248472 165816 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
52948296 19074 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288924 19074 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 13 2 6 7.6 CCCCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008917 202782 None 5 Human Functional pIC50 = 8.6 8.6 -6 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL62152 202782 None 5 Human Functional pIC50 = 8.6 8.6 -6 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49798086 10821 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 578 9 2 4 5.0 C=CCN(C(=O)NCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172046 10821 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 578 9 2 4 5.0 C=CCN(C(=O)NCc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
11577846 77118 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207654 77118 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
145985461 165496 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.5 CCc1nnc(C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
CHEMBL4240475 165496 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 505 8 1 6 5.5 CCc1nnc(C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1 10.1021/acs.jmedchem.8b01077
126567264 165807 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4248282 165807 None 0 Human Functional pIC50 = 8.6 8.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
3008932 202644 None 1 Human Functional pIC50 = 8.6 8.6 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 202644 None 1 Human Functional pIC50 = 8.6 8.6 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008904 199964 None 1 Human Functional pIC50 = 8.6 8.6 1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59511 199964 None 1 Human Functional pIC50 = 8.6 8.6 1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145983733 165470 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 571 8 1 6 6.5 O=C(N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C3CC3)nnc1C(F)(F)F)C2)c1ccsc1)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
CHEMBL4239790 165470 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 571 8 1 6 6.5 O=C(N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C3CC3)nnc1C(F)(F)F)C2)c1ccsc1)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
145982775 165547 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 7 4.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(=O)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4241721 165547 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 483 8 1 7 4.6 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(=O)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
145985042 165665 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4244672 165665 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 517 8 1 6 5.8 Cc1nnc(C2CC2)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
72711955 92650 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435861 92650 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
16663418 10811 None 20 Human Functional pIC50 = 8.5 8.5 -1 2
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172035 10811 None 20 Human Functional pIC50 = 8.5 8.5 -1 2
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3008930 198678 None 1 Human Functional pIC50 = 8.5 8.5 1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 198678 None 1 Human Functional pIC50 = 8.5 8.5 1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
16663418 10811 None 20 Human Functional pIC50 = 8.5 8.5 -1 2
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1172035 10811 None 20 Human Functional pIC50 = 8.5 8.5 -1 2
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.046
44194676 10827 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 637 11 3 6 3.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172052 10827 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 637 11 3 6 3.3 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49864973 15783 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222771 15783 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 640 11 2 6 3.3 C=CCN(C(=O)Cc1ccc(S(=O)(=O)NC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
3500 1525 None 13 Human Functional pIC50 = 7.7 7.7 245 2
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
491774 1525 None 13 Human Functional pIC50 = 7.7 7.7 245 2
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
CHEMBL1196395 1525 None 13 Human Functional pIC50 = 7.7 7.7 245 2
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
49798083 10819 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 9 1 5 5.6 C=CCN(C(=O)OCc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172044 10819 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 9 1 5 5.6 C=CCN(C(=O)OCc1ccc(Br)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52948295 19061 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288911 19061 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
145983844 165800 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 484 8 2 7 3.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)[C@@H]1CCC(=O)N1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4248119 165800 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 484 8 2 7 3.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)[C@@H]1CCC(=O)N1)c1cccs1 10.1021/acs.jmedchem.8b01077
72713859 92700 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435911 92700 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
3008919 100763 None 1 Human Functional pIC50 = 6.7 6.7 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
CHEMBL292894 100763 None 1 Human Functional pIC50 = 6.7 6.7 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
10184169 12818 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188324 12818 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL536063 12818 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
56661526 66410 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 562 8 3 6 3.5 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813447 66410 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 562 8 3 6 3.5 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851866 66410 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 562 8 3 6 3.5 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
57331340 104576 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 10 0 4 5.4 CCN(Cc1ccc(C)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104677 104576 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 10 0 4 5.4 CCN(Cc1ccc(C)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
118727182 117384 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 511 8 0 3 6.2 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)c2ccc(F)cc2)cc1Cl 10.1016/j.bmc.2014.12.052
CHEMBL3397993 117384 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 511 8 0 3 6.2 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)c2ccc(F)cc2)cc1Cl 10.1016/j.bmc.2014.12.052
46191232 199672 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593046 199672 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 618 6 0 4 5.7 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21927139 14377 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 518 9 1 5 5.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)nc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200232 14377 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 518 9 1 5 5.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)nc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL3216934 14377 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 518 9 1 5 5.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)nc1)CC2 10.1016/j.bmc.2010.05.057
168293785 192174 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1csc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5204027 192174 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1csc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)c1 10.1021/acs.jmedchem.2c01383
52944618 19071 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 797 13 2 6 6.1 C=CCN(C(=O)Cc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288921 19071 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 797 13 2 6 6.1 C=CCN(C(=O)Cc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
10186729 13951 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196666 13951 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL557789 13951 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
56678576 66626 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813449 66626 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852754 66626 None 0 Human Functional pIC50 = 4.7 4.7 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
118727181 117383 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 431 7 0 3 4.7 CC(=O)N(CCCN1CCN(Cc2ccc(F)cc2)CC1C)c1ccc(C)c(Cl)c1 10.1016/j.bmc.2014.12.052
CHEMBL3397992 117383 None 0 Human Functional pIC50 = 5.7 5.7 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 431 7 0 3 4.7 CC(=O)N(CCCN1CCN(Cc2ccc(F)cc2)CC1C)c1ccc(C)c(Cl)c1 10.1016/j.bmc.2014.12.052
3008911 100979 None 1 Human Functional pIC50 = 5.7 5.7 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
CHEMBL294271 100979 None 1 Human Functional pIC50 = 5.7 5.7 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3cccc4ccn(C)c34)CC2)CC1 10.1021/jm031046g
52947063 19052 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 788 12 1 6 7.7 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288874 19052 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 788 12 1 6 7.7 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225533 199675 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593080 199675 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
73355478 92666 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435877 92666 None 0 Human Functional pIC50 = 7.7 7.7 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
49798081 10817 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 5 5.0 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172042 10817 None 0 Human Functional pIC50 = 6.7 6.7 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 5 5.0 C=CCN(C(=O)OCc1ccc(F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
16659334 14002 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1197042 14002 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL559168 14002 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
3008931 202645 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 202645 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
90656333 111067 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 7 1 6 4.6 CC(C)Oc1ccc(N2CCN(Cc3ccc(Br)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263029 111067 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 7 1 6 4.6 CC(C)Oc1ccc(N2CCN(Cc3ccc(Br)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
56678574 66377 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 593 10 4 7 3.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCC(O)CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813443 66377 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 593 10 4 7 3.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCC(O)CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851694 66377 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 593 10 4 7 3.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCC(O)CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56664937 66409 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 8 3 6 3.8 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813446 66409 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 8 3 6 3.8 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851865 66409 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 8 3 6 3.8 CCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
118727190 117392 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 521 7 0 5 4.3 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3398001 117392 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 521 7 0 5 4.3 CC(=O)N1CCC(C(=O)N(CCCN2CCN(c3ccc(C#N)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
122185637 122918 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 470 8 2 2 4.5 CCc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(CC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3604310 122918 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 470 8 2 2 4.5 CCc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(CC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606111 122918 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 470 8 2 2 4.5 CCc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(CC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
52948264 19050 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288872 19050 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225532 199671 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593042 199671 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 547 6 0 5 3.8 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
44404643 72220 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cellsInhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198114 72220 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cellsInhibition of MIP-1beta stimulated calcium transients in CCR5-expressing CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
3008930 198678 None 1 Human Functional pIC50 = 7.6 7.6 1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58004 198678 None 1 Human Functional pIC50 = 7.6 7.6 1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145983159 165927 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 497 8 1 7 4.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2=CCOCC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4250560 165927 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 497 8 1 7 4.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2=CCOCC2)s1 10.1021/acs.jmedchem.8b01077
3008932 202644 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 202644 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytesMigration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells oractivated human peripheral blood lymphocytes
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
72711506 92691 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435902 92691 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
162674876 183333 None 0 Human Functional pIC50 = 5.6 5.6 -109 2
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1169 26 7 15 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4797451 183333 None 0 Human Functional pIC50 = 5.6 5.6 -109 2
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1169 26 7 15 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
46225428 199939 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594914 199939 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 5 0 5 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
52948295 19061 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288911 19061 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 780 11 2 6 7.3 C=CCN(C(=O)Nc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
118727173 117375 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 538 8 0 4 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397984 117375 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 538 8 0 4 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
118727178 117380 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 528 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397989 117380 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 528 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2cccc(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
3002977 2458 None 71 Human Functional pIC50 = 7.6 7.6 2 4
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
803 2458 None 71 Human Functional pIC50 = 7.6 7.6 2 4
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
806 2458 None 71 Human Functional pIC50 = 7.6 7.6 2 4
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 7.6 7.6 2 4
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
CHEMBL256907 2458 None 71 Human Functional pIC50 = 7.6 7.6 2 4
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
CHEMBL584744 2458 None 71 Human Functional pIC50 = 7.6 7.6 2 4
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
DB04835 2458 None 71 Human Functional pIC50 = 7.6 7.6 2 4
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2013.11.013
57331278 104583 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104684 104583 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
3008908 202666 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL61466 202666 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 439 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Cl)cc3)CC2)CC1 10.1021/jm031046g
57331274 104581 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 538 9 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104682 104581 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 538 9 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
56661524 66429 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813438 66429 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851951 66429 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
16124598 10727 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 472 6 2 5 5.3 O=C(O)c1ccccc1Oc1ncc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
CHEMBL1171008 10727 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 472 6 2 5 5.3 O=C(O)c1ccccc1Oc1ncc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
145986205 165659 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 532 8 1 6 5.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)nc1 10.1021/acs.jmedchem.8b01077
CHEMBL4244470 165659 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 532 8 1 6 5.5 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(F)nc1 10.1021/acs.jmedchem.8b01077
76313867 104591 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104694 104591 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
46837553 103405 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 569 10 1 6 6.2 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)COc1ccccc1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2010.03.003
CHEMBL3084747 103405 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated GTPgammaS binding by scintillation proximity assay
ChEMBL 569 10 1 6 6.2 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)COc1ccccc1)c1ccc(C(F)(F)F)cc1 10.1016/j.ejmech.2010.03.003
90656342 111128 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 488 8 2 7 3.8 CC(=O)Nc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263321 111128 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 488 8 2 7 3.8 CC(=O)Nc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
118727183 117385 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)C1 10.1016/j.bmc.2014.12.052
CHEMBL3397994 117385 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)C1 10.1016/j.bmc.2014.12.052
11433338 69198 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 594 10 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926874 69198 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 594 10 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
52944616 19064 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288914 19064 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 827 13 2 7 6.9 C=CCN(C(=O)NCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008934 198691 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58101 198691 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
11693007 76259 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205851 76259 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
57331307 104588 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 11 0 4 5.1 CCN(CCc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104691 104588 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 580 11 0 4 5.1 CCN(CCc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
23577386 66370 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813435 66370 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851672 66370 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 626 11 3 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
122185617 122910 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 498 8 2 2 5.6 Cc1c(CNC(=O)c2ccc(C(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604300 122910 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 498 8 2 2 5.6 Cc1c(CNC(=O)c2ccc(C(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606050 122910 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 498 8 2 2 5.6 Cc1c(CNC(=O)c2ccc(C(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
52949523 19056 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 854 13 1 7 8.4 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288878 19056 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 854 13 1 7 8.4 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225514 199823 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594208 199823 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225512 201598 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL605727 201598 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 489 5 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
126567281 165508 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.8b01077
CHEMBL4240742 165508 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.8b01077
49864977 15789 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222777 15789 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
3008909 199098 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL58897 199098 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 473 4 1 3 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm031046g
491773 12826 None 1 Human Functional pIC50 = 6.6 6.6 67 2
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188399 12826 None 1 Human Functional pIC50 = 6.6 6.6 67 2
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL536288 12826 None 1 Human Functional pIC50 = 6.6 6.6 67 2
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
11634966 12876 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188808 12876 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL537425 12876 None 0 Human Functional pIC50 = 6.6 6.6 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
491773 12826 None 1 Human Functional pIC50 = 6.6 6.6 67 2
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188399 12826 None 1 Human Functional pIC50 = 6.6 6.6 67 2
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL536288 12826 None 1 Human Functional pIC50 = 6.6 6.6 67 2
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
90656339 111125 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 446 7 2 7 3.4 CC(C)Oc1ccc(N2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263318 111125 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 446 7 2 7 3.4 CC(C)Oc1ccc(N2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
46225515 199653 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592940 199653 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 551 6 0 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225350 201156 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL603325 201156 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 515 7 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)CC4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
10280945 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188557 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536743 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
10280945 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188557 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL536743 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
10280945 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188557 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL536743 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
21064281 14329 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 596 10 2 6 4.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170877 14329 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 596 10 2 6 4.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200018 14329 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 596 10 2 6 4.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
10280945 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1188557 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL536743 12838 None 0 Human Functional pIC50 = 7.6 7.6 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
457871 100721 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL292625 100721 None 1 Human Functional pIC50 = 7.6 7.6 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
3008918 199382 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59101 199382 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
23577370 66362 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813270 66362 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851623 66362 None 0 Human Functional pIC50 = 5.6 5.6 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
73351059 92793 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 8 1 5 5.6 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436819 92793 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 8 1 5 5.6 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
56678576 66626 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813449 66626 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852754 66626 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 9 3 6 3.9 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
90656343 111129 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 474 8 1 7 3.9 CC(C)Oc1ccc(N2CCN(Cc3ccc(N(C)C)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263322 111129 None 0 Human Functional pIC50 = 4.6 4.6 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 474 8 1 7 3.9 CC(C)Oc1ccc(N2CCN(Cc3ccc(N(C)C)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
3008926 201844 None 1 Human Functional pIC50 = 6.6 6.6 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
CHEMBL60711 201844 None 1 Human Functional pIC50 = 6.6 6.6 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
73355550 92773 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 1 5 5.2 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436720 92773 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 1 5 5.2 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
50993435 57197 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 511 8 1 5 5.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(Cc1ccccc1)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649914 57197 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 511 8 1 5 5.2 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(Cc1ccccc1)CC3)C2)c1ccccc1 10.1021/jm100978n
10272003 58877 None 1 Human Functional pIC50 = 5.5 5.5 -4 3
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 395 2 2 5 3.4 Cc1nn(C)c2ncc(C(=O)NC(=O)Nc3ccc(F)c(C(F)(F)F)c3)cc12 10.1021/jm1012903
CHEMBL1688888 58877 None 1 Human Functional pIC50 = 5.5 5.5 -4 3
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 395 2 2 5 3.4 Cc1nn(C)c2ncc(C(=O)NC(=O)Nc3ccc(F)c(C(F)(F)F)c3)cc12 10.1021/jm1012903
145983098 165735 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 7 1 7 4.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)N2CCN(C)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4246290 165735 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 7 1 7 4.3 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)N2CCN(C)CC2)s1 10.1021/acs.jmedchem.8b01077
118727189 117391 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3398000 117391 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
57402799 69206 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 603 9 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926884 69206 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 603 9 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
57397597 69208 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 619 10 1 6 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926886 69208 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 619 10 1 6 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
10106 872 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
91820689 872 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
CHEMBL4249798 872 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
145985672 165390 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 501 8 1 6 5.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4237964 165390 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 501 8 1 6 5.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
49871007 58811 None 13 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 assessed as inhibition of ERK phosphorylationAntagonist activity at CCR5 assessed as inhibition of ERK phosphorylation
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58811 None 13 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 assessed as inhibition of ERK phosphorylationAntagonist activity at CCR5 assessed as inhibition of ERK phosphorylation
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
49871007 58811 None 13 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58811 None 13 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
50992575 57200 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 7 1 5 4.4 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649917 57200 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 463 7 1 5 4.4 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C(C)C)CC3)C2)c1ccccc1 10.1021/jm100978n
46225533 199675 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593080 199675 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 590 6 0 4 4.9 Cc1cc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008935 202727 None 1 Human Functional pIC50 = 8.5 8.5 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61828 202727 None 1 Human Functional pIC50 = 8.5 8.5 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008913 101974 None 1 Human Functional pIC50 = 8.5 8.5 -1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL301454 101974 None 1 Human Functional pIC50 = 8.5 8.5 -1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3013684 77036 None 1 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207182 77036 None 1 Human Functional pIC50 = 8.5 8.5 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
122668190 165396 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 469 8 1 6 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4238063 165396 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 469 8 1 6 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1cccs1 10.1021/acs.jmedchem.8b01077
49798087 10822 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 10 2 6 4.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172047 10822 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 589 10 2 6 4.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52941648 19067 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288917 19067 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008929 195635 None 1 Human Functional pIC50 = 8.5 8.5 -1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL556314 195635 None 1 Human Functional pIC50 = 8.5 8.5 -1 2
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
44194587 10886 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 636 11 1 6 3.5 C=CCN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172626 10886 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 636 11 1 6 3.5 C=CCN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
73347894 92652 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435863 92652 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3008929 195635 None 1 Human Functional pIC50 = 8.5 8.5 -1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL556314 195635 None 1 Human Functional pIC50 = 8.5 8.5 -1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
49798129 10836 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 529 9 1 4 4.2 C=CCN(C(=O)Cc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172157 10836 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 529 9 1 4 4.2 C=CCN(C(=O)Cc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
16663418 10811 None 20 Human Functional pIC50 = 8.5 8.5 -1 2
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevationAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevation
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172035 10811 None 20 Human Functional pIC50 = 8.5 8.5 -1 2
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevationAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced calcium elevation
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
53319838 58810 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688242 58810 None 0 Human Functional pIC50 = 8.5 8.5 - 1
Antagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxisAntagonist activity at CCR5 in IL-10 stimulated human PBMC cells assessed as MIP-1beta induced chemotaxis
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
3008923 198897 None 1 Human Functional pIC50 = 8.5 8.5 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
CHEMBL58441 198897 None 1 Human Functional pIC50 = 8.5 8.5 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
59458245 92655 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435866 92655 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711508 92694 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435905 92694 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49798133 10730 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 4 4.9 C=CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171030 10730 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 563 9 1 4 4.9 C=CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
52947091 19062 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288912 19062 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008924 199701 None 1 Human Functional pIC50 = 8.4 8.4 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
CHEMBL59328 199701 None 1 Human Functional pIC50 = 8.4 8.4 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
3008905 198716 None 1 Human Functional pIC50 = 8.4 8.4 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58248 198716 None 1 Human Functional pIC50 = 8.4 8.4 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
52947091 19062 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288912 19062 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 794 12 2 6 7.0 C=CCN(C(=O)NCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
11585418 76009 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205539 76009 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
49864977 15787 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222775 15787 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 681 11 3 6 4.0 C=CCN(C(=O)NCc1ccc(S(=O)(=O)NC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
118727179 117381 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 556 7 0 4 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCN(C(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397990 117381 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 556 7 0 4 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCN(C(=O)c3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
11399408 69203 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 622 9 1 4 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(Cl)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926880 69203 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 622 9 1 4 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(Cl)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
46225528 199664 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592993 199664 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225526 199731 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593520 199731 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
49864968 15778 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222766 15778 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
49864976 15786 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 606 9 2 4 5.2 C=CCN(C(=O)NCc1ccc(F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222774 15786 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 606 9 2 4 5.2 C=CCN(C(=O)NCc1ccc(F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
3008932 202644 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 202644 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
118727175 117377 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3F)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397986 117377 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccccc3F)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
11598797 12924 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1189134 12924 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL538084 12924 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
10143882 14343 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 511 8 1 4 5.4 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(Cc2ccccc2)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1171289 14343 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 511 8 1 4 5.4 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(Cc2ccccc2)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1200078 14343 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 511 8 1 4 5.4 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(Cc2ccccc2)C1=O 10.1016/j.bmc.2010.05.057
505866 28422 None 1 Human Functional pIC50 = 6.5 6.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137524 28422 None 1 Human Functional pIC50 = 6.5 6.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505865 29277 None 1 Human Functional pIC50 = 6.5 6.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138282 29277 None 1 Human Functional pIC50 = 6.5 6.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505867 29700 None 1 Human Functional pIC50 = 6.5 6.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138645 29700 None 1 Human Functional pIC50 = 6.5 6.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
72711280 92689 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
CHEMBL2435900 92689 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
10205915 12803 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188208 12803 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL535616 12803 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 441 11 1 3 4.4 CCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
10116073 14402 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 469 7 1 4 4.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(C(=O)OCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173708 14402 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 469 7 1 4 4.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(C(=O)OCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200300 14402 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 469 7 1 4 4.3 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(C(=O)OCc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
23577448 66625 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 9 3 6 4.2 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813448 66625 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 9 3 6 4.2 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852753 66625 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 9 3 6 4.2 CCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3001322 443 None 23 Rabbit Functional pIC50 = 4.5 4.5 -75857 5
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 443 None 23 Rabbit Functional pIC50 = 4.5 4.5 -75857 5
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 443 None 23 Rabbit Functional pIC50 = 4.5 4.5 -75857 5
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 443 None 23 Rabbit Functional pIC50 = 4.5 4.5 -75857 5
Antagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rabbit CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3001322 443 None 23 Rat Functional pIC50 = 4.5 4.5 -75857 5
Antagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 443 None 23 Rat Functional pIC50 = 4.5 4.5 -75857 5
Antagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 443 None 23 Rat Functional pIC50 = 4.5 4.5 -75857 5
Antagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 443 None 23 Rat Functional pIC50 = 4.5 4.5 -75857 5
Antagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at rat CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
122185615 122909 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 526 6 2 2 6.0 Cc1c(CNC(=O)c2ccc(C(C)(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604299 122909 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 526 6 2 2 6.0 Cc1c(CNC(=O)c2ccc(C(C)(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606049 122909 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 526 6 2 2 6.0 Cc1c(CNC(=O)c2ccc(C(C)(C)C)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(C(C)(C)C)cc1)CCC2 10.1016/j.bmcl.2015.06.029
3008925 100912 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
CHEMBL293900 100912 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
3008931 202645 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 202645 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
71451541 81778 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 569 10 1 6 4.9 Cc1ccncc1CN(C(=O)CC1CCOCC1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
CHEMBL2164214 81778 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 569 10 1 6 4.9 Cc1ccncc1CN(C(=O)CC1CCOCC1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(Cl)nc2C)CC1 10.1021/ml2002604
168286382 191731 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 570 10 2 8 4.4 CNS(=O)(=O)c1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5197247 191731 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 570 10 2 8 4.4 CNS(=O)(=O)c1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
46225513 201407 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604680 201407 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
52943425 19065 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 812 13 3 6 6.2 C=CCN(C(=O)NCc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288915 19065 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 812 13 3 6 6.2 C=CCN(C(=O)NCc1ccc(C(N)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
49864967 15777 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 620 11 1 8 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222765 15777 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 620 11 1 8 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2010.05.046
118727177 117379 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 494 8 0 4 4.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccccc2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397988 117379 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 494 8 0 4 4.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccccc2)CC1 10.1016/j.bmc.2014.12.052
72711049 92683 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
CHEMBL2435894 92683 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
49798920 14340 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 423 6 1 5 2.4 COCC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(C)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1171103 14340 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 423 6 1 5 2.4 COCC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(C)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1200062 14340 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 423 6 1 5 2.4 COCC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(C)C1=O 10.1016/j.bmc.2010.05.057
57331277 104577 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 584 10 0 4 5.2 CCN(Cc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104678 104577 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 584 10 0 4 5.2 CCN(Cc1ccc(F)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
10204589 13041 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL1189988 13041 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL539854 13041 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
56681915 66415 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813440 66415 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851889 66415 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
72714317 92676 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
CHEMBL2435887 92676 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
122668167 165872 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 523 9 1 6 5.9 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cc2ccc(F)cc2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4249259 165872 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 523 9 1 6 5.9 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cc2ccc(F)cc2)s1 10.1021/acs.jmedchem.8b01077
16659334 14002 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1197042 14002 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL559168 14002 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
21064295 14327 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 574 10 2 5 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170875 14327 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 574 10 2 5 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200016 14327 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 574 10 2 5 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
505870 27625 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL136977 27625 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
505880 27720 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137038 27720 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505879 28645 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137728 28645 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505881 29449 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138437 29449 None 1 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44357063 119142 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL342842 119142 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44357079 119339 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344261 119339 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
118727185 117387 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 604 9 0 4 6.3 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(C(=O)c3ccccc3)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
CHEMBL3397996 117387 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 604 9 0 4 6.3 Cc1ccc(N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)C(=O)C2CCN(C(=O)c3ccccc3)CC2)cc1Cl 10.1016/j.bmc.2014.12.052
10118535 14319 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 8 1 4 4.8 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(CC(C)C)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1170471 14319 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 8 1 4 4.8 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(CC(C)C)C1=O 10.1016/j.bmc.2010.05.057
CHEMBL1199972 14319 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 8 1 4 4.8 CC(C)CC1NC(=O)C2(CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)N(CC(C)C)C1=O 10.1016/j.bmc.2010.05.057
23577409 66416 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813439 66416 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851891 66416 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
23577328 66432 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1813454 66432 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851967 66432 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
46225345 200037 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 549 6 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)CC(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595559 200037 None 0 Human Functional pIC50 = 6.5 6.5 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 549 6 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)CC(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
11192476 69196 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 578 9 1 4 7.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926872 69196 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 578 9 1 4 7.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.09.133
52947090 19059 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 773 11 2 5 7.6 C=CCN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288909 19059 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 773 11 2 5 7.6 C=CCN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3001322 443 None 23 Human Functional pIC50 = 7.5 7.5 -123 5
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
805 443 None 23 Human Functional pIC50 = 7.5 7.5 -123 5
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
CHEMBL1255794 443 None 23 Human Functional pIC50 = 7.5 7.5 -123 5
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
DB06497 443 None 23 Human Functional pIC50 = 7.5 7.5 -123 5
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
11597 673 None 5 Human Functional pIC50 = 7.5 7.5 -11 2
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
23725180 673 None 5 Human Functional pIC50 = 7.5 7.5 -11 2
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
CHEMBL4781426 673 None 5 Human Functional pIC50 = 7.5 7.5 -11 2
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00373
23577388 66376 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 611 10 2 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813434 66376 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 611 10 2 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851692 66376 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 611 10 2 7 4.3 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
52943424 19063 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288913 19063 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 833 12 2 7 6.8 C=CCN(C(=O)Nc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21926130 14382 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 519 8 1 5 4.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c(C)nn(-c3ccccc3)c1C)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200253 14382 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 519 8 1 5 4.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c(C)nn(-c3ccccc3)c1C)CC2 10.1016/j.bmc.2010.05.057
CHEMBL3216711 14382 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 519 8 1 5 4.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1c(C)nn(-c3ccccc3)c1C)CC2 10.1016/j.bmc.2010.05.057
57331276 104582 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 556 9 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104683 104582 None 0 Human Functional pIC50 = 7.5 7.5 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 556 9 1 4 4.5 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(F)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
3008905 198716 None 1 Human Functional pIC50 = 6.5 6.5 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58248 198716 None 1 Human Functional pIC50 = 6.5 6.5 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccc(C#N)cc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
23577362 66374 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813433 66374 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851690 66374 None 0 Human Functional pIC50 = 5.5 5.5 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56678578 66401 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 618 12 3 6 5.0 CCCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813451 66401 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 618 12 3 6 5.0 CCCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851823 66401 None 0 Human Functional pIC50 = 4.5 4.5 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 618 12 3 6 5.0 CCCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
46225429 200083 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595902 200083 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225348 200170 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596519 200170 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 515 6 0 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225347 200042 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595584 200042 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 559 5 0 5 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
44356876 28040 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137272 28040 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44129650 10815 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 10 1 7 4.2 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172040 10815 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 623 10 1 7 4.2 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49798084 10806 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 544 9 2 4 4.4 C=CCN(C(=O)NCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171966 10806 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 544 9 2 4 4.4 C=CCN(C(=O)NCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
56676455 66449 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817916 66449 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852060 66449 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057819 66449 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
56676455 66449 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817916 66449 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852060 66449 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057819 66449 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 456 18 0 0 9.7 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
46225530 199665 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592997 199665 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 550 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225527 199692 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593184 199692 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
49864970 15780 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222768 15780 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 630 9 2 4 5.5 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2010.05.046
11947758 60118 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668021 60118 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739499 60118 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
23577382 66436 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813432 66436 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851977 66436 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
122185619 122911 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 570 6 2 2 4.9 Cc1c(CNC(=O)c2ccc(Br)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Br)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604301 122911 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 570 6 2 2 4.9 Cc1c(CNC(=O)c2ccc(Br)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Br)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606051 122911 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 570 6 2 2 4.9 Cc1c(CNC(=O)c2ccc(Br)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Br)cc1)CCC2 10.1016/j.bmcl.2015.06.029
57392302 69204 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 618 10 1 5 6.8 COc1cccc(CN(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.09.133
CHEMBL1926882 69204 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 618 10 1 5 6.8 COc1cccc(CN(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.09.133
73355553 92790 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 417 6 2 6 3.7 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436816 92790 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 417 6 2 6 3.7 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
56681917 66434 None 0 Human Functional pIC50 = 5.4 5.4 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813450 66434 None 0 Human Functional pIC50 = 5.4 5.4 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851972 66434 None 0 Human Functional pIC50 = 5.4 5.4 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
23577360 66371 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 10 3 6 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(N)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813271 66371 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 10 3 6 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(N)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851675 66371 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 576 10 3 6 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(N)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
162659856 181236 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 914 27 5 11 5.6 CNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4761614 181236 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 914 27 5 11 5.6 CNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
162658125 181094 None 0 Human Functional pIC50 = 5.4 5.4 -100 3
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(Cl)c2)cc1 10.1021/acs.jmedchem.0c01137
CHEMBL4760108 181094 None 0 Human Functional pIC50 = 5.4 5.4 -100 3
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(Cl)c2)cc1 10.1021/acs.jmedchem.0c01137
162666730 182272 None 1 Human Functional pIC50 = 5.4 5.4 -562 3
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 589 9 2 6 6.5 N#CSCCNC(=O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)cc1 10.1021/acs.jmedchem.0c01137
CHEMBL4783861 182272 None 1 Human Functional pIC50 = 5.4 5.4 -562 3
Antagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting methodAntagonist activity at human CCR5 expressed in human U2OS cell membranes as inhibition of [35S]GTPgammaS binding pre-incubated for 30 mins before CCL3 stimulation and followed by further incubation for 90 mins by scintillation counting method
ChEMBL 589 9 2 6 6.5 N#CSCCNC(=O)c1ccc(Oc2ccc(Cl)cc2NS(=O)(=O)c2ccc(Cl)c(C(F)(F)F)c2)cc1 10.1021/acs.jmedchem.0c01137
145984591 165919 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 587 8 1 6 7.0 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C(C)C)nnc2C(F)(F)F)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4250366 165919 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 587 8 1 6 7.0 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C(C)C)nnc2C(F)(F)F)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
49798158 10883 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 10 1 6 3.6 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172623 10883 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 607 10 1 6 3.6 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
11585625 77082 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207447 77082 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
72712598 92637 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435848 92637 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
50992246 58469 None 2 Human Functional pIC50 = 8.4 8.4 -1 5
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683074 58469 None 2 Human Functional pIC50 = 8.4 8.4 -1 5
Antagonist activity at human CCR5 receptor by chemotaxis assayAntagonist activity at human CCR5 receptor by chemotaxis assay
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
168276745 190596 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 503 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
CHEMBL5180628 190596 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 503 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
72714076 92672 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435883 92672 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
52943390 19055 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 795 12 1 7 7.4 C=CCN(C(=O)OCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288877 19055 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 795 12 1 7 7.4 C=CCN(C(=O)OCc1ccc(C#N)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
52943389 19054 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288876 19054 None 0 Human Functional pIC50 = 8.4 8.4 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 848 13 1 8 7.0 C=CCN(C(=O)OCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
145986145 165487 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 573 8 1 6 6.7 CC(C)c1nnc(C(F)(F)F)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4240242 165487 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 573 8 1 6 6.7 CC(C)c1nnc(C(F)(F)F)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
72711277 92686 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435897 92686 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44511861 69217 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926895 69217 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 549 10 1 6 5.7 COc1ccc(N(Cc2cnccc2C)C2CCN([C@@H](C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
52944586 19051 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288873 19051 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 12 1 6 8.6 C=CCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21064299 14328 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 610 11 2 6 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170876 14328 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 610 11 2 6 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200017 14328 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 610 11 2 6 5.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(NS(C)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
168275071 190448 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 534 9 2 7 5.5 CC(=O)Nc1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
CHEMBL5178495 190448 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 534 9 2 7 5.5 CC(=O)Nc1cccc(C(=O)N[C@@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2cccs2)c1 10.1021/acs.jmedchem.2c01383
70685193 73122 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 410 6 0 4 5.6 Cc1nc2cnccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.8b00180
CHEMBL2011438 73122 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 410 6 0 4 5.6 Cc1nc2cnccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.8b00180
9956238 60196 None 1 Human Functional pIC50 = 6.4 6.4 -3 4
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 467 8 2 8 3.0 Cc1nn(C)c2nc(N(C)CCN(C)C)c(C(=O)NC(=O)Nc3cccc(OC(C)C)c3)cc12 10.1021/jm1012903
CHEMBL1688889 60196 None 1 Human Functional pIC50 = 6.4 6.4 -3 4
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 467 8 2 8 3.0 Cc1nn(C)c2nc(N(C)CCN(C)C)c(C(=O)NC(=O)Nc3cccc(OC(C)C)c3)cc12 10.1021/jm1012903
CHEMBL1739922 60196 None 1 Human Functional pIC50 = 6.4 6.4 -3 4
Antagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assayAntagonist activity at CCR5 in human PBMC cells assessed as inhibition of CCL4-induced chemotaxis after 2 hrs trans-well migration assay
ChEMBL 467 8 2 8 3.0 Cc1nn(C)c2nc(N(C)CCN(C)C)c(C(=O)NC(=O)Nc3cccc(OC(C)C)c3)cc12 10.1021/jm1012903
10208679 12840 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188565 12840 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536751 12840 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
3008921 168230 None 1 Human Functional pIC50 = 6.4 6.4 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
CHEMBL433635 168230 None 1 Human Functional pIC50 = 6.4 6.4 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
52940989 19053 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 828 13 1 8 7.3 C=CCN(C(=O)OCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288875 19053 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 828 13 1 8 7.3 C=CCN(C(=O)OCc1ccc(C(=O)OC)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008933 201629 None 1 Human Functional pIC50 = 7.4 7.4 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 531 6 0 4 6.5 Cc1cc(C)c(S(=O)(=O)N2CCC(C)(N3CCC(N(c4ccccc4)c4ccccc4)CC3)CC2)c(C)c1 10.1021/jm031046g
CHEMBL60589 201629 None 1 Human Functional pIC50 = 7.4 7.4 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 531 6 0 4 6.5 Cc1cc(C)c(S(=O)(=O)N2CCC(C)(N3CCC(N(c4ccccc4)c4ccccc4)CC3)CC2)c(C)c1 10.1021/jm031046g
90656335 111069 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 475 8 2 7 3.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(C(=O)O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263031 111069 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 475 8 2 7 3.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(C(=O)O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
52944587 19058 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288880 19058 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
49799711 14405 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173712 14405 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200303 14405 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 533 9 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226128 14112 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198003 14112 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL592944 14112 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 547 10 2 5 5.7 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(O)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
3008922 198706 None 1 Human Functional pIC50 = 7.4 7.4 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 513 7 0 5 6.0 COc1cccc(OC)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58176 198706 None 1 Human Functional pIC50 = 7.4 7.4 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 513 7 0 5 6.0 COc1cccc(OC)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
52942223 19072 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 14 1 6 7.1 C=CCN(C(=O)CCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288922 19072 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 810 14 1 6 7.1 C=CCN(C(=O)CCc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
3008912 201070 None 1 Human Functional pIC50 = 7.4 7.4 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
CHEMBL60279 201070 None 1 Human Functional pIC50 = 7.4 7.4 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
72712371 92660 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435871 92660 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
10278617 95180 None 3 Human Functional pIC50 = 7.4 7.4 1 2
Antagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 95180 None 3 Human Functional pIC50 = 7.4 7.4 1 2
Antagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
72712372 92661 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
CHEMBL2435872 92661 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
73355554 92797 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 431 7 2 6 4.1 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436824 92797 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 431 7 2 6 4.1 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
53324598 60110 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668020 60110 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739382 60110 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
5275761 77116 None 1 Human Functional pIC50 = 7.4 7.4 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207633 77116 None 1 Human Functional pIC50 = 7.4 7.4 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
53324598 60110 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1668020 60110 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1739382 60110 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
6320546 60121 None 1 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668022 60121 None 1 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739500 60121 None 1 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
168295761 192459 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 497 9 1 10 3.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cn2cnnn2)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5208613 192459 None 0 Human Functional pIC50 = 7.4 7.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 497 9 1 10 3.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)Cn2cnnn2)s1 10.1021/acs.jmedchem.2c01383
21064338 14398 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 506 8 1 5 5.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1nc(-c3ccccc3)oc1C)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173645 14398 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 506 8 1 5 5.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1nc(-c3ccccc3)oc1C)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200293 14398 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 506 8 1 5 5.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1nc(-c3ccccc3)oc1C)CC2 10.1016/j.bmc.2010.05.057
44356952 119274 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343745 119274 None 0 Human Functional pIC50 = 6.4 6.4 - 1
Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5Inhibition over 48 hr of BAL strain HIV infrction of HeLa Magi cells expressing CCR5
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
73349498 92765 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 1 5 6.0 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436712 92765 None 0 Human Functional pIC50 = 4.4 4.4 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 1 5 6.0 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
3008919 100763 None 1 Human Functional pIC50 = 6.3 6.3 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
CHEMBL292894 100763 None 1 Human Functional pIC50 = 6.3 6.3 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
46225514 199823 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL594208 199823 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 537 7 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(S(=O)(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
90656337 111070 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 8 1 8 3.2 CC(C)Oc1ccc(N2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263033 111070 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 509 8 1 8 3.2 CC(C)Oc1ccc(N2CCN(Cc3ccc(S(C)(=O)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
90656338 111071 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 445 7 1 6 4.1 Cc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263034 111071 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 445 7 1 6 4.1 Cc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
52944086 19060 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 787 12 2 5 7.3 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288910 19060 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 787 12 2 5 7.3 C=CCN(C(=O)NCc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225349 200048 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595610 200048 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3001322 443 None 23 Human Functional pIC50 = 7.3 7.3 -123 5
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 443 None 23 Human Functional pIC50 = 7.3 7.3 -123 5
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 443 None 23 Human Functional pIC50 = 7.3 7.3 -123 5
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 443 None 23 Human Functional pIC50 = 7.3 7.3 -123 5
Antagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity at human CCR5 assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
3008910 199630 None 1 Human Functional pIC50 = 6.3 6.3 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 1 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL59285 199630 None 1 Human Functional pIC50 = 6.3 6.3 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 481 5 1 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm031046g
53389083 66444 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817912 66444 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852020 66444 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057816 66444 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2012.05.127
53389083 66444 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817912 66444 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852020 66444 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057816 66444 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 438 16 0 0 9.5 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCC2 10.1016/j.bmcl.2011.07.058
56661530 66435 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 616 8 3 6 4.0 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CC(F)(F)F)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1813457 66435 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 616 8 3 6 4.0 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CC(F)(F)F)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851975 66435 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 616 8 3 6 4.0 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CC(F)(F)F)cc2)cc1 10.1016/j.bmc.2011.05.022
122185621 122912 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 482 6 2 2 4.7 Cc1c(CNC(=O)c2ccc(Cl)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Cl)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604302 122912 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 482 6 2 2 4.7 Cc1c(CNC(=O)c2ccc(Cl)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Cl)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606052 122912 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 482 6 2 2 4.7 Cc1c(CNC(=O)c2ccc(Cl)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(Cl)cc1)CCC2 10.1016/j.bmcl.2015.06.029
11947758 60118 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668021 60118 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739499 60118 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
73346462 92798 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 2 6 4.5 CCOc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436825 92798 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 8 2 6 4.5 CCOc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
57331308 104579 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 591 10 0 5 5.0 CCN(Cc1ccc(C#N)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104680 104579 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 591 10 0 5 5.0 CCN(Cc1ccc(C#N)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
3008926 201844 None 1 Human Functional pIC50 = 7.3 7.3 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
CHEMBL60711 201844 None 1 Human Functional pIC50 = 7.3 7.3 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c[nH]c3ccccc23)CC1 10.1021/jm031046g
3008937 200098 None 1 Human Functional pIC50 = 7.3 7.3 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59602 200098 None 1 Human Functional pIC50 = 7.3 7.3 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
15942352 81768 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 505 8 1 5 4.6 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)N(C)C)CC1 10.1021/ml2002604
CHEMBL2164204 81768 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in P4R5 cells co-expressing CD4, and LTR-beta-gal construct assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat cells expressing HIV-1 JRFLenv and HIV-1 Tat by beta-galactosidase activity based cell-cell fusion assay
ChEMBL 505 8 1 5 4.6 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N(Cc2ccsc2)C(=O)N(C)C)CC1 10.1021/ml2002604
86294766 110679 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 502 10 1 7 4.7 CCN(CC)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3259855 110679 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 502 10 1 7 4.7 CCN(CC)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
23577362 66374 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813433 66374 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851690 66374 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 612 10 3 7 3.5 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(S(N)(=O)=O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
10230510 66414 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 537 10 3 6 3.7 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813436 66414 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 537 10 3 6 3.7 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851888 66414 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 537 10 3 6 3.7 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56659272 66469 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817915 66469 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852160 66469 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057817 66469 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
56659272 66469 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817915 66469 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852160 66469 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057817 66469 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
54581479 60884 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1762313 60884 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
118727188 117390 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397999 117390 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)C[C@H]2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
44194675 10828 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 651 11 2 6 3.6 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172053 10828 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 651 11 2 6 3.6 C=CCN(C(=O)NCc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
50992574 57199 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 435 6 1 5 3.6 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C)CC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649916 57199 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 435 6 1 5 3.6 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CN(C)CC3)C2)c1ccccc1 10.1021/jm100978n
46225528 199664 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL592993 199664 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 619 6 0 5 5.1 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCC(F)(F)CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
72714321 92680 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
CHEMBL2435891 92680 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
3008902 202678 None 1 Human Functional pIC50 = 8.3 8.3 -1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61536 202678 None 1 Human Functional pIC50 = 8.3 8.3 -1 2
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
145985889 165391 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 498 8 1 7 3.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(=O)N(C)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4238007 165391 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 498 8 1 7 3.7 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(=O)N(C)C1)c1cccs1 10.1021/acs.jmedchem.8b01077
59458213 92693 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435904 92693 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
49798131 10867 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 574 10 1 6 4.2 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172439 10867 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 574 10 1 6 4.2 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3013575 75768 None 1 Human Functional pIC50 = 8.3 8.3 - 1
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL204821 75768 None 1 Human Functional pIC50 = 8.3 8.3 - 1
Inhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cellsInhibition of replication of R5 HIV1 Ba-L in MOLT4/CCR5 cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
168273684 190388 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
CHEMBL5177519 190388 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 553 8 1 6 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1Cl 10.1021/acs.jmedchem.2c01383
145984717 165532 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 511 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C(C)(C)C(F)(F)F)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4241284 165532 None 0 Human Functional pIC50 = 8.3 8.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 511 8 1 6 5.8 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C(C)(C)C(F)(F)F)c1cccs1 10.1021/acs.jmedchem.8b01077
3001322 443 None 23 Human Functional pIC50 = 8.3 8.3 -123 5
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
805 443 None 23 Human Functional pIC50 = 8.3 8.3 -123 5
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
CHEMBL1255794 443 None 23 Human Functional pIC50 = 8.3 8.3 -123 5
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
DB06497 443 None 23 Human Functional pIC50 = 8.3 8.3 -123 5
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmcl.2010.12.109
51039119 176215 None 33 Human Functional pIC50 = 8.2 8.2 1 3
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
CHEMBL4594419 176215 None 33 Human Functional pIC50 = 8.2 8.2 1 3
Antagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulationAntagonist activity at CCR5 in human whole blood assessed as inhibition of MIP-1beta-induced CD11b upregulation
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
25024699 92636 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435847 92636 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
72711047 92681 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435892 92681 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
3001322 443 None 23 Human Functional pIC50 = 8.2 8.2 -123 5
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 443 None 23 Human Functional pIC50 = 8.2 8.2 -123 5
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 443 None 23 Human Functional pIC50 = 8.2 8.2 -123 5
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 443 None 23 Human Functional pIC50 = 8.2 8.2 -123 5
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxisAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced chemotaxis
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
5275762 77091 None 1 Human Functional pIC50 = 8.2 8.2 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207485 77091 None 1 Human Functional pIC50 = 8.2 8.2 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
57402798 69197 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 5 6.1 COc1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926873 69197 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 540 10 1 5 6.1 COc1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
10208080 13061 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
CHEMBL1190106 13061 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
CHEMBL540108 13061 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
10228759 14345 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 9 1 4 4.7 CCCCN1C(=O)C(CCC)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1171291 14345 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 9 1 4 4.7 CCCCN1C(=O)C(CCC)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200080 14345 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 9 1 4 4.7 CCCCN1C(=O)C(CCC)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
3500 1525 None 13 Human Functional pIC50 = 7.3 7.3 245 2
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1016/j.bmcl.2009.11.018
491774 1525 None 13 Human Functional pIC50 = 7.3 7.3 245 2
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1016/j.bmcl.2009.11.018
CHEMBL1196395 1525 None 13 Human Functional pIC50 = 7.3 7.3 245 2
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1016/j.bmcl.2009.11.018
10228761 13927 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1196469 13927 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL557150 13927 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
10228761 13927 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196469 13927 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL557150 13927 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56664935 66389 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 7 3 6 3.4 CN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813444 66389 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 7 3 6 3.4 CN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851773 66389 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 7 3 6 3.4 CN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
6320546 60121 None 1 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1668022 60121 None 1 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1739500 60121 None 1 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
122668161 165603 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)c2ccccc2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4242946 165603 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 491 8 1 6 5.8 Cc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)c2ccccc2)s1 10.1021/acs.jmedchem.8b01077
90656341 111127 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 477 8 1 7 4.6 CSc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263320 111127 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 477 8 1 7 4.6 CSc1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
6320546 60121 None 1 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1668022 60121 None 1 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1739500 60121 None 1 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H]([C@@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3008919 100763 None 1 Human Functional pIC50 = 6.3 6.3 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
CHEMBL292894 100763 None 1 Human Functional pIC50 = 6.3 6.3 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 453 5 0 3 6.0 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm031046g
73351060 92795 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 10 1 6 5.4 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436822 92795 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 10 1 6 5.4 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
52941008 19068 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 772 12 1 5 7.1 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288918 19068 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 772 12 1 5 7.1 C=CCN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21926948 14321 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 503 9 1 4 5.5 CCCCN1C(=O)C(CC2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170694 14321 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 503 9 1 4 5.5 CCCCN1C(=O)C(CC2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1199991 14321 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 503 9 1 4 5.5 CCCCN1C(=O)C(CC2CCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56681915 66415 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813440 66415 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851889 66415 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 591 10 3 6 5.0 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
57331305 104592 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 5.1 CCN(Cc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104695 104592 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 566 10 0 4 5.1 CCN(Cc1ccccc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
52941648 19067 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288917 19067 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 822 12 1 5 8.0 C=CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
16728787 12841 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188566 12841 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536754 12841 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16728787 12841 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188566 12841 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL536754 12841 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
46225531 200171 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596523 200171 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21927225 14339 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 473 7 1 4 4.2 CC#CCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1171096 14339 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 473 7 1 4 4.2 CC#CCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200061 14339 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 473 7 1 4 4.2 CC#CCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
6479877 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1186558 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057533 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL469649 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
6479877 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1186558 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057533 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL469649 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
162660784 181266 None 0 Human Functional pIC50 = 6.3 6.3 -25 2
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1225 30 7 15 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4761986 181266 None 0 Human Functional pIC50 = 6.3 6.3 -25 2
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 1225 30 7 15 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
6479877 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1186558 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057533 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL469649 12511 None 3 Human Functional pIC50 = 5.3 5.3 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
46225395 201291 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604070 201291 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL5078769 214582 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assayAntagonist activity at human CCR5 receptor expressed in HEK293 cells co-expressing Galpha15 assessed as inhibition of RNATES-induced intracellular calcium flux measured after 10 mins by FLIPR calcium mobilization assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(C)=O)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCNC(=O)CCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(C(C)=O)CC3)c3ccc(C)c(Cl)c3)CC2)cc1)C(N)=O 10.1021/acs.jmedchem.1c00781
9978318 122351 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL359986 122351 None 0 Human Functional pIC50 = 5.3 5.3 - 1
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
46225395 201291 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604070 201291 None 0 Human Functional pIC50 = 6.3 6.3 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 503 6 0 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
46225513 201407 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL604680 201407 None 0 Human Functional pIC50 = 7.3 7.3 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 505 7 1 6 2.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C(C)(C)CO)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3001322 443 None 23 Human Functional pIC50 = 5.3 5.3 -123 5
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 443 None 23 Human Functional pIC50 = 5.3 5.3 -123 5
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 443 None 23 Human Functional pIC50 = 5.3 5.3 -123 5
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 443 None 23 Human Functional pIC50 = 5.3 5.3 -123 5
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
73349506 92788 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 9 1 6 5.0 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436814 92788 None 0 Human Functional pIC50 = 4.3 4.3 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 473 9 1 6 5.0 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
49799707 14325 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 544 9 2 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)Nc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170873 14325 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 544 9 2 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)Nc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200014 14325 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 544 9 2 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)Nc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL5074744 214327 None 0 Human Functional pIC50 = 7.2 7.2 -1 3
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
21925890 14374 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 508 8 1 5 5.2 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1csc(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1172870 14374 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 508 8 1 5 5.2 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1csc(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200223 14374 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 508 8 1 5 5.2 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1csc(-c3ccccc3)n1)CC2 10.1016/j.bmc.2010.05.057
3008921 168230 None 1 Human Functional pIC50 = 6.2 6.2 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
CHEMBL433635 168230 None 1 Human Functional pIC50 = 6.2 6.2 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 459 5 0 3 6.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)C2CCCCC2)CC1 10.1021/jm031046g
46225344 200067 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595760 200067 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 535 5 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4cccc(F)c4)CCN(C(=O)C(C)(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21927257 14320 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 569 11 1 6 5.1 CCCCN1C(=O)C(CC(=O)OCc2ccccc2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1170660 14320 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 569 11 1 6 5.1 CCCCN1C(=O)C(CC(=O)OCc2ccccc2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1199989 14320 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 569 11 1 6 5.1 CCCCN1C(=O)C(CC(=O)OCc2ccccc2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
73352534 92791 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 7 2 6 4.1 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436817 92791 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 459 7 2 6 4.1 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
56657984 66386 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 548 7 3 6 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4C)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1813445 66386 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 548 7 3 6 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4C)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851766 66386 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 548 7 3 6 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4C)cc2)cc1 10.1016/j.bmc.2011.05.022
72714320 92679 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435890 92679 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
49798080 10814 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 629 10 1 6 5.7 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172039 10814 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 629 10 1 6 5.7 C=CCN(C(=O)OCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
49798088 10824 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 628 10 2 5 5.3 C=CCN(C(=O)NCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172049 10824 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 628 10 2 5 5.3 C=CCN(C(=O)NCc1ccc(OC(F)(F)F)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
3008914 201007 None 1 Human Functional pIC50 = 8.2 8.2 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
CHEMBL60225 201007 None 1 Human Functional pIC50 = 8.2 8.2 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 573 6 0 3 7.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm031046g
16728325 10812 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 575 10 1 6 4.8 C=CCN(C(=O)OCc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1172036 10812 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 575 10 1 6 4.8 C=CCN(C(=O)OCc1ccc(OC)cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
59458159 92697 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435908 92697 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
56647076 92670 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435881 92670 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
11692945 76531 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL206088 76531 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
118727174 117376 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397985 117376 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(F)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
49864974 15784 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
CHEMBL1222772 15784 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 656 9 2 4 6.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2C[C@H]1CN(C(=O)C2CCCC2)C[C@]1(O)c1cccc(F)c1 10.1016/j.bmcl.2010.05.046
126567286 165375 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1csc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1021/acs.jmedchem.8b01077
CHEMBL4237581 165375 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1csc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)c1 10.1021/acs.jmedchem.8b01077
145986277 165897 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 549 9 1 7 6.0 COc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
CHEMBL4249941 165897 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 549 9 1 7 6.0 COc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)s1 10.1021/acs.jmedchem.8b01077
56647023 92669 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435880 92669 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
52944587 19058 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288880 19058 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 837 12 2 5 8.1 C=CCN(C(=O)NCc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
52944617 19066 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 813 12 2 7 7.4 C=CCN(C(=O)Nc1ccc(OC(C)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288916 19066 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 813 12 2 7 7.4 C=CCN(C(=O)Nc1ccc(OC(C)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225531 200171 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596523 200171 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 522 6 0 4 3.9 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
44395386 127536 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL366260 127536 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
3008934 198691 None 1 Human Functional pIC50 = 7.2 7.2 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58101 198691 None 1 Human Functional pIC50 = 7.2 7.2 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
73352529 92768 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 501 10 1 6 5.7 CCN(CC)c1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436715 92768 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 501 10 1 6 5.7 CCN(CC)c1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
73346461 92796 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 461 8 1 7 4.4 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436823 92796 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 461 8 1 7 4.4 CCOc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
3008937 200098 None 1 Human Functional pIC50 = 7.2 7.2 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59602 200098 None 1 Human Functional pIC50 = 7.2 7.2 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
90666577 109396 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
CHEMBL3219779 109396 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
101577042 183140 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4795179 183140 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
112500047 124468 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
CHEMBL3639964 124468 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.Flux Assay: Then the Ca2+ functional activity of bivalent ligand 1 was evaluated in the Gqi5 transfected CCR5-MOLT-4 cells as described in the literature.3 As expected, no CCR5 agonism was detected for the bivalent ligand 1 (data not shown). In the RANTES induced Ca2+ flux inhibition assay (Table 3), the bivalent ligand 1 was approximately 60-fold less potent than maraviroc. A more significant potency decrease (nearly 300 times) was observed for the monovalent ligand 3, compared to maraviroc. In order to figure out the possible reasons for such a dramatic drop of their potency, two analogues (4 and 5, FIG. 14) of mavaviroc carrying gradient steric hindrance characters at the same substitution position were evaluated under the same condition. Compound 4 showed a modest reduction of the potency (Table 2). However, the inhibition potency of the N-t-Boc protected analogue 5 dropped to micromolar (IC50=1.57+/-0.18 uM). It thus appeared that steric hindrance may play an essential role.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
118727192 117394 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 430 7 1 4 4.5 N#Cc1ccc(N2CCN(CCC(NC(=O)C3CCCCC3)c3ccccc3)CC2)cc1 10.1016/j.bmc.2014.12.052
CHEMBL3398003 117394 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 430 7 1 4 4.5 N#Cc1ccc(N2CCN(CCC(NC(=O)C3CCCCC3)c3ccccc3)CC2)cc1 10.1016/j.bmc.2014.12.052
90656330 111066 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 465 7 1 6 4.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(Cl)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263026 111066 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 465 7 1 6 4.5 CC(C)Oc1ccc(N2CCN(Cc3ccc(Cl)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
49798349 10789 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccccc1Oc1ccc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
CHEMBL1171786 10789 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at CCR5Antagonist activity at CCR5
ChEMBL 471 6 2 4 5.9 O=C(O)c1ccccc1Oc1ccc(Cl)cc1NS(=O)(=O)c1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2010.04.142
73347961 92794 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436820 92794 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
73347961 92794 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.bmcl.2014.03.073
CHEMBL2436820 92794 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 429 7 2 4 5.3 CCOc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.bmcl.2014.03.073
10416 1877 None 30 Human Functional pIC50 = 5.2 5.2 -309 2
Antagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assayAntagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assay
ChEMBL 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 10.1021/jm301572h
46861584 1877 None 30 Human Functional pIC50 = 5.2 5.2 -309 2
Antagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assayAntagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assay
ChEMBL 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 10.1021/jm301572h
CHEMBL2018969 1877 None 30 Human Functional pIC50 = 5.2 5.2 -309 2
Antagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assayAntagonist activity at CCR5 receptor (unknown origin) by [35S]GTPgammaS binding assay
ChEMBL 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 10.1021/jm301572h
52947064 19057 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 823 11 2 5 8.5 C=CCN(C(=O)Nc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288879 19057 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 823 11 2 5 8.5 C=CCN(C(=O)Nc1ccc(C(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
10278617 95180 None 3 Crab-eating macaque Functional pIC50 = 7.2 7.2 -1 2
Antagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 95180 None 3 Crab-eating macaque Functional pIC50 = 7.2 7.2 -1 2
Antagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilizationAntagonist activity at cynomolgus monkey CCR5 expressed in CHO cells assessed as MIP-1-alpha-induced Ca2+ mobilization
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
57331304 104580 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 9 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)N(C)Cc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104681 104580 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 9 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)N(C)Cc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
73357100 92792 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 10 1 4 6.6 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436818 92792 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 10 1 4 6.6 CCOc1ccc(C2CCN(Cc3ccc(N(CC)CC)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
90656326 111063 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
CHEMBL3263022 111063 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 476 8 1 8 3.7 CC(C)Oc1ccc(N2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.bmcl.2014.03.073
52949553 19069 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 832 13 1 7 6.4 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288919 19069 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 832 13 1 7 6.4 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
46225394 200108 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596081 200108 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
16658856 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817909 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852220 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057810 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
16658856 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1817909 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852220 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057810 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
16658856 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817909 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852220 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057810 66475 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C/c1c(C)c(/C=C/CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
73349499 92769 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 475 8 1 7 4.8 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436716 92769 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 475 8 1 7 4.8 CC(C)Oc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
46225529 199693 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593195 199693 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 591 6 0 5 4.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
145961982 161530 None 0 Human Functional pIC50 = 6.2 6.2 -10 2
Antagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assayAntagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assay
ChEMBL 553 8 1 6 4.3 CN(C1CCN(CCCN2CCCc3c(ccnc3Nc3ccc(Cl)c(Cl)c3)C2=O)CC1)S(C)(=O)=O 10.1016/j.bmc.2018.05.027
CHEMBL4128498 161530 None 0 Human Functional pIC50 = 6.2 6.2 -10 2
Antagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assayAntagonist activity at CCR5 (unknown origin) expressed in CHOK1 cells co-expressing Ga16 assessed as inhibition of Rantes-induced intracellular Ca2+ mobilization preincubated for 10 mins followed by Rantes addition by fluo-4 AM dye based assay
ChEMBL 553 8 1 6 4.3 CN(C1CCN(CCCN2CCCc3c(ccnc3Nc3ccc(Cl)c(Cl)c3)C2=O)CC1)S(C)(=O)=O 10.1016/j.bmc.2018.05.027
56661524 66429 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813438 66429 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851951 66429 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 549 10 3 6 3.8 CCCCN1C(=O)[C@@H]([C@H](O)C2CCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
73354018 92766 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 443 7 2 4 5.7 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436713 92766 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 443 7 2 4 5.7 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
46225394 200108 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL596081 200108 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 501 6 0 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
3008918 199382 None 1 Human Functional pIC50 = 7.2 7.2 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59101 199382 None 1 Human Functional pIC50 = 7.2 7.2 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
126567281 165508 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.2c01383
CHEMBL4240742 165508 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 520 8 1 7 5.4 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cscn1 10.1021/acs.jmedchem.2c01383
122185625 122905 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 504 8 2 6 3.2 Cc1c(CNC(=O)c2ccc([N+](=O)[O-])cc2)c(C)[n+]2c(c1CNC(=O)c1ccc([N+](=O)[O-])cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604304 122905 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 504 8 2 6 3.2 Cc1c(CNC(=O)c2ccc([N+](=O)[O-])cc2)c(C)[n+]2c(c1CNC(=O)c1ccc([N+](=O)[O-])cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606026 122905 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 504 8 2 6 3.2 Cc1c(CNC(=O)c2ccc([N+](=O)[O-])cc2)c(C)[n+]2c(c1CNC(=O)c1ccc([N+](=O)[O-])cc1)CCC2 10.1016/j.bmcl.2015.06.029
168284187 190853 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 519 7 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C(F)(F)F)c1csc2ccccc12 10.1021/acs.jmedchem.2c01383
CHEMBL5184527 190853 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 519 7 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C(F)(F)F)c1csc2ccccc12 10.1021/acs.jmedchem.2c01383
23577370 66362 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813270 66362 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851623 66362 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 549 9 3 6 4.6 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56681917 66434 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813450 66434 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851972 66434 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 604 11 3 6 4.6 CCCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
46225429 200083 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595902 200083 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5Antagonist activity at human CCR5
ChEMBL 527 5 0 5 4.2 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C(C)(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
21926618 14338 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 475 8 1 4 4.8 C/C=C/CN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1171095 14338 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 475 8 1 4 4.8 C/C=C/CN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200060 14338 None 0 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 475 8 1 4 4.8 C/C=C/CN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
122185635 122917 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 474 8 2 4 3.4 COc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(OC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3604309 122917 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 474 8 2 4 3.4 COc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(OC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
CHEMBL3606103 122917 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 474 8 2 4 3.4 COc1ccc(C(=O)NCc2c(C)c(CNC(=O)c3ccc(OC)cc3)c3[n+](c2C)CCC3)cc1 10.1016/j.bmcl.2015.06.029
44511966 69211 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cncc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926889 69211 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 515 10 1 6 5.1 COc1ccc(N(Cc2cnccc2C)C2CCN([C@H](C)CCNC(=O)c3c(C)cncc3C)CC2)cc1 10.1016/j.bmcl.2011.09.133
57394058 69227 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 510 9 1 6 5.0 Cc1ccncc1CN(c1ccccc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926905 69227 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 510 9 1 6 5.0 Cc1ccncc1CN(c1ccccc1)C1CCN([C@H](C)CCNC(=O)c2c(C)cc(C#N)nc2C)CC1 10.1016/j.bmcl.2011.09.133
21867666 162057 None 90 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) by HTS assayAntagonist activity at CCR5 (unknown origin) by HTS assay
ChEMBL 112 0 2 2 -0.6 C1NCC2CNCC12 10.1016/j.ejmech.2018.01.085
CHEMBL4160473 162057 None 90 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) by HTS assayAntagonist activity at CCR5 (unknown origin) by HTS assay
ChEMBL 112 0 2 2 -0.6 C1NCC2CNCC12 10.1016/j.ejmech.2018.01.085
76313867 104591 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysisAntagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysis
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104694 104591 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysisAntagonist activity at CCR5 (unknown origin) expressed in CHO cell membranes assessed as inhibition of RANTES-stimulated [35S]-GTPgammaS binding after 1 hr by liquid scintillation counting analysis
ChEMBL 566 10 0 4 4.9 CCN(C(=O)Cc1ccccc1)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
5275760 77062 None 1 Human Functional pIC50 = 8.2 8.2 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207301 77062 None 1 Human Functional pIC50 = 8.2 8.2 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
72711278 92687 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435898 92687 None 0 Human Functional pIC50 = 8.2 8.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
3008935 202727 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61828 202727 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 468 5 0 4 5.6 Cc1ccnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
73346389 92668 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435879 92668 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
72711507 92692 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435903 92692 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
16728787 12841 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188566 12841 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL536754 12841 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
3008918 199382 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59101 199382 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 467 5 0 3 6.3 Cc1ccccc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
183790 3740 None 11 Human Functional pIC50 = 8.1 8.1 -2 5
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
783 3740 None 11 Human Functional pIC50 = 8.1 8.1 -2 5
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
CHEMBL1178786 3740 None 11 Human Functional pIC50 = 8.1 8.1 -2 5
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
3008932 202644 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5Antagonistic activity against human C-C chemokine receptor type 5
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 202644 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5Antagonistic activity against human C-C chemokine receptor type 5
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008932 202644 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61373 202644 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 560 6 0 6 6.5 Cc1nc(-c2ccncc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
3008923 198897 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
CHEMBL58441 198897 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 521 5 0 3 7.3 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1021/jm031046g
3008928 202655 None 1 Human Functional pIC50 = 8.1 8.1 -1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61424 202655 None 1 Human Functional pIC50 = 8.1 8.1 -1 2
Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.Rises in intracellular [Ca2+] levels by using [Ca2+] sensitive Fluo4 dye in C-C chemokine receptor type 5-transfected CHO cells.
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
168296928 192238 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5205216 192238 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 576 9 1 8 4.2 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCN(S(C)(=O)=O)CC2)s1 10.1021/acs.jmedchem.2c01383
72711051 92685 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
CHEMBL2435896 92685 None 0 Human Functional pIC50 = 6.2 6.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
73346454 92775 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 457 7 2 4 5.3 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436722 92775 None 0 Human Functional pIC50 = 4.2 4.2 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 457 7 2 4 5.3 COc1ccc(C2CCN(Cc3ccc(NC(C)=O)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
49799680 14379 None 1 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 502 8 1 4 5.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(-c3cccnc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200241 14379 None 1 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 502 8 1 4 5.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(-c3cccnc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL3217146 14379 None 1 Human Functional pIC50 = 7.2 7.2 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 502 8 1 4 5.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(-c3cccnc3)cc1)CC2 10.1016/j.bmc.2010.05.057
23577378 66430 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813269 66430 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851957 66430 None 0 Human Functional pIC50 = 5.2 5.2 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3013673 76957 None 1 Human Functional pIC50 = 7.1 7.1 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
CHEMBL207085 76957 None 1 Human Functional pIC50 = 7.1 7.1 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
122668217 192264 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 454 8 1 7 4.4 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)CC#N)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5205626 192264 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 454 8 1 7 4.4 Cc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)CC#N)s1 10.1021/acs.jmedchem.2c01383
44395365 124471 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
CHEMBL363999 124471 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Inhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1beta ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 386 7 2 7 1.8 CC(OC(=O)/C=C/c1ccc(O)cc1)C(=O)[C@H]1C[C@@H]1[C@H](O)[C@H]1CC=CC(=O)O1 10.1016/j.bmcl.2004.08.021
73355552 92789 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 447 7 1 7 4.0 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436815 92789 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 447 7 1 7 4.0 COc1ccc(C2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
23577382 66436 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813432 66436 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851977 66436 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 590 10 3 6 4.2 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)NC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
3008916 162359 None 1 Human Functional pIC50 = 7.1 7.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 509 7 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)Cc3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL416512 162359 None 1 Human Functional pIC50 = 7.1 7.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 509 7 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)Cc3ccccc3)CC2)CC1 10.1021/jm031046g
57331339 104584 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 563 9 1 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(C#N)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104685 104584 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 563 9 1 5 4.2 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCc3ccc(C#N)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
57331275 104585 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 10 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104688 104585 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 552 10 1 4 4.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccccc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
10182763 13894 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL1196226 13894 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
CHEMBL556188 13894 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 419 6 1 3 3.6 CC(C)C[C@H]1NC(=O)C2(CCN(Cc3ccccc3)CC2)N(Cc2ccccc2)C1=O 10.1021/jm060051s
73347956 92774 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 415 6 2 4 4.9 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436721 92774 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 415 6 2 4 4.9 COc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1ccccc1 10.1016/j.ejmech.2013.09.004
73355549 92770 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 2 6 4.5 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
CHEMBL2436717 92770 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 445 7 2 6 4.5 CC(C)Oc1ccc(C2CCN(Cc3ccc(N)cc3)CC2)cc1NC(=O)c1cnccn1 10.1016/j.ejmech.2013.09.004
16728787 12841 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1188566 12841 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL536754 12841 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2011.05.022
56669616 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817910 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852129 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057811 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2012.05.127
56669616 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1817910 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852129 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057811 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.ejmech.2012.07.049
56669616 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817910 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852129 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057811 66462 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 428 18 0 0 8.9 CCCCCCCCCCc1c(C)c(CCCCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
16728784 12795 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188107 12795 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL535172 12795 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
21064126 14344 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 1 4 5.4 CCCCN1C(=O)[C@H](CC(C)(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1171290 14344 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 1 4 5.4 CCCCN1C(=O)[C@H](CC(C)(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200079 14344 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 491 8 1 4 5.4 CCCCN1C(=O)[C@H](CC(C)(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
21064297 14403 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 531 9 1 4 6.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173710 14403 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 531 9 1 4 6.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200301 14403 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 531 9 1 4 6.2 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226124 14116 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 545 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198013 14116 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 545 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL593204 14116 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 545 10 1 4 6.3 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(C)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
90666580 109399 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 657 13 3 8 4.7 CNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
CHEMBL3219782 109399 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challengeAntagonist activity at CCR5 in Gqi5 transfected human MOLT4 cells assessed as inhibition of RANTES-stimulated Ca2+ influx preincubated for 15 mins followed by DAMGO challenge
ChEMBL 657 13 3 8 4.7 CNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
57390535 69205 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 613 9 1 5 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
CHEMBL1926883 69205 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 613 9 1 5 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2cccc(C#N)c2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.09.133
3002977 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
803 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
806 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
CHEMBL256907 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
CHEMBL584744 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
DB04835 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.8b01077
3002977 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
803 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
806 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
CHEMBL256907 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
CHEMBL584744 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
DB04835 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.2c01383
145985237 165522 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1cscc1[C@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
CHEMBL4241066 165522 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 533 8 1 6 6.3 Cc1cscc1[C@H](CCN1[C@H]2CC[C@@H]1C[C@@H](n1c(C)nnc1C(C)C)C2)NC(=O)C1CCC(F)(F)CC1 10.1021/acs.jmedchem.8b01077
3008937 200098 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL59602 200098 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 469 5 0 5 5.0 Cc1ncnc(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
5275764 76034 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205706 76034 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
118727171 117373 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 549 8 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397982 117373 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 549 8 0 5 4.7 CC(=O)N1CCC(C(=O)N(CCCN2CCN(Cc3ccc(C#N)cc3)CC2C)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
122668179 192495 None 2 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 601 8 1 6 6.0 Cc1nc2c(n1[C@@H]1C[C@H]3CC[C@@H](C1)N3CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1)CCN(C(=O)C(C)C)C2 10.1021/acs.jmedchem.2c01383
CHEMBL5209067 192495 None 2 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 601 8 1 6 6.0 Cc1nc2c(n1[C@@H]1C[C@H]3CC[C@@H](C1)N3CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccsc1)CCN(C(=O)C(C)C)C2 10.1021/acs.jmedchem.2c01383
3008931 202645 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL61374 202645 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 559 6 0 5 7.1 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
52948264 19050 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288872 19050 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in HOS cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 815 13 1 8 7.5 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
16728324 10805 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 545 9 1 5 4.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
CHEMBL1171965 10805 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assayAntagonist activity at CCR5 expressed in CHO cells assessed as inhibition of RANTES-induced [35S]GTPgamma binding by scintillation proximity assay
ChEMBL 545 9 1 5 4.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.bmcl.2010.05.102
118727186 117388 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 540 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2C[C@@H]3C[C@H]2CN3Cc2ccc(F)cc2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397997 117388 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 540 8 0 4 4.7 CC(=O)N1CCC(C(=O)N(CCCN2C[C@@H]3C[C@H]2CN3Cc2ccc(F)cc2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
49864969 15779 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
CHEMBL1222767 15779 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Inhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS bindingInhibition of human CCR5 expressed in CHO cells assessed as inhibition of RANTES-stimulated [35S]GTPgammaS binding
ChEMBL 608 10 1 7 4.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.05.046
3008924 199701 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
CHEMBL59328 199701 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against monkey C-C chemokine receptor type 5.Antagonistic activity against monkey C-C chemokine receptor type 5.
ChEMBL 503 5 0 3 7.1 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm031046g
3008903 163176 None 1 Human Functional pIC50 = 7.1 7.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3C#N)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL418120 163176 None 1 Human Functional pIC50 = 7.1 7.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3C#N)c3ccccc3)CC2)CC1 10.1021/jm031046g
72712158 92654 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435865 92654 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
122185627 122915 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 450 6 2 2 3.7 Cc1c(CNC(=O)c2ccc(F)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(F)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3604305 122915 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 450 6 2 2 3.7 Cc1c(CNC(=O)c2ccc(F)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(F)cc1)CCC2 10.1016/j.bmcl.2015.06.029
CHEMBL3606099 122915 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hrAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of CCL5-induced calcium mobilization after 1 hr
ChEMBL 450 6 2 2 3.7 Cc1c(CNC(=O)c2ccc(F)cc2)c(C)[n+]2c(c1CNC(=O)c1ccc(F)cc1)CCC2 10.1016/j.bmcl.2015.06.029
49799705 14399 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 529 9 1 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173646 14399 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 529 9 1 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200294 14399 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 529 9 1 4 5.4 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(C(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56661522 66649 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 10 3 6 3.4 CCCCN1C(=O)[C@@H]([C@H](O)C2CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813437 66649 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 10 3 6 3.4 CCCCN1C(=O)[C@@H]([C@H](O)C2CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1852861 66649 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 535 10 3 6 3.4 CCCCN1C(=O)[C@@H]([C@H](O)C2CC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
126567273 165838 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 514 8 1 6 5.3 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccnc1 10.1021/acs.jmedchem.8b01077
CHEMBL4248733 165838 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 514 8 1 6 5.3 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccnc1 10.1021/acs.jmedchem.8b01077
72711279 92688 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
CHEMBL2435899 92688 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
11569805 13923 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196449 13923 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL556995 13923 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16659334 14002 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1197042 14002 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL559168 14002 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
11569805 13923 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196449 13923 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL556995 13923 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
56683103 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1817914 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL1852172 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057815 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2012.05.127
56683103 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1817914 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL1852172 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057815 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.ejmech.2012.07.049
56683103 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1817914 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1852172 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057815 66472 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Antagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometryAntagonist activity at human CCR5 receptor expressed in MOLT4/CCR5 cells assessed as inhibition of CCL5-induced intracellular calcium mobilization by spectrophotometry
ChEMBL 452 16 0 0 9.8 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCCCC2 10.1016/j.bmcl.2011.07.058
72713858 92699 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435910 92699 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
46225349 200048 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL595610 200048 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 539 6 0 5 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CCN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
491775 12875 None 1 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188807 12875 None 1 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL537424 12875 None 1 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
21064329 14337 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 565 9 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(S(=O)(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1171069 14337 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 565 9 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(S(=O)(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200059 14337 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 565 9 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(S(=O)(=O)c3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226122 14111 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 579 10 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(S(=O)(=O)c3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198002 14111 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 579 10 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(S(=O)(=O)c3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL592918 14111 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 579 10 1 5 5.0 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(S(=O)(=O)c3ccccc3)c1)CC2 10.1016/j.bmcl.2009.11.018
76310164 104587 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 586 10 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104690 104587 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 586 10 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(C(=O)NCCc3ccc(Cl)cc3)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
52945865 19070 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
CHEMBL1288920 19070 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infectionAntagonist activity at CCR5 in human peripheral blood lymphocytes cells assessed as inhibition of HIV-1 Ba-L infection
ChEMBL 838 13 1 6 7.9 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC2(c3cccc(F)c3)CCN(C(=O)c3cc(S(=O)(=O)NC(C)(C)C)c(F)cc3Cl)CC2)CC1 10.1016/j.bmcl.2010.10.033
21064283 14330 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1170878 14330 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1200019 14330 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assayAntagonist activity at human CCR5 expressed in HOS cells assessed as inhibition of cell fusion with HIV gp120 expressing HEK293 cells by LTR luciferase assay
ChEMBL 561 10 2 5 5.6 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
145984103 165869 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 541 7 1 7 4.3 CC(=O)N1CCN(C(=O)N[C@@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)c2ccc(C)s2)CC1 10.1021/acs.jmedchem.8b01077
CHEMBL4249241 165869 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 541 7 1 7 4.3 CC(=O)N1CCN(C(=O)N[C@@H](CCN2[C@H]3CC[C@@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)c2ccc(C)s2)CC1 10.1021/acs.jmedchem.8b01077
9978318 122351 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Inhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL359986 122351 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Inhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of 50% of RANTES co-receptor of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C/C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
44395386 127536 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
CHEMBL366260 127536 None 0 Human Functional pIC50 = 5.1 5.1 - 1
Inhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assayInhibition of MIP-1alpha ligand of chemokine receptor 5 induced calcium signal in U-87-CCR5 cells by calcium mobilization assay
ChEMBL 400 8 1 7 2.1 COc1ccc(/C=C\C(=O)OC(C)C(=O)[C@H]2C[C@@H]2[C@H](O)[C@H]2CC=CC(=O)O2)cc1 10.1016/j.bmcl.2004.08.021
73349500 92771 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 8 2 6 4.9 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436718 92771 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 487 8 2 6 4.9 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
50993436 57198 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 421 6 2 5 3.3 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CNCC3)C2)c1ccccc1 10.1021/jm100978n
CHEMBL1649915 57198 None 0 Human Functional pIC50 = 8.1 8.1 - 1
Antagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assayAntagonist activity at CCR5 receptor expressed in HeLa-P4 cells co-expressing CD4 assessed as inhibition of infusion to HIV gp120 expressed in CHO-tat10 cells after 20 hrs by cell-cell fusion assay
ChEMBL 421 6 2 5 3.3 CC(=O)N[C@@H](CCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nc3c1CNCC3)C2)c1ccccc1 10.1021/jm100978n
3008936 198694 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
CHEMBL58109 198694 None 1 Human Functional pIC50 = 8.1 8.1 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 484 5 0 4 4.8 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1021/jm031046g
126567306 165675 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
CHEMBL4244935 165675 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 519 8 1 6 6.0 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccs1 10.1021/acs.jmedchem.8b01077
122668196 191959 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 501 8 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(F)s1 10.1021/acs.jmedchem.2c01383
CHEMBL5200961 191959 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as intracellular calcium change incubated for 15 mins by Fluo-4 AM calcium flux assay
ChEMBL 501 8 1 6 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCCCC1)c1ccc(F)s1 10.1021/acs.jmedchem.2c01383
145985894 165405 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 569 8 1 6 7.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1csc2ccccc12 10.1021/acs.jmedchem.8b01077
CHEMBL4238266 165405 None 0 Human Functional pIC50 = 8.0 8.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assayAntagonist activity at CCR5 (unknown origin) expressed in HEK293 cells co-expressing Galpha16 assessed as inhibition of RANTES-induced calcium flux preincubated for 10 mins followed by RANTES addition by fluo-4AM-based fluorescence assay
ChEMBL 569 8 1 6 7.2 Cc1nnc(C(C)C)n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1csc2ccccc12 10.1021/acs.jmedchem.8b01077
5275763 96789 None 1 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL264832 96789 None 1 Human Functional pIC50 = 8.0 8.0 - 1
Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5Inhibition of membrane fusion between HIV1 JR-FL Env-expressing COS7 cells and MOLT4/CCR5
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
3008925 100912 None 1 Human Functional pIC50 = 8 8.0 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
CHEMBL293900 100912 None 1 Human Functional pIC50 = 8 8.0 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 492 5 1 3 6.5 CC1(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CCN(C(=O)c2cccc3[nH]ccc23)CC1 10.1021/jm031046g
57401041 69200 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 568 10 1 6 5.9 COC(=O)c1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
CHEMBL1926876 69200 None 0 Human Functional pIC50 = 7.1 7.1 - 1
Antagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assayAntagonist activity against human CCR5 assessed as inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envolop protein after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 568 10 1 6 5.9 COC(=O)c1ccc(N(Cc2ccccc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)cc1 10.1016/j.bmcl.2011.09.133
10159218 13933 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1196504 13933 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
CHEMBL557199 13933 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilizationAntagonist activity against human recombinant CCR5 expressed in CHO cells assessed as inhibition of human MIP-1-alpha-stimulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
10159218 13933 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1196504 13933 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL557199 13933 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmc.2010.05.057
10159218 13933 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1196504 13933 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL557199 13933 None 0 Human Functional pIC50 = 6.1 6.1 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1016/j.bmcl.2009.11.018
73351055 92772 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 471 9 1 4 6.2 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436719 92772 None 0 Human Functional pIC50 = 4.1 4.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 471 9 1 4 6.2 CCN(CC)c1ccc(CN2CCC(c3ccc(OC)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
118727187 117389 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCCN(Cc3ccc(F)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
CHEMBL3397998 117389 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilizationAntagonist activity against CCR5 (unknown origin) expressed in CHO cells co-expressing Galpha16 incubated for 10 mins assessed as inhibition of RANTES-induced calcium mobilization
ChEMBL 542 8 0 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCCN(Cc3ccc(F)cc3)CC2)c2ccc(C)c(Cl)c2)CC1 10.1016/j.bmc.2014.12.052
72712374 92663 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
CHEMBL2435874 92663 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
72714318 92677 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
CHEMBL2435888 92677 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in HEK293F cell membranes assessed as inhibition of RANTES-induced calcium flux preincubated for 15 mins by spectrophotometric analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
3008912 201070 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
CHEMBL60279 201070 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonistic activity against human C-C chemokine receptor type 5.Antagonistic activity against human C-C chemokine receptor type 5.
ChEMBL 458 4 1 4 5.4 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc4ccn(C)c4c3)CC2)CC1 10.1021/jm031046g
23577378 66430 None 0 Human Functional pIC50 = 4.0 4.0 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1813269 66430 None 0 Human Functional pIC50 = 4.0 4.0 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
CHEMBL1851957 66430 None 0 Human Functional pIC50 = 4.0 4.0 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization
ChEMBL 563 10 2 6 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(OC)cc3)cc1)CC2 10.1016/j.bmc.2011.05.022
21064289 14400 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 535 9 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(F)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1173647 14400 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 535 9 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(F)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1200295 14400 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 535 9 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(F)cc3)cc1)CC2 10.1016/j.bmc.2010.05.057
46226130 14113 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 549 10 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(F)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1198009 14113 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 549 10 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(F)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL593111 14113 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 549 10 1 4 6.1 CCCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCc1cccc(Oc3ccc(F)cc3)c1)CC2 10.1016/j.bmcl.2009.11.018
46225527 199692 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593184 199692 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 571 6 0 6 3.3 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CCOC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
62707282 77174 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057534 77174 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2078850 77174 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
54752875 77188 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2057813 77188 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
CHEMBL2079028 77188 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM stainingAntagonist activity at CCR5 receptor expressed in human MOLT4 cells assessed as inhibition of CCl5-induced calcium mobilization after 1 hr by Fluor-4-AM staining
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.bmcl.2012.05.127
62707282 77174 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057534 77174 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2078850 77174 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C\c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
54752875 77188 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2057813 77188 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079028 77188 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C/CCCCCCCC)c(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
70692903 77205 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2064265 77205 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
CHEMBL2079297 77205 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assayAntagonist activity at CCR5 receptor in human MOLT4 cells assessed as inhibition of chemokine-induced calcium mobilization using Fluo-4-AM dye based fluorometric assay
ChEMBL 286 8 0 0 5.3 CCCCCCCC/C=C/c1c(C)cc(C)[n+]2c1CCC2 10.1016/j.ejmech.2012.07.049
73352528 92767 None 0 Human Functional pIC50 = 4.0 4.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 8 2 4 6.1 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
CHEMBL2436714 92767 None 0 Human Functional pIC50 = 4.0 4.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader methodAntagonist activity at CCR5 (unknown origin) expressed in MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium ion mobilization after 15 mins by microplate reader method
ChEMBL 485 8 2 4 6.1 CC(=O)Nc1ccc(CN2CCC(c3ccc(OC(C)C)c(NC(=O)c4ccccc4)c3)CC2)cc1 10.1016/j.ejmech.2013.09.004
46225526 199731 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
CHEMBL593520 199731 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human recombinant CCR5 by cell-cell fusion assayAntagonist activity at human recombinant CCR5 by cell-cell fusion assay
ChEMBL 523 6 0 5 3.3 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC3(c4ccccc4)CN(C(=O)C4CC(F)(F)C4)C3)C[C@@H]2C1 10.1016/j.bmcl.2009.11.072
57331306 104578 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 600 10 0 4 5.7 CCN(Cc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
CHEMBL3104679 104578 None 0 Human Functional pIC50 = 7.0 7.0 - 1
Inhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assayInhibition of CCR5 (unknown origin) expressed in CHO cells assessed as inhibition of RANTES-induced intracellular Ca2+ mobilization after 10 mins by Fluo-4 AM staining-based fluorescence assay
ChEMBL 600 10 0 4 5.7 CCN(Cc1ccc(Cl)cc1)C(=O)C1CCN(CCCN(C(=O)C2CCN(C(C)=O)CC2)c2cccc(Cl)c2)CC1 10.1016/j.ejmech.2013.11.013
491775 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188807 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL537424 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilizationAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1-alpha-stimulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
491775 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL1188807 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
CHEMBL537424 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assayAntagonist activity at human CCR5 expressed in CHO cells assessed as inhibition of MIP-1alpha-induced calcium mobilization Ca assay
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2010.12.109
491775 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL1188807 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
CHEMBL537424 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilizationAntagonist activity at human CCR5 receptor expressed in CHO cells assessed as inhibition of MIP-1-alpha-stmulated calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmc.2010.05.057
491775 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL1188807 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
CHEMBL537424 12875 None 1 Human Functional pIC50 = 7.0 7.0 - 1
Antagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilizationAntagonist activity at human CCR5 receptor overexpressed in CHO cells assessed as inhibition of MIP-1-alpha-induced calcium mobilization
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2009.11.018
162677463 183574 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 857 23 5 11 4.1 CNC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4800480 183574 None 0 Human Functional pIC50 = 6.0 6.0 - 1
Antagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysisAntagonist activity at CCR5 receptor in human MOLT4 cells transfected with Gqi5 assessed as inhibition of RANTES-induced calcium mobilization incubated for 15 mins prior to RANTES addition and measured for 120 secs by Fluo-4AM dye based fluorescence analysis
ChEMBL 857 23 5 11 4.1 CNC(=O)COCC(=O)NCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL5089300 215199 None 0 Human Functional pIC50 = 6.0 6.0 -13 2
Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assayAntagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
90656334 111068 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 489 8 1 8 3.6 COC(=O)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
CHEMBL3263030 111068 None 0 Human Functional pIC50 = 5.0 5.0 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysisAntagonist activity at CCR5 (unknown origin) expressed in human MOLT4 cells assessed as inhibition of RANTES-stimulated calcium mobilization treated for 15 mins prior to RANTES addition by spectrophotometric analysis
ChEMBL 489 8 1 8 3.6 COC(=O)c1ccc(CN2CCN(c3ccc(OC(C)C)c(NC(=O)c4cnccn4)c3)CC2)cc1 10.1016/j.bmcl.2014.03.073
23577328 66432 None 0 Human Functional pIC50 = 4.0 4.0 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1813454 66432 None 0 Human Functional pIC50 = 4.0 4.0 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
CHEMBL1851967 66432 None 0 Human Functional pIC50 = 4.0 4.0 - 1
Antagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assayAntagonist activity against human CCR5 receptor assessed as inhibition of HIV1 gp120-induced cell-cell fusion between viral envolop protein expressing human HEK293 cells to human CD4/CCR5 receptor expressing HOS cells after 24 hrs by luciferase reporter gene assay
ChEMBL 592 10 3 7 3.1 CNC(=O)c1ccc(Oc2ccc(CN3CCC4(CC3)C(=O)N[C@H]([C@H](O)C3CCCCC3)C(=O)N4CCOC)cc2)cc1 10.1016/j.bmc.2011.05.022
60196353 81621 None 2 Human Functional pKd = 8.8 8.8 - 0
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.6b01801
CHEMBL2163486 81621 None 2 Human Functional pKd = 8.8 8.8 - 0
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.6b01801
137643501 158391 None 0 Human Functional pKd = 8 8.0 - 0
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]1CC2 10.1021/acs.jmedchem.6b01801
CHEMBL4089991 158391 None 0 Human Functional pKd = 8 8.0 - 0
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]1CC2 10.1021/acs.jmedchem.6b01801
137631641 156607 None 0 Human Functional pKd = 6.5 6.5 - 0
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@H]1CC2 10.1021/acs.jmedchem.6b01801
CHEMBL4068906 156607 None 0 Human Functional pKd = 6.5 6.5 - 0
Antagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assayAntagonist activity at human CCR5 expressed in HEK 293 Glosensor cells assessed as reduction in RANTES-induced intracellular calcium levels preincubated for 30 mins followed by RANTES addition measured at 2 secs time interval for 5 mins by Fluo-4-AM dye based fluorescence assay
ChEMBL 471 6 1 5 4.5 Cc1nnc2n1[C@H]1CCN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@H]1CC2 10.1021/acs.jmedchem.6b01801
3009353 168023 None 1 Human Functional pKi = 9.0 9.0 - 0
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 531 6 0 5 5.7 CCC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
CHEMBL432170 168023 None 1 Human Functional pKi = 9.0 9.0 - 0
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 531 6 0 5 5.7 CCC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
3009354 205274 None 1 Human Functional pKi = 8.9 8.9 - 0
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 579 6 0 5 6.1 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](Cc3ccccc3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
CHEMBL79061 205274 None 1 Human Functional pKi = 8.9 8.9 - 0
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 579 6 0 5 6.1 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](Cc3ccccc3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
3009356 105621 None 1 Human Functional pKi = 8.8 8.8 - 0
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 543 6 0 5 5.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](CC3CC3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
CHEMBL312344 105621 None 1 Human Functional pKi = 8.8 8.8 - 0
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 543 6 0 5 5.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](CC3CC3)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
3009355 3987 None 26 Human Functional pKi = 8.6 8.6 -1 2
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
807 3987 None 26 Human Functional pKi = 8.6 8.6 -1 2
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
CHEMBL82301 3987 None 26 Human Functional pKi = 8.6 8.6 -1 2
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
DB06652 3987 None 26 Human Functional pKi = 8.6 8.6 -1 2
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm0304515
483747 105407 None 3 Human Functional pKi = 8.6 8.6 - 1
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
CHEMBL311795 105407 None 3 Human Functional pKi = 8.6 8.6 - 1
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0304515
10436045 3514 None 4 Human Functional pKi = 5.4 5.4 - 1
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 499 9 3 3 6.4 O=C(/C=C/c1ccc(c(c1)Cl)Cl)NCCCCCN1CCC(CC1)c1c[nH]c2c1cc(O)cc2 10.1016/s0960-894x(00)00347-4
782 3514 None 4 Human Functional pKi = 5.4 5.4 - 1
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 499 9 3 3 6.4 O=C(/C=C/c1ccc(c(c1)Cl)Cl)NCCCCCN1CCC(CC1)c1c[nH]c2c1cc(O)cc2 10.1016/s0960-894x(00)00347-4
CHEMBL432713 3514 None 4 Human Functional pKi = 5.4 5.4 - 1
Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5Compound was evaluated for the antagonist activity against C-C chemokine receptor type 5
ChEMBL 499 9 3 3 6.4 O=C(/C=C/c1ccc(c(c1)Cl)Cl)NCCCCCN1CCC(CC1)c1c[nH]c2c1cc(O)cc2 10.1016/s0960-894x(00)00347-4
3009352 96637 None 1 Human Functional pKi = 8.3 8.3 - 0
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 517 5 0 5 5.3 CC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
CHEMBL263555 96637 None 1 Human Functional pKi = 8.3 8.3 - 0
Antagonistic activity against C-C chemokine receptor type 5Antagonistic activity against C-C chemokine receptor type 5
ChEMBL 517 5 0 5 5.3 CC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm0304515
15664 83786 None 101 Human Functional pEC50 = 8.3 8.3 2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
CHEMBL2205807 83786 None 101 Human Functional pEC50 = 8.3 8.3 2 3
Allosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysisAllosteric modulation at human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr assessed as [3H]IP3 turnover by liquid scintillation counting analysis
Drug Central 184 1 0 2 2.8 Cc1ccc(-c2ccc(C)cn2)nc1 None
10585 1078 None 1 Human Functional pIC50 = 7.1 7.1 -1 2
Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.
Guide to Pharmacology 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 31742400
145996522 1078 None 1 Human Functional pIC50 = 7.1 7.1 -1 2
Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.
Guide to Pharmacology 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 31742400
CHEMBL4531005 1078 None 1 Human Functional pIC50 = 7.1 7.1 -1 2
Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.Antagonist effect on CCL3-induced β-arrestin recruitment in U2OS cells stably expressing human CCR5.
Guide to Pharmacology 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 31742400
10106 872 None 0 Human Functional pIC50 = 8.5 8.5 - 1
In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.
Guide to Pharmacology 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 30234300
91820689 872 None 0 Human Functional pIC50 = 8.5 8.5 - 1
In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.
Guide to Pharmacology 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 30234300
CHEMBL4249798 872 None 0 Human Functional pIC50 = 8.5 8.5 - 1
In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.In a whole cell intracellular calcium mobilisation assay using HEK293 cells expressing hCCR5.
Guide to Pharmacology 519 8 1 6 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccsc1)CCN1[C@@H]2CC[C@H]1C[C@@H](C2)n1c(C)nnc1C(C)C 30234300
10750 2577 None 0 Human Functional pIC50 = 5.4 5.4 -5011 2
UnclassifiedUnclassified
Guide to Pharmacology 532 5 2 5 6.3 Clc1ccc(cc1)C1(O)CCN(CC1(C)C)CC/C=C\1/c2cc(ccc2OCc2c1cccn2)C(O)(C)C 17715391
18437138 2577 None 0 Human Functional pIC50 = 5.4 5.4 -5011 2
UnclassifiedUnclassified
Guide to Pharmacology 532 5 2 5 6.3 Clc1ccc(cc1)C1(O)CCN(CC1(C)C)CC/C=C\1/c2cc(ccc2OCc2c1cccn2)C(O)(C)C 17715391
11597 673 None 5 Human Functional pIC50 = 7.1 7.1 -11 2
UnclassifiedUnclassified
Guide to Pharmacology 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 34141082
23725180 673 None 5 Human Functional pIC50 = 7.1 7.1 -11 2
UnclassifiedUnclassified
Guide to Pharmacology 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 34141082
CHEMBL4781426 673 None 5 Human Functional pIC50 = 7.1 7.1 -11 2
UnclassifiedUnclassified
Guide to Pharmacology 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 34141082
769 824 None 0 Human Functional pIC50 = 7.7 7.7 -14 3
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10477718
3002977 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
803 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
806 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL1201187 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL256907 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL584744 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
DB04835 2458 None 71 Human Functional pIC50 = 8.1 8.1 2 4
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
486830 4000 None 0 Human Functional pIC50 = 8.3 8.3 -6 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9287217
768 4000 None 0 Human Functional pIC50 = 8.3 8.3 -6 5
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9287217
68764898 671 None 2 Human Functional pIC50 = 8.6 8.6 -3 2
UnclassifiedUnclassified
Guide to Pharmacology 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 25893046
9430 671 None 2 Human Functional pIC50 = 8.6 8.6 -3 2
UnclassifiedUnclassified
Guide to Pharmacology 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 25893046
CHEMBL3577945 671 None 2 Human Functional pIC50 = 8.6 8.6 -3 2
UnclassifiedUnclassified
Guide to Pharmacology 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 25893046
3500 1525 None 13 Human Functional pIC50 = 8.7 8.7 245 2
UnclassifiedUnclassified
Guide to Pharmacology 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 11454872
491774 1525 None 13 Human Functional pIC50 = 8.7 8.7 245 2
UnclassifiedUnclassified
Guide to Pharmacology 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 11454872
CHEMBL1196395 1525 None 13 Human Functional pIC50 = 8.7 8.7 245 2
UnclassifiedUnclassified
Guide to Pharmacology 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 11454872
5275766 3736 None 40 Human Functional pIC50 None 8.5 8.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 16640339
800 3736 None 40 Human Functional pIC50 None 8.5 8.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 16640339
CHEMBL207004 3736 None 40 Human Functional pIC50 None 8.5 8.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 16640339
11285792 878 None 34 Human Functional pIC50 None 8.6 8.6 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299
801 878 None 34 Human Functional pIC50 None 8.6 8.6 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299
CHEMBL2110727 878 None 34 Human Functional pIC50 None 8.6 8.6 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299
DB11758 878 None 34 Human Functional pIC50 None 8.6 8.6 -3 6
UnclassifiedUnclassified
Guide to Pharmacology 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 16251299




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

CHEMBL2372983 210329 None 0 Human Binding pEC50 = 9.7 9.7 - 0
Effective concentration for antagonistic activity by inhibition of T-tropic strain of HIV-1 through its specific binding to a chemokine receptorEffective concentration for antagonistic activity by inhibition of T-tropic strain of HIV-1 through its specific binding to a chemokine receptor
ChEMBL None None None NCCCC[C@@H]1NC(=O)[C@@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CCCN=C(N)N)c2ccc3ccccc3c2)CSSC[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H]2CCCN2C1=O 10.1016/s0960-894x(00)00664-8
483407 166038 None 21 Human Binding pEC50 = 9 9.0 - 1
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/C6MD00311G
CHEMBL425618 166038 None 21 Human Binding pEC50 = 9 9.0 - 1
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1039/C6MD00311G
129908110 155953 None 0 Human Binding pEC50 = 5.0 5.0 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 485 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4061273 155953 None 0 Human Binding pEC50 = 5.0 5.0 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 485 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908195 158787 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 493 11 1 7 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)Cc3cccs3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4094196 158787 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 493 11 1 7 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)Cc3cccs3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908301 156696 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 516 10 1 8 4.9 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
132519568 156696 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 516 10 1 8 4.9 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4069939 156696 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 516 10 1 8 4.9 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908428 158951 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 417 8 3 5 4.6 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4095938 158951 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 417 8 3 5 4.6 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
129908452 156030 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 518 11 1 8 4.8 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4062349 156030 None 0 Human Binding pEC50 = 4.8 4.8 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 518 11 1 8 4.8 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc([N+](=O)[O-])cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
3002977 2458 None 71 Human Binding pEC50 = 7.8 7.8 -3 2
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
803 2458 None 71 Human Binding pEC50 = 7.8 7.8 -3 2
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
806 2458 None 71 Human Binding pEC50 = 7.8 7.8 -3 2
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL1201187 2458 None 71 Human Binding pEC50 = 7.8 7.8 -3 2
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL256907 2458 None 71 Human Binding pEC50 = 7.8 7.8 -3 2
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
CHEMBL584744 2458 None 71 Human Binding pEC50 = 7.8 7.8 -3 2
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
DB04835 2458 None 71 Human Binding pEC50 = 7.8 7.8 -3 2
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/acs.jmedchem.1c00408
129908456 157872 None 0 Human Binding pEC50 = 4.7 4.7 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 395 8 3 4 4.8 O=C(CCc1ccc(NC(=O)C2CCCCC2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4083941 157872 None 0 Human Binding pEC50 = 4.7 4.7 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 395 8 3 4 4.8 O=C(CCc1ccc(NC(=O)C2CCCCC2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
129908453 157884 None 0 Human Binding pEC50 = 4.7 4.7 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 479 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4084066 157884 None 0 Human Binding pEC50 = 4.7 4.7 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 479 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908111 157668 None 0 Human Binding pEC50 = 4.7 4.7 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 501 10 1 7 5.0 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4081563 157668 None 0 Human Binding pEC50 = 4.7 4.7 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 501 10 1 7 5.0 COc1ccc(C(=O)Nc2ccc(CCC(=O)/C=C/c3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
129908196 157028 None 0 Human Binding pEC50 = 4.6 4.6 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 389 8 3 4 4.5 O=C(CCc1ccc(NC(=O)c2ccccc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4073567 157028 None 0 Human Binding pEC50 = 4.6 4.6 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 389 8 3 4 4.5 O=C(CCc1ccc(NC(=O)c2ccccc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
129908454 158084 None 0 Human Binding pEC50 = 4.6 4.6 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 487 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4086440 158084 None 0 Human Binding pEC50 = 4.6 4.6 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 487 10 1 6 5.2 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccc(C)cc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908109 158340 None 0 Human Binding pEC50 = 4.5 4.5 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 477 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4089429 158340 None 0 Human Binding pEC50 = 4.5 4.5 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 477 9 1 6 5.3 CC(=O)Oc1ccc(/C=C/C(=O)CCc2ccc(NC(=O)C3CCCCC3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908455 156259 None 0 Human Binding pEC50 = 4.5 4.5 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 503 11 1 7 4.9 COc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4064975 156259 None 0 Human Binding pEC50 = 4.5 4.5 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 503 11 1 7 4.9 COc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(OC(C)=O)c(OC(C)=O)c3)cc2)cc1 10.1039/C6MD00311G
129908558 156171 None 0 Human Binding pEC50 = 4.4 4.4 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 403 8 3 4 4.8 Cc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
CHEMBL4063935 156171 None 0 Human Binding pEC50 = 4.4 4.4 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 403 8 3 4 4.8 Cc1ccc(C(=O)Nc2ccc(CCC(=O)CCc3ccc(O)c(O)c3)cc2)cc1 10.1039/C6MD00311G
129907953 159501 None 0 Human Binding pEC50 = 4.4 4.4 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 434 9 3 6 4.4 O=C(CCc1ccc(NC(=O)c2ccc([N+](=O)[O-])cc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
132519569 159501 None 0 Human Binding pEC50 = 4.4 4.4 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 434 9 3 6 4.4 O=C(CCc1ccc(NC(=O)c2ccc([N+](=O)[O-])cc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4101931 159501 None 0 Human Binding pEC50 = 4.4 4.4 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 434 9 3 6 4.4 O=C(CCc1ccc(NC(=O)c2ccc([N+](=O)[O-])cc2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
129908281 158572 None 0 Human Binding pEC50 = 5.3 5.3 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 473 10 1 6 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccccc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
CHEMBL4091826 158572 None 0 Human Binding pEC50 = 5.3 5.3 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 473 10 1 6 4.9 CC(=O)Oc1ccc(CCC(=O)CCc2ccc(NC(=O)c3ccccc3)cc2)cc1OC(C)=O 10.1039/C6MD00311G
129908560 156929 None 0 Human Binding pEC50 = 4.3 4.3 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 409 9 3 5 4.5 O=C(CCc1ccc(NC(=O)Cc2cccs2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL4072528 156929 None 0 Human Binding pEC50 = 4.3 4.3 - 0
Antagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assayAntagonist activity at CCR5 in human TZM-bl cells infected with CCR5-tropic HIV-1 Bal assessed as inhibition of viral entry after 3 days by luciferase reporter gene assay
ChEMBL 409 9 3 5 4.5 O=C(CCc1ccc(NC(=O)Cc2cccs2)cc1)CCc1ccc(O)c(O)c1 10.1039/C6MD00311G
CHEMBL5074744 214327 None 0 Human Binding pEC50 = 7.0 7.0 - 2
Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysisInhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
483747 105407 None 3 Human Binding pIC50 = 11 11.0 177 4
Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL311795 105407 None 3 Human Binding pIC50 = 11 11.0 177 4
Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5Inhibition of 0.1 nM of MIP-1beta induced migration of recombinant mouse pro-B cell line BA/F3 expressing human CCR5
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
44590586 176808 None 0 Human Binding pIC50 = 10.3 10.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460845 176808 None 0 Human Binding pIC50 = 10.3 10.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
10076141 78387 None 0 Human Binding pIC50 = 10.2 10.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21106 78387 None 0 Human Binding pIC50 = 10.2 10.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10076141 78387 None 0 Human Binding pIC50 = 10.2 10.2 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21106 78387 None 0 Human Binding pIC50 = 10.2 10.2 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL181276 208979 None 52 Human Binding pIC50 = 10.2 10.2 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 Bal assessed inhibition of CD4 dependent gp120 Bal binding to CCR5 by western blot analysisAntagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 Bal assessed inhibition of CD4 dependent gp120 Bal binding to CCR5 by western blot analysis
ChEMBL None None None C[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O 10.1016/j.ejmech.2020.112819
10076141 78387 None 0 Human Binding pIC50 = 10.2 10.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21106 78387 None 0 Human Binding pIC50 = 10.2 10.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 11 1 3 6.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44590681 175171 None 0 Human Binding pIC50 = 10.2 10.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 553 11 1 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL457043 175171 None 0 Human Binding pIC50 = 10.2 10.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 553 11 1 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44273531 75030 None 0 Human Binding pIC50 = 10 10.0 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20345 75030 None 0 Human Binding pIC50 = 10 10.0 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
501062 77732 None 1 Human Binding pIC50 = 10 10.0 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20896 77732 None 1 Human Binding pIC50 = 10 10.0 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
501062 77732 None 1 Human Binding pIC50 = 10 10.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL20896 77732 None 1 Human Binding pIC50 = 10 10.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44273531 75030 None 0 Human Binding pIC50 = 10 10.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20345 75030 None 0 Human Binding pIC50 = 10 10.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 4 6.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44332684 107178 None 0 Human Binding pIC50 = 10 10.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL316475 107178 None 0 Human Binding pIC50 = 10 10.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501060 108584 None 1 Human Binding pIC50 = 10 10.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL320386 108584 None 1 Human Binding pIC50 = 10 10.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501055 4611 None 1 Human Binding pIC50 = 10 10.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL102826 4611 None 1 Human Binding pIC50 = 10 10.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501062 77732 None 1 Human Binding pIC50 = 10 10.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL20896 77732 None 1 Human Binding pIC50 = 10 10.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 11 1 3 6.1 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44332684 107178 None 0 Human Binding pIC50 = 10 10.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL316475 107178 None 0 Human Binding pIC50 = 10 10.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 11 1 3 5.7 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501060 108584 None 1 Human Binding pIC50 = 10 10.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL320386 108584 None 1 Human Binding pIC50 = 10 10.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 474 10 1 3 5.7 O=C(O)[C@@H](C1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
490018 111621 None 1 Human Binding pIC50 = 10 10.0 - 0
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 568 11 0 6 6.1 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1021/acs.jmedchem.6b01309
CHEMBL328445 111621 None 1 Human Binding pIC50 = 10 10.0 - 0
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 568 11 0 6 6.1 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1021/acs.jmedchem.6b01309
490018 111621 None 1 Human Binding pIC50 = 10 10.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 568 11 0 6 6.1 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL328445 111621 None 1 Human Binding pIC50 = 10 10.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 568 11 0 6 6.1 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
3002976 207275 None 1 Human Binding pIC50 = 10 10.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL93139 207275 None 1 Human Binding pIC50 = 10 10.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44373756 50617 None 0 Human Binding pIC50 = 9.9 9.9 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL157491 50617 None 0 Human Binding pIC50 = 9.9 9.9 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
11988311 179336 None 0 Human Binding pIC50 = 9.9 9.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 451 8 1 5 5.2 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473558 179336 None 0 Human Binding pIC50 = 9.9 9.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 451 8 1 5 5.2 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44590750 176894 None 0 Human Binding pIC50 = 9.8 9.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 10 2 3 5.1 CCN(C(=O)NCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461687 176894 None 0 Human Binding pIC50 = 9.8 9.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 10 2 3 5.1 CCN(C(=O)NCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
71451877 82569 None 0 Human Binding pIC50 = 9.8 9.8 - 0
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 638 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCC(S(C)(=O)=O)CC2)CC1 10.1021/jm300682j
CHEMBL2178577 82569 None 0 Human Binding pIC50 = 9.8 9.8 - 0
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 638 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)C2CCC(S(C)(=O)=O)CC2)CC1 10.1021/jm300682j
44274043 76552 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20622 76552 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
44273830 79608 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21147 79608 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
3002977 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
3002977 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
803 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
803 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
806 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
806 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
CHEMBL1201187 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
CHEMBL1201187 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
CHEMBL256907 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
CHEMBL256907 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
CHEMBL584744 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
CHEMBL584744 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
DB04835 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.008
DB04835 2458 None 71 Human Binding pIC50 = 9.7 9.7 -3 2
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2009.01.009
10414981 108139 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL319593 108139 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
44332341 109650 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 10 1 7 5.3 Cn1nnnc1-c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL322422 109650 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 10 1 7 5.3 Cn1nnnc1-c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
44274043 76552 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20622 76552 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 11 1 3 6.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44273830 79608 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21147 79608 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 11 1 3 7.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(C(F)(F)F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10414981 108139 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL319593 108139 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
501063 208430 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL99909 208430 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
10414981 108139 None 0 Human Binding pIC50 = 9.7 9.7 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00606-6
CHEMBL319593 108139 None 0 Human Binding pIC50 = 9.7 9.7 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 542 10 2 6 5.3 OC1(CCCc2ccc(-c3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00606-6
501063 208430 None 1 Human Binding pIC50 = 9.7 9.7 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL99909 208430 None 1 Human Binding pIC50 = 9.7 9.7 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 488 10 1 3 6.1 O=C(O)[C@@H](C1CCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501055 4611 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL102826 4611 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 502 10 1 3 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516310 59608 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 642 12 1 6 7.1 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL171958 59608 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 642 12 1 6 7.1 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516257 59981 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL173400 59981 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516288 60396 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174927 60396 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516256 128645 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366770 128645 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516289 131544 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2ccc3ccccc3c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369235 131544 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 9 1 5 7.2 CCn1nc(Cc2ccc3ccccc3c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
490023 112509 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 574 10 0 6 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL329893 112509 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 574 10 0 6 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490019 167976 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 582 10 0 6 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL431852 167976 None 1 Human Binding pIC50 = 9.7 9.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 582 10 0 6 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
9916998 79984 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212731 79984 None 0 Human Binding pIC50 = 9.7 9.7 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
3010274 189221 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511493 189221 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010273 191954 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520091 191954 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44342962 111215 None 0 Human Binding pIC50 = 9.6 9.6 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 529 10 1 5 5.9 O=C(O)C(CC1CC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL326487 111215 None 0 Human Binding pIC50 = 9.6 9.6 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 529 10 1 5 5.9 O=C(O)C(CC1CC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
44342961 114533 None 0 Human Binding pIC50 = 9.6 9.6 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 10 1 5 6.3 O=C(O)C(CC1CCC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL333619 114533 None 0 Human Binding pIC50 = 9.6 9.6 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 10 1 5 6.3 O=C(O)C(CC1CCC1)N1CC(c2ccccc2)[C@@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)C1 10.1016/j.bmcl.2004.04.078
3010274 189221 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511493 189221 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 543 10 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010273 191954 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520091 191954 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 529 10 1 5 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
11285792 878 None 34 Mouse Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
801 878 None 34 Mouse Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
CHEMBL2110727 878 None 34 Mouse Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
DB11758 878 None 34 Mouse Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1016/j.ejmech.2018.01.085
11614352 550 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
7686 550 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
CHEMBL1951914 550 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 10.1016/j.bmcl.2011.12.117
3010264 183801 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480503 183801 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010264 183801 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480503 183801 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010264 183801 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL480503 183801 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
10347790 78457 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21117 78457 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565720 174327 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL455073 174327 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
20672370 78031 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 531 11 1 4 6.1 N#Cc1ccc(CCCC2CCN(C[C@H]3CN([C@H](CC4CCC4)C(=O)O)C[C@@H]3c3cccc(F)c3)CC2)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL20988 78031 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 531 11 1 4 6.1 N#Cc1ccc(CCCC2CCN(C[C@H]3CN([C@H](CC4CCC4)C(=O)O)C[C@@H]3c3cccc(F)c3)CC2)cc1 10.1016/s0960-894x(02)00829-6
10347790 78457 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21117 78457 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
20672362 99434 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 10 1 3 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL282921 99434 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 10 1 3 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00829-6
10369469 70347 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 1 5 5.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL194497 70347 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 1 5 5.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
489315 107358 None 2 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL317710 107358 None 2 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
10347790 78457 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL21117 78457 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 11 1 3 6.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565720 174327 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL455073 174327 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 11 1 3 7.5 O=C(O)[C@@H](CC1CCCCC1)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72712598 92637 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435848 92637 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 591 5 0 4 6.6 Cc1cc(Cl)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
516231 59851 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172894 59851 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5ccccc5c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516245 59858 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172916 59858 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516235 60215 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL174004 60215 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516224 61653 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL177127 61653 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516234 98998 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL279992 98998 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516233 128677 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366868 128677 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516202 130279 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 5 7.3 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367987 130279 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 5 7.3 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516314 130681 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 662 11 1 5 8.2 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368329 130681 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 662 11 1 5 8.2 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516216 131435 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369059 131435 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 13 1 6 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516262 166362 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 9 1 5 7.0 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL427493 166362 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 9 1 5 7.0 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516232 168529 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 11 1 5 6.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL435472 168529 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 11 1 5 6.3 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL181276 208979 None 52 Human Binding pIC50 = 9.5 9.5 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 CM235 assessed inhibition of CD4 dependent gp120 CM235 binding to CCR5 by western blot analysisAntagonist activity at CCR5 (unknown origin) expressed in human HOS cells co-expressing HIV-1 FITC-gp120 CM235 assessed inhibition of CD4 dependent gp120 CM235 binding to CCR5 by western blot analysis
ChEMBL None None None C[C@@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O 10.1016/j.ejmech.2020.112819
16007088 79974 None 21 Human Binding pIC50 = 9.5 9.5 - 0
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1021/jm300682j
CHEMBL212689 79974 None 21 Human Binding pIC50 = 9.5 9.5 - 0
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1021/jm300682j
16007088 79974 None 21 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212689 79974 None 21 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
16007088 79974 None 21 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL212689 79974 None 21 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2011.12.117
3010271 183840 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480693 183840 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44590633 176202 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459384 176202 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
3010271 183840 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480693 183840 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010271 183840 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL480693 183840 None 1 Human Binding pIC50 = 9.5 9.5 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 10 1 5 5.8 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44401488 70075 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 9 1 5 5.6 CCc1ccn2c(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)cnc2c1 10.1016/j.bmcl.2005.02.030
CHEMBL193984 70075 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 9 1 5 5.6 CCc1ccn2c(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)cnc2c1 10.1016/j.bmcl.2005.02.030
53260398 62861 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 0 4 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
CHEMBL1784385 62861 None 0 Human Binding pIC50 = 9.5 9.5 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 0 4 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
3002977 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
803 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
806 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL1201187 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL256907 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL584744 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
DB04835 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 MGC26-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
44565038 186856 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489513 186856 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491679 186856 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
3010268 78718 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 10 2 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112559 78718 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 10 2 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44273996 75559 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20453 75559 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565673 177639 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL464132 177639 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
44273996 75559 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20453 75559 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44273888 98766 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278117 98766 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44357079 119339 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344261 119339 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 541 11 1 6 4.8 CCCN(c1ncc(F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
3001322 443 None 23 Mouse Binding pIC50 = 9.4 9.4 - 1
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
805 443 None 23 Mouse Binding pIC50 = 9.4 9.4 - 1
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
CHEMBL1255794 443 None 23 Mouse Binding pIC50 = 9.4 9.4 - 1
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
DB06497 443 None 23 Mouse Binding pIC50 = 9.4 9.4 - 1
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.ejmech.2018.01.085
44332489 4752 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 557 10 2 5 4.7 C[n+]1n[nH]c(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/s0960-894x(02)00605-4
CHEMBL103790 4752 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 557 10 2 5 4.7 C[n+]1n[nH]c(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/s0960-894x(02)00605-4
44273996 75559 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL20453 75559 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 11 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565673 177639 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL464132 177639 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 556 10 1 7 5.3 Cn1nnc(-c2ccc(CCCC3(O)CCN(C[C@H]4CN(CC5CCCCC5)C[C@@H]4c4ccccc4)CC3)cc2)n1 10.1016/j.ejmech.2008.01.040
58834969 92646 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 586 8 1 6 5.9 Cc1nc(Sc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435857 92646 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 586 8 1 6 5.9 Cc1nc(Sc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516292 60276 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 9 1 5 7.3 CCn1nc(Cc2ccc(C(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174214 60276 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 9 1 5 7.3 CCn1nc(Cc2ccc(C(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516201 60461 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 608 12 1 6 6.2 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL175348 60461 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 608 12 1 6 6.2 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516246 61070 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176459 61070 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516255 61280 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL176669 61280 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516279 96477 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 11 1 6 7.8 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL262402 96477 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 11 1 6 7.8 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516230 128467 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366611 128467 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 610 11 1 5 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc5ccccc45)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516274 128680 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366873 128680 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516221 132568 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369812 132568 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516271 168255 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
CHEMBL433793 168255 None 1 Human Binding pIC50 = 9.4 9.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
20664161 79006 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL2113086 79006 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
3002977 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
803 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
806 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL1201187 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL256907 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL584744 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
DB04835 2458 None 71 Human Binding pIC50 = 9.4 9.4 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 YU2-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
57391721 71061 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 11 0 6 4.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951913 71061 None 0 Human Binding pIC50 = 9.4 9.4 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 11 0 6 4.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
3009355 3987 None 26 Human Binding pIC50 = 9.4 9.4 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
807 3987 None 26 Human Binding pIC50 = 9.4 9.4 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
CHEMBL82301 3987 None 26 Human Binding pIC50 = 9.4 9.4 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
DB06652 3987 None 26 Human Binding pIC50 = 9.4 9.4 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/jm300682j
44590634 174803 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.0 CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL456226 174803 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.0 CCN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44565080 187082 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN([C@H](C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491319 187082 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN([C@H](C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
20672360 77316 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 3 6.4 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20831 77316 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 3 6.4 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
20672386 98755 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278085 98755 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44273888 98766 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278117 98766 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 558 11 1 4 5.5 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CC[S+]([O-])c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44590440 179202 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)C(=O)C3CC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL472464 179202 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)C(=O)C3CC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
44357078 119399 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL344641 119399 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1ncc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44401956 133576 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4c(Cl)cc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL371177 133576 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4c(Cl)cc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
20672386 98755 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL278085 98755 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 506 11 1 3 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565742 179118 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 548 11 1 3 6.8 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471920 179118 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 548 11 1 3 6.8 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCC(F)(F)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10163007 95096 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255429 95096 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501046 109673 None 1 Human Binding pIC50 = 9.3 9.3 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322603 109673 None 1 Human Binding pIC50 = 9.3 9.3 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
72714079 92675 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435886 92675 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516311 59909 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.7 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173091 59909 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.7 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516312 60000 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 678 12 1 6 8.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173479 60000 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 678 12 1 6 8.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516192 60027 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL173583 60027 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516282 60403 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 11 1 6 6.6 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174996 60403 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 11 1 6 6.6 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516228 60418 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 12 1 7 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL175079 60418 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 12 1 7 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516227 60459 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 7 5.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5c(c4)OCO5)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL175341 60459 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 7 5.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc5c(c4)OCO5)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516313 61130 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 2 6 6.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176528 61130 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 2 6 6.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
44385583 61498 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 578 9 1 5 6.2 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177071 61498 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 578 9 1 5 6.2 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516251 96890 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL265723 96890 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516205 128466 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366610 128466 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516259 129728 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367416 129728 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 12 1 5 7.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(-c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
44384782 130192 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 6.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(NC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367897 130192 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 6.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(NC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516248 130283 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368000 130283 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516198 131822 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 612 12 1 6 6.2 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369398 131822 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 612 12 1 6 6.2 CCn1nc(Cc2ccc(OC(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516237 131899 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369478 131899 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 628 11 1 5 7.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516249 132106 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369593 132106 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 652 13 1 6 7.8 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(Oc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
3010272 189450 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL513564 189450 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010272 189450 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL513564 189450 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
3010272 189450 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL513564 189450 None 1 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 5 5.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44564930 179362 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 5.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473759 179362 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 5.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCCCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
57391722 71063 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 637 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951917 71063 None 0 Human Binding pIC50 = 9.3 9.3 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 637 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44565761 188315 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL500631 188315 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010275 78717 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 572 11 2 4 6.2 CCc1[nH]c(Cc2ccccc2)nc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112558 78717 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 572 11 2 4 6.2 CCc1[nH]c(Cc2ccccc2)nc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
44565761 188315 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL500631 188315 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 11 2 4 6.1 CCc1nc(Cc2ccccc2)[nH]c1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44565762 179193 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472412 179193 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44401965 71316 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 549 9 1 7 4.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc([N+](=O)[O-])cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL195753 71316 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 549 9 1 7 4.9 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc([N+](=O)[O-])cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44565762 179193 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472412 179193 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 10 2 4 6.2 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3008904 199964 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL59511 199964 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
58834906 92642 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 1 6 6.2 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435853 92642 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 1 6 6.2 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
3010276 78716 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 578 10 2 4 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112557 78716 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 578 10 2 4 6.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
516337 130177 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL367837 130177 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516333 120338 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL352981 120338 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516293 59694 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 10 1 5 7.7 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172296 59694 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 636 10 1 5 7.7 CCn1nc(Cc2ccc(-c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516194 59948 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 12 1 6 6.6 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173254 59948 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 12 1 6 6.6 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516280 61065 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 10 1 6 6.9 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176426 61065 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 10 1 6 6.9 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516223 61376 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176933 61376 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516199 96514 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 562 10 2 6 5.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL262663 96514 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 562 10 2 6 5.3 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516291 96635 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 1 5 7.2 CCn1nc(Cc2ccc(C(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL263529 96635 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 10 1 5 7.2 CCn1nc(Cc2ccc(C(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516252 129818 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367560 129818 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 626 13 1 6 6.6 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516212 130082 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL367700 130082 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516209 130712 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368467 130712 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516290 131927 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 9 1 5 6.3 CCn1nc(Cc2ccc(C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369494 131927 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 574 9 1 5 6.3 CCn1nc(Cc2ccc(C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516250 132130 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369659 132130 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516253 158206 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL408800 158206 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516196 166080 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 12 1 6 7.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL425845 166080 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 12 1 6 7.4 CCn1nc(Cc2ccc(Oc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516281 166296 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.0 CCn1nc(Cc2ccc(OCC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL427122 166296 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 11 1 6 7.0 CCn1nc(Cc2ccc(OCC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
3010261 192381 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520755 192381 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010261 192381 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL520755 192381 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010261 192381 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL520755 192381 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
57403932 71060 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 6 3.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951912 71060 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 6 3.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
57396952 71062 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 655 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951915 71062 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 655 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(Cl)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
501056 107470 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318406 107470 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501056 107470 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318406 107470 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3008917 202782 None 5 Crab-eating macaque Binding pIC50 = 9.2 9.2 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL62152 202782 None 5 Crab-eating macaque Binding pIC50 = 9.2 9.2 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501056 107470 None 1 Human Binding pIC50 = 9.2 9.2 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL318406 107470 None 1 Human Binding pIC50 = 9.2 9.2 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 462 10 1 3 5.5 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
58835217 92645 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 9 1 6 5.8 CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435856 92645 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 9 1 6 5.8 CCc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
44415755 138697 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 451 9 2 3 4.0 O=C(Cc1ccc(F)cc1)NC1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
CHEMBL377914 138697 None 0 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 451 9 2 3 4.0 O=C(Cc1ccc(F)cc1)NC1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
3010279 78711 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 564 10 2 4 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112552 78711 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 564 10 2 4 5.9 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3[nH]c(Cc4ccccc4)nc3Cl)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2004.04.078
516285 59702 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 9 1 7 5.8 CCn1nc(Cc2ccc3c(c2)OCO3)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172322 59702 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 9 1 7 5.8 CCn1nc(Cc2ccc3c(c2)OCO3)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516229 59961 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL173308 59961 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 13 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516308 60466 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 13 1 6 7.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL175394 60466 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 13 1 6 7.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516275 61431 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 7.0 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177033 61431 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 7.0 CCn1nc(Cc2ccc(OC3CCC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516220 62120 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL177648 62120 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 14 1 6 7.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OCc5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516287 119990 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
CHEMBL349974 119990 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 11 1 6 6.6 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1F 10.1016/j.bmcl.2003.12.006
516276 130659 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368204 130659 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516269 168542 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2cccc(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL435554 168542 None 1 Human Binding pIC50 = 9.2 9.2 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2cccc(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
3010267 78719 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 512 10 2 4 5.1 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112560 78719 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 512 10 2 4 5.1 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3c[nH]c(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44461741 168051 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 619 14 1 6 5.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL432360 168051 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 619 14 1 6 5.3 C=CCN(C(=O)NCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
76330829 85612 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 605 13 1 6 5.6 C=CCN(C(=O)Nc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282506 85612 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 605 13 1 6 5.6 C=CCN(C(=O)Nc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
16073660 79776 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL211866 79776 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
44565853 179031 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL471251 179031 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010278 78712 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 589 11 1 5 7.0 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112553 78712 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 589 11 1 5 7.0 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
44565853 179031 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL471251 179031 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 571 11 1 5 6.8 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
76327166 85615 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282509 85615 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
501051 4485 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL101961 4485 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516260 59839 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL172854 59839 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44273960 99223 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL281607 99223 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565719 179116 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471909 179116 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
516342 189238 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511634 189238 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44274108 99152 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 516 10 1 4 6.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL281176 99152 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 516 10 1 4 6.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44273960 99223 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL281607 99223 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
490022 111592 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL328260 111592 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
44357072 98490 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL275998 98490 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 553 12 1 7 4.7 CCCN(c1nccc(OC)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
490020 111601 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL328297 111601 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
20664149 69844 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 580 9 1 5 6.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(-c5ccccc5)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193822 69844 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 580 9 1 5 6.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(-c5ccccc5)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
516260 59839 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL172854 59839 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516236 168541 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
CHEMBL435538 168541 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
490020 111601 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL328297 111601 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
501051 4485 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL101961 4485 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516260 59839 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL172854 59839 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44273960 99223 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL281607 99223 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 524 11 1 3 6.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(CCCc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565719 179116 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471909 179116 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 530 11 1 4 6.4 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCSc3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
516342 189238 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511634 189238 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447734 95137 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255644 95137 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
10413034 95178 None 0 Crab-eating macaque Binding pIC50 = 9.1 9.1 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255856 95178 None 0 Crab-eating macaque Binding pIC50 = 9.1 9.1 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501051 4485 None 1 Human Binding pIC50 = 9.1 9.1 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL101961 4485 None 1 Human Binding pIC50 = 9.1 9.1 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 512 10 2 4 5.4 O=C(O)[C@@H](c1ccccc1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
486605 104362 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL310106 104362 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
486605 104362 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of human CCR5 in PBMC cellInhibition of human CCR5 in PBMC cell
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1021/acs.jmedchem.6b01309
CHEMBL310106 104362 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of human CCR5 in PBMC cellInhibition of human CCR5 in PBMC cell
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1cccc(C(N)=O)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1021/acs.jmedchem.6b01309
44384927 168560 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3oncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL435709 168560 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3oncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516197 59621 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 6.5 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172013 59621 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 11 1 6 6.5 CCn1nc(Cc2ccc(OC(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516309 59704 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 14 1 6 7.7 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL172327 59704 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 658 14 1 6 7.7 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516260 59839 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172854 59839 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 9 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516273 60470 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 13 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL175424 60470 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 13 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516218 61263 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 13 1 6 6.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176624 61263 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 13 1 6 6.8 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516244 61726 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL177168 61726 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516195 61765 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177204 61765 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 11 1 6 6.8 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516242 96658 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
CHEMBL263787 96658 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
516304 120494 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 726 12 1 7 7.4 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL354413 120494 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 726 12 1 7 7.4 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516272 120826 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 12 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL355809 120826 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 12 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516200 128053 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 601 11 1 7 5.5 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366492 128053 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 601 11 1 7 5.5 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516258 128520 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366742 128520 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 5 7.3 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516191 131614 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL369278 131614 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
44325665 111400 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 632 10 0 6 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327241 111400 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 632 10 0 6 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490022 111592 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL328260 111592 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 588 10 0 6 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490020 111601 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL328297 111601 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 616 10 0 6 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44401760 168584 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(C(F)(F)F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL435886 168584 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 572 8 1 5 6.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(C(F)(F)F)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44565037 192982 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489324 192982 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL522259 192982 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
20672384 69582 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193440 69582 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 542 10 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44565852 172659 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL449758 172659 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44401751 70076 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 538 8 1 5 5.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193988 70076 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 538 8 1 5 5.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ccc(Cl)cn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44565852 172659 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL449758 172659 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 555 11 1 5 6.4 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010277 78715 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 573 11 1 5 6.5 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112556 78715 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 573 11 1 5 6.5 CCc1nc(Cc2ccccc2)oc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
516366 168563 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL435727 168563 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565718 178957 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470510 178957 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44274106 76521 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 548 10 1 5 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL20602 76521 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 548 10 1 5 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
516203 60335 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
CHEMBL174457 60335 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 11 1 5 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
516366 168563 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
CHEMBL435727 168563 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.005
44205000 170193 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 594 8 0 6 7.0 COC(=O)C(c1ccc(F)cc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL444497 170193 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 594 8 0 6 7.0 COC(=O)C(c1ccc(F)cc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
516366 168563 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL435727 168563 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 574 12 1 5 6.4 CCC(CC)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565718 178957 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470510 178957 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 562 11 1 5 5.1 CC(C)C[C@H](C(=O)O)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
10413034 95178 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255856 95178 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
16041411 92574 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 572 8 1 6 5.6 O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2434978 92574 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 572 8 1 6 5.6 O=C(O)c1ccc(Sc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
58835113 92633 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 607 8 1 7 5.6 O=C(O)c1ccc(Sc2ncc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2435844 92633 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 607 8 1 7 5.6 O=C(O)c1ccc(Sc2ncc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
58834946 92634 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 2 7 5.5 Cc1nc(Nc2ccc(C(=O)O)cc2)ncc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435845 92634 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 604 8 2 7 5.5 Cc1nc(Nc2ccc(C(=O)O)cc2)ncc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(Cl)c2)CC1 10.1021/jm401101p
72711741 92648 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435859 92648 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711739 92696 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435907 92696 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 551 8 1 4 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
59458247 92701 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435912 92701 None 0 Human Binding pIC50 = 9.1 9.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 571 8 1 5 6.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
516208 59497 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL171468 59497 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(C#N)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516286 60393 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 10 1 7 5.9 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174904 60393 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 615 10 1 7 5.9 CCn1nc(Cc2ccc(OC)c(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516270 61223 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL176604 61223 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 11 1 6 6.4 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516300 128462 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 10 1 5 7.2 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366600 128462 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 10 1 5 7.2 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516213 129323 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
CHEMBL367102 129323 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 13 1 6 6.4 CCOc1cccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)c1 10.1016/j.bmcl.2003.12.006
516298 130682 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368332 130682 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516236 168541 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL435538 168541 None 1 Human Binding pIC50 = 9.1 9.1 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 560 11 1 5 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
3009355 3987 None 26 Mouse Binding pIC50 = 9.0 9.0 - 1
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
807 3987 None 26 Mouse Binding pIC50 = 9.0 9.0 - 1
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
CHEMBL82301 3987 None 26 Mouse Binding pIC50 = 9.0 9.0 - 1
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
DB06652 3987 None 26 Mouse Binding pIC50 = 9.0 9.0 - 1
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/j.ejmech.2018.01.085
44590635 176897 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 493 10 1 3 5.1 CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461690 176897 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 493 10 1 3 5.1 CCN(C(=O)Cc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
76335673 104786 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 652 18 1 6 8.8 Cc1nnc(CCCCCCCCCCN=[N+]=[N-])n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
CHEMBL3109175 104786 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 652 18 1 6 8.8 Cc1nnc(CCCCCCCCCCN=[N+]=[N-])n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
489315 107358 None 2 Human Binding pIC50 = 9 9.0 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00652-7
CHEMBL317710 107358 None 2 Human Binding pIC50 = 9 9.0 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 474 9 1 3 6.1 OC1(CCCc2ccccc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00652-7
23650547 179077 None 0 Human Binding pIC50 = 9 9.0 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471623 179077 None 0 Human Binding pIC50 = 9 9.0 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
44590394 183880 None 0 Human Binding pIC50 = 9 9.0 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 485 6 0 3 5.0 Cc1cccc(C)c1C(=O)N1[C@H]2CC[C@@H]1C[C@@H](N1CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C1)C2 10.1016/j.bmcl.2009.01.012
CHEMBL481068 183880 None 0 Human Binding pIC50 = 9 9.0 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 485 6 0 3 5.0 Cc1cccc(C)c1C(=O)N1[C@H]2CC[C@@H]1C[C@@H](N1CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C1)C2 10.1016/j.bmcl.2009.01.012
59959034 79008 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cnccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL2113088 79008 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cnccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44332814 163669 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 11 2 6 5.2 OC1(CCCc2ccc(Cc3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL420465 163669 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 556 11 2 6 5.2 OC1(CCCc2ccc(Cc3nnn[nH]3)cc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
16073662 139274 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 630 11 0 6 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL379082 139274 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 630 11 0 6 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
25132603 103289 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 5 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084499 103289 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 5 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
44565854 183861 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 559 11 1 5 6.7 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL480890 183861 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 559 11 1 5 6.7 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
501045 208412 None 1 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL99788 208412 None 1 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
10280445 95138 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255645 95138 None 0 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
3008928 202655 None 1 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61424 202655 None 1 Human Binding pIC50 = 9 9.0 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501043 4681 None 1 Human Binding pIC50 = 9 9.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL103343 4681 None 1 Human Binding pIC50 = 9 9.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501047 4756 None 1 Human Binding pIC50 = 9 9.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL103813 4756 None 1 Human Binding pIC50 = 9 9.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 504 10 2 4 5.5 OC[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501045 208412 None 1 Human Binding pIC50 = 9 9.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL99788 208412 None 1 Human Binding pIC50 = 9 9.0 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
72711958 92653 None 0 Human Binding pIC50 = 9 9.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435864 92653 None 0 Human Binding pIC50 = 9 9.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
59458245 92655 None 0 Human Binding pIC50 = 9 9.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435866 92655 None 0 Human Binding pIC50 = 9 9.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3010280 78714 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 563 10 1 5 6.4 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
CHEMBL2112555 78714 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 563 10 1 5 6.4 CCc1nc(Cc2ccccc2)sc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2004.04.078
516336 130619 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368183 130619 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1ncc(CCc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
3002976 207275 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL93139 207275 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 634 14 0 7 5.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@](C)(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
516307 59637 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 12 1 6 7.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL172079 59637 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 12 1 6 7.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
44384584 59831 None 0 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172820 59831 None 0 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516193 61050 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 6 6.2 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176337 61050 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 602 12 1 6 6.2 CCn1nc(Cc2ccc(OC3CC3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516296 61766 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177205 61766 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516190 129671 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL367383 129671 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C(C)C)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516215 130677 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL368309 130677 None 1 Human Binding pIC50 = 9 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 15 1 6 7.2 CCCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
44273816 99044 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 588 10 1 5 5.6 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL280344 99044 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 588 10 1 5 5.6 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCS(=O)(=O)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44357379 28136 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL137327 28136 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 535 11 1 6 4.7 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ncccn3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00988-5
16073670 141055 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 648 11 0 6 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL382435 141055 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 648 11 0 6 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(Cl)c2)CC1 10.1016/j.bmcl.2006.03.089
57400374 71055 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 603 11 0 6 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951906 71055 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 603 11 0 6 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
16728787 12841 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188566 12841 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536754 12841 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 533 9 2 5 4.9 CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
10163007 95096 None 0 Crab-eating macaque Binding pIC50 = 9.0 9.0 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255429 95096 None 0 Crab-eating macaque Binding pIC50 = 9.0 9.0 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008927 198856 None 1 Crab-eating macaque Binding pIC50 = 9.0 9.0 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58387 198856 None 1 Crab-eating macaque Binding pIC50 = 9.0 9.0 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
58835114 92643 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 8 1 6 5.8 Cc1cccc([C@@H]2CN(C3CCOCC3)C(=O)N2C2CCN(Cc3ccc(Oc4ccc(C(=O)O)cc4)nc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435854 92643 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 584 8 1 6 5.8 Cc1cccc([C@@H]2CN(C3CCOCC3)C(=O)N2C2CCN(Cc3ccc(Oc4ccc(C(=O)O)cc4)nc3C)CC2)c1 10.1021/jm401101p
58834953 92647 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 569 8 1 6 4.9 Cc1nc(Oc2ccc(C(N)=O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435858 92647 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 569 8 1 6 4.9 Cc1nc(Oc2ccc(C(N)=O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711740 92698 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435909 92698 None 0 Human Binding pIC50 = 9.0 9.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3010260 78713 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 8 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(-c4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL2112554 78713 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 543 8 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(-c4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516175 59371 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL170829 59371 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516283 59892 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 9 2 6 5.7 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173019 59892 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 9 2 6 5.7 CCn1nc(Cc2ccc(O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516261 60005 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 9 1 5 6.6 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173492 60005 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 9 1 5 6.6 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516178 61057 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)c(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176391 61057 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)c(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516295 129753 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367489 129753 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 604 10 1 5 6.7 CCn1nc(Cc2ccc(F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516267 130203 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 11 1 7 6.9 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367916 130203 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 11 1 7 6.9 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516278 130280 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 12 1 6 7.6 CCn1nc(Cc2ccc(OCc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367988 130280 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 666 12 1 6 7.6 CCn1nc(Cc2ccc(OCc3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516240 131434 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL369040 131434 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 700 13 1 7 6.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(S(=O)(=O)c5ccccc5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516214 131603 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL369277 131603 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516306 132124 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369632 132124 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 616 11 1 6 6.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516222 169173 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL440554 169173 None 1 Human Binding pIC50 = 9.0 9.0 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 644 12 1 6 6.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(F)(F)F)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516361 59910 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL173095 59910 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516362 60457 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL175327 60457 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516172 120383 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL353331 120383 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516343 179065 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471542 179065 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44357063 119142 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL342842 119142 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ccncn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
44356952 119274 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343745 119274 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 591 11 1 6 5.7 CCCN(c1nccc(C(F)(F)F)n1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
516361 59910 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL173095 59910 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516362 60457 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL175327 60457 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516172 120383 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL353331 120383 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
11525100 83523 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 444 7 1 4 5.2 Cc1nc2ccccc2n1C1(C)CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203619 83523 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 444 7 1 4 5.2 Cc1nc2ccccc2n1C1(C)CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
516361 59910 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL173095 59910 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 572 11 1 5 6.2 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516362 60457 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL175327 60457 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 558 11 1 5 5.8 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
516172 120383 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL353331 120383 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516343 179065 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471542 179065 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)on3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711742 92649 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435860 92649 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72714078 92674 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435885 92674 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
52946954 18375 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 549 7 0 6 3.4 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271208 18375 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 549 7 0 6 3.4 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
3013684 77036 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207182 77036 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 547 8 0 3 6.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
44384875 59904 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL173064 59904 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516335 130110 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 10 2 4 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3CCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL367787 130110 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 10 2 4 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3CCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516204 59191 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 11 1 5 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(CC4CCCCC4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL170118 59191 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 566 11 1 5 6.6 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(CC4CCCCC4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516284 59827 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 11 1 7 6.0 CCn1nc(Cc2ccc(OC)c(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172806 59827 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 11 1 7 6.0 CCn1nc(Cc2ccc(OC)c(OC)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516243 130080 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
CHEMBL367697 130080 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 618 14 1 6 6.8 CCCOc1ccc(Cc2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)[C@H](C)CC)C[C@@H]4c4cccc(F)c4)CC3)n(CC)n2)cc1 10.1016/j.bmcl.2003.12.006
516211 168504 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL435347 168504 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 12 1 6 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516172 120383 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cell
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL353331 120383 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cell
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516172 120383 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL353331 120383 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsInhibitory concentration to displace [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.006
145967247 164411 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting methodDisplacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting method
ChEMBL 574 11 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@@H]2C[C@@H](N(C)[C@H](C(=O)O)C(C)C)C[C@H]2c2cccc(F)c2)CC1 10.1021/acs.jmedchem.8b00180
CHEMBL4213499 164411 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting methodDisplacement of [125I]-labeled MIP-1alpha from human CCR5 expressed in CHO cell membranes after 240 mins by TopCount scintillation counting method
ChEMBL 574 11 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@@H]2C[C@@H](N(C)[C@H](C(=O)O)C(C)C)C[C@H]2c2cccc(F)c2)CC1 10.1021/acs.jmedchem.8b00180
3002977 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
803 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
806 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL1201187 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL256907 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL584744 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
DB04835 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 92RW-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
44565038 186856 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489513 186856 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491679 186856 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 473 8 1 5 5.0 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC(F)(F)C2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
3010262 183881 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL481080 183881 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447732 155099 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL401929 155099 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
58835000 92632 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 8 1 6 5.2 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)c(C)n2)cc1 10.1021/jm401101p
CHEMBL2435843 92632 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 583 8 1 6 5.2 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)c(C)n2)cc1 10.1021/jm401101p
58835027 92640 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 8 1 6 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2435851 92640 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 8 1 6 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4cccc(Cl)c4)CC3)cn2)cc1 10.1021/jm401101p
3010262 183881 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL481080 183881 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3csc(Cc4ccccc4)n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516207 60001 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL173482 60001 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516217 61198 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176571 61198 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 630 13 1 6 7.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC5CCC5)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516176 61364 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176850 61364 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2cccc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516219 61381 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL176980 61381 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516187 61684 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 686 12 1 7 6.5 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177156 61684 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 686 12 1 7 6.5 CCn1nc(Cc2ccc(S(=O)(=O)c3ccccc3)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516189 120272 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 1 6 5.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL352511 120272 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 1 6 5.6 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516264 129460 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367169 129460 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 9 1 6 5.9 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516239 129476 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL367246 129476 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 585 11 1 6 5.9 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(C#N)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516181 132571 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 580 10 1 5 6.3 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369822 132571 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 580 10 1 5 6.3 CCn1nc(Cc2ccc(Cl)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
183790 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
783 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
CHEMBL1178786 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Antagonist activity at CCR5 (unknown origin)Antagonist activity at CCR5 (unknown origin)
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
49768863 103503 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1016/j.bmcl.2009.01.008
CHEMBL3085107 103503 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 513 8 1 5 6.0 Cc1nc(C(C)C)n([C@H]2C[C@@H]3CC[C@H](C2)N3CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)n1 10.1016/j.bmcl.2009.01.008
183790 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm300682j
783 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm300682j
CHEMBL1178786 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm300682j
183790 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
783 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
CHEMBL1178786 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm0509703
3008913 101974 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL301454 101974 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
183790 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysis
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
783 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysis
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
CHEMBL1178786 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells after 40 mins by scintillation counting analysis
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
3002977 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
803 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
806 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
CHEMBL1201187 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
CHEMBL256907 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
CHEMBL584744 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
DB04835 2458 None 71 Human Binding pIC50 = 8.9 8.9 -3 2
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.01.080
183790 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Inhibition of CCL5 binding to CCR5 expressed in CHO cellsInhibition of CCL5 binding to CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
783 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Inhibition of CCL5 binding to CCR5 expressed in CHO cellsInhibition of CCL5 binding to CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
CHEMBL1178786 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Inhibition of CCL5 binding to CCR5 expressed in CHO cellsInhibition of CCL5 binding to CCR5 expressed in CHO cells
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2011.07.058
183790 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Inhibition of CCR5Inhibition of CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2008.12.050
783 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Inhibition of CCR5Inhibition of CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2008.12.050
CHEMBL1178786 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Inhibition of CCR5Inhibition of CCR5
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.bmcl.2008.12.050
58835024 92641 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 570 8 1 6 5.5 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435852 92641 None 0 Human Binding pIC50 = 8.9 8.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 570 8 1 6 5.5 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516225 130692 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368375 130692 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 576 11 2 6 5.7 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(O)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
183790 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
783 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
CHEMBL1178786 3740 None 11 Human Binding pIC50 = 8.9 8.9 6 2
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
474160 12025 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 497 6 1 3 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1183361 12025 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 497 6 1 3 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL292548 12025 None 1 Human Binding pIC50 = 8.9 8.9 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 497 6 1 3 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
44273872 99573 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL283788 99573 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
44356944 119217 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343366 119217 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 509 10 1 6 4.3 CCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
516173 60293 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL174304 60293 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516173 60293 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL174304 60293 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44273872 99573 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL283788 99573 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 12 1 5 5.7 COC(=O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
3010265 183908 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL481274 183908 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
58835155 92644 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 8 1 6 5.6 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435855 92644 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 8 1 6 5.6 Cc1nc(Oc2ccc(C(=O)O)cc2)ccc1CN1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2cccc(F)c2)CC1 10.1021/jm401101p
486632 79552 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL2114183 79552 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
483369 164406 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL421342 164406 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
486604 205673 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82168 205673 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
3010265 183908 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL481274 183908 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 541 9 1 5 6.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516226 59640 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172090 59640 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516299 59935 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173202 59935 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 622 10 1 5 6.8 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516173 60293 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL174304 60293 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 546 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516301 128054 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 654 10 1 5 7.6 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366494 128054 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 654 10 1 5 7.6 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516268 131356 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368823 131356 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 590 10 1 6 6.0 CCn1nc(Cc2ccc(OC)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
474168 11257 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 551 6 1 3 6.9 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C(F)(F)F)cc4)ccc3OCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL1179044 11257 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 551 6 1 3 6.9 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C(F)(F)F)cc4)ccc3OCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL56565 11257 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 551 6 1 3 6.9 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C(F)(F)F)cc4)ccc3OCC2)cc1)C1CCOCC1 10.1021/jm9906264
483369 164406 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL421342 164406 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 622 14 0 7 5.9 CCCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461689 205651 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL81926 205651 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44590682 175173 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1cccc(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL457044 175173 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 509 10 1 3 5.6 CCN(C(=O)Cc1cccc(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44274090 76462 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL20598 76462 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
21341080 79734 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 4 6.3 O=C(CCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL21167 79734 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 534 10 1 4 6.3 O=C(CCC1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
3002977 2458 None 71 Human Binding pIC50 = 8.8 8.8 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
803 2458 None 71 Human Binding pIC50 = 8.8 8.8 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
806 2458 None 71 Human Binding pIC50 = 8.8 8.8 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL1201187 2458 None 71 Human Binding pIC50 = 8.8 8.8 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL256907 2458 None 71 Human Binding pIC50 = 8.8 8.8 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
CHEMBL584744 2458 None 71 Human Binding pIC50 = 8.8 8.8 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
DB04835 2458 None 71 Human Binding pIC50 = 8.8 8.8 -3 2
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml400370w
505881 29449 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138437 29449 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 537 10 1 6 5.0 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
516367 59717 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL172371 59717 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
516365 120273 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL352514 120273 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
516294 120382 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL353330 120382 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
57402175 71047 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 658 11 0 7 3.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)C(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951898 71047 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 658 11 0 7 3.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)C(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
44274090 76462 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL20598 76462 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 11 2 4 5.6 CC(O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/j.ejmech.2008.01.040
516365 120273 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL352514 120273 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 10 1 5 5.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010270 183802 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL480504 183802 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010270 183802 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL480504 183802 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 513 10 1 5 5.4 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516294 120382 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL353330 120382 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 586 10 1 5 6.6 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516247 127554 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366328 127554 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 12 1 6 7.2 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC(C)(C)C)cc4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516266 129744 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 10 1 7 5.4 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367461 129744 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 638 10 1 7 5.4 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516238 130618 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL368182 130618 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
44357375 116001 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL335562 116001 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1cncnc1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
11635721 72231 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198150 72231 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
11635721 72231 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL198150 72231 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 596 11 0 6 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
9810893 103539 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085307 103539 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
11513274 103541 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
CHEMBL3085309 103541 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 734 17 1 9 8.0 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3Cc2cnn(C)c2)cc1 10.1021/jm0509703
10186910 95179 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
CHEMBL255857 95179 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
25024699 92636 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
CHEMBL2435847 92636 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 558 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1021/jm401101p
72711956 92651 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435862 92651 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
59458103 92695 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435906 92695 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5275759 77114 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207630 77114 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 590 9 0 5 5.2 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C#N)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
11505350 168785 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL437494 168785 None 0 Human Binding pIC50 = 8.8 8.8 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 565 8 0 4 6.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Sc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516185 127811 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL366400 127811 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2cccc(C#N)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516302 130709 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 611 10 1 6 6.4 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368459 130709 None 1 Human Binding pIC50 = 8.8 8.8 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 611 10 1 6 6.4 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
9914742 166633 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL428104 166633 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
9914742 166633 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL428104 166633 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/s0960-894x(02)00988-5
9914742 166633 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL428104 166633 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 523 11 1 6 4.7 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@H](CC3CCC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.ejmech.2008.01.040
44447735 95139 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255646 95139 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
183790 3740 None 11 Human Binding pIC50 = 8.7 8.7 6 2
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
783 3740 None 11 Human Binding pIC50 = 8.7 8.7 6 2
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
CHEMBL1178786 3740 None 11 Human Binding pIC50 = 8.7 8.7 6 2
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/jm9906264
474167 12027 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 527 8 1 4 6.3 CCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1183370 12027 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 527 8 1 4 6.3 CCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL293393 12027 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 527 8 1 4 6.3 CCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCOCC4)cc2)CCO3)cc1 10.1021/jm9906264
3013575 75768 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL204821 75768 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 682 17 1 7 8.4 CCCCOCCOc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc([S+]([O-])Cc4cncn4CCC)cc2)CCN3CC(C)C)cc1 10.1021/jm0509703
76316241 85609 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 6 5.2 C=CCN(C(=O)c1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282503 85609 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 6 5.2 C=CCN(C(=O)c1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
486604 205673 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL82168 205673 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
11467704 205820 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL83335 205820 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
5275829 206026 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL85086 206026 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461628 105259 None 0 Human Binding pIC50 = 8 8.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL311532 105259 None 0 Human Binding pIC50 = 8 8.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461714 205346 None 0 Human Binding pIC50 = 8 8.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79667 205346 None 0 Human Binding pIC50 = 8 8.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
483344 5096 None 1 Human Binding pIC50 = 8 8.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 581 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105570 5096 None 1 Human Binding pIC50 = 8 8.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 581 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44335765 5436 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL107380 5436 None 0 Human Binding pIC50 = 8 8.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
5481702 205821 None 1 Human Binding pIC50 = 8 8.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
CHEMBL83338 205821 None 1 Human Binding pIC50 = 8 8.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
505867 29700 None 1 Human Binding pIC50 = 8 8.0 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138645 29700 None 1 Human Binding pIC50 = 8 8.0 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
54582105 62870 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2cc(F)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784400 62870 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2cc(F)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
44401731 171193 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 499 7 2 3 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3c[nH]c4ccccc34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL445925 171193 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 499 7 2 3 6.1 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3c[nH]c4ccccc34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
496972 108223 None 1 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL319689 108223 None 1 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
505867 29700 None 1 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL138645 29700 None 1 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 8 0 4 4.8 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496972 108223 None 1 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL319689 108223 None 1 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
46882916 5641 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.7 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077779 5641 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.7 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46883031 5725 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.4 CCCC[C@H]1CN(CC2CCCCO2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078335 5725 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.4 CCCC[C@H]1CN(CC2CCCCO2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
11786927 60966 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 624 10 1 7 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762463 60966 None 0 Human Binding pIC50 = 8 8.0 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 624 10 1 7 5.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2011.02.058
44461628 105259 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311532 105259 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.5 CCN(C(=O)Oc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461714 205346 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79667 205346 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 543 14 0 5 5.6 CCCCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481702 205821 None 1 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481702 205821 None 1 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL83338 205821 None 1 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83338 205821 None 1 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
16064151 121237 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 6 1 5 5.2 CC(C)[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
CHEMBL3577948 121237 None 0 Human Binding pIC50 = 8 8.0 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 6 1 5 5.2 CC(C)[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
5481702 205821 None 1 Human Binding pIC50 = 8 8.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL83338 205821 None 1 Human Binding pIC50 = 8 8.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
5275841 123315 None 1 Human Binding pIC50 = 8 8.0 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 5.2 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL361585 123315 None 1 Human Binding pIC50 = 8 8.0 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 5.2 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
72714321 92680 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
CHEMBL2435891 92680 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
76316185 85596 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 10 3 3 8.1 CCc1cccc(CC)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281968 85596 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 10 3 3 8.1 CCc1cccc(CC)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
76327120 85594 None 0 Human Binding pIC50 = 7 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 598 8 3 3 7.9 Cc1cc(C)c(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1007/s00044-012-0118-7
CHEMBL2281966 85594 None 0 Human Binding pIC50 = 7 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 598 8 3 3 7.9 Cc1cc(C)c(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1007/s00044-012-0118-7
478449 85610 None 1 Human Binding pIC50 = 7 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282504 85610 None 1 Human Binding pIC50 = 7 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
76309037 85613 None 0 Human Binding pIC50 = 7 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.2 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282507 85613 None 0 Human Binding pIC50 = 7 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.2 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461560 205307 None 0 Human Binding pIC50 = 7 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79315 205307 None 0 Human Binding pIC50 = 7 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
5481754 206466 None 1 Human Binding pIC50 = 7 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1007/s00044-011-9863-2
CHEMBL88159 206466 None 1 Human Binding pIC50 = 7 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1007/s00044-011-9863-2
489337 5618 None 2 Human Binding pIC50 = 7 7.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 9 2 3 6.5 CC(CCN1CCC(c2ccccc2)CC1)(CN1C(=O)N[C@H](Cc2c[nH]c3ccccc23)C1=O)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL107749 5618 None 2 Human Binding pIC50 = 7 7.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 9 2 3 6.5 CC(CCN1CCC(c2ccccc2)CC1)(CN1C(=O)N[C@H](Cc2c[nH]c3ccccc23)C1=O)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
5481704 164417 None 1 Human Binding pIC50 = 7 7.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL421356 164417 None 1 Human Binding pIC50 = 7 7.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
478496 206310 None 1 Human Binding pIC50 = 7 7.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1016/s0960-894x(00)00637-5
CHEMBL87167 206310 None 1 Human Binding pIC50 = 7 7.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1016/s0960-894x(00)00637-5
5481744 206546 None 1 Human Binding pIC50 = 7 7.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1016/s0960-894x(00)00637-5
CHEMBL88644 206546 None 1 Human Binding pIC50 = 7 7.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1016/s0960-894x(00)00637-5
5481750 206627 None 1 Human Binding pIC50 = 7 7.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1016/s0960-894x(00)00637-5
CHEMBL89167 206627 None 1 Human Binding pIC50 = 7 7.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1016/s0960-894x(00)00637-5
44392229 65624 None 0 Human Binding pIC50 = 7 7.0 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 8 1 2 5.5 CN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183406 65624 None 0 Human Binding pIC50 = 7 7.0 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 8 1 2 5.5 CN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54584053 62868 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 586 6 0 4 7.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2c(C(F)(F)F)nc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784398 62868 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 586 6 0 4 7.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2c(C(F)(F)F)nc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
44401734 69161 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc(=O)c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL192456 69161 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc(=O)c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
496970 4671 None 1 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL103268 4671 None 1 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
496970 4671 None 1 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL103268 4671 None 1 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1ccccc1CCCC1(O)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44431977 87975 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 599 8 3 4 6.8 Cc1cc(C)c(NC(=O)NCC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1016/j.bmcl.2007.01.050
CHEMBL234208 87975 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 599 8 3 4 6.8 Cc1cc(C)c(NC(=O)NCC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)c(C)c1 10.1016/j.bmcl.2007.01.050
44455001 97642 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL271076 97642 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
46882871 5686 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 6.0 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3ccccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077988 5686 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 6.0 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3ccccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882985 5708 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078141 5708 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
54586339 60888 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2C#N)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762317 60888 None 0 Human Binding pIC50 = 7 7.0 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2C#N)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
478440 104259 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL309922 104259 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44461560 205307 None 0 Human Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79315 205307 None 0 Human Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 COC(=O)N(Cc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481714 205334 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79566 205334 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44461831 205767 None 0 Human Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82879 205767 None 0 Human Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 547 12 0 4 5.5 CCCN(C(=O)c1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481716 205858 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1016/s0960-894x(01)00491-7
CHEMBL83745 205858 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1016/s0960-894x(01)00491-7
5481704 164417 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL421356 164417 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479858 206702 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 480 9 0 3 5.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL89715 206702 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 480 9 0 3 5.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
482147 206882 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL90747 206882 None 1 Human Binding pIC50 = 7 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479877 207018 None 2 Human Binding pIC50 = 7 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL91522 207018 None 2 Human Binding pIC50 = 7 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44273846 78223 None 0 Human Binding pIC50 = 6 6.0 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 2 4 4.8 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCP(=O)(O)c3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL21058 78223 None 0 Human Binding pIC50 = 6 6.0 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 542 11 2 4 4.8 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCP(=O)(O)c3ccccc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
76315543 85261 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cncc2ccccc12 10.1007/s00044-011-9863-2
CHEMBL2259881 85261 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cncc2ccccc12 10.1007/s00044-011-9863-2
76322864 85262 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 504 8 0 6 3.2 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1cn(C)cn1 10.1007/s00044-011-9863-2
CHEMBL2259882 85262 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 504 8 0 6 3.2 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1cn(C)cn1 10.1007/s00044-011-9863-2
76334365 85583 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 425 4 0 3 4.6 Brc1ccc(COc2ccc(Br)cc2N2CCOCC2)cc1 10.1007/s00044-012-0118-7
CHEMBL2281892 85583 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 425 4 0 3 4.6 Brc1ccc(COc2ccc(Br)cc2N2CCOCC2)cc1 10.1007/s00044-012-0118-7
76319944 85614 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 11 1 4 4.0 CCCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282508 85614 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 11 1 4 4.0 CCCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461785 104452 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 459 9 1 5 3.3 COC(=O)NC1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL310369 104452 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 459 9 1 5 3.3 COC(=O)NC1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
5481746 112780 None 1 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1007/s00044-011-9863-2
CHEMBL330570 112780 None 1 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1007/s00044-011-9863-2
11188669 145379 None 3 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1007/s00044-012-0118-7
CHEMBL391379 145379 None 3 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1007/s00044-012-0118-7
44461790 164562 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL421527 164562 None 0 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
478412 167968 None 1 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
CHEMBL431795 167968 None 1 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
5481703 205789 None 1 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83107 205789 None 1 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
478499 206500 None 1 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1007/s00044-011-9863-2
CHEMBL88344 206500 None 1 Human Binding pIC50 = 6 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1007/s00044-011-9863-2
5481741 111478 None 1 Human Binding pIC50 = 6 6.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 556 8 0 4 6.4 CN(Cc1ccccc1)C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL327703 111478 None 1 Human Binding pIC50 = 6 6.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 556 8 0 4 6.4 CN(Cc1ccccc1)C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
5481705 163479 None 1 Human Binding pIC50 = 6 6.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL420057 163479 None 1 Human Binding pIC50 = 6 6.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
11502371 153126 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of MIP1-alpha from CCR5 receptorDisplacement of MIP1-alpha from CCR5 receptor
ChEMBL 407 5 1 2 5.0 C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C1CCOCC1 10.1016/j.bmcl.2007.01.115
CHEMBL397647 153126 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of MIP1-alpha from CCR5 receptorDisplacement of MIP1-alpha from CCR5 receptor
ChEMBL 407 5 1 2 5.0 C[N+](C)(Cc1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1)C1CCOCC1 10.1016/j.bmcl.2007.01.115
57403173 67868 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 409 9 1 4 3.7 N#Cc1cccc(C(=O)NCCCN2CCC(COCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910166 67868 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 409 9 1 4 3.7 N#Cc1cccc(C(=O)NCCCN2CCC(COCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2011.09.013
6479877 12511 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]-gp120 from human CCR5Displacement of [125I]-gp120 from human CCR5
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL1186558 12511 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]-gp120 from human CCR5Displacement of [125I]-gp120 from human CCR5
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL2057533 12511 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]-gp120 from human CCR5Displacement of [125I]-gp120 from human CCR5
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
CHEMBL469649 12511 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]-gp120 from human CCR5Displacement of [125I]-gp120 from human CCR5
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1016/j.bmcl.2011.07.058
15485365 188658 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 8 1 4 6.3 O=C1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL503631 188658 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 8 1 4 6.3 O=C1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
11188669 145379 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL391379 145379 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2006.09.052
11188669 145379 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL391379 145379 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 0 3 4.5 Clc1ccc(COc2ccc(Br)cc2CN2CCOCC2)cc1 10.1016/j.bmcl.2007.01.050
6479877 12511 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1021/np049974l
CHEMBL1186558 12511 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1021/np049974l
CHEMBL2057533 12511 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1021/np049974l
CHEMBL469649 12511 None 3 Human Binding pIC50 = 6 6.0 - 0
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 424 16 0 0 9.1 CCCCCCCC/C=C\c1c(C)c(/C=C\CCCCCCCC)c2[n+](c1C)CCC2 10.1021/np049974l
53326700 58461 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683066 58461 None 0 Human Binding pIC50 = 6 6.0 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
11329244 71114 None 11 Human Binding pIC50 = 6 6.0 - 0
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 71114 None 11 Human Binding pIC50 = 6 6.0 - 0
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11272103 124373 None 0 Human Binding pIC50 = 6 6.0 - 0
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 124373 None 0 Human Binding pIC50 = 6 6.0 - 0
Inhibition of C-C chemokine receptor type 5Inhibition of C-C chemokine receptor type 5
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
21148035 79554 None 0 Human Binding pIC50 = 6 6.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 9 0 5 3.4 CN(C[C@@H](CCN1CCC(N2CCOC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL2114185 79554 None 0 Human Binding pIC50 = 6 6.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 9 0 5 3.4 CN(C[C@@H](CCN1CCC(N2CCOC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44461790 164562 None 0 Human Binding pIC50 = 6 6.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL421527 164562 None 0 Human Binding pIC50 = 6 6.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 9 1 5 4.5 CN(C[C@@H](CCN1CCC(NC(=O)OC(C)(C)C)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
478439 205865 None 1 Human Binding pIC50 = 6 6.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83773 205865 None 1 Human Binding pIC50 = 6 6.0 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481705 163479 None 1 Human Binding pIC50 = 6 6.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL420057 163479 None 1 Human Binding pIC50 = 6 6.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
478307 105817 None 1 Human Binding pIC50 = 5 5.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL312701 105817 None 1 Human Binding pIC50 = 5 5.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5482809 164267 None 1 Human Binding pIC50 = 5 5.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 588 9 0 4 7.3 CCN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL421168 164267 None 1 Human Binding pIC50 = 5 5.0 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 588 9 0 4 7.3 CCN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
11224188 87657 None 0 Human Binding pIC50 = 5 5.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL233635 87657 None 0 Human Binding pIC50 = 5 5.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
11224188 87657 None 0 Human Binding pIC50 = 5 5.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL233635 87657 None 0 Human Binding pIC50 = 5 5.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 429 7 0 2 6.3 CN(Cc1ccccc1)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
44590849 176708 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CC(N(C)C2CCN(C(c3ccccc3)c3ccccc3)CC2)C1 10.1016/j.bmcl.2009.01.012
CHEMBL459985 176708 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CC(N(C)C2CCN(C(c3ccccc3)c3ccccc3)CC2)C1 10.1016/j.bmcl.2009.01.012
10393635 172608 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 5.9 O=C1CC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL449125 172608 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 5.9 O=C1CC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
44570307 178311 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 4 0 6 3.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC3(CC2)CCN(S(C)(=O)=O)CC3c2ccccc2)CC1 10.1016/j.bmcl.2008.10.115
CHEMBL465106 178311 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 4 0 6 3.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC3(CC2)CCN(S(C)(=O)=O)CC3c2ccccc2)CC1 10.1016/j.bmcl.2008.10.115
483362 14524 None 1 Human Binding pIC50 = 5.0 5.0 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120204 14524 None 1 Human Binding pIC50 = 5.0 5.0 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44404656 135274 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 551 10 1 5 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(N)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372640 135274 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 551 10 1 5 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(N)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
3007227 59594 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8gInhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8g
ChEMBL 582 11 1 5 6.6 CCc1cc(CCc2ccccc2)nn1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL171911 59594 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8gInhibitory activity against human CX3C chemokine receptor 5 when co-administered with compound 8g
ChEMBL 582 11 1 5 6.6 CCc1cc(CCc2ccccc2)nn1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
11204472 60970 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 638 10 1 7 6.6 COC(=O)c1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
CHEMBL1762468 60970 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 638 10 1 7 6.6 COC(=O)c1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
10186910 95179 None 0 Crab-eating macaque Binding pIC50 = 7.0 7.0 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
CHEMBL255857 95179 None 0 Crab-eating macaque Binding pIC50 = 7.0 7.0 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 533 6 0 6 4.9 Cc1nc(CN(c2ccccc2)C2CCN(C3(C)CCN(C(=O)c4c(C)cc[n+]([O-])c4C)CC3)CC2)cs1 10.1016/j.bmcl.2008.01.108
53322809 58455 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683060 58455 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
4716524 87469 None 3 Human Binding pIC50 = 6.0 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL233385 87469 None 3 Human Binding pIC50 = 6.0 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
44431965 89894 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
CHEMBL237896 89894 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
44374088 120076 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL350763 120076 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
25230970 188619 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 590 7 0 7 3.3 CCCCC1CN(S(=O)(=O)N2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL502927 188619 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 590 7 0 7 3.3 CCCCC1CN(S(=O)(=O)N2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
46888455 8765 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 447 7 1 3 4.2 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C(C)C)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096447 8765 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 447 7 1 3 4.2 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C(C)C)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44404644 135291 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 687 14 1 6 6.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372733 135291 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 687 14 1 6 6.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
44573335 187299 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 5 1 5 5.0 CN/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492960 187299 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 5 1 5 5.0 CN/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
11569805 13923 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196449 13923 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL556995 13923 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
16730521 87831 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 613 10 3 4 7.0 CCc1cccc(CC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL233847 87831 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 613 10 3 4 7.0 CCc1cccc(CC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
52944537 18310 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 8 0 5 4.4 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270693 18310 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 8 0 5 4.4 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
11527582 76426 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205964 76426 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 664 10 1 5 5.9 CC(C)(C)NC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
10208080 13061 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
CHEMBL1190106 13061 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
CHEMBL540108 13061 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 10 1 4 4.7 C=CCOc1ccc(CN2CCC3(CC2)C(=O)NC(CC2CCCCC2)C(=O)N3CCCC)cc1 10.1021/jm060051s
44384969 168279 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 594 10 1 5 6.9 CCn1ncc(C2(c3ccccc3)CC2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL433980 168279 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 594 10 1 5 6.9 CCn1ncc(C2(c3ccccc3)CC2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
5275835 122932 None 1 Human Binding pIC50 = 8.0 8.0 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL360667 122932 None 1 Human Binding pIC50 = 8.0 8.0 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
59458213 92693 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435904 92693 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 8 1 4 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
516357 188256 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
CHEMBL499793 188256 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
44384011 59952 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL173262 59952 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516357 188256 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
CHEMBL499793 188256 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 9 2 4 6.7 CC(C)(c1ccccc1)c1cc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)[nH]n1 10.1016/j.ejmech.2008.01.040
72714320 92679 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435890 92679 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
505875 25973 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL135432 25973 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
505868 27777 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137072 27777 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
20664115 180105 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL474838 180105 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44392220 64688 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 1 3 6.1 C=CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181858 64688 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 1 3 6.1 C=CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392111 122512 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 0 4 5.7 CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360106 122512 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 0 4 5.7 CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16073672 141057 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 638 12 0 6 5.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL382436 141057 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 638 12 0 6 5.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
479853 112011 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328908 112011 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479873 206468 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1F 10.1016/s0960-894x(00)00639-9
CHEMBL88164 206468 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1F 10.1016/s0960-894x(00)00639-9
479859 206767 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 10 0 3 5.9 CCc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
CHEMBL90141 206767 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 10 0 3 5.9 CCc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
479847 206985 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL91374 206985 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 606 8 0 5 5.6 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
474165 11285 None 2 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 481 6 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(CC[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179191 11285 None 2 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 481 6 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(CC[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL64163 11285 None 2 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 481 6 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(CC[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
44392147 166300 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 516 11 0 5 5.4 COc1cc(OC)c(OC)cc1CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL427144 166300 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 516 11 0 5 5.4 COc1cc(OC)c(OC)cc1CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728626 91206 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 396 5 3 3 4.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc2ccccc12 10.1016/j.bmcl.2006.09.052
CHEMBL239998 91206 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 396 5 3 3 4.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc2ccccc12 10.1016/j.bmcl.2006.09.052
4716524 87469 None 3 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL233385 87469 None 3 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 6 1 2 4.8 CCNCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
44431965 89894 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL237896 89894 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 522 7 2 5 4.5 OC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
474154 11281 None 2 Human Binding pIC50 = 6.0 6.0 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 6 1 1 6.5 C[N+]1(CCc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
CHEMBL1179158 11281 None 2 Human Binding pIC50 = 6.0 6.0 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 6 1 1 6.5 C[N+]1(CCc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
CHEMBL62611 11281 None 2 Human Binding pIC50 = 6.0 6.0 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 6 1 1 6.5 C[N+]1(CCc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
483356 12354 None 1 Human Binding pIC50 = 5.0 5.0 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 647 14 0 7 7.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL118544 12354 None 1 Human Binding pIC50 = 5.0 5.0 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 647 14 0 7 7.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
2600 3777 None 74 Human Binding pIC50 = 6.0 6.0 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
2608 3777 None 74 Human Binding pIC50 = 6.0 6.0 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
5405 3777 None 74 Human Binding pIC50 = 6.0 6.0 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
CHEMBL17157 3777 None 74 Human Binding pIC50 = 6.0 6.0 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
DB00342 3777 None 74 Human Binding pIC50 = 6.0 6.0 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
483332 4883 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnc(-c3ccccc3)n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104464 4883 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnc(-c3ccccc3)n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
483343 5116 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 536 11 0 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105659 5116 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 536 11 0 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
516346 131341 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368757 131341 None 1 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
155491018 174081 None 1 Human Binding pIC50 = 7.0 7.0 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4544504 174081 None 1 Human Binding pIC50 = 7.0 7.0 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 395 3 2 5 3.1 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Br)c1 10.1021/acs.jmedchem.9b00742
72711281 92690 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
CHEMBL2435901 92690 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 547 8 1 6 4.6 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)n1 10.1021/jm401101p
5481712 105902 None 1 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL312808 105902 None 1 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
16728630 151005 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL395843 151005 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
486595 205922 None 1 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
CHEMBL84120 205922 None 1 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
5481707 206597 None 1 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
CHEMBL88976 206597 None 1 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
25205767 7114 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 598 6 0 6 4.9 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085225 7114 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 598 6 0 6 4.9 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46890428 7226 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 599 6 0 7 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@@H]3c3ccccn3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085721 7226 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 599 6 0 7 4.3 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@@H]3c3ccccn3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888565 8712 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 499 7 1 5 4.0 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095827 8712 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 499 7 1 5 4.0 Cc1cc(C#N)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888583 8989 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 557 8 1 5 4.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098357 8989 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 557 8 1 5 4.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
505875 25973 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL135432 25973 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505868 27777 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137072 27777 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44404724 135200 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 564 11 0 5 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(SC)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372134 135200 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 564 11 0 5 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(SC)cc2)CC1 10.1016/j.bmcl.2005.08.014
44401763 68630 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL191803 68630 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44401863 70206 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc4c3=O)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL194078 70206 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc4c3=O)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
496985 107390 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccncc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL317908 107390 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccncc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
505875 25973 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL135432 25973 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 487 8 0 5 4.8 C=CCN(c1ncccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
505868 27777 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137072 27777 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 488 8 0 4 5.6 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
20664115 180105 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL474838 180105 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3nnc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
46883029 5785 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 571 7 0 7 4.8 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(=O)oc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078712 5785 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 571 7 0 7 4.8 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(=O)oc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44447735 95139 None 0 Crab-eating macaque Binding pIC50 = 7.9 7.9 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255646 95139 None 0 Crab-eating macaque Binding pIC50 = 7.9 7.9 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccn3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008930 198678 None 1 Crab-eating macaque Binding pIC50 = 7.9 7.9 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58004 198678 None 1 Crab-eating macaque Binding pIC50 = 7.9 7.9 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
11692945 76531 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL206088 76531 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3C(N)=O)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516352 168538 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 574 9 2 5 6.2 COc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)[nH]n2)cc1 10.1016/j.bmcl.2003.12.004
CHEMBL435526 168538 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 574 9 2 5 6.2 COc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4cccc(F)c4)CC3)[nH]n2)cc1 10.1016/j.bmcl.2003.12.004
490008 207410 None 2 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 537 7 0 4 5.9 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL93961 207410 None 2 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 537 7 0 4 5.9 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
489594 112754 None 2 Human Binding pIC50 = 6.9 6.9 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
CHEMBL330528 112754 None 2 Human Binding pIC50 = 6.9 6.9 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
5481752 106892 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cnc2ccccc2c1 10.1016/s0960-894x(00)00637-5
CHEMBL314551 106892 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cnc2ccccc2c1 10.1016/s0960-894x(00)00637-5
5481707 206597 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
CHEMBL88976 206597 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 612 8 0 6 5.7 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
54580468 60890 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762319 60890 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
44461623 167833 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL430818 167833 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481726 205759 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL82838 205759 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
486608 205936 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 486 10 1 4 3.6 CCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL84268 205936 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 486 10 1 4 3.6 CCN(C(=O)NC)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478308 111433 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 462 9 0 3 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL327484 111433 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 462 9 0 3 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
478418 85611 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282505 85611 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 471 10 0 4 3.8 CCN(C(C)=O)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
478439 205865 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL83773 205865 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 458 9 2 4 2.9 CNC(=O)NC1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
16728630 151005 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL395843 151005 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 347 6 3 5 2.6 N=C(N)N/N=C/c1cc([N+](=O)[O-])ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
77281925 187755 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@](C)(O)C(=O)O)C1=O 10.1021/np060121y
CHEMBL495654 187755 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@](C)(O)C(=O)O)C1=O 10.1021/np060121y
474151 11292 None 2 Human Binding pIC50 = 5.9 5.9 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 5 1 2 5.3 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCOCC1 10.1021/jm9906264
CHEMBL1179234 11292 None 2 Human Binding pIC50 = 5.9 5.9 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 5 1 2 5.3 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCOCC1 10.1021/jm9906264
CHEMBL65649 11292 None 2 Human Binding pIC50 = 5.9 5.9 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 5 1 2 5.3 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCOCC1 10.1021/jm9906264
516346 131341 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368757 131341 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516346 131341 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368757 131341 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 583 10 2 6 6.0 CCn1nc(-c2ccc(CN)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
54581478 60881 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 538 6 1 5 5.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2=NOCc3cc(Br)ccc32)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762309 60881 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 538 6 1 5 5.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2=NOCc3cc(Br)ccc32)CC1 10.1016/j.bmcl.2011.02.058
155554273 174211 None 0 Human Binding pIC50 = 6.9 6.9 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4548396 174211 None 0 Human Binding pIC50 = 6.9 6.9 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1ccc(Cl)c(Cl)c1 10.1021/acs.jmedchem.9b00742
44590395 178961 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL470578 178961 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
66768640 121224 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 515 13 6 5 2.6 CCC[C@H](O)[C@H](CNCC1CC1)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
CHEMBL3577934 121224 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 515 13 6 5 2.6 CCC[C@H](O)[C@H](CNCC1CC1)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
25131901 103280 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 7 0 4 7.2 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084490 103280 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 546 7 0 4 7.2 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
3011725 71052 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951903 71052 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
44573098 187359 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 496 6 1 7 4.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2nnn[nH]2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL493312 187359 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 496 6 1 7 4.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2nnn[nH]2)CC1 10.1016/j.bmcl.2009.02.014
483347 107383 None 2 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 621 12 2 5 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL317860 107383 None 2 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 621 12 2 5 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
46888582 8709 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 507 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095816 8709 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 507 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
11421221 63761 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL180155 63761 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
44565874 178959 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL470512 178959 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
44573301 169648 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 554 6 0 6 6.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL443730 169648 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 554 6 0 6 6.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC(C)C)CC1 10.1016/j.bmcl.2009.02.014
44573341 188331 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 604 8 0 6 7.5 COC(=O)C(c1cccc(C)c1C)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL500824 188331 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 604 8 0 6 7.5 COC(=O)C(c1cccc(C)c1C)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
44573252 193100 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 7 0 6 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncco2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL522659 193100 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 509 7 0 6 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncco2)CC1 10.1016/j.bmcl.2009.02.014
44565874 178959 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470512 178959 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3ncc4ccccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
46880850 7477 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.9 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOCC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087028 7477 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.9 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOCC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
56647076 92670 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435881 92670 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
516188 61276 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 547 10 1 6 5.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176655 61276 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 547 10 1 6 5.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
73355478 92666 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435877 92666 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
44590717 189555 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 475 10 1 3 5.0 CCN(C(=O)Cc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL514410 189555 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 475 10 1 3 5.0 CCN(C(=O)Cc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
72714078 92674 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435885 92674 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5482810 107000 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.3 CCN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL315293 107000 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.3 CCN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
44404641 72534 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 637 12 1 5 6.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199119 72534 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 637 12 1 5 6.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
54585384 60879 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 554 9 1 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762307 60879 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 554 9 1 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
11410758 60883 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 589 9 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762312 60883 None 1 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 589 9 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
11193076 60968 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 648 9 1 5 7.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C(F)(F)F)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762466 60968 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 648 9 1 5 7.9 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C(F)(F)F)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
57398009 67870 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 460 6 0 4 4.4 COc1ccc(C)cc1S(=O)(=O)N1CCC(CN2CCC(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.09.013
CHEMBL1910168 67870 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 460 6 0 4 4.4 COc1ccc(C)cc1S(=O)(=O)N1CCC(CN2CCC(c3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2011.09.013
16728618 91804 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241251 91804 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
11408704 87000 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL232412 87000 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44431953 88290 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234844 88290 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44431926 145377 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL391378 145377 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1016/j.bmcl.2007.01.050
3377049 90011 None 2 Human Binding pIC50 = 5.9 5.9 - 0
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 357 5 1 5 2.8 CC1CCCN(CC(O)COc2ccc3c4c(c(=O)oc3c2)CCC4)C1 10.1021/acs.jmedchem.6b01309
CHEMBL2381331 90011 None 2 Human Binding pIC50 = 5.9 5.9 - 0
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 357 5 1 5 2.8 CC1CCCN(CC(O)COc2ccc3c4c(c(=O)oc3c2)CCC4)C1 10.1021/acs.jmedchem.6b01309
479838 111618 None 1 Human Binding pIC50 = 5.9 5.9 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328438 111618 None 1 Human Binding pIC50 = 5.9 5.9 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
11408704 87000 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL232412 87000 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 465 7 0 4 5.5 CCOC(=O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
44431953 88290 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234844 88290 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 1 3 4.9 NCC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
16728618 91804 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL241251 91804 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
44431926 145377 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1007/s00044-012-0118-7
CHEMBL391378 145377 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 379 5 0 2 5.3 Clc1ccc(COc2ccc(Br)cc2CN2CCCC2)cc1 10.1007/s00044-012-0118-7
16073664 138747 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(OC)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL378035 138747 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(OC)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
73355478 92666 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435877 92666 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 509 7 0 3 7.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(Oc3ccccc3)cc2)CC1 10.1021/jm401101p
52942058 18296 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 511 8 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270594 18296 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 511 8 0 5 4.2 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
66768099 121222 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 517 13 6 5 2.9 CCC[C@H](O)[C@H](CNCC(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
CHEMBL3577932 121222 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 517 13 6 5 2.9 CCC[C@H](O)[C@H](CNCC(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
16728643 147799 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL393274 147799 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
76323541 85600 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 367 6 0 2 5.5 CCN(CC)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL2281971 85600 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 367 6 0 2 5.5 CCN(CC)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
11350639 88065 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL234634 88065 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
5481751 106971 None 1 Human Binding pIC50 = 4.9 4.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1007/s00044-011-9863-2
CHEMBL315084 106971 None 1 Human Binding pIC50 = 4.9 4.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1007/s00044-011-9863-2
44373973 51166 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL157983 51166 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
44590583 174725 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 517 11 1 4 5.1 CCN(C(=O)Cc1ccc(OC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2009.01.009
CHEMBL456019 174725 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 517 11 1 4 5.1 CCN(C(=O)Cc1ccc(OC)cc1)[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2009.01.009
3002977 2458 None 71 Human Binding pIC50 = 7.9 7.9 -3 2
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
803 2458 None 71 Human Binding pIC50 = 7.9 7.9 -3 2
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
806 2458 None 71 Human Binding pIC50 = 7.9 7.9 -3 2
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
CHEMBL1201187 2458 None 71 Human Binding pIC50 = 7.9 7.9 -3 2
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
CHEMBL256907 2458 None 71 Human Binding pIC50 = 7.9 7.9 -3 2
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
CHEMBL584744 2458 None 71 Human Binding pIC50 = 7.9 7.9 -3 2
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
DB04835 2458 None 71 Human Binding pIC50 = 7.9 7.9 -3 2
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmcl.2010.03.095
46888563 8665 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095517 8665 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 5 3.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888524 8889 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 7 1 3 5.4 O=C(N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(Cl)cccc3Cl)C[C@H]2C1)c1ccccc1)C1CCCC1 10.1016/j.bmcl.2010.03.095
CHEMBL1097515 8889 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 513 7 1 3 5.4 O=C(N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(Cl)cccc3Cl)C[C@H]2C1)c1ccccc1)C1CCCC1 10.1016/j.bmcl.2010.03.095
505865 29277 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL138282 29277 None 1 Human Binding pIC50 = 7.9 7.9 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 516 8 0 4 6.0 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44373973 51166 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL157983 51166 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 588 9 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
46882076 5608 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 567 7 0 7 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077358 5608 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 567 7 0 7 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
72714076 92672 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435883 92672 None 0 Human Binding pIC50 = 7.9 7.9 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711740 92698 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435909 92698 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 581 9 1 5 5.2 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
16728643 147799 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL393274 147799 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
11444710 60893 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762326 60893 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
54581480 60896 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccnc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
CHEMBL1762330 60896 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccnc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
11490468 60902 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ncccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762336 60902 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ncccc2Cl)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
489811 111501 None 2 Human Binding pIC50 = 6.9 6.9 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327800 111501 None 2 Human Binding pIC50 = 6.9 6.9 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
489812 207066 None 2 Human Binding pIC50 = 6.9 6.9 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1cccc(C(=O)N2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL91793 207066 None 2 Human Binding pIC50 = 6.9 6.9 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 454 6 0 3 5.4 COc1cccc(C(=O)N2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)c1 10.1016/s0960-894x(01)00545-5
478495 206926 None 1 Human Binding pIC50 = 5.9 5.9 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL91045 206926 None 1 Human Binding pIC50 = 5.9 5.9 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
44392155 65839 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1cccc(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183514 65839 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1cccc(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11350639 88065 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL234634 88065 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
11350639 88065 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL234634 88065 None 0 Human Binding pIC50 = 5.9 5.9 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 381 7 0 2 5.5 CCN(CC)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
16728648 91219 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1016/j.bmcl.2006.09.052
CHEMBL240037 91219 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1016/j.bmcl.2006.09.052
10483364 193074 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 7 1 5 5.6 O=C(c1ccco1)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL522493 193074 None 0 Human Binding pIC50 = 6.9 6.9 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 7 1 5 5.6 O=C(c1ccco1)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
16728788 83434 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
CHEMBL219770 83434 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 450 7 1 7 3.4 Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)CSc1nnc(C)n1-c1ccccc1 10.1021/jm061389p
16728648 91219 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1007/s00044-012-0118-7
CHEMBL240037 91219 None 0 Human Binding pIC50 = 4.9 4.9 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 1 5 3.9 CN(/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1)C1=NCCN1 10.1007/s00044-012-0118-7
25057602 5775 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 517 7 0 4 6.0 CCCCC1N(Cc2ccccc2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078647 5775 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 517 7 0 4 6.0 CCCCC1N(Cc2ccccc2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44590332 179048 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 7 1 3 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(CNC(=O)C3CC3)(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471403 179048 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 7 1 3 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(CNC(=O)C3CC3)(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2009.01.012
91884571 181458 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 471 5 3 5 2.5 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(C)(C)C)n2)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4764460 181458 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 471 5 3 5 2.5 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(C)(C)C)n2)C1=O 10.1021/acsmedchemlett.1c00082
10053691 192633 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 1 5 5.2 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL521699 192633 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 1 5 5.2 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
11246827 87973 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234206 87973 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
11177360 147263 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
CHEMBL392868 147263 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
478494 206637 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1007/s00044-011-9863-2
CHEMBL89221 206637 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1007/s00044-011-9863-2
76308985 85586 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 570 8 3 3 7.3 Cc1ccc(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)cc1 10.1007/s00044-012-0118-7
CHEMBL2281958 85586 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 570 8 3 3 7.3 Cc1ccc(NC(=O)NCC2(O)CCC(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)cc1 10.1007/s00044-012-0118-7
5481716 205858 None 1 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1007/s00044-011-9863-2
CHEMBL83745 205858 None 1 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 551 8 0 4 5.2 CN1C(=O)c2ccccc2C12CCN(CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1cccc(Cl)c1)CC2 10.1007/s00044-011-9863-2
483335 5619 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 13 0 8 5.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(CC#N)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL107750 5619 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 13 0 8 5.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(CC#N)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
483336 109652 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 562 13 0 9 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc([N+](=O)[O-])c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL322439 109652 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 562 13 0 9 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc([N+](=O)[O-])c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
483330 110571 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2ncc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL325357 110571 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2ncc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
46888454 8764 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 419 6 1 3 3.6 CC(=O)N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(C)cccc3C)C[C@H]2C1)c1ccccc1 10.1016/j.bmcl.2010.03.095
CHEMBL1096446 8764 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 419 6 1 3 3.6 CC(=O)N[C@@H](CCN1C[C@H]2CN(C(=O)c3c(C)cccc3C)C[C@H]2C1)c1ccccc1 10.1016/j.bmcl.2010.03.095
46888497 8964 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 4 3.6 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098151 8964 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 475 7 1 4 3.6 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
57403931 71046 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 618 12 0 7 3.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951897 71046 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 618 12 0 7 3.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
44454999 97641 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL271075 97641 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1)c1ccccc1 10.1016/j.bmcl.2007.12.058
46882077 5609 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 591 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077359 5609 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 591 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
44461559 104168 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL309657 104168 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461521 167858 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL431009 167858 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481703 205789 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83107 205789 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481703 205789 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL83107 205789 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 572 8 0 5 5.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
490011 111391 None 2 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 495 7 0 4 5.1 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327186 111391 None 2 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 495 7 0 4 5.1 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44461559 104168 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL309657 104168 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 569 12 0 5 6.0 CCN(C(=O)OCC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461521 167858 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL431009 167858 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 515 12 0 5 4.8 CCCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
73346389 92668 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435879 92668 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
16041594 92638 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 555 8 1 5 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435849 92638 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 555 8 1 5 5.8 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
25132254 62860 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784384 62860 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
54582110 62879 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm200279v
CHEMBL1784479 62879 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm200279v
25133962 103285 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084495 103285 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 600 6 0 4 8.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
478501 105977 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1016/s0960-894x(00)00637-5
CHEMBL313072 105977 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1016/s0960-894x(00)00637-5
44392130 122375 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 471 9 0 4 5.3 CN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360044 122375 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 471 9 0 4 5.3 CN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11246827 87973 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234206 87973 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 407 5 0 3 4.8 O=C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
11177360 147263 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
CHEMBL392868 147263 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
44461774 169111 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL440137 169111 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
489835 207803 None 2 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 428 6 0 2 5.9 Fc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL96217 207803 None 2 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 428 6 0 2 5.9 Fc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
44431969 89960 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 575 8 3 4 6.0 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1ccc(F)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL238118 89960 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 575 8 3 4 6.0 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1ccc(F)cc1 10.1016/j.bmcl.2007.01.050
483360 12310 None 1 Human Binding pIC50 = 4.8 4.8 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 569 14 0 6 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CCC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL118501 12310 None 1 Human Binding pIC50 = 4.8 4.8 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 569 14 0 6 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CCC(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
3010252 113803 None 1 Human Binding pIC50 = 4.8 4.8 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 585 14 0 7 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL332458 113803 None 1 Human Binding pIC50 = 4.8 4.8 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 585 14 0 7 6.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44461774 169111 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL440137 169111 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 473 9 0 5 3.6 COC(=O)N(C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
473305 112300 None 2 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 460 6 0 3 5.0 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329131 112300 None 2 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 460 6 0 3 5.0 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
72714318 92677 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
CHEMBL2435888 92677 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
489807 207292 None 2 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 438 6 0 2 5.4 O=C(Cc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93229 207292 None 2 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 438 6 0 2 5.4 O=C(Cc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
155531379 171603 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 532 7 1 5 2.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](N(C)S(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4465351 171603 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 532 7 1 5 2.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](N(C)S(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
54581070 62869 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 610 7 0 6 6.2 Cc1nc2cc(S(C)(=O)=O)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784399 62869 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 610 7 0 6 6.2 Cc1nc2cc(S(C)(=O)=O)ccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
23294214 169158 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 7 1 4 6.9 O=C(c1ccccc1)N1CCCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL440465 169158 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 7 1 4 6.9 O=C(c1ccccc1)N1CCCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
16728619 90639 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL238949 90639 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
483337 5097 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 585 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(Cl)c2Cl)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105572 5097 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 585 12 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(Cl)c2Cl)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
516345 59817 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL172761 59817 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3013673 76957 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
CHEMBL207085 76957 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 461 8 0 3 4.6 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccccc3)CC2)c2ccccc2)CC1 10.1021/jm051034q
516349 59865 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 622 9 1 5 7.8 CCn1nc(-c2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL172944 59865 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 622 9 1 5 7.8 CCn1nc(-c2cccc3ccccc23)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
516345 59817 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL172761 59817 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 579 9 1 6 6.4 CCn1nc(-c2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
6320581 122785 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 527 8 0 5 4.8 CN(C[C@@H](CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL360522 122785 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 527 8 0 5 4.8 CN(C[C@@H](CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
72714076 92672 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435883 92672 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5482811 112824 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 CCN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL330734 112824 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 CCN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
479868 207083 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1cc(C)cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
CHEMBL91892 207083 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1cc(C)cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
5482807 106856 None 1 Human Binding pIC50 = 5.8 5.8 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 560 8 1 4 6.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL314486 106856 None 1 Human Binding pIC50 = 5.8 5.8 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 560 8 1 4 6.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
16728619 90639 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL238949 90639 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 404 6 3 5 2.6 COC(=O)c1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
11534473 90697 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 14 1 5 8.0 CCN(CC)CCCC(NC(=O)CCOc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1)C(C)C 10.1016/j.bmcl.2006.10.060
CHEMBL239144 90697 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 14 1 5 8.0 CCN(CC)CCCC(NC(=O)CCOc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1)C(C)C 10.1016/j.bmcl.2006.10.060
57400373 71050 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951901 71050 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
42606792 109806 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 517 7 1 5 3.0 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL3233178 109806 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 517 7 1 5 3.0 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
44564931 189508 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 467 8 1 6 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL514000 189508 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 467 8 1 6 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
76319890 85593 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 662 8 3 3 8.3 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281965 85593 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 662 8 3 3 8.3 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
11267381 87829 None 2 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL233845 87829 None 2 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
16728622 91079 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL239783 91079 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
16728616 91568 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-012-0118-7
CHEMBL240638 91568 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1007/s00044-012-0118-7
16728625 147526 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1007/s00044-012-0118-7
CHEMBL393068 147526 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1007/s00044-012-0118-7
11690481 83522 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 428 7 1 4 4.5 Cc1nc2ccccc2n1C1[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@H]12 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203618 83522 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 428 7 1 4 4.5 Cc1nc2ccccc2n1C1[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@H]12 10.1111/j.1747-0285.2006.00376.x
10228761 13927 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1196469 13927 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL557150 13927 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 463 8 1 4 4.6 CCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
490010 207807 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 509 7 0 4 5.5 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL96242 207807 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 509 7 0 4 5.5 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
54581076 62882 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 7 0 5 6.8 COc1cccc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1 10.1021/jm200279v
CHEMBL1784483 62882 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 7 0 5 6.8 COc1cccc(C(=O)N2CCC(CCN3C4CCC3CC(n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1 10.1021/jm200279v
44590718 174799 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccccc1OC)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL456224 174799 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccccc1OC)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
489595 167878 None 2 Human Binding pIC50 = 6.8 6.8 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
CHEMBL431111 167878 None 2 Human Binding pIC50 = 6.8 6.8 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
44431976 147432 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 663 8 3 4 7.2 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL393002 147432 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 663 8 3 4 7.2 Cc1cc(Br)cc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
16728622 91079 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL239783 91079 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
16728616 91568 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1016/j.bmcl.2006.09.052
CHEMBL240638 91568 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc([N+](=O)[O-])c1 10.1016/j.bmcl.2006.09.052
16728625 147526 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL393068 147526 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 422 6 3 3 4.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(-c2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
11267381 87829 None 2 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL233845 87829 None 2 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 325 4 1 2 4.1 NCc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
1167892 83436 None 1 Human Binding pIC50 = 4.8 4.8 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
CHEMBL219781 83436 None 1 Human Binding pIC50 = 4.8 4.8 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 463 9 1 6 4.7 Cc1ccc(NC(=O)CSc2nnc(CCN3CCCCC3)n2Cc2ccccc2)c(C)c1 10.1021/jm061389p
54587374 60876 None 0 Human Binding pIC50 = 4.8 4.8 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 8 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762303 60876 None 0 Human Binding pIC50 = 4.8 4.8 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 8 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
72714317 92676 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
CHEMBL2435887 92676 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 546 8 1 5 5.2 Cc1ccccc1C1CN(C2CCCCC2)C(=O)N1C1CCN(C(C)CCNC(=O)c2c(C)ncnc2C)CC1 10.1021/jm401101p
72711050 92684 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435895 92684 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44565035 186818 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 7 1 6 3.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489323 186818 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 7 1 6 3.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCOCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
54585369 60574 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 568 9 1 5 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1760024 60574 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 568 9 1 5 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
54580093 62878 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)cc2)CC1 10.1021/jm200279v
CHEMBL1784478 62878 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 550 6 0 4 6.9 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)cc2)CC1 10.1021/jm200279v
54583049 62863 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 526 5 0 5 5.7 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC(=O)C1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
CHEMBL1784388 62863 None 0 Human Binding pIC50 = 5.8 5.8 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 526 5 0 5 5.7 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC(=O)C1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
478495 206926 None 1 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
CHEMBL91045 206926 None 1 Human Binding pIC50 = 5.8 5.8 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 626 14 0 4 7.2 CCCCCCCCS(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
162668957 182758 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 495 5 3 7 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(C)(C)C)nc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4790208 182758 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 495 5 3 7 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(C)(C)C)nc23)C1=O 10.1021/acsmedchemlett.1c00082
25230826 170020 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 582 7 0 7 4.5 CCCCC1CN(S(=O)(=O)c2ccccn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL444255 170020 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 582 7 0 7 4.5 CCCCC1CN(S(=O)(=O)c2ccccn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
483345 4971 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104867 4971 None 1 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
44335765 5436 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL107380 5436 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 610 12 0 6 6.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(c2ccccc2)C2c3ccccc3C(=O)N2CC)CC1 10.1016/s0960-894x(01)00655-2
46888496 8963 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 471 7 1 4 4.5 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccoc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098150 8963 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 471 7 1 4 4.5 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccoc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44404643 72220 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198114 72220 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 611 12 1 6 4.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
44392096 131783 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL369311 131783 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2005.08.014
56647023 92669 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435880 92669 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
44573299 188848 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 555 7 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C(C)C)C(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL506788 188848 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 555 7 0 4 7.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C(C)C)C(C)C)CC1 10.1016/j.bmcl.2009.02.014
46882872 5687 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 5.9 CCCCC1N(CC2CCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077989 5687 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 7 0 4 5.9 CCCCC1N(CC2CCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46864993 6234 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081486 6234 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
53321616 58458 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683063 58458 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
68769802 121238 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 493 7 1 6 4.2 COC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
CHEMBL3577949 121238 None 0 Human Binding pIC50 = 7.8 7.8 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 493 7 1 6 4.2 COC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
3010256 189260 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511806 189260 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010256 189260 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligandInhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL511806 189260 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligandInhibitory concentration against C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
3010256 189260 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511806 189260 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccccc4)no3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711278 92687 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435898 92687 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
15950679 92657 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435868 92657 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
44392094 166272 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 0 4 5.8 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL426960 166272 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 11 0 4 5.8 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54586286 60819 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 9 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(CCCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762143 60819 None 0 Human Binding pIC50 = 6.8 6.8 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 516 9 1 5 4.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(CCCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
5481711 205951 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL84374 205951 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
479872 206480 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)ccc1F 10.1016/s0960-894x(00)00639-9
CHEMBL88219 206480 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 494 9 0 3 5.8 Cc1cc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)ccc1F 10.1016/s0960-894x(00)00639-9
479852 206794 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL90291 206794 None 1 Human Binding pIC50 = 6.8 6.8 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 528 8 0 5 4.7 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44392211 123289 None 4 Human Binding pIC50 = 5.8 5.8 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 433 7 1 2 5.6 CN(C(=O)NC1CCCCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL361444 123289 None 4 Human Binding pIC50 = 5.8 5.8 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 433 7 1 2 5.6 CN(C(=O)NC1CCCCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
72714077 92673 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435884 92673 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
44590944 189880 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1nnc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)o1 10.1016/j.bmcl.2009.01.009
CHEMBL516939 189880 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1nnc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)o1 10.1016/j.bmcl.2009.01.009
44565036 186855 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 481 7 1 6 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCN(C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489512 186855 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 481 7 1 6 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)N2CCN(C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
24794656 180874 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 450 4 3 6 2.0 CC(=O)N[C@@H]1C[C@H](N)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4757452 180874 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 450 4 3 6 2.0 CC(=O)N[C@@H]1C[C@H](N)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
9915724 77290 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 12 1 5 5.4 COP(=O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccccc1 10.1016/s0960-894x(02)00829-6
CHEMBL20818 77290 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 556 12 1 5 5.4 COP(=O)(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccccc1 10.1016/s0960-894x(02)00829-6
25230771 172561 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 7 0 6 5.1 CCCCC1CN(S(=O)(=O)c2ccccc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL448610 172561 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 7 0 6 5.1 CCCCC1CN(S(=O)(=O)c2ccccc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
25230773 172817 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 563 7 0 5 5.5 CCCCC1C(=O)N(Cc2ccc(F)cc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL451400 172817 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 563 7 0 5 5.5 CCCCC1C(=O)N(Cc2ccc(F)cc2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44570267 177438 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 587 7 0 6 4.6 CCCC[C@H]1CN(S(=O)(=O)CC(F)(F)F)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL463874 177438 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 587 7 0 6 4.6 CCCC[C@H]1CN(S(=O)(=O)CC(F)(F)F)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
46888544 8774 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 464 7 1 5 3.7 Cc1noc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096486 8774 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 464 7 1 5 3.7 Cc1noc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44404650 133551 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 570 10 0 4 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL370998 133551 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 570 10 0 4 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
52942071 18327 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 547 8 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270798 18327 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 547 8 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CCN(CC(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
5275764 76034 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL205706 76034 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 636 10 0 5 5.0 CN(C)C(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
44325489 106980 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 474 5 0 2 6.6 O=C(c1cccc2ccccc12)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL315159 106980 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 474 5 0 2 6.6 O=C(c1cccc2ccccc12)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
489825 207447 None 2 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 416 5 0 2 5.3 O=C(C1CCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL94179 207447 None 2 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 416 5 0 2 5.3 O=C(C1CCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
72711507 92692 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435903 92692 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
72711047 92681 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435892 92681 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
59458103 92695 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435906 92695 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 537 8 1 4 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72713860 92702 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435913 92702 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
478452 85608 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282502 85608 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
478448 104137 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL309447 104137 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461522 205372 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79907 205372 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
54580081 62871 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 0 5 6.2 Cc1nc2cccnc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784401 62871 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 0 5 6.2 Cc1nc2cccnc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
25132255 103284 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 524 6 0 4 6.7 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C2CCCC2)CC1 10.1021/jm800598a
CHEMBL3084494 103284 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 524 6 0 4 6.7 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)C2CCCC2)CC1 10.1021/jm800598a
68772423 171962 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 541 7 1 7 3.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4470701 171962 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 541 7 1 7 3.6 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](CS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
44392159 62914 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 445 7 1 2 6.0 CN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL178477 62914 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 445 7 1 2 6.0 CN(C(=O)Nc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11353001 58806 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688239 58806 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
11753754 60895 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccnc1OC(c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762329 60895 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccnc1OC(c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
44392144 65207 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccccc1F)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182557 65207 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccccc1F)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728610 152699 None 7 Human Binding pIC50 = 5.7 5.7 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1016/j.bmcl.2006.09.052
CHEMBL397295 152699 None 7 Human Binding pIC50 = 5.7 5.7 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1016/j.bmcl.2006.09.052
17016126 90012 None 8 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 497 7 1 5 5.3 COc1ccccc1C(CNC(=O)c1cc(-c2ccc(Br)cc2)on1)N1CCC(C)CC1 10.1021/acs.jmedchem.6b01309
CHEMBL2381332 90012 None 8 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 497 7 1 5 5.3 COc1ccccc1C(CNC(=O)c1cc(-c2ccc(Br)cc2)on1)N1CCC(C)CC1 10.1021/acs.jmedchem.6b01309
16728610 152699 None 7 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1007/s00044-012-0118-7
CHEMBL397295 152699 None 7 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 346 5 3 3 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1 10.1007/s00044-012-0118-7
72714319 92678 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
CHEMBL2435889 92678 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
72712374 92663 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
CHEMBL2435874 92663 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
9869601 91776 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL241097 91776 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
44565559 189766 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL516027 189766 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
54581071 62873 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 8 0 5 6.9 CCOc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784403 62873 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 562 8 0 5 6.9 CCOc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
23294208 97146 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 6.8 O=C1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL26790 97146 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 590 8 1 4 6.8 O=C1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
25131900 103278 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 610 6 0 5 8.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084488 103278 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 610 6 0 5 8.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
16728614 91567 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL240637 91567 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
16728649 168999 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1007/s00044-012-0118-7
CHEMBL439223 168999 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1007/s00044-012-0118-7
5481726 205759 None 1 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL82838 205759 None 1 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 564 9 0 3 7.0 CN(C[C@@H](CCN1CCC(c2cccc(C(F)(F)F)c2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
489308 5287 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 587 13 0 5 7.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
CHEMBL106569 5287 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 587 13 0 5 7.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
42623163 178870 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 8 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL469724 178870 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 8 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
489338 5172 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 655 12 2 5 6.6 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL105975 5172 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 655 12 2 5 6.6 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
496975 108543 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 546 12 2 4 6.1 O=C(O)CCc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL320149 108543 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 546 12 2 4 6.1 O=C(O)CCc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
25256856 193283 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 510 5 0 6 5.4 CO/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL524001 193283 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 510 5 0 6 5.4 CO/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
11503459 83520 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203615 83520 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
501052 107433 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318210 107433 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010263 189222 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511494 189222 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447731 95097 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255430 95097 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008902 202678 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61536 202678 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
183790 3740 None 11 Human Binding pIC50 = 8.7 8.7 6 2
Displacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting methodDisplacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting method
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
783 3740 None 11 Human Binding pIC50 = 8.7 8.7 6 2
Displacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting methodDisplacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting method
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
CHEMBL1178786 3740 None 11 Human Binding pIC50 = 8.7 8.7 6 2
Displacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting methodDisplacement of [3H]TAK-779 from CCR5 (unknown origin) after 120 mins by scintillation counting method
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2017.04.046
501052 107433 None 1 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL318210 107433 None 1 Human Binding pIC50 = 8.7 8.7 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 10 2 4 4.7 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
483382 79553 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL2114184 79553 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 13 0 5 5.8 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461684 104897 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 604 14 0 6 5.1 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311248 104897 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 604 14 0 6 5.1 C=CCN(C(=O)Cc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
21147749 105294 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311549 105294 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
486606 205341 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79622 205341 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
486601 205564 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL81252 205564 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
44461707 205662 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82048 205662 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
11467704 205820 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83335 205820 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 620 14 0 7 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5275829 206026 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL85086 206026 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44415800 80521 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
CHEMBL214818 80521 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
3010263 189222 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL511494 189222 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 9 1 5 6.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ncc(Cc4ccccc4)s3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
6320582 63259 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL179141 63259 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 541 8 0 5 5.0 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OC(C)(C)C)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
6320585 63271 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL179209 63271 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
5275829 206026 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL85086 206026 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
516182 59622 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 614 10 1 5 6.7 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172019 59622 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 614 10 1 5 6.7 CCn1nc(Cc2ccc(C(F)(F)F)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516277 131381 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 10 1 6 7.2 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368979 131381 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 632 10 1 6 7.2 CCn1nc(Cc2ccc(OC(C)(C)C)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516172 120383 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL353331 120383 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
490017 167840 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 517 8 0 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL430867 167840 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 517 8 0 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490014 207387 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 559 8 0 4 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL93851 207387 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 559 8 0 4 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3Cl)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
516354 188234 None 2 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL499483 188234 None 2 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516354 188234 None 2 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL499483 188234 None 2 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(C(F)(F)c4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44383787 59301 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C(F)(F)c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL170543 59301 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 576 9 2 4 6.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C(F)(F)c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516206 59731 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL172436 59731 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 11 1 5 8.1 CC[C@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cc(C(F)(F)F)cc(C(F)(F)F)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516172 120383 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL353331 120383 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516325 59790 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL172659 59790 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
516325 59790 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL172659 59790 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
11636141 103542 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085310 103542 None 0 Human Binding pIC50 = 8.7 8.7 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 683 17 1 8 7.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CCC)cc1 10.1021/jm0509703
3008928 202655 None 1 Crab-eating macaque Binding pIC50 = 8.7 8.7 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61424 202655 None 1 Crab-eating macaque Binding pIC50 = 8.7 8.7 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 483 5 0 5 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3013701 77092 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207487 77092 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 643 10 0 6 4.7 CS(=O)(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
516353 130178 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 600 11 1 5 6.8 CCn1nc(CCc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL367838 130178 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 600 11 1 5 6.8 CCn1nc(CCc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.004
516325 59790 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL172659 59790 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)n[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516177 129783 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367529 129783 None 1 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 564 10 1 5 5.8 CCn1nc(Cc2ccccc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
474170 11277 None 2 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 564 7 1 3 7.5 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL1179149 11277 None 2 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 564 7 1 3 7.5 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL62339 11277 None 2 Human Binding pIC50 = 8.7 8.7 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 564 7 1 3 7.5 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
44404705 72049 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197641 72049 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2005.08.014
516339 128468 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL366626 128468 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
3008927 198856 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58387 198856 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
516339 128468 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL366626 128468 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
516263 61367 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 9 1 5 8.1 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL176859 61367 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 696 9 1 5 8.1 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516303 61685 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 664 11 1 7 6.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL177157 61685 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 664 11 1 7 6.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516174 131451 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 552 10 1 5 6.2 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL369151 131451 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 552 10 1 5 6.2 CCn1nc(CC2CCCCC2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516339 128468 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL366626 128468 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.6 CCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
44590683 175580 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL457960 175580 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 543 10 1 3 6.3 CCN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
68764898 671 None 2 Human Binding pIC50 = 8.6 8.6 - 3
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
9430 671 None 2 Human Binding pIC50 = 8.6 8.6 - 3
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
CHEMBL3577945 671 None 2 Human Binding pIC50 = 8.6 8.6 - 3
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
3011734 71056 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 12 0 6 4.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951907 71056 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 617 12 0 6 4.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC)CC2)CC1 10.1016/j.bmcl.2011.12.117
11650548 103540 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085308 103540 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 697 17 1 8 8.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4nncn4CCC)cc2)CCCN3CC(C)C)cc1 10.1021/jm0509703
68764898 671 None 2 Human Binding pIC50 = 8.6 8.6 - 3
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
9430 671 None 2 Human Binding pIC50 = 8.6 8.6 - 3
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
CHEMBL3577945 671 None 2 Human Binding pIC50 = 8.6 8.6 - 3
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
486601 205564 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL81252 205564 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 597 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2003.12.004
10008665 168486 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3O[C@H](c4ccccc4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL435259 168486 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN3O[C@H](c4ccccc4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
20664156 124613 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL364070 124613 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
20664156 124613 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL364070 124613 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 7 1 5 5.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711047 92681 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
CHEMBL2435892 92681 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Cl)c2)CC1 10.1021/jm401101p
478445 205329 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 576 13 1 4 5.6 CCCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79530 205329 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 576 13 1 4 5.6 CCCN(C(=O)NCc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
3500 1525 None 13 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
491774 1525 None 13 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
CHEMBL1196395 1525 None 13 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 483 7 1 5 3.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C21CCN(CC2)Cc1ccc2c(c1)OCCO2 10.1021/jm060051s
CHEMBL5267875 193539 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of wild type CCR5 (unknown origin)Inhibition of wild type CCR5 (unknown origin)
ChEMBL 455 9 2 3 4.6 CCCC[C@H]1C[C@@H](N(C)C(C)C)CC[C@H]1NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1 10.1021/acs.jmedchem.6b01309
478440 104259 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL309922 104259 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 534 11 2 4 4.4 CN(CC(CCN1CCC(NC(=O)NCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL3109173 211085 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL None None None Cc1nnc(CCCCCCCCCCn2cc(COCCOCCOCCOCCOCc3ccc(C(=O)N4CCC4=O)cc3)nn2)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
44401686 70032 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 9 1 5 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL193972 70032 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 528 9 1 5 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(CCn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
3008917 202782 None 5 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL62152 202782 None 5 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 481 5 0 3 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
516254 128678 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL366871 128678 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 620 13 1 7 6.0 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4ccc(OC)c(OC)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
516179 130683 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368333 130683 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2cc(F)cc(F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
516241 78910 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 5.5 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(CN)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
CHEMBL2112951 78910 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 589 12 2 6 5.5 CC[C@@H](C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cc(Cc4cccc(CN)c4)nn3CC)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.006
20664163 168647 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL436290 168647 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
20664163 168647 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL436290 168647 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
20664163 168647 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL436290 168647 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4cccnc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3008904 199964 None 1 Crab-eating macaque Binding pIC50 = 8.6 8.6 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL59511 199964 None 1 Crab-eating macaque Binding pIC50 = 8.6 8.6 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 537 6 0 5 5.0 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3cccc(C#N)c3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
11570778 140917 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL382252 140917 None 0 Human Binding pIC50 = 8.6 8.6 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3cccc(C(N)=O)c3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516364 59762 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 528 10 1 5 5.5 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL172551 59762 None 1 Human Binding pIC50 = 8.6 8.6 - 0
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 528 10 1 5 5.5 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
16663418 10811 None 20 Mouse Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.ejmech.2018.01.085
CHEMBL1172035 10811 None 20 Mouse Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 590 10 1 7 4.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@H]2CN(C(=O)C3CCCC3)C[C@]2(O)c2ccccc2)CC1 10.1016/j.ejmech.2018.01.085
3008930 198678 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL58004 198678 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1nc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
11585418 76009 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205539 76009 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 597 8 0 5 5.1 CC(=O)N1CCC(C(=O)N(CCCN2CCC(S(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516363 59384 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 542 11 1 5 5.9 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL170892 59384 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5Inhibitory concentration of compound to displace [125I]-MIP-1 alpha from CX3C chemokine receptor 5
ChEMBL 542 11 1 5 5.9 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@H](CC(C)C)C(=O)O)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.005
501053 4589 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102675 4589 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501059 107517 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318681 107517 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496971 107561 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL318909 107561 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
516328 128112 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366536 128112 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516332 130671 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368265 130671 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44565791 180748 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475606 180748 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44336415 167997 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 524 9 1 5 5.0 O=S(=O)(c1cccs1)N1CC(CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL432010 167997 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 524 9 1 5 5.0 O=S(=O)(c1cccs1)N1CC(CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
46890342 7113 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 6 1 6 4.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085224 7113 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 6 1 6 4.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
25205766 7117 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085229 7117 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888581 8708 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 511 8 1 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095815 8708 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 511 8 1 5 3.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
16073667 96821 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2F)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL265131 96821 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(F)c2F)CC1 10.1016/j.bmcl.2006.03.089
16073665 138580 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 664 11 0 6 5.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(F)(F)F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL377551 138580 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 664 11 0 6 5.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(F)(F)F)c2)CC1 10.1016/j.bmcl.2006.03.089
15958353 83519 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 430 7 1 4 5.0 Cc1nc2ccccc2n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203614 83519 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 430 7 1 4 5.0 Cc1nc2ccccc2n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1111/j.1747-0285.2006.00376.x
516338 59402 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
CHEMBL170987 59402 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.ejmech.2008.01.040
44455144 97909 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 486 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272490 97909 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 486 8 1 5 6.0 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
52918140 60904 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762338 60904 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
478448 104137 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL309447 104137 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 0 4 5.9 CCCN(C(=O)N(C)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461522 205372 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79907 205372 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461835 205753 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL82786 205753 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 575 14 0 4 5.8 CCCN(C(=O)CCc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44415740 80180 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 458 9 1 5 4.9 O=C(N[C@@H](CCN1CCC(c2noc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
CHEMBL213541 80180 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 458 9 1 5 4.9 O=C(N[C@@H](CCN1CCC(c2noc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
11693007 76259 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL205851 76259 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 548 8 1 4 5.7 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Nc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
10277467 13082 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
CHEMBL1190217 13082 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
CHEMBL540366 13082 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 443 7 1 5 3.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2 10.1021/jm060051s
516338 59402 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL170987 59402 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1cc(Cc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
489324 108233 None 1 Human Binding pIC50 = 6.7 6.7 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 555 8 1 4 5.6 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](Cc4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
CHEMBL319697 108233 None 1 Human Binding pIC50 = 6.7 6.7 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 555 8 1 4 5.6 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](Cc4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
44404638 132740 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 533 10 1 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(N)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL369947 132740 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 533 10 1 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(N)cc2)CC1 10.1016/j.bmcl.2005.08.014
44404730 140890 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 605 12 1 6 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NOC(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL382079 140890 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 605 12 1 6 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NOC(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
44401608 124322 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL363564 124322 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 487 8 1 6 4.3 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
9869601 91776 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241097 91776 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 394 5 3 3 3.9 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
44565559 189766 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL516027 189766 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4cccnc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
478409 205902 None 1 Human Binding pIC50 = 6.7 6.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83963 205902 None 1 Human Binding pIC50 = 6.7 6.7 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481866 111603 None 1 Human Binding pIC50 = 6.7 6.7 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 566 8 0 6 4.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328339 111603 None 1 Human Binding pIC50 = 6.7 6.7 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 566 8 0 6 4.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479865 207109 None 2 Human Binding pIC50 = 6.7 6.7 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1 10.1016/s0960-894x(00)00639-9
CHEMBL92094 207109 None 2 Human Binding pIC50 = 6.7 6.7 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1 10.1016/s0960-894x(00)00639-9
457679 169313 None 1 Human Binding pIC50 = 6.7 6.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 7 0 2 5.8 c1ccc(CCN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL441635 169313 None 1 Human Binding pIC50 = 6.7 6.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 7 0 2 5.8 c1ccc(CCN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL5269098 193588 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Antagonist activity at human CCR5 receptorAntagonist activity at human CCR5 receptor
ChEMBL 576 5 0 6 4.9 O=C(CCC(=O)N1CCN(c2ccnc3cc(Cl)ccc23)CC1)N1CCN(c2ccnc3cc(Cl)ccc23)CC1 10.1021/acs.jmedchem.6b01309
16728614 91567 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL240637 91567 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1cccc(COc2ccc(Br)cc2/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
16728649 168999 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL439223 168999 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 420 5 2 5 4.0 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCCN2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL5268295 193555 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 565 7 1 9 7.1 O=C(C1=C(O)C(=O)N(c2nnc(SCc3ccc(Cl)cc3)s2)C1c1cccs1)c1cc2ccccc2o1 10.1021/acs.jmedchem.6b01309
479837 206732 None 1 Human Binding pIC50 = 5.7 5.7 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL89929 206732 None 1 Human Binding pIC50 = 5.7 5.7 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
10445499 178886 None 1 Human Binding pIC50 = 4.7 4.7 - 0
Inhibition of MIP1alpha binding to human CCR5 receptorInhibition of MIP1alpha binding to human CCR5 receptor
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np049974l
CHEMBL469856 178886 None 1 Human Binding pIC50 = 4.7 4.7 - 0
Inhibition of MIP1alpha binding to human CCR5 receptorInhibition of MIP1alpha binding to human CCR5 receptor
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np049974l
53326702 58466 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683071 58466 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
53326701 58463 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683068 58463 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
72712160 92658 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
CHEMBL2435869 92658 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
10416552 188447 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 628 8 1 6 4.7 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
CHEMBL502593 188447 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 628 8 1 6 4.7 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
53324141 58465 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683070 58465 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
76312665 85584 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 520 7 1 4 5.7 CC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281956 85584 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 520 7 1 4 5.7 CC1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1007/s00044-012-0118-7
25206070 7118 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 584 5 0 6 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085231 7118 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 584 5 0 6 4.7 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
44356876 28040 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137272 28040 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 554 8 0 4 6.4 C=CCN(c1ccc(C(F)(F)F)cn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
16073663 77795 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2ccc(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL209251 77795 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2ccc(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
44573297 187225 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 499 5 0 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492544 187225 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 499 5 0 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)N(C)C)CC1 10.1016/j.bmcl.2009.02.014
6320585 63271 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL179209 63271 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(CC(C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
44590945 176400 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
CHEMBL459599 176400 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 396 7 1 5 4.0 Cc1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
11656080 83524 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 488 7 1 5 5.5 Cc1nc2ccccc2n1[C@@H]1C[C@H]2CSC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203620 83524 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 488 7 1 5 5.5 Cc1nc2ccccc2n1[C@@H]1C[C@H]2CSC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
516344 127820 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366450 127820 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44431967 146045 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 521 7 1 5 4.3 CN1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL391886 146045 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 521 7 1 5 4.3 CN1CCN(CC2(O)CCN(Cc3cc(Br)ccc3OCc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2007.01.050
44392131 65820 None 3 Human Binding pIC50 = 5.7 5.7 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 453 9 1 2 6.4 C=CCN(C(=O)Nc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183492 65820 None 3 Human Binding pIC50 = 5.7 5.7 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 453 9 1 2 6.4 C=CCN(C(=O)Nc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54682467 189281 None 30 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 276 0 1 5 2.1 CC1OC(=O)C=C2C3=C(OC(C)(C)CC3)C(=O)C(O)=C21 10.1021/np030146m
CHEMBL512035 189281 None 30 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 276 0 1 5 2.1 CC1OC(=O)C=C2C3=C(OC(C)(C)CC3)C(=O)C(O)=C21 10.1021/np030146m
53325088 58809 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 531 3 1 6 3.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H]3c4ccc(C(F)(F)F)cc4C[C@H]3O)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688241 58809 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 531 3 1 6 3.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H]3c4ccc(C(F)(F)F)cc4C[C@H]3O)[C@@H](C)C2)CC1 10.1021/ml1001536
53389902 172497 None 0 Human Binding pIC50 = 6.7 6.7 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 349 3 2 5 2.8 Nc1nc2[nH]c(C3CC3)c(Cc3ccc(Cl)c(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
CHEMBL4483373 172497 None 0 Human Binding pIC50 = 6.7 6.7 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 349 3 2 5 2.8 Nc1nc2[nH]c(C3CC3)c(Cc3ccc(Cl)c(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
54583459 60880 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 566 9 1 5 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(CCNC(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762308 60880 None 0 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 566 9 1 5 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(CCNC(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/j.bmcl.2011.02.058
72712161 92659 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435870 92659 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
25230770 188770 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 577 6 0 6 5.1 CCCCC1CN(C(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL505595 188770 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 577 6 0 6 5.1 CCCCC1CN(C(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
52949128 18141 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 607 7 0 6 4.3 Cc1cccc(Cl)c1S(=O)(=O)C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1269386 18141 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 607 7 0 6 4.3 Cc1cccc(Cl)c1S(=O)(=O)C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
25230898 173999 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 589 7 0 7 4.2 CCCCC1CN(S(=O)(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL454253 173999 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 589 7 0 7 4.2 CCCCC1CN(S(=O)(=O)C2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
25230827 184007 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 7 0 6 4.2 CCCCC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL481980 184007 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 7 0 6 4.2 CCCCC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44404642 133425 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 617 11 1 5 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)C(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL370552 133425 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 617 11 1 5 6.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)C(C)(C)C)cc2)CC1 10.1016/j.bmcl.2005.08.014
72714321 92680 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
CHEMBL2435891 92680 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(Br)c2)CC1 10.1021/jm401101p
516344 127820 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366450 127820 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
46883028 5812 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 495 5 0 6 4.3 CCCC[C@H]1CN(C)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078937 5812 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 495 5 0 6 4.3 CCCC[C@H]1CN(C)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
68767078 121234 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 457 7 1 5 5.0 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(Cl)cc23)C1=O 10.1021/ml500505q
CHEMBL3577944 121234 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 457 7 1 5 5.0 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(Cl)cc23)C1=O 10.1021/ml500505q
57656833 75227 None 0 Human Binding pIC50 = 7.7 7.7 - 1
Inhibition of human CCR5 by FLIPR analysisInhibition of human CCR5 by FLIPR analysis
ChEMBL 427 3 2 4 2.4 CC(C)N1CCN[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.04.118
CHEMBL2036782 75227 None 0 Human Binding pIC50 = 7.7 7.7 - 1
Inhibition of human CCR5 by FLIPR analysisInhibition of human CCR5 by FLIPR analysis
ChEMBL 427 3 2 4 2.4 CC(C)N1CCN[C@@H](C(=O)N2CCN(C(=O)Nc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.04.118
516344 127820 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL366450 127820 None 1 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 6.5 CCn1nc(-c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
44325917 156311 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 553 7 0 4 6.4 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL406552 156311 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 553 7 0 4 6.4 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44325710 207100 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 541 11 0 5 5.2 COC(=O)N(CC1CCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL92013 207100 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 541 11 0 5 5.2 COC(=O)N(CC1CCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
53321427 58464 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683069 58464 None 0 Human Binding pIC50 = 7.7 7.7 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.3 CCO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
54580469 60898 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
CHEMBL1762332 60898 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1cccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
11570431 91980 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Inhibition of CCR5Inhibition of CCR5
ChEMBL 564 13 1 4 7.9 CCN(CC)CCCC(C)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
CHEMBL241502 91980 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Inhibition of CCR5Inhibition of CCR5
ChEMBL 564 13 1 4 7.9 CCN(CC)CCCC(C)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
44325511 112565 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 7 0 3 7.5 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3cccc(-c4ccsc4)c3)C2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL330065 112565 None 0 Human Binding pIC50 = 6.7 6.7 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 7 0 3 7.5 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3cccc(-c4ccsc4)c3)C2)cc1 10.1016/s0960-894x(01)00545-5
44392092 63641 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1cccc(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180095 63641 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1cccc(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54580080 62862 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 1 4 6.3 Cc1nc2ccccc2n1C1CC2CCC(C1)C2NCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
CHEMBL1784386 62862 None 0 Human Binding pIC50 = 5.7 5.7 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 512 5 1 4 6.3 Cc1nc2ccccc2n1C1CC2CCC(C1)C2NCC1(c2ccccc2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm200279v
3258407 84902 None 19 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
CHEMBL223686 84902 None 19 Human Binding pIC50 = 4.7 4.7 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 389 9 1 5 4.9 C=C(C)Cc1c(C)c(C#N)c2nc3ccccc3n2c1NCCCN(CC)CC 10.1021/jm061389p
57396949 71044 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 568 10 0 6 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951895 71044 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 568 10 0 6 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
483334 108581 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 593 13 0 7 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(-c3ccccc3)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL320365 108581 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 593 13 0 7 6.9 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc(-c3ccccc3)c2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
505873 27944 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137206 27944 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
44401985 71414 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL195930 71414 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44573339 173442 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 602 8 1 6 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc(Cl)s2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL452913 173442 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 602 8 1 6 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc(Cl)s2)CC1 10.1016/j.bmcl.2009.02.014
44573300 193211 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 526 5 0 6 6.1 CS/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL523512 193211 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 526 5 0 6 6.1 CS/C(=N/C#N)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
505873 27944 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137206 27944 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44401985 71414 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195930 71414 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010258 179097 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471722 179097 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
46882082 5614 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 623 9 0 7 6.0 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC(C)C)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077364 5614 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 623 9 0 7 6.0 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC(C)C)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
53324304 58462 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683067 58462 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 497 6 1 5 3.9 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
3010258 179097 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL471722 179097 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
516340 59804 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL172721 59804 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 568 10 1 5 6.1 Cn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
44384012 161659 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 10 1 6 6.1 CCn1ncc(C(=O)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL413058 161659 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 10 1 6 6.1 CCn1ncc(C(=O)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
505873 27944 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137206 27944 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1cccnc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44401985 71414 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195930 71414 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3cnc4ncccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010258 179097 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471722 179097 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nc(-c4ccccc4)c[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
5482808 206645 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 576 8 1 4 5.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL89251 206645 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 576 8 1 4 5.6 O=S(=O)(NC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
44392093 63490 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 502 9 0 2 7.0 CN(C(=O)Cc1ccc(-c2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL179950 63490 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 502 9 0 2 7.0 CN(C(=O)Cc1ccc(-c2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
483361 96410 None 1 Human Binding pIC50 = 5.6 5.6 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL261935 96410 None 1 Human Binding pIC50 = 5.6 5.6 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44590864 176717 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 472 8 2 4 4.9 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(n2cc(-c3ccccc3)[nH]c2=O)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460009 176717 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 472 8 2 4 4.9 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(n2cc(-c3ccccc3)[nH]c2=O)CC1 10.1016/j.bmcl.2009.01.009
3117 207839 None 103 Human Binding pIC50 = 4.6 4.6 -8 16
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 207839 None 103 Human Binding pIC50 = 4.6 4.6 -8 16
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
25132945 172466 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 642 8 1 6 5.1 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)CC1)CC2 10.1021/jm800598a
CHEMBL448199 172466 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 642 8 1 6 5.1 O=C1NCN(c2ccccc2)C12CCN(CCOC1(c3ccc(Cl)c(Cl)c3)CCN(S(=O)(=O)c3ccccc3)CC1)CC2 10.1021/jm800598a
5481714 205334 None 1 Human Binding pIC50 = 4.6 4.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79566 205334 None 1 Human Binding pIC50 = 4.6 4.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CC(O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
44590704 190479 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CCC(N(C)C2CN(C(c3ccccc3)c3ccccc3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL517893 190479 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 468 6 0 4 4.7 Cc1ccnc(C)c1C(=O)N1CCC(N(C)C2CN(C(c3ccccc3)c3ccccc3)C2)CC1 10.1016/j.bmcl.2009.01.012
46890427 6597 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 514 4 0 5 4.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1083126 6597 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 514 4 0 5 4.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
44573298 189024 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 7 0 4 6.4 CCN(CC)C(=O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL509179 189024 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 7 0 4 6.4 CCN(CC)C(=O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
10186729 13951 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196666 13951 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL557789 13951 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
46882873 5699 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 525 7 0 5 5.2 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078072 5699 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 525 7 0 5 5.2 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46883027 5784 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 579 7 0 7 5.1 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078711 5784 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 579 7 0 7 5.1 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
501048 109621 None 1 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322232 109621 None 1 Human Binding pIC50 = 7.6 7.6 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44392196 65592 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 481 10 1 2 6.4 C=CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183261 65592 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 481 10 1 2 6.4 C=CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
474155 12053 None 2 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CC3)cc1 10.1021/jm9906264
CHEMBL1183547 12053 None 2 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CC3)cc1 10.1021/jm9906264
CHEMBL303964 12053 None 2 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CC3)cc1 10.1021/jm9906264
5482456 205312 None 1 Human Binding pIC50 = 5.6 5.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
CHEMBL79369 205312 None 1 Human Binding pIC50 = 5.6 5.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
483352 112884 None 2 Human Binding pIC50 = 4.6 4.6 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL331007 112884 None 2 Human Binding pIC50 = 4.6 4.6 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
483341 109192 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 550 12 0 5 7.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL321539 109192 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 550 12 0 5 7.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44590222 179108 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 419 5 1 3 3.7 CC(=O)NC(c1ccccc1)C1CN(C2CCN(C(=O)c3c(C)cccc3C)CC2)C1 10.1016/j.bmcl.2009.01.012
CHEMBL471844 179108 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 419 5 1 3 3.7 CC(=O)NC(c1ccccc1)C1CN(C2CCN(C(=O)c3c(C)cccc3C)CC2)C1 10.1016/j.bmcl.2009.01.012
489312 4916 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 508 9 0 4 5.9 O=S(=O)(c1cccs1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL104628 4916 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 508 9 0 4 5.9 O=S(=O)(c1cccs1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
25230829 183233 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 519 6 0 6 3.6 CCCCC1CN(S(C)(=O)=O)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL479627 183233 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 519 6 0 6 3.6 CCCCC1CN(S(C)(=O)=O)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
483339 4884 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 522 11 0 5 6.5 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104474 4884 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 522 11 0 5 6.5 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
489331 5255 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL106381 5255 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
46890429 7227 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 641 8 0 7 5.5 CCO[C@H]1CC[C@H](CN2C[C@H](c3ccccn3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085722 7227 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 641 8 0 7 5.5 CCO[C@H]1CC[C@H](CN2C[C@H](c3ccccn3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
46888604 8561 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 8 1 5 4.4 Cc1nc(Cl)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1094518 8561 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 545 8 1 5 4.4 Cc1nc(Cl)nc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
16073666 78462 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 650 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)c(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL211175 78462 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 650 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)c(F)c(F)c2)CC1 10.1016/j.bmcl.2006.03.089
16073674 79897 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212408 79897 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 626 12 0 7 4.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(OC)c2)CC1 10.1016/j.bmcl.2006.03.089
11520480 103544 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.3 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085312 103544 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.3 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CCC)cc1 10.1021/jm0509703
44555481 5714 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078231 5714 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
11342841 5788 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078723 5788 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 555 7 0 7 4.6 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882078 5610 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 581 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077360 5610 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 581 7 0 7 4.9 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
44461561 205375 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79930 205375 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478410 205900 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83957 205900 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
474157 11279 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 465 5 1 1 7.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCC3)cc1 10.1021/jm9906264
CHEMBL1179155 11279 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 465 5 1 1 7.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCC3)cc1 10.1021/jm9906264
CHEMBL62549 11279 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 465 5 1 1 7.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCC3)cc1 10.1021/jm9906264
44590800 176790 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 3 5.7 CCN(C(=O)c1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460629 176790 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 3 5.7 CCN(C(=O)c1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
72711048 92682 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435893 92682 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
489328 5017 None 2 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 515 9 1 3 5.9 O=C1N[C@H](Cc2ccccc2)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL105109 5017 None 2 Human Binding pIC50 = 6.6 6.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 515 9 1 3 5.9 O=C1N[C@H](Cc2ccccc2)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
478413 205380 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79958 205380 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44415756 79801 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 471 9 1 5 4.9 Cc1nnc(Cc2ccccc2)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
CHEMBL212017 79801 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 471 9 1 5 4.9 Cc1nnc(Cc2ccccc2)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
478409 205902 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83963 205902 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 530 9 0 3 6.7 CN(C[C@@H](CCN1CCC(c2ccc(Cl)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
478410 205900 None 1 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83957 205900 None 1 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 514 9 0 3 6.2 CN(C[C@@H](CCN1CCC(c2ccc(F)cc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
70848 206670 None 112 Human Binding pIC50 = 4.6 4.6 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 206670 None 112 Human Binding pIC50 = 4.6 4.6 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
54585963 62867 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 7 1 5 6.5 CNc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784397 62867 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 7 1 5 6.5 CNc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
54580082 62872 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 548 7 0 5 6.5 COc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784402 62872 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 548 7 0 5 6.5 COc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
54581068 62864 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 6 0 4 5.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(N2C(=O)c4ccccc4C2=O)C3)(c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784391 62864 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 547 6 0 4 5.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(N2C(=O)c4ccccc4C2=O)C3)(c2ccccc2)CC1 10.1021/jm200279v
70848 206670 None 112 Human Binding pIC50 = 4.6 4.6 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
CHEMBL89445 206670 None 112 Human Binding pIC50 = 4.6 4.6 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 233 2 0 3 3.2 c1ccc(-c2cccc(-c3ccccn3)n2)nc1 10.1021/jm301121j
456374 206748 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 410 6 0 2 5.8 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL90015 206748 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 410 6 0 2 5.8 c1ccc(CN2C[C@H](CN3CCC(c4ccccc4)CC3)[C@@H](c3ccccc3)C2)cc1 10.1016/s0960-894x(01)00545-5
54582104 62866 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 1 5 6.1 Nc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784396 62866 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 533 6 1 5 6.1 Nc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
489594 112754 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
CHEMBL330528 112754 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00232-3
46890340 7106 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 654 6 1 6 4.6 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085217 7106 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 654 6 1 6 4.6 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)cc(C#N)nc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
25206071 7108 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 631 6 0 7 4.5 COC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085219 7108 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 631 6 0 7 4.5 COC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
46888526 8929 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 503 8 1 4 4.8 COc1cc(C)c(C(=O)N2C[C@@H]3CN(CC[C@H](NC(=O)C4CCCC4)c4ccccc4)C[C@@H]3C2)c(C)c1 10.1016/j.bmcl.2010.03.095
CHEMBL1097816 8929 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 503 8 1 4 4.8 COc1cc(C)c(C(=O)N2C[C@@H]3CN(CC[C@H](NC(=O)C4CCCC4)c4ccccc4)C[C@@H]3C2)c(C)c1 10.1016/j.bmcl.2010.03.095
44404639 72351 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 575 11 1 5 5.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(C)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198497 72351 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 575 11 1 5 5.1 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(C)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
489594 112754 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL330528 112754 None 2 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
53325639 58468 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683073 58468 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
3010257 178956 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470507 178956 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44404710 72426 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 561 11 1 5 4.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198777 72426 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 561 11 1 5 4.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2005.08.014
478399 205875 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83818 205875 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
489820 111419 None 2 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 425 5 0 3 4.8 O=C(c1cccnc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327354 111419 None 2 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 425 5 0 3 4.8 O=C(c1cccnc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44392132 66092 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183875 66092 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)cc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
5481747 111549 None 1 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1007/s00044-011-9863-2
CHEMBL328025 111549 None 1 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1007/s00044-011-9863-2
44532866 188796 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 615 6 1 4 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)Nc2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL505908 188796 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 615 6 1 4 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)Nc2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2009.02.014
478493 206791 None 1 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
CHEMBL90272 206791 None 1 Human Binding pIC50 = 5.6 5.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1007/s00044-011-9863-2
44373672 52458 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL159097 52458 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
76317476 104785 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 996 35 1 15 8.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCn1cc(COCCOCCOCCOCCOCc2ccc(C(=O)N3CCC3=O)cc2)nn1)c1ccccc1 10.1021/ml400370w
CHEMBL3109174 104785 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 996 35 1 15 8.1 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCn1cc(COCCOCCOCCOCCOCc2ccc(C(=O)N3CCC3=O)cc2)nn1)c1ccccc1 10.1021/ml400370w
25230899 172725 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 585 7 0 8 3.8 CCCCC1CN(S(=O)(=O)c2cn(C)cn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL450639 172725 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 585 7 0 8 3.8 CCCCC1CN(S(=O)(=O)c2cn(C)cn2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
483331 5224 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cc3ccccc3n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL106231 5224 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cc3ccccc3n2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
25205921 7116 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)CC3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085228 7116 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 574 6 0 6 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCOCC4)CC3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888566 8945 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 8 1 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098014 8945 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 8 1 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
3010257 178956 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL470507 178956 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44431986 167337 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 617 10 3 6 5.8 COc1cccc(OC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL429442 167337 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 617 10 3 6 5.8 COc1cccc(OC)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44455031 155161 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
CHEMBL402242 155161 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
44555482 5787 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 589 7 0 6 6.0 CCCC[C@H]1CN(CC2CCC(F)(F)CC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078714 5787 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 589 7 0 6 6.0 CCCC[C@H]1CN(CC2CCC(F)(F)CC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882083 5615 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 621 9 0 7 5.8 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC3CC3)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077365 5615 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 621 9 0 7 5.8 CCCC[C@H]1CN(C[C@H]2CC[C@H](OC3CC3)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
3010257 178956 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL470507 178956 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 527 8 1 5 6.3 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3nocc3-c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
72713860 92702 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435913 92702 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5481859 205356 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79716 205356 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481861 168002 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL432040 168002 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
5481859 205356 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL79716 205356 None 1 Human Binding pIC50 = 6.6 6.6 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44392136 64837 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1cc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc(OC)c1 10.1016/j.bmcl.2004.10.044
CHEMBL182010 64837 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1cc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc(OC)c1 10.1016/j.bmcl.2004.10.044
44455103 155743 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL405634 155743 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
44455177 161027 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 9 1 5 4.9 CCCNC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL411640 161027 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 9 1 5 4.9 CCCNC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
53389637 170565 None 0 Human Binding pIC50 = 6.6 6.6 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 317 3 2 5 2.4 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4450273 170565 None 0 Human Binding pIC50 = 6.6 6.6 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 317 3 2 5 2.4 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
72712372 92661 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
CHEMBL2435872 92661 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 499 6 0 6 4.7 Cn1nnc(-c2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)n1 10.1021/jm401101p
44431944 88090 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234672 88090 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
483338 5106 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 518 12 0 8 4.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cncn2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105606 5106 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 518 12 0 8 4.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cncn2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44404702 72073 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 532 10 0 4 5.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197714 72073 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 532 10 0 4 5.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C)cc2)CC1 10.1016/j.bmcl.2005.08.014
16728784 12795 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188107 12795 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL535172 12795 None 0 Human Binding pIC50 = 7.6 7.6 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.1 CCCCN1C(=O)C(CC(C)(C)O)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
5275840 64882 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 483 8 0 4 3.6 CN1C(=O)CCC2CN(CC[C@](C)(CN(C)S(=O)(=O)c3ccccc3)c3ccccc3)CCC21 10.1016/j.bmcl.2004.12.044
CHEMBL182188 64882 None 1 Human Binding pIC50 = 7.6 7.6 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 483 8 0 4 3.6 CN1C(=O)CCC2CN(CC[C@](C)(CN(C)S(=O)(=O)c3ccccc3)c3ccccc3)CCC21 10.1016/j.bmcl.2004.12.044
44564984 187057 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 508 8 1 6 4.2 CC(=O)N1CCC(C(=O)N[C@@H](CC(C)N2CCC(n3c(C)nnc3C(C)C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491154 187057 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 508 8 1 6 4.2 CC(=O)N1CCC(C(=O)N[C@@H](CC(C)N2CCC(n3c(C)nnc3C(C)C)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
56647023 92669 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435880 92669 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 552 8 1 4 6.4 NC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
44565558 179241 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472799 179241 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44431944 88090 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234672 88090 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 411 5 0 2 5.6 FC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
52948162 18384 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 531 8 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(C(=O)CC(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271310 18384 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 531 8 0 5 4.6 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(C(=O)CC(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
11669935 58452 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 467 5 1 4 4.3 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](NC2CCOCC2)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683055 58452 None 0 Human Binding pIC50 = 6.6 6.6 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 467 5 1 4 4.3 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](NC2CCOCC2)C1 10.1016/j.bmcl.2011.01.015
52949601 18186 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 515 7 0 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1269884 18186 None 0 Human Binding pIC50 = 5.6 5.6 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 515 7 0 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(C(=O)C4CCCC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
57392726 67869 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 490 8 0 5 4.2 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910167 67869 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assayDisplacement of [125I]-MIP-1- alpha from CCR5 expressed in CHO K1 cells by scintillation proximity assay
ChEMBL 490 8 0 5 4.2 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
154572822 171099 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 542 7 2 7 2.8 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4457723 171099 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 542 7 2 7 2.8 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
16728624 90302 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1007/s00044-012-0118-7
CHEMBL238546 90302 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1007/s00044-012-0118-7
44565558 179241 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL472799 179241 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
16728785 12828 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188408 12828 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536298 12828 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)[C@@H](CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
44565558 179241 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472799 179241 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccncc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44455072 95583 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
CHEMBL257728 95583 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
25133964 103288 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 5 0 5 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084498 103288 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 5 0 5 8.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
44374086 54979 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL161594 54979 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
44392117 65235 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 510 9 0 3 6.3 CN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182684 65235 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 510 9 0 3 6.3 CN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
54583458 60877 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 530 9 1 5 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762304 60877 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 530 9 1 5 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCNC(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
16728624 90302 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL238546 90302 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 452 8 3 4 4.4 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(OCc2ccccc2)cc1 10.1016/j.bmcl.2006.09.052
162657824 181124 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 482 5 3 4 2.9 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(F)(F)F)c2)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4760566 181124 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 482 5 3 4 2.9 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cccc(C(F)(F)F)c2)C1=O 10.1021/acsmedchemlett.1c00082
72711279 92688 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
CHEMBL2435899 92688 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccnc2)CC1 10.1021/jm401101p
5481715 104406 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL310305 104406 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
489306 5175 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 510 12 0 4 6.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
CHEMBL105987 5175 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 510 12 0 4 6.3 CN(CC(CCN1CCC(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
CHEMBL3109172 211084 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL None None None Cc1nnc(CCCCCCCCCCn2cc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCNC(=O)OC(C)(C)C)cc3)nn2)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/ml400370w
11285792 878 None 34 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
801 878 None 34 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
CHEMBL2110727 878 None 34 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
DB11758 878 None 34 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at CCR5 assessed as inhibition of CCL3 bindingAntagonist activity at CCR5 assessed as inhibition of CCL3 binding
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm300682j
44590439 179169 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(Cc3ccccc3)C(=O)C3CCC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL472260 179169 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 6 0 3 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCC(N(Cc3ccccc3)C(=O)C3CCC3)CC2)CC1 10.1016/j.bmcl.2009.01.012
489342 5394 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 667 13 2 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL107128 5394 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 667 13 2 5 6.7 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
46888478 8808 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 487 7 1 3 5.1 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096764 8808 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 487 7 1 3 5.1 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
3002977 2458 None 71 Human Binding pIC50 = 8.5 8.5 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
803 2458 None 71 Human Binding pIC50 = 8.5 8.5 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
806 2458 None 71 Human Binding pIC50 = 8.5 8.5 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
CHEMBL1201187 2458 None 71 Human Binding pIC50 = 8.5 8.5 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
CHEMBL256907 2458 None 71 Human Binding pIC50 = 8.5 8.5 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
CHEMBL584744 2458 None 71 Human Binding pIC50 = 8.5 8.5 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
DB04835 2458 None 71 Human Binding pIC50 = 8.5 8.5 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/jm300682j
44565791 180748 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL475606 180748 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
496971 107561 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
CHEMBL318909 107561 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
44573253 187262 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 0 5 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ccco2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492728 187262 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 0 5 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ccco2)CC1 10.1016/j.bmcl.2009.02.014
10438399 188948 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1C 10.1016/j.bmcl.2009.02.014
CHEMBL508114 188948 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)c1C 10.1016/j.bmcl.2009.02.014
10030170 189065 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 538 6 0 6 6.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL509665 189065 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 538 6 0 6 6.2 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC(C)C)CC1 10.1016/j.bmcl.2009.02.014
3009355 3987 None 26 Human Binding pIC50 = 8.5 8.5 - 1
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
807 3987 None 26 Human Binding pIC50 = 8.5 8.5 - 1
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
CHEMBL82301 3987 None 26 Human Binding pIC50 = 8.5 8.5 - 1
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
DB06652 3987 None 26 Human Binding pIC50 = 8.5 8.5 - 1
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1021/ml1001536
501053 4589 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102675 4589 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501059 107517 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL318681 107517 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496971 107561 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL318909 107561 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.8 O=C(O)c1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
516328 128112 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL366536 128112 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516332 130671 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL368265 130671 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44565791 180748 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475606 180748 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4cccnn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
3008913 101974 None 1 Crab-eating macaque Binding pIC50 = 8.5 8.5 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL301454 101974 None 1 Crab-eating macaque Binding pIC50 = 8.5 8.5 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 495 6 0 3 6.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
501053 4589 None 1 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL102675 4589 None 1 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 450 9 2 4 4.0 C[C@H](C(=O)O)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501059 107517 None 1 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL318681 107517 None 1 Human Binding pIC50 = 8.5 8.5 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 460 10 1 3 5.3 O=C(O)[C@@H](C1CC1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44461275 104904 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311261 104904 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
486607 205563 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL81245 205563 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 654 14 1 6 5.7 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
44461817 205781 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83057 205781 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461699 205877 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83823 205877 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
68764925 121235 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 477 6 1 5 4.9 CC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
CHEMBL3577946 121235 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 477 6 1 5 4.9 CC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/ml500505q
516328 128112 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL366536 128112 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 12 1 5 7.2 CCCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516332 130671 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368265 130671 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1ncc(Cc2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
478450 85606 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282500 85606 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 561 13 0 4 5.4 CCCN(C(=O)Cc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461275 104904 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL311261 104904 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccc(C)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
486606 205341 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79622 205341 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 14 1 6 5.1 CCCN(C(=O)OCc1ccc(C(N)=O)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461699 205877 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL83823 205877 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1cccc(C)c1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
49871007 58811 None 13 Human Binding pIC50 = 8.5 8.5 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm300682j
CHEMBL1688243 58811 None 13 Human Binding pIC50 = 8.5 8.5 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/jm300682j
57395178 71043 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 620 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951894 71043 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 620 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3cccc(F)c3)CC2)CC1 10.1016/j.bmcl.2011.12.117
11285792 878 None 34 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 878 None 34 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 878 None 34 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 878 None 34 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
516184 59617 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL172004 59617 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 571 10 1 6 5.5 CCn1nc(Cc2ccc(C#N)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
474161 11271 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 513 6 1 3 6.9 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCSCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179115 11271 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 513 6 1 3 6.9 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCSCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL61208 11271 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 513 6 1 3 6.9 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCSCC4)cc2)CCO3)cc1 10.1021/jm9906264
44564887 179537 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 425 8 1 5 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL474154 179537 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 425 8 1 5 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C(C)C)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44590752 176896 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461689 176896 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.5 CCN(C(=O)OCc1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44564886 189670 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 9 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL515261 189670 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 437 9 1 5 4.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44447734 95137 None 0 Crab-eating macaque Binding pIC50 = 8.5 8.5 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255644 95137 None 0 Crab-eating macaque Binding pIC50 = 8.5 8.5 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 523 5 0 5 6.1 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2008.01.108
11577846 77118 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207654 77118 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 581 8 0 4 5.4 CC(=O)N1CCC(C(=O)N(CCCN2CCC([S+]([O-])c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516183 130202 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 682 10 1 5 7.7 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL367901 130202 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 682 10 1 5 7.7 CCn1nc(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
3008929 195635 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL556314 195635 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3013689 77039 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207190 77039 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 583 9 0 4 5.5 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
474163 12035 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 483 8 1 2 7.2 CCC(CC)[N+](C)(C)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C)cc4)ccc3OCC2)cc1 10.1021/jm9906264
CHEMBL1183396 12035 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 483 8 1 2 7.2 CCC(CC)[N+](C)(C)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C)cc4)ccc3OCC2)cc1 10.1021/jm9906264
CHEMBL294788 12035 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 483 8 1 2 7.2 CCC(CC)[N+](C)(C)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(C)cc4)ccc3OCC2)cc1 10.1021/jm9906264
44590753 176352 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 511 9 1 4 6.1 CCN(C(=O)Oc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459567 176352 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 511 9 1 4 6.1 CCN(C(=O)Oc1ccc(Cl)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
3008929 195635 None 1 Crab-eating macaque Binding pIC50 = 8.5 8.5 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL556314 195635 None 1 Crab-eating macaque Binding pIC50 = 8.5 8.5 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 498 5 0 4 5.2 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
68767049 121232 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 553 9 3 4 4.9 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NCC)C1=O 10.1021/ml500505q
CHEMBL3577942 121232 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 553 9 3 4 4.9 CCC[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1CC[C@H](NC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NCC)C1=O 10.1021/ml500505q
44565557 179240 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472798 179240 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44565557 179240 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL472798 179240 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
57393451 71064 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C(F)(F)F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951918 71064 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(C(F)(F)F)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
16659334 14002 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1197042 14002 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL559168 14002 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
44565557 179240 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL472798 179240 None 0 Human Binding pIC50 = 8.5 8.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 505 8 1 6 4.4 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cnc4ncccn34)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
5275766 3736 None 40 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
800 3736 None 40 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
CHEMBL207004 3736 None 40 Human Binding pIC50 = 8.5 8.5 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 552 9 1 4 4.7 CC(=O)N1CCC(CC1)C(=O)N(c1ccc(c(c1)Cl)C)CCCN1CCC(CC1)Cc1ccc(cc1)C(=O)N 10.1021/jm051034q
516186 60040 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 624 11 1 7 5.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL173630 60040 None 1 Human Binding pIC50 = 8.5 8.5 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 624 11 1 7 5.0 CCn1nc(Cc2ccc(S(C)(=O)=O)cc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
44565674 178691 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL468150 178691 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
51039119 176215 None 33 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP-1beta from CCR5 in human peripheral T cellsDisplacement of [125I]MIP-1beta from CCR5 in human peripheral T cells
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
CHEMBL4594419 176215 None 33 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP-1beta from CCR5 in human peripheral T cellsDisplacement of [125I]MIP-1beta from CCR5 in human peripheral T cells
ChEMBL 484 5 3 8 2.2 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3cc(C(C)(C)C)nn23)C1=O 10.1021/acsmedchemlett.1c00373
44565674 178691 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL468150 178691 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 590 12 1 3 8.3 C=C(Cc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44447732 155099 None 0 Crab-eating macaque Binding pIC50 = 8.4 8.4 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL401929 155099 None 0 Crab-eating macaque Binding pIC50 = 8.4 8.4 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 504 5 0 4 6.5 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1016/j.bmcl.2008.01.108
501044 4387 None 1 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL101333 4387 None 1 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 608 12 1 5 7.2 O=C(OCc1ccccc1)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44389412 62509 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(C[C@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL178189 62509 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 620 11 0 7 5.3 CN(C[C@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
44590798 190991 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 4 5.5 CCN(C(=O)Oc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL518640 190991 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 9 1 4 5.5 CCN(C(=O)Oc1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44565721 188696 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL504250 188696 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44274022 98793 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 11 1 5 5.6 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC3(c4ccc(F)cc4)OCCO3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL278383 98793 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 568 11 1 5 5.6 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC3(c4ccc(F)cc4)OCCO3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
44565721 188696 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL504250 188696 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 570 14 2 5 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(OCCO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44590684 175665 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 489 10 1 3 5.3 CCN(C(=O)Cc1ccc(C)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL458157 175665 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 489 10 1 3 5.3 CCN(C(=O)Cc1ccc(C)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
3010269 179102 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471766 179102 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
72711508 92694 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435905 92694 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 539 7 1 4 5.6 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C(C)(C)C)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
5275765 138232 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL377026 138232 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 572 9 1 4 5.0 CC(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
3010269 179102 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL471766 179102 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
474169 11274 None 2 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 550 7 1 3 7.1 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL1179143 11274 None 2 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 550 7 1 3 7.1 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
CHEMBL62180 11274 None 2 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 550 7 1 3 7.1 C[N+](C)(Cc1ccc(NC(=O)C2=Cc3cc(-c4ccc(N5CCCC5)cc4)ccc3CCC2)cc1)C1CCOCC1 10.1021/jm9906264
3010269 179102 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471766 179102 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 501 9 1 5 5.3 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)o3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
505878 119186 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL343160 119186 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1ccccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
11353001 58806 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688239 58806 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 525 3 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(Br)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
516305 78911 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 587 10 1 6 6.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL2112952 78911 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 587 10 1 6 6.0 CCn1nc(Cc2cccnc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
44564929 179261 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 423 8 1 5 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL472953 179261 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 423 8 1 5 4.4 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
478451 85607 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282501 85607 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
478444 171131 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL445836 171131 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44461707 205662 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL82048 205662 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 577 13 0 5 6.0 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
501049 4332 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL100958 4332 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501057 4748 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL103782 4748 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44374086 54979 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL161594 54979 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
478307 105817 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00652-7
CHEMBL312701 105817 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00652-7
25230828 172641 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 595 9 0 6 5.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](OCC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL449621 172641 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 595 9 0 6 5.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](OCC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44570269 177572 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 552 7 0 6 5.8 CCCCC1C(=O)C(CC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL464054 177572 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 552 7 0 6 5.8 CCCCC1C(=O)C(CC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
46888564 8666 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 2 4 3.4 Cc1cc(=O)[nH]c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095518 8666 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 2 4 3.4 Cc1cc(=O)[nH]c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888605 9039 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cc(F)cc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098664 9039 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 8 1 5 4.1 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cc(F)cc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44374086 54979 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL161594 54979 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 5 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4O[C@H](c5ccccc5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
11433740 5796 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.6 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078753 5796 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 537 7 0 4 6.6 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
54581479 60884 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762313 60884 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 588 9 1 4 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(N(Cc2ccccc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
54583460 60886 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 593 7 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Oc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762315 60886 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 593 7 1 5 7.0 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Oc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
11422270 60905 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 630 10 1 6 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762339 60905 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 630 10 1 6 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)n2)c2ccc(OC(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11180743 60967 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 580 9 1 5 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762464 60967 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 580 9 1 5 6.8 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
46880775 6380 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1082201 6380 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
11844212 98647 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR5Inhibition of CCR5
ChEMBL 590 7 1 2 7.7 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC2(C=Cc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm060439n
CHEMBL277279 98647 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR5Inhibition of CCR5
ChEMBL 590 7 1 2 7.7 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC2(C=Cc3ccccc32)CC1)c1ccc(F)cc1 10.1021/jm060439n
52947038 18253 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 8 0 6 2.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270303 18253 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 8 0 6 2.8 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cccc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
478307 105817 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL312701 105817 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44461561 205375 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79930 205375 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478307 105817 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL312701 105817 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
478302 206738 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 538 8 0 5 4.3 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL89958 206738 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 538 8 0 5 4.3 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44461561 205375 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL79930 205375 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 529 10 0 5 5.2 CCN(C(=O)OC(C)(C)C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
25057877 5776 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 6 0 4 5.9 CCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078648 5776 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 509 6 0 4 5.9 CCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
482150 112735 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 9 0 5 5.1 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL330486 112735 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 9 0 5 5.1 CN(C[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479867 206869 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.7 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL90691 206869 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.7 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479857 163506 None 1 Human Binding pIC50 = 5.5 5.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL420242 163506 None 1 Human Binding pIC50 = 5.5 5.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 496 9 0 3 6.0 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccccc1Cl)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
65237 137622 None 105 Human Binding pIC50 = 4.5 4.5 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 137622 None 105 Human Binding pIC50 = 4.5 4.5 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
72711051 92685 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
CHEMBL2435896 92685 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 610 8 1 5 5.6 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccc(Br)cc2)CC1 10.1021/jm401101p
44431946 88110 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234674 88110 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
49768639 89577 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 591 7 1 6 5.2 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL2374447 89577 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 591 7 1 6 5.2 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
72714320 92679 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435890 92679 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 546 8 1 5 5.2 Cc1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44455223 95331 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 492 8 1 5 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL256584 95331 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 492 8 1 5 5.8 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
490007 167843 None 2 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 503 7 0 4 5.3 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL430905 167843 None 2 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 503 7 0 4 5.3 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
54584058 62880 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 568 6 0 4 7.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)c(F)c2)CC1 10.1021/jm200279v
CHEMBL1784480 62880 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 568 6 0 4 7.1 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccc(F)c(F)c2)CC1 10.1021/jm200279v
6320579 122178 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 547 10 0 5 5.1 CN(C[C@@H](CCN1CCC(N2C[C@@H](c3ccccc3)OC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL359752 122178 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 547 10 0 5 5.1 CN(C[C@@H](CCN1CCC(N2C[C@@H](c3ccccc3)OC2=O)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
44392142 65265 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 524 10 0 3 6.7 CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182817 65265 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 524 10 0 3 6.7 CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392149 65356 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 10 0 4 5.8 O=C(Cc1ccc([N+](=O)[O-])cc1)N(C1CC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182929 65356 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 497 10 0 4 5.8 O=C(Cc1ccc([N+](=O)[O-])cc1)N(C1CC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44404605 72577 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 536 10 0 4 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199258 72577 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 536 10 0 4 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
44455225 95375 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 477 8 0 5 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL256792 95375 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 477 8 0 5 5.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
16728632 91571 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 370 5 3 3 4.0 N=C(N)N/N=C/c1cc(Cl)cc(Cl)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240641 91571 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 370 5 3 3 4.0 N=C(N)N/N=C/c1cc(Cl)cc(Cl)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
44431946 88110 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234674 88110 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 436 7 1 3 5.3 CCNC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
53321482 58459 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683064 58459 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
44590738 175755 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2CC3CCC(C2)N3C(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL458351 175755 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2CC3CCC(C2)N3C(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.012
52944644 18239 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 523 8 0 6 2.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270209 18239 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 523 8 0 6 2.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
72714319 92678 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
CHEMBL2435889 92678 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 5 5.5 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2Cl)CC1 10.1021/jm401101p
44564985 187085 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 413 7 1 6 4.2 COC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
CHEMBL491328 187085 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 413 7 1 6 4.2 COC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
65237 137622 None 105 Human Binding pIC50 = 4.5 4.5 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
CHEMBL375781 137622 None 105 Human Binding pIC50 = 4.5 4.5 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 208 0 0 2 3.4 Cc1ccc2ccc3ccc(C)nc3c2n1 10.1021/jm301121j
76330769 85591 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 592 8 3 3 7.2 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1007/s00044-012-0118-7
CHEMBL2281963 85591 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 592 8 3 3 7.2 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1007/s00044-012-0118-7
489344 5449 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 681 13 2 5 6.9 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL107439 5449 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 681 13 2 5 6.9 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
25206397 7110 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 6 1 6 4.1 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085221 7110 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 6 1 6 4.1 CNC(=O)N1CCC(CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
44392137 64848 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2005.08.014
CHEMBL182074 64848 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2005.08.014
72711278 92687 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435898 92687 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 564 8 1 5 5.3 Cc1cc(F)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
16073669 79860 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)ccc2F)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL212243 79860 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)ccc2F)CC1 10.1016/j.bmcl.2006.03.089
489818 111427 None 2 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 482 6 0 4 5.2 COC(=O)c1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327392 111427 None 2 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 482 6 0 4 5.2 COC(=O)c1ccccc1C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44392213 166151 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 8 1 2 6.5 CCN(C(=O)Nc1ccc(C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL426250 166151 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 8 1 2 6.5 CCN(C(=O)Nc1ccc(C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44573097 193102 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 506 6 0 6 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2ncccn2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL522669 193102 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 506 6 0 6 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(c2ncccn2)CC1 10.1016/j.bmcl.2009.02.014
44431971 88796 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 593 8 3 4 6.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1016/j.bmcl.2007.01.050
CHEMBL236421 88796 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 593 8 3 4 6.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(F)cccc1F 10.1016/j.bmcl.2007.01.050
474153 11291 None 2 Human Binding pIC50 = 5.5 5.5 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 431 5 1 1 6.0 Cc1cccc[n+]1Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
CHEMBL1179232 11291 None 2 Human Binding pIC50 = 5.5 5.5 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 431 5 1 1 6.0 Cc1cccc[n+]1Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
CHEMBL65605 11291 None 2 Human Binding pIC50 = 5.5 5.5 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 431 5 1 1 6.0 Cc1cccc[n+]1Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
6480206 184358 None 2 Human Binding pIC50 = 4.5 4.5 - 0
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 370 1 1 2 5.7 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)C[C@@]5(O)OC/C(=C/C[C@H]3[C@H]12)[C@@H]45 10.1021/np049844c
CHEMBL484427 184358 None 2 Human Binding pIC50 = 4.5 4.5 - 0
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 370 1 1 2 5.7 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)C[C@@]5(O)OC/C(=C/C[C@H]3[C@H]12)[C@@H]45 10.1021/np049844c
66767933 121223 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 531 12 6 5 3.2 CCC[C@H](O)[C@H](CNCC(C)(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
CHEMBL3577933 121223 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrsInhibition of [125I]MCP1-beta binding to CCR5 in human HT1080 cell membranes incubated for 4 to 6 hrs
ChEMBL 531 12 6 5 3.2 CCC[C@H](O)[C@H](CNCC(C)(C)C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NC(C)C 10.1021/ml500505q
44455106 97938 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 9 1 5 5.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NCc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272581 97938 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 9 1 5 5.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NCc1ccccc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
155540798 172933 None 0 Human Binding pIC50 = 6.5 6.5 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cc(Cl)cc(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4516788 172933 None 0 Human Binding pIC50 = 6.5 6.5 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 CC(C)c1[nH]c2nc(N)nn2c(=O)c1Cc1cc(Cl)cc(Cl)c1 10.1021/acs.jmedchem.9b00742
44373768 194857 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL539943 194857 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
46890346 7119 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 612 6 1 6 5.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085232 7119 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 612 6 1 6 5.1 Cc1cc(C#N)nc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C[C@H]4CC[C@H](O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
44392125 131795 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 531 10 1 4 4.6 NS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL369352 131795 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 531 10 1 4 4.6 NS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
44373768 194857 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL539943 194857 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
516331 60289 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 598 11 2 6 5.5 O=C(O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL174283 60289 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 598 11 2 6 5.5 O=C(O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
489823 112374 None 2 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccoc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329555 112374 None 2 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccoc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44373768 194857 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL539943 194857 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/j.ejmech.2008.01.040
44590801 176201 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 529 9 1 3 6.4 CCN(C(=O)c1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459378 176201 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 529 9 1 3 6.4 CCN(C(=O)c1ccc(Cl)c(Cl)c1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
72712160 92658 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
CHEMBL2435869 92658 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ncccn3)cc2)CC1 10.1021/jm401101p
483333 5075 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnnc2-c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL105460 5075 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 9 5.7 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2nnnc2-c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
72712373 92662 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
CHEMBL2435873 92662 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 502 6 0 4 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(N3CCOCC3)cc2)CC1 10.1021/jm401101p
3011722 71049 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951900 71049 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 539 10 0 5 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
54585385 60882 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 513 7 2 4 5.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(O)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762311 60882 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 513 7 2 4 5.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(O)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
5481748 111548 None 1 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1007/s00044-011-9863-2
CHEMBL328024 111548 None 1 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1007/s00044-011-9863-2
5481713 205768 None 1 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL82880 205768 None 1 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
162648673 179948 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 522 6 3 7 3.4 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(OC(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4746510 179948 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 522 6 3 7 3.4 CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(OC(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
25206227 7109 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 651 7 0 7 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCN(S(C)(=O)=O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085220 7109 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 651 7 0 7 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CC4CCN(S(C)(=O)=O)CC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888606 9040 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 536 8 1 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(C#N)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1098665 9040 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 536 8 1 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(C#N)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46882081 5613 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 608 9 0 6 6.2 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077363 5613 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 608 9 0 6 6.2 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
52945332 18284 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 7 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270493 18284 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 529 7 0 5 4.5 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(CC(F)(F)F)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
489824 207237 None 2 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 2 5.7 O=C(C1CCCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL92861 207237 None 2 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 2 5.7 O=C(C1CCCCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
72711049 92683 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
CHEMBL2435894 92683 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
53322810 58470 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 499 6 1 7 2.7 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3nccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683075 58470 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 499 6 1 7 2.7 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3nccc(C(F)(F)F)n3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
76308986 85597 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 10 3 3 9.2 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281969 85597 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 640 10 3 3 9.2 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
478512 106535 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 594 8 0 6 4.7 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cn(C)cn1 10.1016/s0960-894x(00)00637-5
CHEMBL314077 106535 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 594 8 0 6 4.7 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cn(C)cn1 10.1016/s0960-894x(00)00637-5
478493 206791 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL90272 206791 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 557 8 0 4 4.4 CN(C)S(=O)(=O)N(C)C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1 10.1016/s0960-894x(00)00637-5
44392219 64898 None 4 Human Binding pIC50 = 5.5 5.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 392 8 0 2 5.2 CC(C)CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182234 64898 None 4 Human Binding pIC50 = 5.5 5.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 392 8 0 2 5.2 CC(C)CC(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728631 91570 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240640 91570 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
16728631 91570 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL240640 91570 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 320 5 3 3 2.9 N=C(N)N/N=C/c1cc(F)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
72714318 92677 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
CHEMBL2435888 92677 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2F)CC1 10.1021/jm401101p
72711050 92684 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435895 92684 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 590 9 1 7 4.7 COC(=O)c1cccc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
25130569 188308 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 7 1 6 5.2 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
CHEMBL500523 188308 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 596 7 1 6 5.2 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
155529593 171453 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 518 7 2 5 2.2 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
CHEMBL4463290 171453 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 518 7 2 5 2.2 CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(F)(F)F)c3)C2=O)[C@H](NS(C)(=O)=O)C1 10.1021/acsmedchemlett.8b00439
25230896 188254 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 569 6 0 7 5.0 CCCCC1CN(C(=O)OC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL499729 188254 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 569 6 0 7 5.0 CCCCC1CN(C(=O)OC2CCOCC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44431954 86997 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1007/s00044-012-0118-7
CHEMBL232409 86997 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1007/s00044-012-0118-7
11326950 87660 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
CHEMBL233638 87660 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1007/s00044-012-0118-7
5482456 205312 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
CHEMBL79369 205312 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 511 9 0 4 5.3 Cc1ccccc1N1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-011-9863-2
478503 206185 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1007/s00044-011-9863-2
CHEMBL86419 206185 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1007/s00044-011-9863-2
478500 206852 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1007/s00044-011-9863-2
CHEMBL90620 206852 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1007/s00044-011-9863-2
44570177 191418 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 498 5 1 5 4.0 CCCC[C@H]1CN(C(=O)NC)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL519278 191418 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 498 5 1 5 4.0 CCCC[C@H]1CN(C(=O)NC)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
471179 205324 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
CHEMBL79504 205324 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00654-0
5481702 205821 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00655-2
CHEMBL83338 205821 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against human CCR5 receptor stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00655-2
471179 205324 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL79504 205324 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00637-5
44392235 65386 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.2 CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182940 65386 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.2 CCN(C(=O)NCc1cccc(C)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44431984 146877 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 641 10 3 4 8.1 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL392536 146877 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 641 10 3 4 8.1 CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
46864993 6259 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081625 6259 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
44461603 105953 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCOC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL312945 105953 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 569 12 0 5 6.0 CCOC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
471179 205324 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
471179 205324 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL79504 205324 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79504 205324 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44461494 205624 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 4 4.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL81719 205624 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 522 8 0 4 4.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
5482453 205818 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83311 205818 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5482454 205852 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 5.5 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83683 205852 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 551 8 1 4 5.5 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
478296 157918 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL408438 157918 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
471179 205324 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL79504 205324 None 1 Human Binding pIC50 = 7.5 7.5 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
25132254 103282 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084492 103282 None 0 Human Binding pIC50 = 7.5 7.5 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
501058 109680 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL322693 109680 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44392162 64851 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 536 11 0 3 6.8 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182083 64851 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 536 11 0 3 6.8 C=CCN(C(=O)Cc1ccc(OC(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44431954 86997 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL232409 86997 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 6 1 4 4.6 Clc1ccc(COc2ccc(Br)cc2CN2CCC(N3CCNCC3)CC2)cc1 10.1016/j.bmcl.2007.01.050
11326950 87660 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
CHEMBL233638 87660 None 0 Human Binding pIC50 = 6.5 6.5 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 395 5 1 3 4.2 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)C1 10.1016/j.bmcl.2007.01.050
5275833 122145 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL359687 122145 None 1 Human Binding pIC50 = 6.5 6.5 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
489597 99658 None 2 Human Binding pIC50 = 5.5 5.5 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](c2ccccc2)[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)C1 10.1016/s0960-894x(01)00232-3
CHEMBL284380 99658 None 2 Human Binding pIC50 = 5.5 5.5 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 520 5 0 4 4.2 O=S(=O)(c1ccccc1)N1C[C@H](c2ccccc2)[C@H](CN2CCC3(CC2)C[S+]([O-])c2ccccc23)C1 10.1016/s0960-894x(01)00232-3
44392083 65862 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 532 11 0 3 7.0 CN(C(=O)Cc1ccc(OCc2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183554 65862 None 0 Human Binding pIC50 = 5.5 5.5 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 532 11 0 3 7.0 CN(C(=O)Cc1ccc(OCc2ccccc2)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
483363 14677 None 1 Human Binding pIC50 = 5.5 5.5 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120569 14677 None 1 Human Binding pIC50 = 5.5 5.5 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
478387 206650 None 1 Human Binding pIC50 = 5.4 5.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
CHEMBL89279 206650 None 1 Human Binding pIC50 = 5.4 5.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1007/s00044-011-9863-2
501058 109680 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL322693 109680 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501058 109680 None 1 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL322693 109680 None 1 Human Binding pIC50 = 7.4 7.4 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 438 7 1 3 4.8 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
72711277 92686 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435897 92686 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
5275832 62615 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
CHEMBL178337 62615 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 561 10 0 5 5.5 C[C@H]1[C@@H](c2ccccc2)OC(=O)N1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.12.044
76324826 104787 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 576 18 1 6 7.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCN=[N+]=[N-])c1ccccc1 10.1021/ml400370w
CHEMBL3109177 104787 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assayAntagonist activity against CCR5 receptor in human TZM-bl cells assessed as inhibition of HIV-1 JR-FL-induced cell-cell fusion between viral envelope protein expressing human HEK293 cells to TZM-bl cells after 48 hrs by luciferase reporter gene assay
ChEMBL 576 18 1 6 7.9 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)CCCCCCCCCCN=[N+]=[N-])c1ccccc1 10.1021/ml400370w
5481747 111549 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1016/s0960-894x(00)00637-5
CHEMBL328025 111549 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2ccccc12 10.1016/s0960-894x(00)00637-5
44392082 65861 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccccc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183553 65861 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccccc1Cl)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
56750906 122995 None 6 Human Binding pIC50 = 4.4 4.4 - 0
Inhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readoutInhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readout
ChEMBL 332 5 1 3 3.8 c1ccc(Cc2cn[nH]c2C2CCN(Cc3ccncc3)CC2)cc1 10.1021/acsmedchemlett.5b00036
CHEMBL3608763 122995 None 6 Human Binding pIC50 = 4.4 4.4 - 0
Inhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readoutInhibition of CCR5 assessed as reduction in fusion of effector cells expressing JRFL envelope (CCR5-tropic/CD4-dependent) with human HeLa-C14 target cells expressing CD4, CCR5, and CXCR4) by luciferase readout
ChEMBL 332 5 1 3 3.8 c1ccc(Cc2cn[nH]c2C2CCN(Cc3ccncc3)CC2)cc1 10.1021/acsmedchemlett.5b00036
3011719 71041 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 540 10 0 6 3.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951892 71041 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 540 10 0 6 3.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(C)CC2)CC1 10.1016/j.bmcl.2011.12.117
76319891 85599 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)c(F)c1 10.1007/s00044-012-0118-7
CHEMBL2281970 85599 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)c(F)c1 10.1007/s00044-012-0118-7
44570268 188439 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 8 0 6 5.4 CCCCC1C(=O)N(C[C@H]2CC[C@H](OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL502432 188439 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 581 8 0 6 5.4 CCCCC1C(=O)N(C[C@H]2CC[C@H](OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
11421221 63761 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180155 63761 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 11 0 4 5.3 C=CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
18442936 71054 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 10 0 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951905 71054 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 10 0 5 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44590230 178848 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 409 7 1 5 4.0 Cc1nnc(C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL469542 178848 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 409 7 1 5 4.0 Cc1nnc(C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44392143 64827 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 495 7 1 2 7.1 CN(C(=O)Nc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181967 64827 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 495 7 1 2 7.1 CN(C(=O)Nc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392106 122786 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.4 CN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360524 122786 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.4 CN(C(=O)Cc1ccc(C(F)(F)F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
53325385 58456 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683061 58456 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@@H]2C)C1 10.1016/j.bmcl.2011.01.015
57396951 71057 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 640 11 0 7 2.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951909 71057 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 640 11 0 7 2.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cc(F)cc(F)c2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
16728627 147528 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1F 10.1016/j.bmcl.2006.09.052
CHEMBL393069 147528 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 382 5 3 3 3.1 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1F 10.1016/j.bmcl.2006.09.052
155513284 169724 None 0 Human Binding pIC50 = 6.4 6.4 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 343 3 2 5 2.9 Nc1nc2[nH]c(C3CCCC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
CHEMBL4438407 169724 None 0 Human Binding pIC50 = 6.4 6.4 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 343 3 2 5 2.9 Nc1nc2[nH]c(C3CCCC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
44392167 63475 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 519 10 1 4 4.4 CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL179877 63475 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 519 10 1 4 4.4 CCN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
46880847 7547 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 477 7 1 5 4.7 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.01.080
CHEMBL1087533 7547 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 477 7 1 5 4.7 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2010.01.080
491773 12826 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188399 12826 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL536288 12826 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 12 1 3 4.8 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
56647076 92670 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435881 92670 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 553 8 1 4 7.0 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
474150 12029 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCCC1 10.1021/jm9906264
CHEMBL1183377 12029 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCCC1 10.1021/jm9906264
CHEMBL293882 12029 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 451 5 1 1 6.8 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCCC1 10.1021/jm9906264
483355 110382 None 1 Human Binding pIC50 = 5.4 5.4 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 14 0 7 6.8 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL324284 110382 None 1 Human Binding pIC50 = 5.4 5.4 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 14 0 7 6.8 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
54583462 60897 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)nc1 10.1016/j.bmcl.2011.02.058
CHEMBL1762331 60897 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 6.9 Cc1ccc(OC(c2ccc(Br)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)nc1 10.1016/j.bmcl.2011.02.058
44455034 95177 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL255855 95177 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1ccccc1NC(=O)N(CCCN1[C@H]2CC[C@@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1ccccc1 10.1016/j.bmcl.2007.12.058
44590865 176734 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 457 8 2 4 5.1 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2[nH]ncc2-c2ccncc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460217 176734 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 457 8 2 4 5.1 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2[nH]ncc2-c2ccncc2)CC1 10.1016/j.bmcl.2009.01.009
162656188 180913 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 429 5 3 5 1.4 CN[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(C)(C)C)n3)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
CHEMBL4757857 180913 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 429 5 3 5 1.4 CN[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cccc(C(C)(C)C)n3)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
44431949 149025 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL394256 149025 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
57400372 71045 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 604 11 0 7 2.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951896 71045 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 604 11 0 7 2.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44447733 95098 None 0 Crab-eating macaque Binding pIC50 = 7.4 7.4 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255431 95098 None 0 Crab-eating macaque Binding pIC50 = 7.4 7.4 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
72713858 92699 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435910 92699 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
44415821 161703 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1C1CC2COCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
CHEMBL413501 161703 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1C1CC2COCC(C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
72712371 92660 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435871 92660 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
11626984 83525 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203621 83525 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
76316242 85616 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 521 10 0 5 4.7 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-012-0138-3
CHEMBL2282510 85616 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 521 10 0 5 4.7 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1007/s00044-012-0138-3
44461581 205909 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL84029 205909 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
44431949 149025 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL394256 149025 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 450 6 1 3 4.8 CC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
489833 111449 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.1 Cc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL327540 111449 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.1 Cc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
474149 11298 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 437 5 1 1 6.5 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
CHEMBL1179247 11298 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 437 5 1 1 6.5 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
CHEMBL66301 11298 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 437 5 1 1 6.5 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCCC1 10.1021/jm9906264
16728620 90734 None 0 Human Binding pIC50 = 4.4 4.4 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1016/j.bmcl.2006.09.052
CHEMBL239153 90734 None 0 Human Binding pIC50 = 4.4 4.4 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1016/j.bmcl.2006.09.052
16728620 90734 None 0 Human Binding pIC50 = 4.4 4.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1007/s00044-012-0118-7
CHEMBL239153 90734 None 0 Human Binding pIC50 = 4.4 4.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 390 6 4 4 2.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(C(=O)O)c1 10.1007/s00044-012-0118-7
54584052 62865 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 518 6 0 4 6.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2cnc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784395 62865 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 518 6 0 4 6.5 O=C(c1ccccc1)N1CCC(CCN2C3CCC2CC(n2cnc4ccccc42)C3)(c2ccccc2)CC1 10.1021/jm200279v
25131902 187287 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 6 1 5 5.7 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccccc2)CC1 10.1021/jm800598a
CHEMBL492897 187287 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 6 1 5 5.7 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccccc2)CC1 10.1021/jm800598a
10371054 192823 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 7 1 6 4.8 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL522158 192823 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 7 1 6 4.8 O=C(c1ccco1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
76311990 85263 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 8 0 4 4.4 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL2259883 85263 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 500 8 0 4 4.4 C/C=C(\C)[C@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)CN(C)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
16728644 85589 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 408 6 3 3 4.3 CC/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL2281961 85589 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 408 6 3 3 4.3 CC/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
44431951 88289 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234843 88289 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
5481705 163479 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL420057 163479 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 574 8 0 4 6.9 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5481704 164417 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL421356 164417 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 606 8 0 5 5.6 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
478399 205875 None 1 Human Binding pIC50 = 5.4 5.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83818 205875 None 1 Human Binding pIC50 = 5.4 5.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 8 0 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)Cc1ccccc1O2)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
489307 110873 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 603 13 1 6 6.5 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
CHEMBL326111 110873 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 603 13 1 6 6.5 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccc(-c2ccccn2)s1 10.1016/s0960-894x(01)00652-7
483340 5328 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL106803 5328 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 567 12 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2cnc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
489339 5351 None 2 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 635 12 2 5 6.1 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL106907 5351 None 2 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 635 12 2 5 6.1 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
46888479 8809 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 523 7 1 3 5.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096765 8809 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 523 7 1 3 5.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
5481742 107063 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 527 8 0 3 6.8 [O-][S+]1CC2(CCN(CC[C@H](COCc3ccccc3)c3ccc(Cl)c(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(00)00637-5
CHEMBL315707 107063 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 527 8 0 3 6.8 [O-][S+]1CC2(CCN(CC[C@H](COCc3ccccc3)c3ccc(Cl)c(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(00)00637-5
5481743 206497 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 541 7 0 4 6.5 O=C(OC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL88319 206497 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nMBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand at a concentration of 1000 nM
ChEMBL 541 7 0 4 6.5 O=C(OC[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)c1ccccc1 10.1016/s0960-894x(00)00637-5
44573338 188762 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 598 8 1 5 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(F)c2)CCN(C(C(=O)O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL505443 188762 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 598 8 1 5 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(F)c2)CCN(C(C(=O)O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2009.02.014
44573254 193291 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 513 6 1 4 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL524050 193291 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 513 6 1 4 6.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)C)CC1 10.1016/j.bmcl.2009.02.014
501049 4332 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL100958 4332 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
501057 4748 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL103782 4748 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44455069 95442 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
CHEMBL257081 95442 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 500 8 1 5 6.3 Cc1ccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)cc1 10.1016/j.bmcl.2007.12.058
44454977 97976 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccc(Cl)cc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272716 97976 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 520 8 1 5 6.7 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1ccc(Cl)cc1)c1ccccc1 10.1016/j.bmcl.2007.12.058
44555481 5714 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1078231 5714 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 555 7 0 7 4.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2010.02.004
501049 4332 None 1 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL100958 4332 None 1 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 532 10 1 5 5.7 COC(=O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
501057 4748 None 1 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL103782 4748 None 1 Human Binding pIC50 = 8.4 8.4 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 478 7 1 3 5.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3ccc(F)cc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
486602 105996 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 611 13 0 5 6.6 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL313216 105996 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 611 13 0 5 6.6 CCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00492-9
478444 171131 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL445836 171131 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 562 12 1 4 5.9 CCCN(C(=O)Nc1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461689 205651 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL81926 205651 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 13 0 5 6.3 CCCN(C(=O)OCc1ccccc1C)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461823 205944 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL84309 205944 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 577 14 0 5 5.3 CCCN(C(=O)COc1ccccc1)C1CCN(CC[C@@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
516351 60292 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 578 8 2 4 6.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL174303 60292 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 578 8 2 4 6.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
44325542 112304 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 575 8 0 4 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL329140 112304 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 575 8 0 4 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3cccc4ccccc34)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
490016 112348 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 531 8 0 4 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL329417 112348 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 531 8 0 4 5.9 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
516326 61058 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL176392 61058 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516326 61058 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL176392 61058 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
10280445 95138 None 0 Crab-eating macaque Binding pIC50 = 8.4 8.4 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255645 95138 None 0 Crab-eating macaque Binding pIC50 = 8.4 8.4 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 539 5 0 5 5.3 CC1(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CCN(C(=O)c2c(Cl)c[n+]([O-])cc2Cl)CC1 10.1016/j.bmcl.2008.01.108
516326 61058 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL176392 61058 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 1 5 5.9 Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
68764898 671 None 2 Human Binding pIC50 = 8.4 8.4 - 3
Antagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulationAntagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulation
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
9430 671 None 2 Human Binding pIC50 = 8.4 8.4 - 3
Antagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulationAntagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulation
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
CHEMBL3577945 671 None 2 Human Binding pIC50 = 8.4 8.4 - 3
Antagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulationAntagonist activity against CCR5 in whole blood (unknown origin) assessed as reduction in CD11b upregulation
ChEMBL 491 7 1 5 5.3 CCC[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/ml500505q
44384642 59834 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 566 9 2 4 6.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C3(c4ccccc4)CC3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL172845 59834 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 566 9 2 4 6.4 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3n[nH]cc3C3(c4ccccc4)CC3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
10117348 13925 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
CHEMBL1196455 13925 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
CHEMBL557015 13925 None 0 Human Binding pIC50 = 8.4 8.4 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 455 8 1 4 4.1 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(OC)cc1)CC2 10.1021/jm060051s
474162 11280 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 509 6 1 3 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCC(=O)CC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179157 11280 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 509 6 1 3 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCC(=O)CC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL62598 11280 None 1 Human Binding pIC50 = 8.4 8.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 509 6 1 3 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)C4CCC(=O)CC4)cc2)CCO3)cc1 10.1021/jm9906264
53319838 58810 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688242 58810 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 545 4 0 6 4.4 CO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
516327 129730 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL367421 129730 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
5275760 77062 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL207301 77062 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 623 10 0 6 5.1 COC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
11585625 77082 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207447 77082 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 648 10 1 6 4.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NS(=O)(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
516327 129730 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL367421 129730 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516327 129730 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL367421 129730 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 582 11 1 5 6.8 CCCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
11527691 103545 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CCC)cc1 10.1021/jm0509703
CHEMBL3085313 103545 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 696 17 1 7 8.9 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CCC)cc1 10.1021/jm0509703
516334 120428 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL353827 120428 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44274042 163137 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL417825 163137 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
44274042 163137 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
CHEMBL417825 163137 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/s0960-894x(02)00829-6
516334 120428 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL353827 120428 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44274042 163137 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL417825 163137 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 540 12 2 4 5.5 O=C(O)[C@@H](CC1CC1)N1C[C@H](CN2CCC(CCC(CO)c3ccc(F)cc3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
516334 120428 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL353827 120428 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 540 9 2 4 5.9 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516329 130180 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 622 10 1 5 7.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC(F)(F)F)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL367863 130180 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 622 10 1 5 7.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(Cc4ccccc4)nn3CC(F)(F)F)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
44590799 176789 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 479 9 1 3 5.2 CCN(C(=O)c1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460628 176789 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 479 9 1 3 5.2 CCN(C(=O)c1ccc(F)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
44564982 193185 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 499 8 1 6 4.1 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC[S+]([O-])CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL523267 193185 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 499 8 1 6 4.1 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CC[S+]([O-])CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
5481746 112780 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/s0960-894x(00)00637-5
CHEMBL330570 112780 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 666 9 0 4 7.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(-c2ccccc2)cc1 10.1016/s0960-894x(00)00637-5
478503 206185 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1016/s0960-894x(00)00637-5
CHEMBL86419 206185 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 620 9 0 5 6.0 COc1ccc(S(=O)(=O)N(C)C[C@@H](CCN2CCC3(CC2)C[S+]([O-])c2ccccc23)c2ccc(Cl)c(Cl)c2)cc1 10.1016/s0960-894x(00)00637-5
478500 206852 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1016/s0960-894x(00)00637-5
CHEMBL90620 206852 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc(Cl)cc1 10.1016/s0960-894x(00)00637-5
44412984 140115 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL380083 140115 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(S(C)(=O)=O)cc2)c2cc(F)cc(F)c2)CC1 10.1016/j.bmcl.2006.03.089
44573302 188615 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 580 6 0 6 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL502909 188615 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 580 6 0 6 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)SC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
54580467 60885 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 591 7 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Cc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762314 60885 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 591 7 1 4 7.2 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C2(c3ccc(C(F)(F)F)cc3)Cc3ccccc3O2)CC1 10.1016/j.bmcl.2011.02.058
11365412 60892 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 597 9 1 4 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(F)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762324 60892 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 597 9 1 4 7.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(F)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11261876 60901 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
CHEMBL1762335 60901 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)n1 10.1016/j.bmcl.2011.02.058
11478988 60969 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 605 9 1 6 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762467 60969 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 605 9 1 6 6.7 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)n2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
5479787 116597 None 5 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL336672 116597 None 5 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1016/j.bmcl.2011.02.058
44461513 104736 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 487 10 0 5 4.0 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL310645 104736 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 487 10 0 5 4.0 CCN(C(=O)OC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461581 205909 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL84029 205909 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 501 11 0 5 4.4 CCOC(=O)N(CC)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44439314 91965 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 438 7 3 4 4.3 CC/C(=N\NC(=N)N)c1cc(Br)cc(OC)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241476 91965 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 438 7 3 4 4.3 CC/C(=N\NC(=N)N)c1cc(Br)cc(OC)c1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
44431951 88289 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234843 88289 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 466 6 1 4 5.0 COC(=O)NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
486595 205922 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
CHEMBL84120 205922 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 510 9 0 3 6.3 Cc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
479876 112006 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328888 112006 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 468 9 0 4 5.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccs1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44324386 111522 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 303 6 0 2 3.5 CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL327880 111522 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 303 6 0 2 3.5 CC[C@H](CN(C)S(=O)(=O)c1ccccc1)c1ccccc1 10.1016/s0960-894x(00)00639-9
11234566 178885 None 17 Human Binding pIC50 = 4.4 4.4 - 0
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 386 5 1 3 5.3 CC(C)=CCC[C@H](C)[C@H]1CC[C@]2(C)C[C@H]3[C@H](C(=O)C[C@@]3(C)O)/C(C=O)=C\C[C@@H]12 10.1021/np049974l
CHEMBL469855 178885 None 17 Human Binding pIC50 = 4.4 4.4 - 0
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 386 5 1 3 5.3 CC(C)=CCC[C@H](C)[C@H]1CC[C@]2(C)C[C@H]3[C@H](C(=O)C[C@@]3(C)O)/C(C=O)=C\C[C@@H]12 10.1021/np049974l
489313 5448 None 2 Human Binding pIC50 = 7.4 7.4 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 601 10 1 6 6.1 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL107425 5448 None 2 Human Binding pIC50 = 7.4 7.4 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 601 10 1 6 6.1 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
44590739 189599 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2C3CCC2CN(C(c2ccccc2)c2ccccc2)C3)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL514749 189599 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 494 5 0 4 5.2 Cc1ccnc(C)c1C(=O)N1CCC(N2C3CCC2CN(C(c2ccccc2)c2ccccc2)C3)CC1 10.1016/j.bmcl.2009.01.012
44383760 168562 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 2 5 5.6 O=C(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL435724 168562 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 554 9 2 5 5.6 O=C(c1ccccc1)c1c[nH]nc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
72712159 92656 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435867 92656 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
44392126 66094 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 467 6 0 3 5.4 CN(C(=O)N1Cc2ccccc2C1=O)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183885 66094 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 467 6 0 3 5.4 CN(C(=O)N1Cc2ccccc2C1=O)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
52944231 18142 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 618 7 0 7 3.8 CS(=O)(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)S(=O)(=O)c4ccc(C#N)cc4Cl)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
CHEMBL1269387 18142 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 618 7 0 7 3.8 CS(=O)(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)S(=O)(=O)c4ccc(C#N)cc4Cl)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
16728645 149571 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
CHEMBL394684 149571 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
44392253 65257 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 1 3 5.9 CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182780 65257 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 485 10 1 3 5.9 CCN(C(=O)NCc1ccc(OC)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
505876 27878 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 485 8 0 3 6.0 C=CCN(c1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137154 27878 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 485 8 0 3 6.0 C=CCN(c1ccccc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
59458245 92655 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435866 92655 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 617 10 2 5 5.7 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccc(C(=O)O)cc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
16728645 149571 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL394684 149571 None 0 Human Binding pIC50 = 5.4 5.4 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 8 3 3 4.4 CCCC/C(=N\NC(=N)N)c1cc(Cl)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
44374017 119998 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL350027 119998 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 430 4 0 3 6.0 c1ccc(C2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
25205764 6668 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 554 8 0 6 4.3 CCCCC1CN(CC2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1083437 6668 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 554 8 0 6 4.3 CCCCC1CN(CC2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
46880775 6232 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081477 6232 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 469 7 1 6 3.6 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCOCC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
474158 11272 None 2 Human Binding pIC50 = 7.4 7.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 467 5 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1179117 11272 None 2 Human Binding pIC50 = 7.4 7.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 467 5 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL61267 11272 None 2 Human Binding pIC50 = 7.4 7.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 467 5 1 2 6.6 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CCO3)cc1 10.1021/jm9906264
72712161 92659 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435870 92659 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cccnc3)cc2)CC1 10.1021/jm401101p
474148 11293 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 423 5 1 1 6.1 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCC1 10.1021/jm9906264
CHEMBL1179235 11293 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 423 5 1 1 6.1 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCC1 10.1021/jm9906264
CHEMBL65681 11293 None 2 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 423 5 1 1 6.1 C[N+]1(Cc2ccc(NC(=O)C3=Cc4cc(-c5ccccc5)ccc4CC3)cc2)CCCC1 10.1021/jm9906264
72712159 92656 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435867 92656 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 493 6 0 2 7.1 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccccc3)cc2)CC1 10.1021/jm401101p
46888546 8858 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 1 4 3.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1097170 8858 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 490 7 1 4 3.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46882080 5612 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 609 9 0 7 5.6 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077362 5612 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 609 9 0 7 5.6 CCCC[C@H]1CN(C[C@H]2CC[C@H](OCC)CC2)C(=O)OC12CCN(C1C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
72713858 92699 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
CHEMBL2435910 92699 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 538 8 1 6 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccsc2)CC1 10.1021/jm401101p
73346388 92667 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435878 92667 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
456615 102744 None 1 Human Binding pIC50 = 6.4 6.4 - 1
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL305026 102744 None 1 Human Binding pIC50 = 6.4 6.4 - 1
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
483353 14683 None 1 Human Binding pIC50 = 5.4 5.4 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120584 14683 None 1 Human Binding pIC50 = 5.4 5.4 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.4 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(C)(CCS(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
25133271 189035 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 7 1 4 6.4 O=C(c1ccccc1)N1CCCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL509298 189035 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 604 7 1 4 6.4 O=C(c1ccccc1)N1CCCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
76330768 85587 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 658 8 3 3 8.9 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1007/s00044-012-0118-7
CHEMBL2281959 85587 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 658 8 3 3 8.9 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1007/s00044-012-0118-7
11166533 148839 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL394115 148839 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
5481745 206487 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1007/s00044-011-9863-2
CHEMBL88261 206487 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1007/s00044-011-9863-2
46882075 5607 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 595 5 0 6 5.1 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
CHEMBL1077355 5607 None 0 Human Binding pIC50 = 7.4 7.4 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 595 5 0 6 5.1 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
5481715 104406 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL310305 104406 None 1 Human Binding pIC50 = 7.4 7.4 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 537 8 1 4 4.9 CN(C[C@@H](CCN1CCC2(CC1)NC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44431975 87942 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 659 8 3 4 7.8 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1016/j.bmcl.2007.01.050
CHEMBL234017 87942 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 659 8 3 4 7.8 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cc(Cl)cc1Cl 10.1016/j.bmcl.2007.01.050
11166533 148839 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL394115 148839 None 0 Human Binding pIC50 = 6.4 6.4 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 7 0 3 5.7 CCOC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
479835 206516 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 8 0 4 5.6 CN(CC(CCN1CCC2(CC1)CSc1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL88455 206516 None 1 Human Binding pIC50 = 6.4 6.4 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 506 8 0 4 5.6 CN(CC(CCN1CCC2(CC1)CSc1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
25133620 187186 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 5 1 5 4.8 CC(C)(C)OC(=O)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
CHEMBL492292 187186 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 518 5 1 5 4.8 CC(C)(C)OC(=O)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
44374136 51710 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL158438 51710 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
44392088 63470 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 0 4 4.6 CN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL179858 63470 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 0 4 4.6 CN(C(=O)Cc1ccc(S(=O)(=O)N(C)C)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16073661 140005 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(F)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL380005 140005 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 614 11 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccc(F)cc2)c2ccc(S(C)(=O)=O)cc2)CC1 10.1016/j.bmcl.2006.03.089
44374136 51710 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL158438 51710 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
490006 111525 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 489 8 0 4 5.6 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327898 111525 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 489 8 0 4 5.6 COC(=O)N(CC1CCCC1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
489822 207448 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 3 5.5 O=C(c1cccs1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL94182 207448 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 430 5 0 3 5.5 O=C(c1cccs1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44374136 51710 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL158438 51710 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 539 8 0 5 6.3 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
76330770 85595 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 584 8 3 3 7.6 Cc1cccc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL2281967 85595 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 584 8 3 3 7.6 Cc1cccc(C)c1NC(=O)NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
24794583 181091 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 464 5 3 6 2.3 CN[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
CHEMBL4760098 181091 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 464 5 3 6 2.3 CN[C@@H]1CC[C@H](N2CC[C@H](Nc3ncnc4ccc(C(F)(F)F)cc34)C2=O)[C@H](NC(C)=O)C1 10.1021/acsmedchemlett.1c00082
46888498 8735 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 383 6 1 3 2.8 CC(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096101 8735 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 383 6 1 3 2.8 CC(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
44431979 87830 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 585 8 3 4 6.4 Cc1cccc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL233846 87830 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 585 8 3 4 6.4 Cc1cccc(C)c1NC(=O)NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44392114 66065 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 442 8 1 3 5.1 CN(C(=O)Cc1ccc(O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183709 66065 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 442 8 1 3 5.1 CN(C(=O)Cc1ccc(O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11154101 88100 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 408 5 1 3 4.6 NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234673 88100 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 408 5 1 3 4.6 NC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
10008490 192601 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 584 7 1 5 5.1 O=C(C1CCCC1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
CHEMBL521529 192601 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 584 7 1 5 5.1 O=C(C1CCCC1)N1CCC(OCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)C1 10.1021/jm800598a
16728613 91566 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL240636 91566 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
44590584 176791 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 463 10 2 4 3.9 COc1ccc(CC(=O)NC2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.01.009
CHEMBL460630 176791 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 463 10 2 4 3.9 COc1ccc(CC(=O)NC2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.01.009
483342 108168 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL319622 108168 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 595 13 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(Cn2c(CC)nc3ccccc32)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
44454972 97825 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272064 97825 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1cccc(Cl)c1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
489817 207278 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 502 5 0 2 6.2 O=C(c1ccccc1Br)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93168 207278 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 502 5 0 2 6.2 O=C(c1ccccc1Br)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
489826 207321 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 402 5 0 2 4.9 O=C(C1CCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93457 207321 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 402 5 0 2 4.9 O=C(C1CCC1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
11189082 147011 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL392659 147011 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
16728613 91566 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240636 91566 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 371 5 3 4 2.7 N#Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
473081 207052 None 2 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.3 CC(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL91697 207052 None 2 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 6 0 2 6.3 CC(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
11249997 88345 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 563 6 1 3 6.9 OC1(c2ccc(Br)cc2)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234894 88345 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 563 6 1 3 6.9 OC1(c2ccc(Br)cc2)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
489595 167878 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
CHEMBL431111 167878 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 536 5 0 5 3.9 O=S1(=O)CC2(CCN(C[C@H]3CN(S(=O)(=O)c4ccccc4)C[C@@H]3c3ccccc3)CC2)c2ccccc21 10.1016/s0960-894x(01)00232-3
44392176 65077 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 1 4 5.3 CCN(C(=O)NCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182380 65077 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 533 10 1 4 5.3 CCN(C(=O)NCc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11189082 147011 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL392659 147011 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 409 5 1 3 4.6 OC1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44565081 187083 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN([C@@H](C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491320 187083 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN([C@@H](C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
44392104 165958 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 452 7 1 3 5.7 CN(C(=O)Nc1cccc(C#N)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL425168 165958 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 452 7 1 3 5.7 CN(C(=O)Nc1cccc(C#N)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
4080740 166173 None 5 Human Binding pIC50 = 4.3 4.3 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 464 10 1 6 3.7 O=C(CSc1nc2ccccc2c(=O)n1CCCN1CCCCC1)NCCc1ccccc1 10.1021/jm061389p
CHEMBL426385 166173 None 5 Human Binding pIC50 = 4.3 4.3 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 464 10 1 6 3.7 O=C(CSc1nc2ccccc2c(=O)n1CCCN1CCCCC1)NCCc1ccccc1 10.1021/jm061389p
24794624 179614 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 492 6 3 6 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4742683 179614 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 492 6 3 6 3.1 CC(=O)N[C@@H]1C[C@H](NC(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
44373852 54620 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL161093 54620 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 480 8 0 3 6.9 c1ccc(CCCC2CCN(C[C@H]3CN4O[C@H](c5ccccc5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
44373721 165317 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL423427 165317 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN3OC4(CCCCC4)C[C@H]3[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00835-6
44590585 191115 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL518794 191115 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 505 11 1 4 5.0 CCN(C(=O)Cc1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
489343 4929 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 647 13 2 5 6.3 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL104698 4929 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 647 13 2 5 6.3 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
505879 28645 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137728 28645 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
496974 4222 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
CHEMBL100336 4222 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00605-4
3011729 71042 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 602 11 0 6 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951893 71042 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 602 11 0 6 4.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCN(c3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
57395179 71059 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 633 12 0 7 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(OC)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951911 71059 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 633 12 0 7 3.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(OC)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
10348408 169436 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C)c1C(C(=O)O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL442619 169436 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 590 8 1 5 7.4 Cc1cccc(C)c1C(C(=O)O)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
44573340 188821 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 576 8 0 6 6.9 COC(=O)C(c1ccccc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL506273 188821 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 576 8 0 6 6.9 COC(=O)C(c1ccccc1)N1CCC(CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nc4ccccc42)C3)(c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
44573336 188955 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 565 5 0 6 5.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)N2CCOCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL508250 188955 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 565 5 0 6 5.1 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)N2CCOCC2)CC1 10.1016/j.bmcl.2009.02.014
11605997 58808 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
CHEMBL1688240 58808 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 515 3 0 5 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN(C3CCc4cc(C(F)(F)F)ccc43)[C@@H](C)C2)CC1 10.1021/ml1001536
496974 4222 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
CHEMBL100336 4222 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1ccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/j.ejmech.2008.01.040
501050 4269 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL100596 4269 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
505879 28645 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137728 28645 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 518 10 1 5 5.5 CCCN(c1cccnc1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
46880887 7496 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.3 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087153 7496 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.3 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
46880849 7549 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087535 7549 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CC(F)(F)C1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
501050 4269 None 1 Human Binding pIC50 = 8.3 8.3 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL100596 4269 None 1 Human Binding pIC50 = 8.3 8.3 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 518 10 2 4 5.6 O=C(O)[C@H](C1CCCCC1)N1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44461476 104163 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL309619 104163 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478414 104761 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL310780 104761 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44461677 168024 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 14 0 5 6.4 CCCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL432182 168024 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 591 14 0 5 6.4 CCCCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
5481713 205768 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
5481713 205768 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL82880 205768 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL82880 205768 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 536 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
44415847 79906 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 457 9 1 5 4.6 O=C(N[C@@H](CCN1CCC(n2cnc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
CHEMBL212437 79906 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 457 9 1 5 4.6 O=C(N[C@@H](CCN1CCC(n2cnc(Cc3ccccc3)n2)CC1)c1ccccc1)C1CCC1 10.1016/j.bmcl.2006.06.012
516180 130559 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
CHEMBL368098 130559 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cellInhibitory concentration for displacement of [125I]-MIP-1 alpha from recombinant human CC chemokine receptor 5 (CCR5) expressed in CHO cell
ChEMBL 582 10 1 5 5.9 CCn1nc(Cc2ccc(F)cc2F)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.006
490013 207226 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 525 8 0 4 5.7 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL92803 207226 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 525 8 0 4 5.7 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(C(=O)c3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44461476 104163 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL309619 104163 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 549 11 0 5 5.2 CN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
54584059 62881 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(Cl)c2)CC1 10.1021/jm200279v
CHEMBL1784481 62881 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2cccc(Cl)c2)CC1 10.1021/jm200279v
25132254 103282 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084492 103282 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 0 4 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
25132604 103290 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 5 0 5 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084500 103290 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 5 0 5 7.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
10278617 95180 None 3 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 95180 None 3 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
3008902 202678 None 1 Crab-eating macaque Binding pIC50 = 8.3 8.3 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL61536 202678 None 1 Crab-eating macaque Binding pIC50 = 8.3 8.3 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 512 6 0 4 5.1 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(Cc3ccccc3)c3ccccc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
5275763 96789 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
CHEMBL264832 96789 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 622 10 1 5 4.7 CNC(=O)c1ccc(CC2CCN(CCCN(C(=O)C3CCN(S(C)(=O)=O)CC3)c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm051034q
3002977 2458 None 71 Mouse Binding pIC50 = 8.3 8.3 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
803 2458 None 71 Mouse Binding pIC50 = 8.3 8.3 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
806 2458 None 71 Mouse Binding pIC50 = 8.3 8.3 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
CHEMBL1201187 2458 None 71 Mouse Binding pIC50 = 8.3 8.3 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
CHEMBL256907 2458 None 71 Mouse Binding pIC50 = 8.3 8.3 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
CHEMBL584744 2458 None 71 Mouse Binding pIC50 = 8.3 8.3 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
DB04835 2458 None 71 Mouse Binding pIC50 = 8.3 8.3 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.ejmech.2018.01.085
25133963 103286 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084496 103286 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 6 0 4 7.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2cccc(Cl)c2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm800598a
50992246 58469 None 2 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683074 58469 None 2 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
5275842 63834 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 604 11 0 6 5.1 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL180274 63834 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 604 11 0 6 5.1 CN(C[C@@](C)(CCN1CCC2C(CCC(=O)N2Cc2ccc([N+](=O)[O-])cc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
57396843 70593 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 12 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1949696 70593 None 0 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 671 12 0 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
516368 131214 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
CHEMBL368637 131214 None 1 Human Binding pIC50 = 8.3 8.3 - 0
Displacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human CX3C chemokine receptor 5 expressed in CHO cells
ChEMBL 560 10 1 5 6.0 CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@](C)(C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 10.1016/j.bmcl.2003.12.005
72711958 92653 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435864 92653 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccncc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
3001322 443 None 23 Human Binding pIC50 = 8.2 8.2 - 1
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
805 443 None 23 Human Binding pIC50 = 8.2 8.2 - 1
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
CHEMBL1255794 443 None 23 Human Binding pIC50 = 8.2 8.2 - 1
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
DB06497 443 None 23 Human Binding pIC50 = 8.2 8.2 - 1
Displacement of MIP-1alpha from human CCR5 expressed in CHO cellsDisplacement of MIP-1alpha from human CCR5 expressed in CHO cells
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1016/j.bmc.2011.05.022
44404640 72533 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 13 1 5 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199118 72533 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 13 1 5 6.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NC(=O)Cc3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
72711955 92650 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435861 92650 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccn3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
501054 4588 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102674 4588 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496984 163451 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL419895 163451 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496973 168081 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL432596 168081 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
478414 104761 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL310780 104761 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 538 12 0 3 6.9 CN(C[C@@H](CCN1CCC(CCCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5481744 206546 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1007/s00044-011-9863-2
CHEMBL88644 206546 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 596 8 0 4 6.2 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCCC1 10.1007/s00044-011-9863-2
11376667 60887 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 579 9 1 4 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762316 60887 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 579 9 1 4 7.4 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11215601 60889 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762318 60889 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 604 9 1 5 7.3 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(C#N)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11238728 60900 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1ccnc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
CHEMBL1762334 60900 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1ccnc(OC(c2ccc(C(F)(F)F)cc2)C2CCN(C(C)CCNC(=O)c3c(Cl)cncc3Cl)CC2)c1 10.1016/j.bmcl.2011.02.058
5481712 105902 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL312808 105902 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 523 8 1 4 5.6 CN(C[C@@H](CCN1CCC2(CC1)CNc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
44415784 79820 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 395 7 1 5 3.6 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
CHEMBL212087 79820 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 395 7 1 5 3.6 Cc1nnc(C)n1C1CCN(CC[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2006.06.012
482148 163317 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL418954 163317 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 544 8 0 6 4.4 CN(CC(CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccsc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
15950679 92657 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435868 92657 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 495 6 0 4 5.9 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3cncnc3)cc2)CC1 10.1021/jm401101p
72712374 92663 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
CHEMBL2435874 92663 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 457 5 1 3 5.3 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc3nc[nH]c3c2)CC1 10.1021/jm401101p
16073671 171373 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 652 11 0 6 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL446187 171373 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 652 11 0 6 5.9 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C(C)(C)C)c2)CC1 10.1016/j.bmcl.2006.03.089
16728621 90742 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL239154 90742 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
479860 206994 None 2 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(C(F)(F)F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL91413 206994 None 2 Human Binding pIC50 = 6.3 6.3 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 530 9 0 3 6.4 CN(CC(CCN1CCC(c2ccccc2)CC1)c1cccc(C(F)(F)F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
16728621 90742 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL239154 90742 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 360 5 3 3 3.2 Cc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
478496 206310 None 1 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1007/s00044-011-9863-2
CHEMBL87167 206310 None 1 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 582 8 0 4 5.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)C1CCCC1 10.1007/s00044-011-9863-2
25133617 103279 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 536 7 0 5 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccco2)CC1 10.1021/jm800598a
CHEMBL3084489 103279 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 536 7 0 5 6.8 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCCC1(c2ccccc2)CCN(C(=O)c2ccco2)CC1 10.1021/jm800598a
12425 6 None 126 Human Binding pIC50 = 4.3 4.3 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 None 126 Human Binding pIC50 = 4.3 4.3 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 None 126 Human Binding pIC50 = 4.3 4.3 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 None 126 Human Binding pIC50 = 4.3 4.3 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
44273850 99605 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 554 12 2 4 5.6 O=C(O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
CHEMBL284010 99605 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Ability to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membraneAbility to displace [125I]- labeled MIP-1alpha from CCR5 receptor expressed on CHO cell membrane
ChEMBL 554 12 2 4 5.6 O=C(O)C(CCC1CCN(C[C@H]2CN([C@H](CC3CC3)C(=O)O)C[C@@H]2c2cccc(F)c2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00829-6
44392137 64848 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL182074 64848 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 530 10 0 4 5.3 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
46883507 6107 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 523 7 0 4 6.3 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1080794 6107 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 523 7 0 4 6.3 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44392168 123284 None 4 Human Binding pIC50 = 5.3 5.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 457 8 0 4 5.4 CN(C(=O)c1cccc([N+](=O)[O-])c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL361414 123284 None 4 Human Binding pIC50 = 5.3 5.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 457 8 0 4 5.4 CN(C(=O)c1cccc([N+](=O)[O-])c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
53389710 172279 None 0 Human Binding pIC50 = 6.3 6.3 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 331 5 2 5 2.6 CCCCc1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
CHEMBL4474757 172279 None 0 Human Binding pIC50 = 6.3 6.3 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 331 5 2 5 2.6 CCCCc1[nH]c2nc(N)nn2c(=O)c1Cc1cccc(Cl)c1 10.1021/acs.jmedchem.9b00742
489808 112440 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccccc1Cl)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329813 112440 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccccc1Cl)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
73347894 92652 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435863 92652 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
44564885 179311 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 10 1 6 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)COCC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473353 179311 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 495 10 1 6 4.6 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)COCC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
25130903 187705 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 8 1 5 5.9 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CCN(Cc3ccco3)C1)CC2 10.1021/jm800598a
CHEMBL495297 187705 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 566 8 1 5 5.9 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CCN(Cc3ccco3)C1)CC2 10.1021/jm800598a
16728786 13967 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1196759 13967 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL558043 13967 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
44455033 95176 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
CHEMBL255854 95176 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 516 9 1 6 6.0 COc1cccc(NC(=O)N(CCCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)c2ccccc2)c1 10.1016/j.bmcl.2007.12.058
12425 6 None 126 Human Binding pIC50 = 4.3 4.3 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
1318 6 None 126 Human Binding pIC50 = 4.3 4.3 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
CHEMBL415879 6 None 126 Human Binding pIC50 = 4.3 4.3 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
DB02365 6 None 126 Human Binding pIC50 = 4.3 4.3 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 180 0 0 2 2.8 C1=CC2=C(C3=C(C=CC=N3)C=C2)N=C1 10.1021/jm301121j
44454975 155480 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1c(Cl)cccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL404056 155480 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 554 8 1 5 7.3 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)Nc1c(Cl)cccc1Cl)c1ccccc1 10.1016/j.bmcl.2007.12.058
44590943 176395 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 439 9 1 6 3.7 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2nnc(CN(C)C)o2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459598 176395 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 439 9 1 6 3.7 CC(C[C@H](NC(=O)C1CCC1)c1ccccc1)N1CCC(c2nnc(CN(C)C)o2)CC1 10.1016/j.bmcl.2009.01.009
44392258 66070 None 3 Human Binding pIC50 = 5.3 5.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.5 CCN(C(=O)NC(C)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183746 66070 None 3 Human Binding pIC50 = 5.3 5.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 469 9 1 2 6.5 CCN(C(=O)NC(C)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
1907637 89963 None 10 Human Binding pIC50 = 5.3 5.3 - 0
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 360 4 1 6 1.3 CN(C)c1ccc(/C=C2\SC(N3CCN(CCO)CC3)=NC2=O)cc1 10.1021/acs.jmedchem.6b01309
CHEMBL2381216 89963 None 10 Human Binding pIC50 = 5.3 5.3 - 0
Inhibition of human CCR5Inhibition of human CCR5
ChEMBL 360 4 1 6 1.3 CN(C)c1ccc(/C=C2\SC(N3CCN(CCO)CC3)=NC2=O)cc1 10.1021/acs.jmedchem.6b01309
53324140 58460 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683065 58460 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 495 6 1 4 5.0 CC[C@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
72712371 92660 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
CHEMBL2435871 92660 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 494 6 0 3 6.5 O=C1N(C2CCCCC2)C[C@@H](c2ccccc2)N1C1CCN(Cc2ccc(-c3ccncc3)cc2)CC1 10.1021/jm401101p
483345 4971 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104867 4971 None 1 Human Binding pIC50 = 7.3 7.3 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 588 10 2 6 5.4 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(c2ccccc2)C2Nc3ccccc3S(=O)(=O)N2)CC1 10.1016/s0960-894x(01)00655-2
489821 111608 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccco1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL328373 111608 None 2 Human Binding pIC50 = 7.3 7.3 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 414 5 0 3 5.0 O=C(c1ccco1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44392109 166299 None 4 Human Binding pIC50 = 5.3 5.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 406 7 0 2 5.6 CN(C(=O)CC(C)(C)C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL427137 166299 None 4 Human Binding pIC50 = 5.3 5.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 406 7 0 2 5.6 CN(C(=O)CC(C)(C)C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44590850 176709 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 441 8 1 3 5.4 Cc1ccnc(C)c1C(=O)NCCN1CCCC(CC(c2ccccc2)c2ccccc2)C1 10.1016/j.bmcl.2009.01.012
CHEMBL459986 176709 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 441 8 1 3 5.4 Cc1ccnc(C)c1C(=O)NCCN1CCCC(CC(c2ccccc2)c2ccccc2)C1 10.1016/j.bmcl.2009.01.012
16073673 77809 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 7 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C#N)c2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL209278 77809 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 621 11 0 7 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2cccc(C#N)c2)CC1 10.1016/j.bmcl.2006.03.089
72712158 92654 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435865 92654 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 609 9 2 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCC(C(=O)O)CC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
72711506 92691 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435902 92691 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 511 8 1 4 4.8 CCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
72711049 92683 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
CHEMBL2435894 92683 None 0 Human Binding pIC50 = 7.3 7.3 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 557 8 1 6 4.8 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(C#N)c2)CC1 10.1021/jm401101p
44392204 65625 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 472 9 0 3 6.1 CSc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL183409 65625 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 472 9 0 3 6.1 CSc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
16073668 79782 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2c(F)cccc2F)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL211903 79782 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 632 11 0 6 4.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@H](c2ccc(S(C)(=O)=O)cc2)c2c(F)cccc2F)CC1 10.1016/j.bmcl.2006.03.089
10159218 13933 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1196504 13933 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
CHEMBL557199 13933 None 0 Human Binding pIC50 = 6.3 6.3 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 385 7 1 3 3.2 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccccc1)CC2 10.1021/jm060051s
54585383 60878 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 544 9 0 5 4.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCN(C)C(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762306 60878 None 0 Human Binding pIC50 = 5.3 5.3 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 544 9 0 5 4.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C(C)CCN(C)C(=O)c2c(C)cc[n+]([O-])c2C)CC1 10.1016/j.bmcl.2011.02.058
44431972 89163 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 625 8 3 4 7.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1016/j.bmcl.2007.01.050
CHEMBL236622 89163 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 625 8 3 4 7.1 O=C(NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1016/j.bmcl.2007.01.050
73346389 92668 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435879 92668 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 580 8 0 4 7.0 CN(C)C(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
489827 112275 None 2 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 418 7 0 2 5.5 CCC(CC)C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL329107 112275 None 2 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 418 7 0 2 5.5 CCC(CC)C(=O)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
76312666 85592 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 3 3 8.3 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1007/s00044-012-0118-7
CHEMBL2281964 85592 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 624 8 3 3 8.3 O=C(NCC1(O)CCC(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1)Nc1c(Cl)cccc1Cl 10.1007/s00044-012-0118-7
479870 106410 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 498 9 0 3 5.6 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc(F)c(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL313950 106410 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 498 9 0 3 5.6 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc(F)c(F)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
5481871 206590 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 4.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(F)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL88927 206590 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 540 8 0 4 4.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(F)cc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
6475311 11294 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 425 6 1 1 6.4 Cc1ccc(-c2cccc(/C=C/C(=O)Nc3ccc(C[N+]4(C)CCCCC4)cc3)c2)cc1 10.1021/jm9906264
CHEMBL1179236 11294 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 425 6 1 1 6.4 Cc1ccc(-c2cccc(/C=C/C(=O)Nc3ccc(C[N+]4(C)CCCCC4)cc3)c2)cc1 10.1021/jm9906264
CHEMBL65696 11294 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 425 6 1 1 6.4 Cc1ccc(-c2cccc(/C=C/C(=O)Nc3ccc(C[N+]4(C)CCCCC4)cc3)c2)cc1 10.1021/jm9906264
16728617 91573 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1016/j.bmcl.2006.09.052
CHEMBL240655 91573 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1016/j.bmcl.2006.09.052
16728617 91573 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1007/s00044-012-0118-7
CHEMBL240655 91573 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccccc1[N+](=O)[O-] 10.1007/s00044-012-0118-7
53318854 58467 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683072 58467 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 511 7 1 5 4.2 COC[C@H]1COCC[C@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
53389845 172959 None 0 Human Binding pIC50 = 6.2 6.2 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 315 3 2 5 2.1 Nc1nc2[nH]c(C3CC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
CHEMBL4517518 172959 None 0 Human Binding pIC50 = 6.2 6.2 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 315 3 2 5 2.1 Nc1nc2[nH]c(C3CC3)c(Cc3cccc(Cl)c3)c(=O)n2n1 10.1021/acs.jmedchem.9b00742
44431962 88346 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL234896 88346 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
44431959 147433 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
CHEMBL393004 147433 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1007/s00044-012-0118-7
44404692 72143 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197907 72143 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
46882948 5777 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.4 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078659 5777 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.4 CCCCC1N(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44392110 63898 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL180498 63898 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
44392166 63951 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 504 8 0 2 6.1 CN(C(=O)Cc1ccc(Br)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180685 63951 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 504 8 0 2 6.1 CN(C(=O)Cc1ccc(Br)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44431962 88346 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234896 88346 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 438 6 2 4 4.0 NCC1(O)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44431959 147433 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL393004 147433 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 477 5 1 3 5.6 OC1(C(F)(F)F)CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
44590441 179023 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 445 6 0 3 4.0 Cc1cccc(C)c1C(=O)N1CCC(N2CC(N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471218 179023 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 445 6 0 3 4.0 Cc1cccc(C)c1C(=O)N1CCC(N2CC(N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
16726107 83487 None 2 Human Binding pIC50 = 5.2 5.2 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
CHEMBL220199 83487 None 2 Human Binding pIC50 = 5.2 5.2 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 475 7 1 6 4.4 Cc1ccc(CN2CCC(CNC(=O)C3CCN(c4ccc(-c5cccs5)nn4)CC3)C2)cc1 10.1021/jm061389p
5481754 206466 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL88159 206466 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 604 9 0 4 6.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
44392135 65120 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 3 5.0 CN(C(=O)C(=O)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182403 65120 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 3 5.0 CN(C(=O)C(=O)c1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44392115 66066 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 7 1 2 6.1 Cc1cccc(NC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
CHEMBL183710 66066 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 441 7 1 2 6.1 Cc1cccc(NC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
5481749 85412 None 1 Human Binding pIC50 = 5.2 5.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 8 0 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2c(c1)CCC2 10.1007/s00044-011-9863-2
CHEMBL2263647 85412 None 1 Human Binding pIC50 = 5.2 5.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 8 0 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2c(c1)CCC2 10.1007/s00044-011-9863-2
76308345 85264 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 5.5 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
CHEMBL2259884 85264 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 5.5 CN(C[C@@H](CCN1CCC2(CC1)CNC(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
76327119 85590 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 339 4 0 2 4.7 CN(C)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL2281962 85590 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 339 4 0 2 4.7 CN(C)c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
11210440 88027 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL234461 88027 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
16728635 91765 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
CHEMBL241057 91765 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1007/s00044-012-0118-7
16728609 167412 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL429641 167412 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
5481859 205356 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79716 205356 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 540 8 0 4 6.3 CN(C[C@@H](CCN1CCC2(CC1)CSc1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5482457 205887 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83882 205887 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
44373926 52096 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL158754 52096 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 596 10 0 7 6.3 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3O[C@H](c4ccccc4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
183790 3740 None 11 Human Binding pIC50 = 8.2 8.2 6 2
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/acs.jmedchem.9b00742
783 3740 None 11 Human Binding pIC50 = 8.2 8.2 6 2
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL1178786 3740 None 11 Human Binding pIC50 = 8.2 8.2 6 2
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1021/acs.jmedchem.9b00742
25205923 7112 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 6 5.6 CCO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085223 7112 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 6 5.6 CCO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
46888453 8763 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 473 7 1 3 4.7 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096445 8763 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 473 7 1 3 4.7 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888525 8928 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 491 7 1 3 4.9 Cc1cc(F)cc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1097815 8928 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 491 7 1 3 4.9 Cc1cc(F)cc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
5479844 110447 None 1 Human Binding pIC50 = 8.2 8.2 1 2
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1016/j.bmcl.2010.03.095
CHEMBL324643 110447 None 1 Human Binding pIC50 = 8.2 8.2 1 2
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1016/j.bmcl.2010.03.095
505869 28264 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137419 28264 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
11503459 83520 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of MIP-1beta from human CCR5 expressed in HEK293 cellsDisplacement of MIP-1beta from human CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1021/acs.jmedchem.8b00180
CHEMBL2203615 83520 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of MIP-1beta from human CCR5 expressed in HEK293 cellsDisplacement of MIP-1beta from human CCR5 expressed in HEK293 cells
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1021/acs.jmedchem.8b00180
496973 168081 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
CHEMBL432596 168081 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/s0960-894x(02)00605-4
496984 163451 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL419895 163451 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
44573256 179016 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 553 6 1 4 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC2CCCCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL471149 179016 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 553 6 1 4 7.0 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC2CCCCC2)CC1 10.1016/j.bmcl.2009.02.014
11503459 83521 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203616 83521 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 456 7 1 4 5.6 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
501054 4588 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL102674 4588 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
496984 163451 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL419895 163451 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2cccnc2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496973 168081 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
CHEMBL432596 168081 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 532 11 2 4 5.8 O=C(O)Cc1cccc(CCCC2(O)CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)c1 10.1016/j.ejmech.2008.01.040
46880774 6231 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1081476 6231 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
46880774 6376 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1082191 6376 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 475 7 1 5 4.2 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
501054 4588 None 1 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
CHEMBL102674 4588 None 1 Human Binding pIC50 = 8.2 8.2 - 0
In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.In vitro binding affinity at CCR5 receptor in the presence of [125I]-MIP-1 alpha.
ChEMBL 436 9 2 4 3.6 O=C(O)CN1C[C@H](CN2CCC(O)(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00606-6
44461274 104867 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 645 13 0 5 7.0 CCCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL311052 104867 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 645 13 0 5 7.0 CCCN(C(=O)OCc1ccc(C(F)(F)F)cc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
478446 205360 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL79770 205360 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44461713 205399 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL80043 205399 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
44415820 80265 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 468 7 1 4 5.6 Cc1nc2ccccc2n1C1CC12CC1CCC2N1CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
CHEMBL213914 80265 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 468 7 1 4 5.6 Cc1nc2ccccc2n1C1CC12CC1CCC2N1CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1016/j.bmcl.2006.06.012
9827221 109700 None 0 Human Binding pIC50 = 8.2 8.2 - 1
Inhibitory activity against C-C chemokine receptor type 5Inhibitory activity against C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL322817 109700 None 0 Human Binding pIC50 = 8.2 8.2 - 1
Inhibitory activity against C-C chemokine receptor type 5Inhibitory activity against C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
44461713 205399 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
CHEMBL80043 205399 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 555 11 0 5 5.6 COC(=O)N(CC1CCCCC1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1007/s00044-012-0138-3
10280945 12838 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188557 12838 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536743 12838 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
10280945 12838 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188557 12838 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL536743 12838 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 517 9 1 4 5.9 CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
44564983 187056 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 515 8 1 7 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCS(=O)(=O)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL491153 187056 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 515 8 1 7 3.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCS(=O)(=O)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
3010259 189167 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511154 189167 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010259 189167 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL511154 189167 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
3010259 189167 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL511154 189167 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 526 8 2 4 6.0 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cnc(-c4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
44404719 134245 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 548 11 0 5 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL371691 134245 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 548 11 0 5 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
44401765 67953 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 514 8 1 5 5.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(Cn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL191139 67953 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 514 8 1 5 5.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(Cn3cnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
72711507 92692 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435903 92692 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 525 9 1 4 5.2 CCCN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
5275839 166115 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 4.8 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL426048 166115 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 559 10 0 4 4.8 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)Cc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
489316 109041 None 2 Human Binding pIC50 = 8.2 8.2 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 458 9 0 2 7.0 c1ccc(CCCC2CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00652-7
CHEMBL321267 109041 None 2 Human Binding pIC50 = 8.2 8.2 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 458 9 0 2 7.0 c1ccc(CCCC2CCN(C[C@H]3CN(CC4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00652-7
489305 164610 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 526 12 1 5 5.4 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
CHEMBL421598 164610 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes.
ChEMBL 526 12 1 5 5.4 CN(CC(CCN1CCC(O)(CCCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(01)00652-7
49871007 58811 None 13 Human Binding pIC50 = 8.2 8.2 - 1
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58811 None 13 Human Binding pIC50 = 8.2 8.2 - 1
Displacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytesDisplacement of [125I]MIP-1beta from CCR5 in IL-10-stimulated human monocytes
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
44447733 95098 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255431 95098 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]RANTES from human CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from human CCR5 expressed in CHO cells
ChEMBL 469 5 0 5 5.1 Cc1cccnc1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
505880 27720 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137038 27720 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505880 27720 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137038 27720 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
16041224 92639 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 556 8 1 6 5.2 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
CHEMBL2435850 92639 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 556 8 1 6 5.2 O=C(O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCOCC5)C[C@H]4c4ccccc4)CC3)cn2)cc1 10.1021/jm401101p
505880 27720 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137038 27720 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 519 10 1 6 4.9 CCCN(c1ncccn1)C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
11700429 103543 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085311 103543 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 710 17 1 7 9.1 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCN3CC(C)C)cc1 10.1021/jm0509703
478352 12034 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 471 8 2 3 5.4 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)CCCO)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL1183391 12034 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 471 8 2 3 5.4 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)CCCO)cc2)CCO3)cc1 10.1021/jm9906264
CHEMBL294501 12034 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 471 8 2 3 5.4 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+](C)(C)CCCO)cc2)CCO3)cc1 10.1021/jm9906264
516358 178382 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL465416 178382 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44384705 120816 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 10 1 5 7.2 CCn1ncc(C(C)(C)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL355749 120816 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 596 10 1 5 7.2 CCn1ncc(C(C)(C)c2ccccc2)c1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
516358 178382 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL465416 178382 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 596 10 1 5 7.2 CCn1nc(C(C)(C)c2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
496983 109853 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL323370 109853 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010266 179101 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471765 179101 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
489314 5406 None 2 Human Binding pIC50 = 7.2 7.2 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 585 10 0 5 6.9 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL107170 5406 None 2 Human Binding pIC50 = 7.2 7.2 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 585 10 0 5 6.9 O=S(=O)(c1ccc(-c2ccccn2)s1)N1C[C@H](CN2CCC(CCCc3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
25206204 188371 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 610 7 0 7 4.7 CCCCC1C(=O)N(CC2CCN(C(=O)OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL501383 188371 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 610 7 0 7 4.7 CCCCC1C(=O)N(CC2CCN(C(=O)OC)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
25230897 191435 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 548 7 0 6 3.5 CCCCC1CN(S(=O)(=O)N(C)C)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL519298 191435 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 548 7 0 6 3.5 CCCCC1CN(S(=O)(=O)N(C)C)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
478502 105976 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(00)00637-5
CHEMBL313071 105976 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(00)00637-5
5481748 111548 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1016/s0960-894x(00)00637-5
CHEMBL328024 111548 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 640 8 0 4 7.1 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2ccccc2c1 10.1016/s0960-894x(00)00637-5
478387 206650 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
CHEMBL89279 206650 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 596 8 0 5 6.0 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccs1 10.1016/s0960-894x(00)00637-5
44392161 63933 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 451 8 0 3 5.2 CN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180656 63933 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 451 8 0 3 5.2 CN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11157818 60891 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762320 60891 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 613 9 1 4 8.1 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
11204141 60899 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccnc1OC(c1ccc(C(F)(F)F)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762333 60899 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 594 9 1 5 7.2 Cc1cccnc1OC(c1ccc(C(F)(F)F)cc1)C1CCN(C(C)CCNC(=O)c2c(Cl)cncc2Cl)CC1 10.1016/j.bmcl.2011.02.058
479871 107144 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1C 10.1016/s0960-894x(00)00639-9
CHEMBL316189 107144 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 490 9 0 3 6.0 Cc1ccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)cc1C 10.1016/s0960-894x(00)00639-9
11210440 88027 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL234461 88027 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
16728612 91367 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 424 5 3 3 3.6 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Br)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240260 91367 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 424 5 3 3 3.6 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Br)cc1 10.1016/j.bmcl.2006.09.052
16728629 91569 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240639 91569 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
16728635 91765 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
CHEMBL241057 91765 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 327 5 3 4 2.6 N#Cc1ccc(OCc2ccc(Cl)cc2)c(/C=N/NC(=N)N)c1 10.1016/j.bmcl.2006.09.052
11210440 88027 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
CHEMBL234461 88027 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 353 5 0 2 4.7 CN(C)Cc1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2007.01.050
3010251 14561 None 1 Human Binding pIC50 = 5.2 5.2 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 571 14 0 7 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)CC)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL120419 14561 None 1 Human Binding pIC50 = 5.2 5.2 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 571 14 0 7 5.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(=O)(=O)CC)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
3010250 114133 None 1 Human Binding pIC50 = 5.2 5.2 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 557 13 0 7 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(C)(=O)=O)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL332908 114133 None 1 Human Binding pIC50 = 5.2 5.2 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 557 13 0 7 5.2 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(C)S(C)(=O)=O)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44559501 172618 None 0 Human Binding pIC50 = 4.2 4.2 - 0
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 523 3 2 7 2.4 CC(=O)O[C@@H]1[C@@H]2O[C@H]2[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4ccccc4)NC(=O)[C@@]123 10.1021/np049974l
CHEMBL449278 172618 None 0 Human Binding pIC50 = 4.2 4.2 - 0
Displacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cellsDisplacement of [125I]gp-120 from human CCR5 receptor expressed in CHO cells
ChEMBL 523 3 2 7 2.4 CC(=O)O[C@@H]1[C@@H]2O[C@H]2[C@@](C)(O)C(=O)[C@@H](C)C/C=C/[C@H]2[C@@H]3O[C@]3(C)[C@@H](C)[C@H]3[C@H](Cc4ccccc4)NC(=O)[C@@]123 10.1021/np049974l
16728629 91569 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
CHEMBL240639 91569 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 336 5 3 3 3.4 N=C(N)N/N=C/c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1007/s00044-012-0118-7
489325 163347 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 541 7 1 4 5.7 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](c4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
CHEMBL419172 163347 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 541 7 1 4 5.7 O=C1CC2(CCN(CCC(CN3C(=O)N[C@H](c4ccccc4)C3=O)c3cccc(Cl)c3)CC2)c2ccccc21 10.1016/s0960-894x(01)00654-0
46883025 5811 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.2 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078936 5811 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 554 7 0 6 5.2 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ccnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46882079 5611 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 605 7 0 7 5.3 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
CHEMBL1077361 5611 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 605 7 0 7 5.3 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)C[C@@H]3CN(C(=O)c4c(C)cc(C#N)nc4C)C[C@@H]3C1)CC2 10.1016/j.bmcl.2010.02.004
11598797 12924 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1189134 12924 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL538084 12924 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
489805 207350 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 439 5 1 2 5.8 O=C(Nc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93644 207350 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 439 5 1 2 5.8 O=C(Nc1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
9909684 64934 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 413 7 0 3 4.8 CN(C(=O)c1ccncc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182266 64934 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 413 7 0 3 4.8 CN(C(=O)c1ccncc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
44565037 192982 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL489324 192982 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL522259 192982 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 501 8 1 5 5.8 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
46890341 7111 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 602 7 0 6 5.2 CO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085222 7111 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 602 7 0 6 5.2 CO[C@H]1CC[C@H](CN2C[C@@H](c3ccccc3)N(C3CCN(C4(C)CCN(C(=O)c5c(C)ncnc5C)CC4)CC3)C2=O)CC1 10.1016/j.bmcl.2010.04.077
44392244 63783 None 3 Human Binding pIC50 = 7.2 7.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 9 1 2 5.9 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180184 63783 None 3 Human Binding pIC50 = 7.2 7.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 455 9 1 2 5.9 CCN(C(=O)NCc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
72711048 92682 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
CHEMBL2435893 92682 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 550 8 1 5 5.0 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2cccc(F)c2)CC1 10.1021/jm401101p
72712597 92665 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
CHEMBL2435876 92665 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
44401593 71066 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195199 71066 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
10840677 11278 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 528 15 1 1 10.2 CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)/C=C/c2cccc(-c3ccc(C)cc3)c2)cc1 10.1021/jm9906264
CHEMBL1179151 11278 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 528 15 1 1 10.2 CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)/C=C/c2cccc(-c3ccc(C)cc3)c2)cc1 10.1021/jm9906264
CHEMBL62454 11278 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 528 15 1 1 10.2 CCCC[P+](CCCC)(CCCC)Cc1ccc(NC(=O)/C=C/c2cccc(-c3ccc(C)cc3)c2)cc1 10.1021/jm9906264
44401593 71066 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL195199 71066 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
44401593 71066 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL195199 71066 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 516 7 2 5 4.7 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3c(=O)[nH]c4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
44439155 91972 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 12 4 6 5.2 COC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
CHEMBL241497 91972 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5Inhibition of CCR5
ChEMBL 594 12 4 6 5.2 COC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCc1cc(-c2cc(Cl)cc(Cl)c2)nn1-c1ccc2ccccc2c1 10.1016/j.bmcl.2006.10.060
52947044 18268 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 559 8 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270401 18268 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 559 8 0 6 3.0 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3cc(F)cc(F)c3)C3CN(S(=O)(=O)C4CC4)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
25132253 103281 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 528 5 0 5 6.9 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084491 103281 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 528 5 0 5 6.9 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OC(C)(C)C)CC1 10.1021/jm800598a
25133961 103283 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 7 0 5 7.3 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm800598a
CHEMBL3084493 103283 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 562 7 0 5 7.3 Cc1nc2ccccc2n1[C@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)OCc2ccccc2)CC1 10.1021/jm800598a
44392103 65246 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 484 9 0 4 5.2 COC(=O)c1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL182731 65246 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 484 9 0 4 5.2 COC(=O)c1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
11606411 85306 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of MIP1alpha from CCR5 receptorDisplacement of MIP1alpha from CCR5 receptor
ChEMBL 550 4 1 2 7.2 C[C@H]1CN([C@@H]2CC[C@](C)(C(=O)NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2)CC[C@@]12C=Cc1ccccc12 10.1021/jm070166b
CHEMBL226066 85306 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of MIP1alpha from CCR5 receptorDisplacement of MIP1alpha from CCR5 receptor
ChEMBL 550 4 1 2 7.2 C[C@H]1CN([C@@H]2CC[C@](C)(C(=O)NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2)CC[C@@]12C=Cc1ccccc12 10.1021/jm070166b
93149 107199 None 84 Human Binding pIC50 = 4.2 4.2 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 107199 None 84 Human Binding pIC50 = 4.2 4.2 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
25231041 188863 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 7 3.6 CCCCC1CN(S(=O)(=O)C2CCN(C=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL506958 188863 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 8 0 7 3.6 CCCCC1CN(S(=O)(=O)C2CCN(C=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44590862 190769 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.1 CCN(C(=O)c1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL518326 190769 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 491 10 1 4 5.1 CCN(C(=O)c1ccc(OC)cc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
5481736 106680 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(01)00654-0
CHEMBL314342 106680 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(01)00654-0
5481736 106680 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL314342 106680 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 568 8 0 3 6.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Cc1ccccc1 10.1016/s0960-894x(00)00637-5
44590751 176895 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 9 1 3 5.5 CCN(C(=O)N(C)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL461688 176895 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 490 9 1 3 5.5 CCN(C(=O)N(C)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
25205600 7228 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 564 7 0 6 4.5 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085723 7228 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 564 7 0 6 4.5 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C#N)nc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
20664160 180908 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL475777 180908 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2005.02.030
20664160 180908 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475777 180908 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
5482457 205887 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL83882 205887 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 524 11 0 3 6.5 CN(C[C@@H](CCN1CCC(CCc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
20664160 180908 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL475777 180908 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 504 8 1 5 5.0 O=C(O)[C@@H](CC1CCC1)N1C[C@H](CN2CCC(c3cn4ccccc4n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.ejmech.2008.01.040
72713859 92700 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435911 92700 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
44392124 65234 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1OC 10.1016/j.bmcl.2004.10.044
CHEMBL182682 65234 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 486 10 0 4 5.4 COc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1OC 10.1016/j.bmcl.2004.10.044
58282592 139959 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Inhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assayInhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assay
ChEMBL 409 6 0 3 6.2 Cc1nc2ccccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.5b00497
CHEMBL3799799 139959 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Inhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assayInhibition of human recombinant CCR5 encoding an HIV-1-longterminal-repeat-regulated beta-galactosidase reporter gene expressed in human HeLaP4 cells assessed as reduction of interaction with HIV-1 gp160 expressed in CHO cells by cell-cell fusion assay
ChEMBL 409 6 0 3 6.2 Cc1nc2ccccc2n1C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1021/acs.jmedchem.5b00497
478413 205380 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79958 205380 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 510 10 0 3 6.1 CN(C[C@@H](CCN1CCC(Cc2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
44392153 64943 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 465 9 0 3 5.6 CCN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182279 64943 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 465 9 0 3 5.6 CCN(C(=O)Cc1ccc(C#N)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
505874 28567 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137650 28567 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
505874 28567 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137650 28567 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
5275761 77116 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207633 77116 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 609 10 1 5 5.0 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(=O)O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
505874 28567 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137650 28567 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 486 8 0 4 5.4 C=CCN(c1ccncc1)C1CCN(C[C@H]2CN(C(=O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
44392169 63860 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL180334 63860 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 444 8 0 2 5.5 CN(C(=O)Cc1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
474156 11287 None 2 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 453 5 1 2 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CO3)cc1 10.1021/jm9906264
CHEMBL1179200 11287 None 2 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 453 5 1 2 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CO3)cc1 10.1021/jm9906264
CHEMBL64591 11287 None 2 Human Binding pIC50 = 6.2 6.2 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 453 5 1 2 6.2 Cc1ccc(-c2ccc3c(c2)C=C(C(=O)Nc2ccc(C[N+]4(C)CCCCC4)cc2)CO3)cc1 10.1021/jm9906264
93149 107199 None 84 Human Binding pIC50 = 4.2 4.2 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
CHEMBL316589 107199 None 84 Human Binding pIC50 = 4.2 4.2 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 194 0 0 2 3.1 Cc1ccnc2c1ccc1cccnc12 10.1021/jm301121j
489806 111512 None 2 Human Binding pIC50 = 7.2 7.2 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
CHEMBL327846 111512 None 2 Human Binding pIC50 = 7.2 7.2 - 0
Ability to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranesAbility to inhibit binding of [125I]-MIP-1 alpha to C-C chemokine receptor type 5 in Chinese hamster ovary (CHO) cell membranes
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00652-7
11520510 103538 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 724 17 1 7 9.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CC(C)C)cc1 10.1021/jm0509703
CHEMBL3085305 103538 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]RANTES from CCR5 expressed in CHO cellsDisplacement of [125I]RANTES from CCR5 expressed in CHO cells
ChEMBL 724 17 1 7 9.5 CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCCCN3CC(C)C)cc1 10.1021/jm0509703
489806 111512 None 2 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL327846 111512 None 2 Human Binding pIC50 = 7.2 7.2 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 424 5 0 2 5.4 O=C(c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
478296 157918 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00232-3
CHEMBL408438 157918 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Ability to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125 I]-MIP-1alpha from C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 522 8 0 4 4.6 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00232-3
10208679 12840 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188565 12840 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL536751 12840 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 493 9 2 5 4.0 CCCCN1C(=O)[C@H]([C@H](O)C(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
11342750 5692 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.4 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078013 5692 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.4 CCCCC1CN(CC2CCCCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
44392148 65281 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 483 9 1 3 5.3 CC(=O)Nc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
CHEMBL182878 65281 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 483 9 1 3 5.3 CC(=O)Nc1ccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1 10.1016/j.bmcl.2004.10.044
44392203 66072 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1cccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
CHEMBL183769 66072 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 456 9 0 3 5.4 COc1cccc(CC(=O)N(C)C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)c1 10.1016/j.bmcl.2004.10.044
44392160 123685 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 2 5.9 CC(C(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1)c1ccccc1 10.1016/j.bmcl.2004.10.044
CHEMBL362168 123685 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 440 8 0 2 5.9 CC(C(=O)N(C)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1)c1ccccc1 10.1016/j.bmcl.2004.10.044
483354 11809 None 2 Human Binding pIC50 = 5.2 5.2 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 12 0 5 6.7 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL118196 11809 None 2 Human Binding pIC50 = 5.2 5.2 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 12 0 5 6.7 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44373767 168638 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL436245 168638 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@@H]3[C@@H](c4ccccc4)CN4OC5(CCCCC5)C[C@@H]34)CC2)cc1 10.1016/s0960-894x(01)00835-6
44392084 64939 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 462 8 0 2 5.7 CN(C(=O)Cc1ccc(F)c(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL182274 64939 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 462 8 0 2 5.7 CN(C(=O)Cc1ccc(F)c(F)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728623 90300 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
CHEMBL238545 90300 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1007/s00044-012-0118-7
478502 105976 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1007/s00044-011-9863-2
CHEMBL313071 105976 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc([N+](=O)[O-])cc1 10.1007/s00044-011-9863-2
5481727 205352 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL79697 205352 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
5481702 205821 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL83338 205821 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
76315544 85265 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 6.1 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
CHEMBL2259885 85265 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 630 9 1 6 6.1 CN(C[C@@H](CCN1CCC2(CC1)CC(=O)Nc1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
489341 4951 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
489341 4951 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
CHEMBL104793 4951 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL104793 4951 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 633 13 2 5 6.1 C=CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2ccccc2)CC1 10.1016/s0960-894x(01)00655-2
46888456 8811 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 459 7 1 3 4.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096768 8811 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 459 7 1 3 4.4 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888545 8857 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 474 7 1 4 4.1 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1097169 8857 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 474 7 1 4 4.1 Cc1ccnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
20664141 79004 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 533 8 1 6 5.0 Cc1cc(C)n2ncc(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)c2n1 10.1016/j.bmcl.2005.02.030
CHEMBL2113084 79004 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 533 8 1 6 5.0 Cc1cc(C)n2ncc(C3CCN(C[C@H]4CN([C@H](CC5CCC5)C(=O)O)C[C@@H]4c4cccc(F)c4)CC3)c2n1 10.1016/j.bmcl.2005.02.030
496983 109853 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
CHEMBL323370 109853 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.Displacement of [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes.
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00605-4
10461319 169485 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 606 8 1 7 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc3c(c2)OCO3)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL443106 169485 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 606 8 1 7 6.5 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccc3c(c2)OCO3)CC1 10.1016/j.bmcl.2009.02.014
44573255 170550 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 5 1 4 6.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)(C)C)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL445003 170550 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 527 5 1 4 6.4 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(=O)NC(C)(C)C)CC1 10.1016/j.bmcl.2009.02.014
44573337 188206 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 592 9 1 6 6.8 COc1ccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.02.014
CHEMBL499109 188206 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 592 9 1 6 6.8 COc1ccc(C(C(=O)O)N2CCC(CCN3[C@H]4CC[C@@H]3C[C@H](n3c(C)nc5ccccc53)C4)(c3ccccc3)CC2)cc1 10.1016/j.bmcl.2009.02.014
10325578 188850 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 564 6 0 6 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL506795 188850 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 564 6 0 6 6.7 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(/C(=N\C#N)OC2CCCC2)CC1 10.1016/j.bmcl.2009.02.014
496983 109853 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL323370 109853 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 9 1 4 5.5 OC1(CCCc2ccccn2)CCN(C[C@H]2CN(CC3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
3010266 179101 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
CHEMBL471765 179101 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.ejmech.2008.01.040
46882947 5680 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.5 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1077912 5680 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 6 5.5 CCCCC1N(CC2CCCCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
46880848 7548 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
CHEMBL1087534 7548 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 455 7 1 6 3.5 Cc1nnc(C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCOC1)c1cccc(F)c1 10.1016/j.bmcl.2010.01.080
3010266 179101 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
CHEMBL471765 179101 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligandInhibition of human C-C chemokine receptor type 5 assayed using [125I]-MIP-1 alpha as radioligand
ChEMBL 500 9 2 4 5.0 CC(C)[C@H](C(=O)O)N1C[C@H](CN2CCC(c3cnc(Cc4ccccc4)[nH]3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2004.04.078
5275829 206026 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL85086 206026 None 1 Human Binding pIC50 = 8.2 8.2 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 563 12 0 5 5.6 CCN(C(=O)OCc1ccccc1)C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44404709 72066 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 576 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(=O)OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL197680 72066 None 0 Human Binding pIC50 = 8.2 8.2 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 576 11 0 6 5.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(C(=O)OC)cc2)CC1 10.1016/j.bmcl.2005.08.014
10008425 103287 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 5 0 4 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
CHEMBL3084497 103287 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 580 5 0 4 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)C(C)(C)C)CC1 10.1021/jm800598a
44590557 176360 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 8 1 5 5.4 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL459571 176360 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 487 8 1 5 5.4 Cc1nnc(C(C)C)n1C1CCN(CC[C@H](NC(=O)C2CCC(F)(F)CC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
516348 127814 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 576 8 2 4 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4cccc5ccccc45)[nH]n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL366439 127814 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 576 8 2 4 7.2 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4cccc5ccccc45)[nH]n3)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2003.12.004
516347 129738 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 551 8 2 5 5.9 N#Cc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4ccccc4)CC3)n[nH]2)cc1 10.1016/j.bmcl.2003.12.004
CHEMBL367446 129738 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 551 8 2 5 5.9 N#Cc1ccc(-c2cc(C3CCN(C[C@H]4CN([C@@H](C(=O)O)C5CCCCC5)C[C@@H]4c4ccccc4)CC3)n[nH]2)cc1 10.1016/j.bmcl.2003.12.004
72711741 92648 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435859 92648 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 579 9 1 4 6.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(CC3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
44404657 133527 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 593 11 1 5 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(C)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL370826 133527 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 593 11 1 5 5.3 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(C)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
25231038 172432 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 9 0 6 5.2 CCCCC1C(=O)N(CC2CCN(CC(F)F)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL447808 172432 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 616 9 0 6 5.2 CCCCC1C(=O)N(CC2CCN(CC(F)F)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
478499 206500 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1016/s0960-894x(00)00637-5
CHEMBL88344 206500 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc(Cl)c1 10.1016/s0960-894x(00)00637-5
44322729 206808 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 629 8 1 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2[nH]ccc2c1 10.1016/s0960-894x(00)00637-5
CHEMBL90385 206808 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 629 8 1 4 6.4 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccc2[nH]ccc2c1 10.1016/s0960-894x(00)00637-5
11250534 60903 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cc(Cl)ccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762337 60903 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 614 9 1 5 7.5 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cc(Cl)ccn2)c2ccc(C(F)(F)F)cc2)CC1 10.1016/j.bmcl.2011.02.058
478412 167968 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
CHEMBL431795 167968 None 1 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 526 10 0 4 6.0 COc1ccccc1C1CCN(CC[C@H](CN(C)S(=O)(=O)c2ccccc2)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00491-7
44415783 80062 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 382 7 1 5 3.6 Cc1nc(C2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)no1 10.1016/j.bmcl.2006.06.012
CHEMBL213009 80062 None 0 Human Binding pIC50 = 7.2 7.2 - 0
Inhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cellsInhibition of [125I]MIP-1beta binding to CCR5 expressed in HEK293 cells
ChEMBL 382 7 1 5 3.6 Cc1nc(C2CCN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)no1 10.1016/j.bmcl.2006.06.012
16728623 90300 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL238545 90300 None 0 Human Binding pIC50 = 6.2 6.2 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 376 6 3 4 2.9 COc1ccc(COc2ccc(Br)cc2/C=N/NC(=N)N)cc1 10.1016/j.bmcl.2006.09.052
5481727 205352 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
CHEMBL79697 205352 None 1 Human Binding pIC50 = 6.2 6.2 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 497 9 0 4 5.0 CN(C[C@@H](CCN1CCN(c2ccccc2)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00491-7
56754672 122997 None 6 Human Binding pIC50 = 4.2 4.2 - 0
Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)
ChEMBL 363 6 1 5 3.2 COc1ncc(CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)cn1 10.1021/acsmedchemlett.5b00036
CHEMBL3608771 122997 None 6 Human Binding pIC50 = 4.2 4.2 - 0
Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)Displacement of [125I]-MIP-1beta form CCR5 (unknown origin)
ChEMBL 363 6 1 5 3.2 COc1ncc(CN2CCC(c3[nH]ncc3Cc3ccccc3)CC2)cn1 10.1021/acsmedchemlett.5b00036
12093170 871 None 31 Human Binding pIC50 = 6.2 6.2 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 1 3 4.2 Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C 10.1021/acs.jmedchem.9b00742
9431 871 None 31 Human Binding pIC50 = 6.2 6.2 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 1 3 4.2 Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C 10.1021/acs.jmedchem.9b00742
CHEMBL4519152 871 None 31 Human Binding pIC50 = 6.2 6.2 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 1 3 4.2 Clc1ccc(c(c1)F)N1[C@H](C2CCCCC2)C(=C(C1=O)O)C(=O)C 10.1021/acs.jmedchem.9b00742
25133270 170483 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 594 7 0 5 5.9 CN1CN(c2ccccc2)C2(CCN(CCCC3(c4ccc(Cl)c(Cl)c4)CCN(C(=O)c4ccco4)C3)CC2)C1=O 10.1021/jm800598a
CHEMBL444915 170483 None 0 Human Binding pIC50 = 5.2 5.2 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 594 7 0 5 5.9 CN1CN(c2ccccc2)C2(CCN(CCCC3(c4ccc(Cl)c(Cl)c4)CCN(C(=O)c4ccco4)C3)CC2)C1=O 10.1021/jm800598a
50992246 58469 None 2 Mouse Binding pIC50 = 7.2 7.2 - 0
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683074 58469 None 2 Mouse Binding pIC50 = 7.2 7.2 - 0
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 498 6 1 6 3.3 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@@](C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)(C(C)C)C1 10.1016/j.bmcl.2011.01.015
9873546 78035 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of CCR5Inhibition of CCR5
ChEMBL 566 8 1 2 7.5 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1 10.1021/jm060439n
CHEMBL209899 78035 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of CCR5Inhibition of CCR5
ChEMBL 566 8 1 2 7.5 O=C(NCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)[C@@H](CCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1 10.1021/jm060439n
23285265 112311 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 512 9 0 3 6.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc2ccccc2c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL329190 112311 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 512 9 0 3 6.5 CN(CC(CCN1CCC(c2ccccc2)CC1)c1ccc2ccccc2c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44392154 66098 None 3 Human Binding pIC50 = 5.1 5.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 430 7 0 2 5.6 CN(C(=O)c1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183907 66098 None 3 Human Binding pIC50 = 5.1 5.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 430 7 0 2 5.6 CN(C(=O)c1ccc(F)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
483351 113349 None 1 Human Binding pIC50 = 5.1 5.1 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 15 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(CC)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL331754 113349 None 1 Human Binding pIC50 = 5.1 5.1 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 633 15 0 7 7.0 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CCC(CC(CC)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44590863 176716 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 461 9 1 3 5.0 CCN(C(=O)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
CHEMBL460008 176716 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 461 9 1 3 5.0 CCN(C(=O)c1ccccc1)C1CCN(C(C)C[C@H](NC(=O)C2CCC2)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.009
11578088 78125 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 612 9 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NC(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL210327 78125 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 612 9 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(NC(=O)c3ccc(F)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
57335017 70336 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 595 8 4 6 2.8 N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
CHEMBL1944776 70336 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 595 8 4 6 2.8 N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
44573127 187224 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 1 5 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncc[nH]2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL492503 187224 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 508 7 1 5 5.9 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(Cc2ncc[nH]2)CC1 10.1016/j.bmcl.2009.02.014
44404645 72461 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 673 13 1 6 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198884 72461 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 673 13 1 6 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(NS(=O)(=O)c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
44392218 64557 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 390 7 0 2 4.9 CN(C(=O)C1CCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181502 64557 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 390 7 0 2 4.9 CN(C(=O)C1CCC1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
52942078 18342 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 505 6 0 6 3.8 COC(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)c4c(C)ncnc4C)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
CHEMBL1270900 18342 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 505 6 0 6 3.8 COC(=O)N1CCC(C(CCN2C[C@H]3CN(C(=O)c4c(C)ncnc4C)C[C@H]3C2)c2ccccc2)CC1 10.1016/j.bmcl.2010.08.118
16728647 149573 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1007/s00044-012-0118-7
CHEMBL394685 149573 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1007/s00044-012-0118-7
478447 205791 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
CHEMBL83113 205791 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 590 13 1 4 6.1 CCCN(C(=O)N[C@@H](C)c1ccccc1)C1CCN(CCC(CN(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/s0960-894x(01)00492-9
16728647 149573 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL394685 149573 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 406 5 2 5 3.6 Clc1ccc(COc2ccc(Br)cc2/C=N/NC2=NCCN2)cc1 10.1016/j.bmcl.2006.09.052
489810 107119 None 2 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccc(Cl)cc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL316073 107119 None 2 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1ccc(Cl)cc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44570270 170308 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 567 7 1 6 4.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL444667 170308 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 567 7 1 6 4.8 CCCCC1C(=O)N(C[C@H]2CC[C@H](O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44392096 131783 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL369311 131783 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 518 10 0 4 5.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
11787124 5694 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.2 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078015 5694 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 541 7 0 7 4.2 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
516315 130186 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1Cc1ccccc1 10.1016/j.bmcl.2003.12.004
CHEMBL367894 130186 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 568 10 1 5 6.4 CCn1nc(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)cc1Cc1ccccc1 10.1016/j.bmcl.2003.12.004
44404601 135487 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372852 135487 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
489340 107836 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 669 12 2 5 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
CHEMBL319233 107836 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 669 12 2 5 6.8 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(C)(CN2C(=O)N[C@H](Cc3c[nH]c4ccccc34)C2=O)c2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00654-0
72713859 92700 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435911 92700 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccc2)CC1 10.1021/jm401101p
53318853 58454 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@H]2C)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683059 58454 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 481 5 1 4 4.6 CC(C)[C@]1(C(=O)N2CCN(c3cccc(C(F)(F)F)c3)CC2)CC[C@@H](N[C@H]2CCOC[C@H]2C)C1 10.1016/j.bmcl.2011.01.015
44392123 129926 None 4 Human Binding pIC50 = 6.1 6.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL367586 129926 None 4 Human Binding pIC50 = 6.1 6.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
25130901 103291 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 5 0 5 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)C1 10.1021/jm800598a
CHEMBL3084501 103291 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 582 5 0 5 7.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccc(Cl)c(Cl)c2)CCN(C(=O)OC(C)(C)C)C1 10.1021/jm800598a
25231105 174098 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 7 0 7 4.0 CCCCC1CN(S(=O)(=O)C2CCN(C(C)=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL454493 174098 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 630 7 0 7 4.0 CCCCC1CN(S(=O)(=O)C2CCN(C(C)=O)CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
44404697 134769 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL371865 134769 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 586 10 0 4 6.5 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2005.08.014
44455180 97932 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 478 8 1 5 5.4 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL272556 97932 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 478 8 1 5 5.4 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC1CCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
516319 60035 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against human Chemokine receptor 5 when co-administered with compound 8fInhibitory activity against human Chemokine receptor 5 when co-administered with compound 8f
ChEMBL 568 10 1 5 6.4 CCc1cc(Cc2ccccc2)n(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL173609 60035 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against human Chemokine receptor 5 when co-administered with compound 8fInhibitory activity against human Chemokine receptor 5 when co-administered with compound 8f
ChEMBL 568 10 1 5 6.4 CCc1cc(Cc2ccccc2)n(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
11598 672 None 9 Human Binding pIC50 = 6.1 6.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
23725177 672 None 9 Human Binding pIC50 = 6.1 6.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
CHEMBL4442783 672 None 9 Human Binding pIC50 = 6.1 6.1 - 1
Antagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptorAntagonist activity at CCR5 (unknown origin) expressed in human HT1080 cells assessed as blockade of MIP1beta-binding to receptor
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
11598 672 None 9 Human Binding pIC50 = 6.1 6.1 - 1
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.1c00082
23725177 672 None 9 Human Binding pIC50 = 6.1 6.1 - 1
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.1c00082
CHEMBL4442783 672 None 9 Human Binding pIC50 = 6.1 6.1 - 1
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.1c00082
5481737 106547 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 570 7 0 4 6.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Oc1ccccc1 10.1016/s0960-894x(00)00637-5
CHEMBL314124 106547 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 570 7 0 4 6.8 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)C(=O)Oc1ccccc1 10.1016/s0960-894x(00)00637-5
44392116 122515 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL360120 122515 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 494 8 0 2 6.7 CN(C(=O)Cc1ccc(Cl)c(Cl)c1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16073659 72542 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL199147 72542 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2005.08.014
16073659 72542 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2006.03.089
CHEMBL199147 72542 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1-alpha to human recombinant CCR5 expressed in CHO cells
ChEMBL 554 10 0 4 5.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2006.03.089
72711277 92686 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
CHEMBL2435897 92686 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 560 8 1 5 5.5 Cc1cc(C)cc(C2CN(C3CCCCC3)C(=O)N2C2CCN(C(C)CCNC(=O)c3c(C)ncnc3C)CC2)c1 10.1021/jm401101p
44392095 123814 None 4 Human Binding pIC50 = 5.1 5.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 402 7 0 3 5.0 CN(C(=O)c1ccco1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL362388 123814 None 4 Human Binding pIC50 = 5.1 5.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 402 7 0 3 5.0 CN(C(=O)c1ccco1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
77281926 187785 None 0 Human Binding pIC50 = 4.1 4.1 - 0
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@@](C)(O)C(=O)O)C1=O 10.1021/np060121y
CHEMBL495854 187785 None 0 Human Binding pIC50 = 4.1 4.1 - 0
Displacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cellsDisplacement of [125I]RANTES from human CCR5 expressed in mouse 3T3 cells
ChEMBL 447 5 4 5 3.4 C/C=C(\C)[C@@H]1CC[C@@H]2C[C@H](C)C[C@H](C)[C@H]2[C@@H]1/C(O)=C1/C(=O)N[C@H](C[C@@](C)(O)C(=O)O)C1=O 10.1021/np060121y
57400375 71058 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 681 12 0 8 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(S(C)(=O)=O)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951910 71058 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 681 12 0 8 3.2 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2cccc(S(C)(=O)=O)c2)C2CCN(S(C)(=O)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
44461804 205948 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
CHEMBL84351 205948 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1007/s00044-012-0138-3
3209888 137596 None 3 Human Binding pIC50 = 4.1 4.1 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 452 6 0 6 4.0 Fc1ccc(Cn2nnnc2C(c2ccccc2F)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm061389p
CHEMBL375591 137596 None 3 Human Binding pIC50 = 4.1 4.1 - 0
Displacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cellsDisplacement of [125I]MIP1beta from CCR5 expressed in CHO-K1 cells
ChEMBL 452 6 0 6 4.0 Fc1ccc(Cn2nnnc2C(c2ccccc2F)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm061389p
667748 83784 None 86 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83784 None 86 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
25133618 187277 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 586 6 1 5 7.0 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
CHEMBL492854 187277 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 586 6 1 5 7.0 CC(C)(C)OC(=O)N1CCC(CCCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)(c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm800598a
1474 154397 None 142 Human Binding pIC50 = 4.1 4.1 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 154397 None 142 Human Binding pIC50 = 4.1 4.1 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
478501 105977 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
CHEMBL313072 105977 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 651 9 0 7 5.5 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc([N+](=O)[O-])c1 10.1007/s00044-011-9863-2
16728611 152700 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
CHEMBL397296 152700 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1007/s00044-012-0118-7
44374016 52393 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
CHEMBL159018 52393 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 472 7 0 3 6.8 c1ccc(CCCC2CCN(C[C@H]3CN4OC5(CCCCC5)C[C@H]4[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00835-6
46890343 7115 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 7 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CCC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085226 7115 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 588 7 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(CCC4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
46888480 8810 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 481 7 1 3 4.9 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccccc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096766 8810 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 481 7 1 3 4.9 Cc1cccc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)c3ccccc3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
72711956 92651 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
CHEMBL2435862 92651 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 588 9 1 5 5.7 Cc1ccncc1CN1C[C@@H](c2ccccc2)N(C2CCN(C(C)CCNC(=O)c3c(C)cc(Cl)nc3C)CC2)C1=O 10.1021/jm401101p
25256857 169800 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 562 8 1 5 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
CHEMBL443936 169800 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membraneDisplacement of [125I]MIP-1beta from CCR5 expressed in CHO cell membrane
ChEMBL 562 8 1 5 6.8 Cc1nc2ccccc2n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCC1(c2ccccc2)CCN(C(C(=O)O)c2ccccc2)CC1 10.1016/j.bmcl.2009.02.014
11641131 83518 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 458 7 1 4 5.8 Cc1nc2ccccc2n1[C@H]1C[C@H](C)N(CC[C@H](NC(=O)C2CCC2)c2ccccc2)[C@H](C)C1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203613 83518 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 458 7 1 4 5.8 Cc1nc2ccccc2n1[C@H]1C[C@H](C)N(CC[C@H](NC(=O)C2CCC2)c2ccccc2)[C@H](C)C1 10.1111/j.1747-0285.2006.00376.x
23650547 179077 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cellsDisplacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cells
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
CHEMBL471623 179077 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cellsDisplacement of [125]Mip1beta form CCR5 receptor expressed in MIP34.10 cells
ChEMBL 459 6 0 3 4.4 Cc1cccc(C)c1C(=O)N1CCC(N2CC[C@@H](N(Cc3ccccc3)C(=O)C3CC3)C2)CC1 10.1016/j.bmcl.2009.01.012
46866599 6381 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.0 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
CHEMBL1082202 6381 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation countingDisplacement of [128I]RANTES from human CCR5 receptor coexpressed with Galphai6 in CHO cells after 2 hrs by scintillation counting
ChEMBL 503 7 1 5 5.0 Cc1nnc(C)n1[C@@H]1C[C@@H]2CN(CC[C@H](NC(=O)C3CCC(F)(F)CC3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.01.080
52946506 18363 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 7 0 6 3.1 Cc1cc(=O)oc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271108 18363 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 541 7 0 6 3.1 Cc1cc(=O)oc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(C)(=O)=O)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
10278617 95180 None 3 Crab-eating macaque Binding pIC50 = 8.1 8.1 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255858 95180 None 3 Crab-eating macaque Binding pIC50 = 8.1 8.1 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 499 5 0 5 4.6 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3cccnc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
20664159 71433 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3nnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
CHEMBL196087 71433 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranesDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 501 7 1 6 4.8 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(n3nnc4ccccc43)CC2)[C@@H](c2ccccc2)C1 10.1016/j.bmcl.2005.02.030
491775 12875 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL1188807 12875 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
CHEMBL537424 12875 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1-alpha from human CCR5 expressed in CHO cells
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1016/j.bmcl.2006.10.084
53325460 58492 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
CHEMBL1683190 58492 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of labeled MIP-1beta from human CCR5 receptorDisplacement of labeled MIP-1beta from human CCR5 receptor
ChEMBL 538 6 1 6 3.6 CO[C@@H]1COCC[C@@H]1N[C@@H]1CC[C@](CC(F)(F)F)(C(=O)N2CCN(c3cc(C(F)(F)F)ccn3)CC2)C1 10.1016/j.bmcl.2011.01.015
44404596 72278 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL198277 72278 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 552 10 0 4 5.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2005.08.014
59458159 92697 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435908 92697 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 567 8 1 5 5.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCOCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
57391720 71048 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 672 12 0 7 3.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951899 71048 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 672 12 0 7 3.6 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CC[C@@H](c2ccccc2)N2CCN(S(=O)(=O)CC(F)(F)F)CC2)CC1 10.1016/j.bmcl.2011.12.117
3011723 71053 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951904 71053 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 615 12 0 5 6.0 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)C2CCN(Cc3ccccc3)CC2)CC1 10.1016/j.bmcl.2011.12.117
5275762 77091 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
CHEMBL207485 77091 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of [125I]RANTES binding to human CCR5 expressed in CHO cellsInhibition of [125I]RANTES binding to human CCR5 expressed in CHO cells
ChEMBL 608 10 1 5 4.4 CS(=O)(=O)N1CCC(C(=O)N(CCCN2CCC(Cc3ccc(C(N)=O)cc3)CC2)c2ccc(Cl)c(Cl)c2)CC1 10.1021/jm051034q
54585964 62874 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 546 7 0 4 7.0 CCc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
CHEMBL1784404 62874 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation countingDisplacement of 125I-MIP-1beta from human CCR5 receptor after 4 hrs by scintillation counting
ChEMBL 546 7 0 4 7.0 CCc1nc2ccccc2n1C1CC2CCC(C1)N2CCC1(c2ccccc2)CCN(C(=O)c2ccccc2)CC1 10.1021/jm200279v
505866 28422 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137524 28422 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
25230971 177574 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 7 0 7 3.2 CCCOC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
CHEMBL464055 177574 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at CCR5 receptor by radiolabeled RANTES binding assayAntagonist activity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 547 7 0 7 3.2 CCCOC1CN(S(=O)(=O)C2CC2)CCC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 10.1016/j.bmcl.2008.10.115
489331 5255 None 2 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
CHEMBL106381 5255 None 2 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligandBinding affinity against C-C chemokine receptor type 5 stably expressed in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as the radioligand
ChEMBL 554 9 2 3 6.3 O=C1N[C@H](Cc2c[nH]c3ccccc23)C(=O)N1CC(CCN1CCC(c2ccccc2)CC1)c1cccc(Cl)c1 10.1016/s0960-894x(01)00654-0
5481745 206487 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1016/s0960-894x(00)00637-5
CHEMBL88261 206487 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 624 8 0 4 6.6 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1ccccc1Cl 10.1016/s0960-894x(00)00637-5
46883026 5783 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 570 7 0 6 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078710 5783 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 570 7 0 6 4.5 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
5481867 112009 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 582 8 0 7 4.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL328898 112009 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 582 8 0 7 4.0 CN(C[C@@H](CCN1CCC2(CC1)CS(=O)(=O)c1ccccc12)c1ccc2c(c1)OCO2)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
479883 206474 None 2 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
CHEMBL88197 206474 None 2 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 476 9 0 3 5.7 Cc1cccc(C(CCN2CCC(c3ccccc3)CC2)CN(C)S(=O)(=O)c2ccccc2)c1 10.1016/s0960-894x(00)00639-9
44392105 65598 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccc(Cl)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL183293 65598 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 460 8 0 2 6.0 CN(C(=O)Cc1ccc(Cl)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728611 152700 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL397296 152700 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 364 5 3 3 3.0 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(F)cc1 10.1016/j.bmcl.2006.09.052
44461804 205948 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
CHEMBL84351 205948 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cellsInhibition of [125I]-MIP-1 alpha binding to human CCR5 receptor expressed in Chinese hamster ovary (CHO) cells
ChEMBL 631 13 0 5 7.2 CN(C[C@@H](CCN1CCC(N(CC2CCCCC2)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(01)00492-9
10445499 178886 None 1 Human Binding pIC50 = 4.1 4.1 - 0
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np030146m
CHEMBL469856 178886 None 1 Human Binding pIC50 = 4.1 4.1 - 0
Displacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPADisplacement of [125I]human-MIP1-alpha from human CCR5 receptor expressed in CHO cells by SPA
ChEMBL 264 0 2 5 2.4 CC1OC(=O)c2c3c(c(O)c(O)c21)OC(C)(C)CC3 10.1021/np030146m
24794585 179522 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 478 5 2 6 2.6 CC(=O)N[C@@H]1C[C@H](N(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
CHEMBL4741305 179522 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 478 5 2 6 2.6 CC(=O)N[C@@H]1C[C@H](N(C)C)CC[C@@H]1N1CC[C@H](Nc2ncnc3ccc(C(F)(F)F)cc23)C1=O 10.1021/acsmedchemlett.1c00082
10585 1078 None 1 Human Binding pIC50 = 7.1 7.1 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1078 None 1 Human Binding pIC50 = 7.1 7.1 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1078 None 1 Human Binding pIC50 = 7.1 7.1 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
44392123 129926 None 4 Human Binding pIC50 = 6.1 6.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL367586 129926 None 4 Human Binding pIC50 = 6.1 6.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 426 8 0 2 5.4 CN(C(=O)Cc1ccccc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
57391591 70338 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 637 10 4 6 3.8 CC(C)N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
CHEMBL1944778 70338 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP-1beta from CCR5Displacement of [125I]MIP-1beta from CCR5
ChEMBL 637 10 4 6 3.8 CC(C)N[C@@H]1CC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)N2CCC2)C[C@@H]1CS(=O)(=O)c1ccccc1 10.1016/j.bmcl.2011.12.057
489829 207422 None 2 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 444 6 0 2 6.4 Clc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
CHEMBL94032 207422 None 2 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 444 6 0 2 6.4 Clc1cccc([C@H]2CN(Cc3ccccc3)C[C@@H]2CN2CCC(c3ccccc3)CC2)c1 10.1016/s0960-894x(01)00545-5
667748 83784 None 86 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
CHEMBL2205805 83784 None 86 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 267 2 0 3 3.9 Clc1cc(-c2ccccn2)nc(-c2ccccn2)c1 10.1021/jm301121j
11597 673 None 5 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00082
23725180 673 None 5 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00082
CHEMBL4781426 673 None 5 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assayAntagonist activity at CCR5 in human HT1080 cell membrane assessed as inhibition of [125I]MIP1beta-binding incubated for 4 to 6 hrs by topcount assay
ChEMBL 506 5 3 6 3.5 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)NC(C)(C)C 10.1021/acsmedchemlett.1c00082
3011721 71051 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
CHEMBL1951902 71051 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1alpha from human recombinant CCR5 expressed in CHO cells
ChEMBL 567 11 0 6 4.4 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)N2CCC(C(C)=O)CC2)CC1 10.1016/j.bmcl.2011.12.117
491775 12875 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL1188807 12875 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
CHEMBL537424 12875 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 477 9 1 4 5.0 CCCCN1C(=O)C(CC(C)C)NC(=O)C12CCN(Cc1ccc(Oc3ccccc3)cc1)CC2 10.1021/jm060051s
76327118 85585 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(Cl)c1 10.1007/s00044-012-0118-7
CHEMBL2281957 85585 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1cccc(Cl)c1 10.1007/s00044-012-0118-7
25205601 6446 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 540 7 0 6 4.0 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1082487 6446 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 540 7 0 6 4.0 CCCCC1CN(C2CCOCC2)C(=O)N1C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/j.bmcl.2010.04.077
16728609 167412 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL429641 167412 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 380 5 3 3 3.5 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
474152 12022 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 8 1 1 6.7 CC[N+](CC)(CC)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
CHEMBL1183357 12022 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 8 1 1 6.7 CC[N+](CC)(CC)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
CHEMBL292345 12022 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Inhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTESInhibitory effect on Chemokine binding to C-C chemokine receptor type 5 using [125I]RANTES
ChEMBL 439 8 1 1 6.7 CC[N+](CC)(CC)Cc1ccc(NC(=O)C2=Cc3cc(-c4ccccc4)ccc3CC2)cc1 10.1021/jm9906264
483364 155232 None 1 Human Binding pIC50 = 5.1 5.1 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL402701 155232 None 1 Human Binding pIC50 = 5.1 5.1 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 619 14 0 7 6.6 C=CCN(C(=O)OCc1ccc([N+](=O)[O-])cc1)C1CCN(CC[C@@H](C[C@@H](C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
10585 1078 None 1 Human Binding pIC50 = 4.1 4.1 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
145996522 1078 None 1 Human Binding pIC50 = 4.1 4.1 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
CHEMBL4531005 1078 None 1 Human Binding pIC50 = 4.1 4.1 - 1
Antagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assayAntagonist activity at human TEV cleavage site-linked CCR5 expressed in human U2OS cells harboring beta-lactamase reporter gene assessed as inhibition of CCL3-induced beta-arrestin recruitment incubated for 30 mins followed by CCL3 stimulation and measured after 16 hrs by Tango assay
ChEMBL 351 3 2 5 3.0 Nc1nn2c(n1)[nH]c(c(c2=O)Cc1cccc(c1Cl)Cl)C(C)C 10.1021/acs.jmedchem.9b00742
1474 154397 None 142 Human Binding pIC50 = 4.1 4.1 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
CHEMBL39879 154397 None 142 Human Binding pIC50 = 4.1 4.1 - 0
Displacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrsDisplacement of [125I]-CCL3 from human CCR5 transfected in COS7 cells coexpressing chimeric Gqi4myr after 3 hrs
ChEMBL 156 1 0 2 2.1 c1ccc(-c2ccccn2)nc1 10.1021/jm301121j
5481750 206627 None 1 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1007/s00044-011-9863-2
CHEMBL89167 206627 None 1 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 591 8 0 5 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccnc1 10.1007/s00044-011-9863-2
44404720 135217 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 594 11 0 4 6.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(-c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL372297 135217 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 594 11 0 4 6.8 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccc(-c3ccccc3)cc2)CC1 10.1016/j.bmcl.2005.08.014
72712597 92665 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
CHEMBL2435876 92665 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 474 6 1 3 4.8 CNC(=O)c1ccc(CN2CCC(N3C(=O)N(C4CCCCC4)C[C@H]3c3ccccc3)CC2)cc1 10.1021/jm401101p
44564884 179310 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 4.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
CHEMBL473352 179310 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 465 8 1 5 4.9 Cc1nnc(C(C)C)n1C1CCN(C(C)C[C@H](NC(=O)CC(F)(F)F)c2ccccc2)CC1 10.1016/j.bmcl.2009.01.008
478494 206637 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1016/s0960-894x(00)00637-5
CHEMBL89221 206637 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 528 7 0 4 4.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(C)(=O)=O 10.1016/s0960-894x(00)00637-5
16728642 91209 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N/NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL240018 91209 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 350 5 3 3 3.8 C/C(=N/NC(=N)N)c1cc(Cl)ccc1OCc1ccc(Cl)cc1 10.1016/j.bmcl.2006.09.052
11259200 88112 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 6 1 3 5.0 O=C(O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
CHEMBL234676 88112 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4Displacement of [125I]MIP1alpha from human CCR5 receptor expressed in HEK293 cells co-expressing CD4
ChEMBL 437 6 1 3 5.0 O=C(O)C1CCN(Cc2cc(Br)ccc2OCc2ccc(Cl)cc2)CC1 10.1016/j.bmcl.2007.01.050
25133619 193309 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 1 5 5.2 CC(C)(C)OC(=O)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
CHEMBL524159 193309 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 532 6 1 5 5.2 CC(C)(C)OC(=O)N1CCC(CCCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)CC1 10.1021/jm800598a
44373748 54946 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
CHEMBL161480 54946 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Ability to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranesAbility to displace [125I]-labeled MIP-1alpha from the C-C chemokine receptor type 5 expressed on CHO cell membranes
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/s0960-894x(01)00835-6
10281316 73720 None 0 Mouse Binding pIC50 = 7.1 7.1 - 0
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 565 13 6 5 3.6 CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NCC 10.1016/j.bmcl.2012.03.007
CHEMBL2018386 73720 None 0 Mouse Binding pIC50 = 7.1 7.1 - 0
Binding affinity to mouse CCR5Binding affinity to mouse CCR5
ChEMBL 565 13 6 5 3.6 CCC[C@H](O)[C@H](CNCc1ccc(C)cc1C)NC(=O)CNC(=O)c1cc(C(F)(F)F)ccc1NC(=O)NCC 10.1016/j.bmcl.2012.03.007
44373748 54946 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL161480 54946 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
44373748 54946 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL161480 54946 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 531 7 0 5 6.2 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@@H]2[C@@H](c3ccccc3)CN3OC4(CCCCC4)C[C@@H]23)CC1 10.1016/j.ejmech.2008.01.040
11634966 12876 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL1188808 12876 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
CHEMBL537425 12876 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5Inhibition of radio-isotope labeled MIP1-alpha binding to human recombinant CCR5
ChEMBL 481 11 1 3 5.3 CCCN1C(=O)[C@@H](CC2CCCCC2)NC(=O)C12CCN(CCCCCCc1ccccc1)CC2 10.1021/jm060051s
483348 15290 None 2 Human Binding pIC50 = 5.1 5.1 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.5 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
CHEMBL121321 15290 None 2 Human Binding pIC50 = 5.1 5.1 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 562 12 0 5 6.5 CCN(C(=O)OCc1ccccc1)C1CCN(CCC(CC(C)S(=O)(=O)c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.03.112
44392078 64355 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 418 7 0 3 5.5 CN(C(=O)c1cccs1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181260 64355 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 418 7 0 3 5.5 CN(C(=O)c1cccs1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
16728628 90317 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1016/j.bmcl.2006.09.052
CHEMBL238549 90317 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1016/j.bmcl.2006.09.052
16728628 90317 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1007/s00044-012-0118-7
CHEMBL238549 90317 None 0 Human Binding pIC50 = 5.1 5.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 421 7 3 6 2.8 COc1ccc([N+](=O)[O-])cc1COc1ccc(Br)cc1/C=N/NC(=N)N 10.1007/s00044-012-0118-7
483350 14636 None 2 Human Binding pIC50 = 4.1 4.1 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 13 0 5 6.9 CCC(CC(CCN1CCC(N(CC)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.03.112
CHEMBL120513 14636 None 2 Human Binding pIC50 = 4.1 4.1 - 0
Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5Concentration required to inhibit [125I]-MIP-1 alpha binding to C-C chemokine receptor type 5
ChEMBL 576 13 0 5 6.9 CCC(CC(CCN1CCC(N(CC)C(=O)OCc2ccccc2)CC1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.03.112
10290194 79024 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 11 1 6 6.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(=O)OC(C)(C)C)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL2113131 79024 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 651 11 1 6 6.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NC(=O)OC(C)(C)C)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
11215950 5693 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 5 5.4 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078014 5693 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 539 7 0 5 5.4 CCCCC1CN(CC2CCOCC2)C(=O)OC12CCN(C1CCN(C(=O)c3c(C)cccc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
489816 207117 None 2 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 500 6 0 2 7.1 O=C(c1ccccc1-c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL92133 207117 None 2 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 500 6 0 2 7.1 O=C(c1ccccc1-c1ccccc1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44564835 179309 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 397 7 1 5 4.0 CC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
CHEMBL473348 179309 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 397 7 1 5 4.0 CC(=O)N[C@@H](CC(C)N1CCC(n2c(C)nnc2C(C)C)CC1)c1ccccc1 10.1016/j.bmcl.2009.01.008
16728615 150704 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1007/s00044-012-0118-7
CHEMBL395607 150704 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1007/s00044-012-0118-7
5481711 205951 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
CHEMBL84374 205951 None 1 Human Binding pIC50 = 6.1 6.1 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 522 8 0 3 6.1 CN(C[C@@H](CCN1CCC2(CCc3ccccc32)CC1)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1007/s00044-011-9863-2
46888584 8640 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 529 8 1 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1095191 8640 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 529 8 1 5 3.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)CC3CC(F)(F)C3)c3cccc(F)c3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
46888499 8736 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 493 7 1 3 5.1 Cc1cccc(Cl)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
CHEMBL1096102 8736 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 493 7 1 3 5.1 Cc1cccc(Cl)c1C(=O)N1C[C@@H]2CN(CC[C@H](NC(=O)C3CCCC3)c3ccccc3)C[C@@H]2C1 10.1016/j.bmcl.2010.03.095
505870 27625 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
CHEMBL136977 27625 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 500 8 0 4 5.6 O=C(C1CCCCC1)N1C[C@H](CN2CCC(N(CC3CC3)c3ccccn3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(02)00988-5
505866 28422 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
CHEMBL137524 28422 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranesDisplacement inhibition of 125-I labeled MIP-alpha from CCR5 receptor expressed on CHO cell membranes
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(02)00988-5
72711742 92649 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435860 92649 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 573 9 1 4 6.0 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3ccccc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
11626984 83517 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
CHEMBL2203612 83517 None 0 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP-1beta from CCR5 receptorDisplacement of [125I]MIP-1beta from CCR5 receptor
ChEMBL 472 7 1 5 4.8 Cc1nc2ccccc2n1[C@@H]1C[C@H]2COC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC1)c1ccccc1 10.1111/j.1747-0285.2006.00376.x
505866 28422 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
CHEMBL137524 28422 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Displacement of [125I]MIP1alpha from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP1alpha from human CCR5 expressed in CHO cells
ChEMBL 475 7 0 4 4.7 CCCN(c1ccccn1)C1CCN(C[C@H]2CN(C(=O)N3CCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.ejmech.2008.01.040
516350 59347 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 612 8 2 4 7.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4Cl)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
CHEMBL170717 59347 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 612 8 2 4 7.5 O=C(O)[C@@H](C1CCCCC1)N1C[C@H](CN2CCC(c3cc(-c4ccc(Cl)cc4Cl)[nH]n3)CC2)[C@@H](c2cccc(F)c2)C1 10.1016/j.bmcl.2003.12.004
516341 131539 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
CHEMBL369189 131539 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assayInhibition of human CX3C chemokine receptor 5 from GP120-membrane-based assay
ChEMBL 596 12 1 5 7.0 CCCn1cc(CCc2ccccc2)c(C2CCN(C[C@H]3CN([C@@H](C(=O)O)C4CCCCC4)C[C@@H]3c3ccccc3)CC2)n1 10.1016/j.bmcl.2003.12.004
516330 130883 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 626 12 1 7 6.0 CCOC(=O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
CHEMBL368517 130883 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory activity against human CC chemokine receptor 5Inhibitory activity against human CC chemokine receptor 5
ChEMBL 626 12 1 7 6.0 CCOC(=O)Cn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2CN([C@@H](C(=O)O)C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1016/j.bmcl.2003.12.004
5275837 63510 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 575 10 0 5 5.4 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
CHEMBL180013 63510 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligandInhibitory concentration against human C-C chemokine receptor type 5 in CHO cells with [125I]-MIP-1 alpha radioligand
ChEMBL 575 10 0 5 5.4 CN(C[C@@](C)(CCN1CCC2C(CCN2C(=O)OCc2ccccc2)C1)c1ccccc1)S(=O)(=O)c1ccccc1 10.1016/j.bmcl.2004.12.044
490012 111502 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 511 9 0 4 6.0 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
CHEMBL327801 111502 None 1 Human Binding pIC50 = 8.1 8.1 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 511 9 0 4 6.0 CCN(C(=O)OCc1ccccc1)C1CCN(C[C@H]2CN(Cc3ccccc3)C[C@@H]2c2ccccc2)CC1 10.1016/s0960-894x(01)00545-5
44404658 136076 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 629 12 1 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NS(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
CHEMBL373214 136076 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cellsDisplacement of [125I]-MIP-1 alpha from human C-C chemokine receptor type 5 expressed in CHO cells
ChEMBL 629 12 1 6 4.7 CCN(C(=O)Cc1ccc(S(C)(=O)=O)cc1)C1CCN(CCC(c2ccc(NS(C)(=O)=O)cc2)c2cccc(F)c2)CC1 10.1016/j.bmcl.2005.08.014
73347894 92652 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435863 92652 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 574 9 1 5 5.4 Cc1cc(Cl)nc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(Cc3cccnc3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
73346388 92667 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
CHEMBL2435878 92667 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 566 8 1 4 6.6 CNC(=O)c1ccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)cc1 10.1021/jm401101p
72714079 92675 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435886 92675 None 0 Human Binding pIC50 = 8.0 8.0 - 0
Displacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysisDisplacement of [125I]-RANTES from CCR5 (unknown origin) expressed in HEK293F cell membranes after 45 mins by microbeta jet liquid scintillation counting analysis
ChEMBL 565 8 1 4 6.1 Cc1cc(Cl)nc(C)c1C(=O)NCC[C@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@H]2c2ccccc2)CC1 10.1021/jm401101p
44447731 95097 None 0 Crab-eating macaque Binding pIC50 = 8.0 8.0 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
CHEMBL255430 95097 None 0 Crab-eating macaque Binding pIC50 = 8.0 8.0 - 0
Displacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cellsDisplacement of radiolabeled MIP-1alpha from cynomolgus monkey CCR5 expressed in CHO cells
ChEMBL 482 5 0 4 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(N(c3ccccc3)c3ccncc3)CC2)CC1 10.1016/j.bmcl.2008.01.108
456319 204074 None 1 Human Binding pIC50 = 7.1 7.1 - 1
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.7 Cc1ccccc1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL70124 204074 None 1 Human Binding pIC50 = 7.1 7.1 - 1
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.7 Cc1ccccc1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
25206069 7107 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 560 5 0 6 4.2 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
CHEMBL1085218 7107 None 0 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity at CCR5 receptor by radiolabeled RANTES binding assayBinding affinity at CCR5 receptor by radiolabeled RANTES binding assay
ChEMBL 560 5 0 6 4.2 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(N3C(=O)N(C4CCOCC4)C[C@H]3c3ccccc3)CC2)CC1 10.1016/j.bmcl.2010.04.077
5481751 106971 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1016/s0960-894x(00)00637-5
CHEMBL315084 106971 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Binding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligandBinding affinity towards human CCR5 receptor in Chinese hamster ovary (CHO) cells using [125I]-MIP-1 alpha as radioligand
ChEMBL 641 8 0 5 6.5 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1ccc(Cl)c(Cl)c1)S(=O)(=O)c1cccc2cccnc12 10.1016/s0960-894x(00)00637-5
479846 207120 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL92147 207120 None 1 Human Binding pIC50 = 7.1 7.1 - 0
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor.
ChEMBL 590 8 0 4 5.9 CN(CC(CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cc(Cl)cc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
16728615 150704 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1016/j.bmcl.2006.09.052
CHEMBL395607 150704 None 0 Human Binding pIC50 = 6.1 6.1 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 391 6 3 5 2.8 N=C(N)N/N=C/c1cc(Br)ccc1OCc1ccc([N+](=O)[O-])cc1 10.1016/j.bmcl.2006.09.052
6480205 191449 None 5 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 368 2 0 2 5.8 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)CC(=O)[C@H]4/C(C=O)=C\C[C@H]3[C@H]12 10.1021/np049844c
CHEMBL519317 191449 None 5 Human Binding pIC50 = 5.1 5.1 - 0
Displacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPADisplacement of human [125I]MIP-1-alpha from human CCR5 overexpressed in CHO cells by SPA
ChEMBL 368 2 0 2 5.8 C=C(C)[C@H]1CC[C@@]2(C)CC[C@]3(C)C[C@H]4[C@@H](C)CC(=O)[C@H]4/C(C=O)=C\C[C@H]3[C@H]12 10.1021/np049844c
72713861 92671 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
CHEMBL2435882 92671 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 532 8 1 5 4.9 Cc1ncnc(C)c1C(=O)NCC[C@@H](C)N1CCC(N2C(=O)N(C3CCCCC3)C[C@@H]2c2ccccc2)CC1 10.1021/jm401101p
72711280 92689 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
CHEMBL2435900 92689 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 533 8 1 6 4.3 Cc1ncnc(C)c1C(=O)NCCC(C)N1CCC(N2C(=O)N(C3CCCCC3)CC2c2ccccn2)CC1 10.1021/jm401101p
44392074 64762 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 505 9 1 4 4.0 CN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
CHEMBL181913 64762 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5Binding of [125I]RANTES to membranes prepared from chinese hamster ovary (CHO) cells stably expressing recombinant human C-C chemokine receptor type 5
ChEMBL 505 9 1 4 4.0 CN(C(=O)Cc1ccc(S(N)(=O)=O)cc1)C1CCN(CCC(c2ccccc2)c2ccccc2)CC1 10.1016/j.bmcl.2004.10.044
10008921 188350 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 612 8 1 5 5.1 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
CHEMBL501077 188350 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 612 8 1 5 5.1 O=C1NCN(c2ccccc2)C12CCN(CCCC1(c3ccc(Cl)c(Cl)c3)CN(S(=O)(=O)c3ccccc3)C1)CC2 10.1021/jm800598a
46882073 5605 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 571 5 0 6 4.7 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
CHEMBL1077353 5605 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 571 5 0 6 4.7 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ncnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
73352463 92635 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
CHEMBL2435846 92635 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Inhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assayInhibition of CCR5 (unknown origin) expressed in human HeLa cells assessed as inhibition of interaction of CHO cells expressing HIV-1 JRFLenv and HIV-1 Tat and human HeLa cells expressing CD4 after 20 hrs by beta-galactosidase reporter gene assay
ChEMBL 553 8 1 4 7.0 O=C(O)c1cccc(Oc2ccc(CN3CCC(N4C(=O)N(C5CCCCC5)C[C@H]4c4ccccc4)CC3)cc2)c1 10.1021/jm401101p
16655051 85588 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 385 5 3 4 3.1 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(C#N)cc1 10.1007/s00044-012-0118-7
CHEMBL2281960 85588 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Antagonist activity at Homo sapiens (human) CCR5 receptorAntagonist activity at Homo sapiens (human) CCR5 receptor
ChEMBL 385 5 3 4 3.1 C/C(=N\NC(=N)N)c1cc(Br)ccc1OCc1ccc(C#N)cc1 10.1007/s00044-012-0118-7
44439313 91964 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 415 6 3 5 3.1 COc1cc(Br)cc(/C(C)=N/NC(=N)N)c1OCc1ccc(C#N)cc1 10.1016/j.bmcl.2006.09.052
CHEMBL241475 91964 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cellsDisplacement of [125I]MIP1-alpha from human CCR5/CD4 expressed in HEK293 cells
ChEMBL 415 6 3 5 3.1 COc1cc(Br)cc(/C(C)=N/NC(=N)N)c1OCc1ccc(C#N)cc1 10.1016/j.bmcl.2006.09.052
52947748 18219 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 525 8 0 6 2.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1270101 18219 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 525 8 0 6 2.9 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CN(S(=O)(=O)C(C)C)C3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
25132946 187704 None 1 Human Binding pIC50 = 5.0 5.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 576 7 1 4 5.5 O=C1CC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
CHEMBL495291 187704 None 1 Human Binding pIC50 = 5.0 5.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 576 7 1 4 5.5 O=C1CC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccc(Cl)c(Cl)c2)CN1Cc1ccccc1 10.1021/jm800598a
25130571 187706 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 498 6 1 5 3.9 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)C1 10.1021/jm800598a
CHEMBL495298 187706 None 0 Human Binding pIC50 = 5.0 5.0 - 0
Displacement of [125I]MIP-1beta from human CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1beta from human CCR5 expressed in CHO cells
ChEMBL 498 6 1 5 3.9 O=C(c1ccco1)N1CCC(CCN2CCC3(CC2)C(=O)NCN3c2ccccc2)(c2ccccc2)C1 10.1021/jm800598a
489809 207406 None 2 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1cccc(Cl)c1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93949 207406 None 2 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 458 5 0 2 6.1 O=C(c1cccc(Cl)c1)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44590946 176401 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 424 8 1 5 4.8 CC(C)c1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
CHEMBL459600 176401 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Antagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assayAntagonist activity at human recombinant CCR5 expressed in human HeLa-P4 cells assessed as inhibition of human HeLa-P4 cells binding to HIV1 gp160 expressing CHO cells by cell-cell fusion assay
ChEMBL 424 8 1 5 4.8 CC(C)c1noc(C2CCN(C(C)C[C@H](NC(=O)C3CCC3)c3ccccc3)CC2)n1 10.1016/j.bmcl.2009.01.009
44455143 155249 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 8 1 5 4.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC(C)C)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL402776 155249 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 452 8 1 5 4.9 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCCN(C(=O)NC(C)C)c1ccccc1 10.1016/j.bmcl.2007.12.058
489815 206766 None 2 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 442 5 0 2 5.6 O=C(c1ccccc1F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL90129 206766 None 2 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 442 5 0 2 5.6 O=C(c1ccccc1F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
46883030 5786 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 623 7 0 7 5.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
CHEMBL1078713 5786 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cellsDisplacement of [125I]RANTES from human CCR5 receptor co-transfected with Galphai6 in CHO cells
ChEMBL 623 7 0 7 5.6 CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC1)CC2 10.1016/j.bmcl.2009.07.122
489814 207349 None 2 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 5 0 2 6.4 O=C(c1ccccc1C(F)(F)F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
CHEMBL93625 207349 None 2 Human Binding pIC50 = 7.0 7.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 492 5 0 2 6.4 O=C(c1ccccc1C(F)(F)F)N1C[C@H](CN2CCC(c3ccccc3)CC2)[C@@H](c2ccccc2)C1 10.1016/s0960-894x(01)00545-5
44455313 95118 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 463 7 0 5 5.5 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
CHEMBL255535 95118 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cellsDisplacement of [125I]MIP1beta from human recombinant CCR5 receptor expressed in CHOK1 cells
ChEMBL 463 7 0 5 5.5 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CCN(C(=O)C1CCCCC1)c1ccccc1 10.1016/j.bmcl.2007.12.058
54584427 60894 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccnc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
CHEMBL1762327 60894 None 0 Human Binding pIC50 = 6.0 6.0 - 0
Displacement of [128I]-RANTES from CCR5 expressed in HEK293F cellsDisplacement of [128I]-RANTES from CCR5 expressed in HEK293F cells
ChEMBL 590 9 1 5 6.6 CC(CCNC(=O)c1c(Cl)cncc1Cl)N1CCC(C(Oc2cccnc2)c2ccc(Br)cc2)CC1 10.1016/j.bmcl.2011.02.058
46882074 5606 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 570 5 0 5 5.3 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
CHEMBL1077354 5606 None 0 Human Binding pIC50 = 7.0 7.0 - 0
Displacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cellsDisplacement of [128I]-RANTES from CCR5 receptor receptors expressed in CHO cells
ChEMBL 570 5 0 5 5.3 CCO[C@H]1Cc2cc(C(F)(F)F)ccc2[C@@H]1N1CCN(C2C[C@@H]3CN(C(=O)c4c(C)ccnc4C)C[C@@H]3C2)C[C@@H]1C 10.1016/j.bmcl.2010.02.004
457845 161798 None 1 Human Binding pIC50 = 6.0 6.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 320 4 1 2 3.9 c1ccc(C2CCN(C[C@H]3CNC[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00545-5
CHEMBL414222 161798 None 1 Human Binding pIC50 = 6.0 6.0 - 0
Inhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cellsInhibitory concentration, binding towards C-C chemokine receptor type 5 using [125I]-MIP-1 alpha as radioligand expressed on CHO cells
ChEMBL 320 4 1 2 3.9 c1ccc(C2CCN(C[C@H]3CNC[C@@H]3c3ccccc3)CC2)cc1 10.1016/s0960-894x(01)00545-5
52943283 18352 None 0 Human Binding pIC50 = 7 7.0 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 553 8 0 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(=O)(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
CHEMBL1271000 18352 None 0 Human Binding pIC50 = 7 7.0 - 0
Inhibition of CCR5 by cell-cell fusion inhibition assayInhibition of CCR5 by cell-cell fusion inhibition assay
ChEMBL 553 8 0 6 3.7 Cc1ncnc(C)c1C(=O)N1C[C@@H]2CN(CCC(c3ccccc3)C3CCN(S(=O)(=O)C(C)C)CC3)C[C@@H]2C1 10.1016/j.bmcl.2010.08.118
1638 2722 None 38 Mouse Binding pKd = 8.0 8.0 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
1676 2722 None 38 Mouse Binding pKd = 8.0 8.0 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
1878 2722 None 38 Mouse Binding pKd = 8.0 8.0 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
5284596 2722 None 38 Mouse Binding pKd = 8.0 8.0 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
CHEMBL80 2722 None 38 Mouse Binding pKd = 8.0 8.0 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
DB01183 2722 None 38 Mouse Binding pKd = 8.0 8.0 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
2984051 55314 None 5 Human Binding pKd = 5 5.0 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 333 6 1 2 4.5 CC(C)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
CHEMBL1618631 55314 None 5 Human Binding pKd = 5 5.0 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 333 6 1 2 4.5 CC(C)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
10287138 73124 None 0 Human Binding pKd = 5.0 5.0 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011440 73124 None 0 Human Binding pKd = 5.0 5.0 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
10287138 73124 None 0 Human Binding pKd = 4.8 4.8 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011440 73124 None 0 Human Binding pKd = 4.8 4.8 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 373 4 1 6 3.3 COc1nc(Cl)c(Cl)nc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
2964123 67665 None 12 Human Binding pKd = 4.7 4.7 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 375 7 1 3 4.3 Brc1ccc(OCc2ccccc2)c(CNCC2CCCO2)c1 10.1021/ml2000017
CHEMBL1907216 67665 None 12 Human Binding pKd = 4.7 4.7 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 375 7 1 3 4.3 Brc1ccc(OCc2ccccc2)c(CNCC2CCCO2)c1 10.1021/ml2000017
1638 2722 None 38 Mouse Binding pKd = 7.7 7.7 -6 17
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
1676 2722 None 38 Mouse Binding pKd = 7.7 7.7 -6 17
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
1878 2722 None 38 Mouse Binding pKd = 7.7 7.7 -6 17
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
5284596 2722 None 38 Mouse Binding pKd = 7.7 7.7 -6 17
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
CHEMBL80 2722 None 38 Mouse Binding pKd = 7.7 7.7 -6 17
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
DB01183 2722 None 38 Mouse Binding pKd = 7.7 7.7 -6 17
Binding affinity to CCR5 in C57BL/6J mouse brain membraneBinding affinity to CCR5 in C57BL/6J mouse brain membrane
ChEMBL 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O 10.1073/pnas.0700295104
10215932 73125 None 1 Human Binding pKd = 4.7 4.7 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011441 73125 None 1 Human Binding pKd = 4.7 4.7 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
11598 672 None 9 Human Binding pKd = 7.6 7.6 - 1
Binding affinity to CCR5 in T-cell (unknown origin)Binding affinity to CCR5 in T-cell (unknown origin)
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
23725177 672 None 9 Human Binding pKd = 7.6 7.6 - 1
Binding affinity to CCR5 in T-cell (unknown origin)Binding affinity to CCR5 in T-cell (unknown origin)
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
CHEMBL4442783 672 None 9 Human Binding pKd = 7.6 7.6 - 1
Binding affinity to CCR5 in T-cell (unknown origin)Binding affinity to CCR5 in T-cell (unknown origin)
ChEMBL 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 10.1021/acsmedchemlett.8b00439
3002977 2458 None 71 Human Binding pKd = 7.6 7.6 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
803 2458 None 71 Human Binding pKd = 7.6 7.6 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
806 2458 None 71 Human Binding pKd = 7.6 7.6 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
CHEMBL1201187 2458 None 71 Human Binding pKd = 7.6 7.6 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
CHEMBL256907 2458 None 71 Human Binding pKd = 7.6 7.6 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
CHEMBL584744 2458 None 71 Human Binding pKd = 7.6 7.6 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
DB04835 2458 None 71 Human Binding pKd = 7.6 7.6 -3 2
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1021/ml2000017
1017290 55856 None 14 Human Binding pKd = 4.6 4.6 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 363 7 2 3 3.9 CC(C)(CO)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
CHEMBL1623307 55856 None 14 Human Binding pKd = 4.6 4.6 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 363 7 2 3 3.9 CC(C)(CO)NCc1cc(Br)ccc1OCc1ccccc1 10.1021/ml2000017
10215932 73125 None 1 Human Binding pKd = 4.5 4.5 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
CHEMBL2011441 73125 None 1 Human Binding pKd = 4.5 4.5 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assayBinding affinity to C-terminus C9-tagged immobilized CCR5 after 1 min by SPR assay
ChEMBL 383 4 1 6 2.8 COc1nc(Br)cnc1NS(=O)(=O)c1ccc(Cl)s1 10.1021/ml2000017
3001322 443 None 23 Human Binding pKd = 8.5 8.5 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
805 443 None 23 Human Binding pKd = 8.5 8.5 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
CHEMBL1255794 443 None 23 Human Binding pKd = 8.5 8.5 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
DB06497 443 None 23 Human Binding pKd = 8.5 8.5 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 10.1021/jm300682j
49871007 58811 None 13 Human Binding pKd = 8.5 8.5 - 1
Activation of CCR5 in human PBMC cellsActivation of CCR5 in human PBMC cells
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
CHEMBL1688243 58811 None 13 Human Binding pKd = 8.5 8.5 - 1
Activation of CCR5 in human PBMC cellsActivation of CCR5 in human PBMC cells
ChEMBL 559 5 0 6 4.8 CCO[C@@H]1Cc2cc(C(F)(F)F)ccc2[C@H]1N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C 10.1021/ml1001536
3373405 55690 None 15 Human Binding pKd = 4.3 4.3 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 394 4 0 3 3.7 COc1ccc(Br)cc1CN1CCCC(C(=O)N2CCCCC2)C1 10.1021/ml2000017
CHEMBL1621896 55690 None 15 Human Binding pKd = 4.3 4.3 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 394 4 0 3 3.7 COc1ccc(Br)cc1CN1CCCC(C(=O)N2CCCCC2)C1 10.1021/ml2000017
1017997 73123 None 10 Human Binding pKd = 5.1 5.1 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 382 7 1 3 4.7 Brc1ccc(OCc2ccccc2)c(CNCc2ccccn2)c1 10.1021/ml2000017
CHEMBL2011439 73123 None 10 Human Binding pKd = 5.1 5.1 - 1
Binding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysisBinding affinity to C-terminus C9-tagged immobilized CCR5 by SPR analysis
ChEMBL 382 7 1 3 4.7 Brc1ccc(OCc2ccccc2)c(CNCc2ccccn2)c1 10.1021/ml2000017
6532436 31643 None 1 Human Binding pKi = 10 10.0 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 616 7 0 5 7.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(-c4ccncc4)cc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140484 31643 None 1 Human Binding pKi = 10 10.0 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 616 7 0 5 7.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(-c4ccncc4)cc3C)CC2)CC1 10.1021/jm030265z
3002977 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
803 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
806 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL1201187 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL256907 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
CHEMBL584744 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
DB04835 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1039/c3md00080j
3002977 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
803 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
806 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL1201187 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL256907 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
CHEMBL584744 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
DB04835 2458 None 71 Rhesus macaque Binding pKi = 9.6 9.6 3 2
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 10.1016/j.bmc.2016.09.059
483407 166038 None 21 Human Binding pKi = 9.6 9.6 - 1
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
CHEMBL425618 166038 None 21 Human Binding pKi = 9.6 9.6 - 1
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 513 8 1 5 6.0 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 nan
6532435 115658 None 1 Human Binding pKi = 9.5 9.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 668 6 0 5 6.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1021/jm030265z
CHEMBL335365 115658 None 1 Human Binding pKi = 9.5 9.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 668 6 0 5 6.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1021/jm030265z
5482301 119880 None 1 Human Binding pKi = 9.5 9.5 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 668 6 0 5 6.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL349008 119880 None 1 Human Binding pKi = 9.5 9.5 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 668 6 0 5 6.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)cncc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
6532434 116147 None 1 Human Binding pKi = 9.4 9.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 6 0 5 6.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1021/jm030265z
CHEMBL335794 116147 None 1 Human Binding pKi = 9.4 9.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 6 0 5 6.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1021/jm030265z
5482300 120053 None 1 Human Binding pKi = 9.4 9.4 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 580 6 0 5 6.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL350563 120053 None 1 Human Binding pKi = 9.4 9.4 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 580 6 0 5 6.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
463616 32048 None 1 Human Binding pKi = 9.2 9.2 2884 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
CHEMBL140827 32048 None 1 Human Binding pKi = 9.2 9.2 2884 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
463616 32048 None 1 Human Binding pKi = 9.2 9.2 2884 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
CHEMBL140827 32048 None 1 Human Binding pKi = 9.2 9.2 2884 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 4 0 4 6.2 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)cncc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
5495582 116788 None 1 Human Binding pKi = 9.2 9.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 684 6 0 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1021/jm030265z
CHEMBL337776 116788 None 1 Human Binding pKi = 9.2 9.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 684 6 0 5 5.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1021/jm030265z
9579116 56275 None 0 Human Binding pKi = 9.2 9.2 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 684 6 0 5 5.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL162880 56275 None 0 Human Binding pKi = 9.2 9.2 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 684 6 0 5 5.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Br)c[n+]([O-])cc3Br)CC2)CC1 10.1016/s0960-894x(02)01063-6
71462570 82564 None 0 Human Binding pKi = 9 9.0 1 3
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 518 5 2 5 5.6 CC1(C)CN(CC/C=C2/c3cc(C(=O)O)ccc3OCc3ncccc32)C[C@H](c2ccc(Cl)cc2)[C@H]1O 10.1021/jm300682j
CHEMBL2178569 82564 None 0 Human Binding pKi = 9 9.0 1 3
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 518 5 2 5 5.6 CC1(C)CN(CC/C=C2/c3cc(C(=O)O)ccc3OCc3ncccc32)C[C@H](c2ccc(Cl)cc2)[C@H]1O 10.1021/jm300682j
44337326 7966 None 0 Human Binding pKi = 9 9.0 1 3
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm015526o
CHEMBL109051 7966 None 0 Human Binding pKi = 9 9.0 1 3
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm015526o
456375 10095 None 1 Human Binding pKi = 9 9.0 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL115487 10095 None 1 Human Binding pKi = 9 9.0 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
183790 3740 None 11 Human Binding pKi = 9.0 9.0 6 2
Antagonist at CCR5 (unknown origin) assessed as inhibitory constantAntagonist at CCR5 (unknown origin) assessed as inhibitory constant
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
783 3740 None 11 Human Binding pKi = 9.0 9.0 6 2
Antagonist at CCR5 (unknown origin) assessed as inhibitory constantAntagonist at CCR5 (unknown origin) assessed as inhibitory constant
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
CHEMBL1178786 3740 None 11 Human Binding pKi = 9.0 9.0 6 2
Antagonist at CCR5 (unknown origin) assessed as inhibitory constantAntagonist at CCR5 (unknown origin) assessed as inhibitory constant
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/j.ejmech.2020.112311
9575320 5149 None 0 Human Binding pKi = 9.0 9.0 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
CHEMBL105821 5149 None 0 Human Binding pKi = 9.0 9.0 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
9574357 109770 None 0 Human Binding pKi = 9.0 9.0 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
CHEMBL323172 109770 None 0 Human Binding pKi = 9.0 9.0 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm015526o
9575320 5149 None 0 Mouse Binding pKi = 9.0 9.0 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
CHEMBL105821 5149 None 0 Mouse Binding pKi = 9.0 9.0 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
9574357 109770 None 0 Mouse Binding pKi = 9.0 9.0 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
CHEMBL323172 109770 None 0 Mouse Binding pKi = 9.0 9.0 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 0 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm0200815
5482298 29280 None 1 Human Binding pKi = 9.0 9.0 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL138285 29280 None 1 Human Binding pKi = 9.0 9.0 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
5479841 30749 None 1 Human Binding pKi = 9.0 9.0 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 0 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL139559 30749 None 1 Human Binding pKi = 9.0 9.0 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 0 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccnc3C)CC2)CC1 10.1021/jm030265z
6533781 29693 None 1 Human Binding pKi = 8.9 8.9 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 596 6 0 5 5.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1021/jm030265z
CHEMBL138640 29693 None 1 Human Binding pKi = 8.9 8.9 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 596 6 0 5 5.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1021/jm030265z
5495581 57067 None 1 Human Binding pKi = 8.9 8.9 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 596 6 0 5 5.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL164484 57067 None 1 Human Binding pKi = 8.9 8.9 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 596 6 0 5 5.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CC1 10.1016/s0960-894x(02)01063-6
5495597 31586 None 1 Human Binding pKi = 8.9 8.9 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140418 31586 None 1 Human Binding pKi = 8.9 8.9 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1021/jm030265z
5495597 31586 None 1 Human Binding pKi = 8.9 8.9 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140418 31586 None 1 Human Binding pKi = 8.9 8.9 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 587 7 0 7 5.7 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(SC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
183790 3740 None 11 Human Binding pKi = 8.9 8.9 6 2
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptorInhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00639-9
783 3740 None 11 Human Binding pKi = 8.9 8.9 6 2
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptorInhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00639-9
CHEMBL1178786 3740 None 11 Human Binding pKi = 8.9 8.9 6 2
Inhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptorInhibitory activity against specific binding of [125I]-MIP-1 alpha to human CCR5 receptor
ChEMBL 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 10.1016/s0960-894x(00)00639-9
5479844 110447 None 1 Human Binding pKi = 8.7 8.7 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL324643 110447 None 1 Human Binding pKi = 8.7 8.7 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
502259 116796 None 1 Human Binding pKi = 8 8.0 61 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL337820 116796 None 1 Human Binding pKi = 8 8.0 61 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
462571 118793 None 1 Human Binding pKi = 8 8.0 97 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
CHEMBL342137 118793 None 1 Human Binding pKi = 8 8.0 97 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
502259 116796 None 1 Human Binding pKi = 8 8.0 61 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL337820 116796 None 1 Human Binding pKi = 8 8.0 61 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 4 0 5 5.9 Cc1nc(C(F)(F)F)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
462571 118793 None 1 Human Binding pKi = 8 8.0 97 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
CHEMBL342137 118793 None 1 Human Binding pKi = 8 8.0 97 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 5 5.2 Cc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
44337326 7966 None 0 Mouse Binding pKi = 6 6.0 -1000 3
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm0200815
CHEMBL109051 7966 None 0 Mouse Binding pKi = 6 6.0 -1000 3
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 600 7 0 5 6.4 COc1ccc(S(=O)(=O)c2ccc(CC3CCN(C4CCN(C(=O)c5ccc(F)c6ccccc56)CC4)CC3)cc2)cc1 10.1021/jm0200815
463892 31875 None 1 Human Binding pKi = 8.0 8.0 18 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
CHEMBL140706 31875 None 1 Human Binding pKi = 8.0 8.0 18 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1016/s0960-894x(02)00918-6
463209 121130 None 1 Human Binding pKi = 8.0 8.0 6 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 519 5 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(OC(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL357557 121130 None 1 Human Binding pKi = 8.0 8.0 6 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 519 5 0 6 4.8 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(OC(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
463210 164913 None 1 Human Binding pKi = 8.0 8.0 15 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 561 4 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL422326 164913 None 1 Human Binding pKi = 8.0 8.0 15 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 561 4 0 5 4.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
457874 78461 None 1 Human Binding pKi = 8.0 8.0 - 1
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CON=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL2111747 78461 None 1 Human Binding pKi = 8.0 8.0 - 1
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CON=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479846 110453 None 1 Mouse Binding pKi = 8.0 8.0 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL324671 110453 None 1 Mouse Binding pKi = 8.0 8.0 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
463892 31875 None 1 Human Binding pKi = 8.0 8.0 18 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
CHEMBL140706 31875 None 1 Human Binding pKi = 8.0 8.0 18 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 533 5 0 6 4.9 COc1nc(C)c(C(=O)N2CCC(C)(N3CCN([C@@H](C)c4ccc(C(F)(F)F)cc4)[C@@H](C)C3)CC2)c(C)n1 10.1021/jm030265z
5495587 119369 None 1 Human Binding pKi = 8.0 8.0 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL344435 119369 None 1 Human Binding pKi = 8.0 8.0 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495587 119369 None 1 Human Binding pKi = 8.0 8.0 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL344435 119369 None 1 Human Binding pKi = 8.0 8.0 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 567 7 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC3CC3)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
511295 9256 None 1 Human Binding pKi = 7.0 7.0 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL110786 9256 None 1 Human Binding pKi = 7.0 7.0 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
511295 9256 None 1 Mouse Binding pKi = 7.0 7.0 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL110786 9256 None 1 Mouse Binding pKi = 7.0 7.0 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 418 4 0 2 5.6 Cc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
463319 119394 None 1 Human Binding pKi = 7.9 7.9 102 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL344607 119394 None 1 Human Binding pKi = 7.9 7.9 102 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
462409 110689 None 1 Human Binding pKi = 7.9 7.9 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL326020 110689 None 1 Human Binding pKi = 7.9 7.9 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
44337251 5435 None 0 Mouse Binding pKi = 7.9 7.9 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 569 8 0 5 5.8 COCCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL107363 5435 None 0 Mouse Binding pKi = 7.9 7.9 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 569 8 0 5 5.8 COCCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
456323 9701 None 1 Human Binding pKi = 7.9 7.9 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
CHEMBL113154 9701 None 1 Human Binding pKi = 7.9 7.9 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
463319 119394 None 1 Human Binding pKi = 7.9 7.9 102 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL344607 119394 None 1 Human Binding pKi = 7.9 7.9 102 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 579 5 0 5 6.5 Cc1nc(-c2ccccc2)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
483746 31318 None 2 Human Binding pKi = 5.9 5.9 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 661 4 0 3 5.4 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3I)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
CHEMBL140183 31318 None 2 Human Binding pKi = 5.9 5.9 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 661 4 0 3 5.4 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3I)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm030265z
5495585 32506 None 1 Human Binding pKi = 7.9 7.9 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL141201 32506 None 1 Human Binding pKi = 7.9 7.9 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495585 32506 None 1 Human Binding pKi = 7.9 7.9 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL141201 32506 None 1 Human Binding pKi = 7.9 7.9 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 595 6 0 6 5.5 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(F)(F)F)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
456339 9545 None 1 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL112299 9545 None 1 Human Binding pKi = 7.8 7.8 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
456339 9545 None 1 Human Binding pKi = 7.8 7.8 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL112299 9545 None 1 Human Binding pKi = 7.8 7.8 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 513 5 1 6 3.9 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
90666578 109397 None 0 Rhesus macaque Binding pKi = 7.8 7.8 - 1
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
CHEMBL3219780 109397 None 0 Rhesus macaque Binding pKi = 7.8 7.8 - 1
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 528 8 2 6 5.5 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(N)cc1 10.1039/c3md00080j
112500049 132483 None 0 Human Binding pKi = 7.8 7.8 - 1
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
CHEMBL3697626 132483 None 0 Human Binding pKi = 7.8 7.8 - 1
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 642 11 2 7 6.7 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COC(C)(C)C)cc1 nan
71718930 87825 None 0 Human Binding pKi = 6.8 6.8 -75 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 601 5 1 7 4.4 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(C(F)(F)F)nc(N3CCc4cc(C(F)(F)F)ccc4C3)c2C)CC1 10.1021/ml400055e
CHEMBL2338390 87825 None 0 Human Binding pKi = 6.8 6.8 -75 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 601 5 1 7 4.4 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(C(F)(F)F)nc(N3CCc4cc(C(F)(F)F)ccc4C3)c2C)CC1 10.1021/ml400055e
90666577 109396 None 0 Rhesus macaque Binding pKi = 6.8 6.8 - 1
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
CHEMBL3219779 109396 None 0 Rhesus macaque Binding pKi = 6.8 6.8 - 1
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2C3CCC2CC(n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1039/c3md00080j
101577042 183140 None 0 Rhesus macaque Binding pKi = 6.8 6.8 - 1
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4795179 183140 None 0 Rhesus macaque Binding pKi = 6.8 6.8 - 1
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 886 25 5 11 4.9 CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@H]3CC[C@@H]2C[C@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1 10.1016/j.bmc.2016.09.059
112500047 124468 None 0 Human Binding pKi = 6.8 6.8 - 1
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
CHEMBL3639964 124468 None 0 Human Binding pKi = 6.8 6.8 - 1
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 643 13 3 8 4.4 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(N)=O)cc1 nan
511306 5254 None 1 Mouse Binding pKi = 6.8 6.8 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL106369 5254 None 1 Mouse Binding pKi = 6.8 6.8 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
511306 5254 None 1 Human Binding pKi = 6.8 6.8 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL106369 5254 None 1 Human Binding pKi = 6.8 6.8 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 434 5 0 3 5.3 COc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
9579325 107347 None 0 Mouse Binding pKi = 7.8 7.8 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 5 4.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm0200815
CHEMBL317644 107347 None 0 Mouse Binding pKi = 7.8 7.8 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 5 4.5 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm0200815
5496112 30779 None 1 Human Binding pKi = 7.8 7.8 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 5 4.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm030265z
CHEMBL139607 30779 None 1 Human Binding pKi = 7.8 7.8 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 5 4.5 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ccc[n+]3[O-])CC2)CC1 10.1021/jm030265z
462989 33102 None 1 Human Binding pKi = 7.8 7.8 14 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL141699 33102 None 1 Human Binding pKi = 7.8 7.8 14 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
9574356 5199 None 0 Human Binding pKi = 7.8 7.8 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm015526o
CHEMBL106098 5199 None 0 Human Binding pKi = 7.8 7.8 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm015526o
9574359 5320 None 0 Human Binding pKi = 7.8 7.8 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm015526o
CHEMBL106767 5320 None 0 Human Binding pKi = 7.8 7.8 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm015526o
9574359 5320 None 0 Mouse Binding pKi = 7.8 7.8 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm0200815
CHEMBL106767 5320 None 0 Mouse Binding pKi = 7.8 7.8 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 527 5 1 5 5.2 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm0200815
5479851 30660 None 1 Human Binding pKi = 7.8 7.8 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 1 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm030265z
CHEMBL139459 30660 None 1 Human Binding pKi = 7.8 7.8 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 1 5 5.2 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3O)CC2)CC1 10.1021/jm030265z
462989 33102 None 1 Human Binding pKi = 7.8 7.8 14 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL141699 33102 None 1 Human Binding pKi = 7.8 7.8 14 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1c[n+]([O-])cc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
456292 96747 None 1 Human Binding pKi = 7.8 7.8 42 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 553 6 0 5 6.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL264442 96747 None 1 Human Binding pKi = 7.8 7.8 42 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 553 6 0 5 6.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
3117 207839 None 103 Human Binding pKi = 4.7 4.7 -8 16
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
CHEMBL964 207839 None 103 Human Binding pKi = 4.7 4.7 -8 16
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC nan
9574356 5199 None 0 Mouse Binding pKi = 7.7 7.7 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106098 5199 None 0 Mouse Binding pKi = 7.7 7.7 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 5 0 5 4.5 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5479840 29183 None 1 Human Binding pKi = 7.7 7.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 5 0 5 4.5 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138198 29183 None 1 Human Binding pKi = 7.7 7.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 5 0 5 4.5 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
511298 109927 None 1 Mouse Binding pKi = 6.7 6.7 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL323454 109927 None 1 Mouse Binding pKi = 6.7 6.7 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
511298 109927 None 1 Human Binding pKi = 6.7 6.7 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL323454 109927 None 1 Human Binding pKi = 6.7 6.7 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 4 1 3 5.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
464036 9744 None 4 Human Binding pKi = 8.7 8.7 1174 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL113436 9744 None 4 Human Binding pKi = 8.7 8.7 1174 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
10617034 208327 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 339 3 2 2 5.1 O=C(O)c1ccc(-c2ccc(-c3cc4c(F)ccc(F)c4o3)[nH]2)cc1 10.1021/jm300682j
CHEMBL99221 208327 None 0 Human Binding pKi = 8.7 8.7 - 1
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 339 3 2 2 5.1 O=C(O)c1ccc(-c2ccc(-c3cc4c(F)ccc(F)c4o3)[nH]2)cc1 10.1021/jm300682j
44341106 9631 None 0 Human Binding pKi = 8.7 8.7 - 1
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 511 5 0 4 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL112686 9631 None 0 Human Binding pKi = 8.7 8.7 - 1
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 511 5 0 4 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479844 110447 None 1 Mouse Binding pKi = 8.7 8.7 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL324643 110447 None 1 Mouse Binding pKi = 8.7 8.7 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
5479846 110453 None 1 Mouse Binding pKi = 8.7 8.7 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL324671 110453 None 1 Mouse Binding pKi = 8.7 8.7 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
5479845 9645 None 1 Human Binding pKi = 8.7 8.7 3 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL112760 9645 None 1 Human Binding pKi = 8.7 8.7 3 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5495584 31546 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140390 31546 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
5479843 113054 None 1 Human Binding pKi = 8.7 8.7 4 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL331140 113054 None 1 Human Binding pKi = 8.7 8.7 4 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5495584 31546 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140390 31546 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 7 0 6 5.4 CCCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
802 415 None 10 Human Binding pKi = 8.7 8.7 -1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
804 415 None 10 Human Binding pKi = 8.7 8.7 -1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
9574343 415 None 10 Human Binding pKi = 8.7 8.7 -1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
CHEMBL78535 415 None 10 Human Binding pKi = 8.7 8.7 -1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm015526o
802 415 None 10 Mouse Binding pKi = 8.7 8.7 1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
804 415 None 10 Mouse Binding pKi = 8.7 8.7 1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
9574343 415 None 10 Mouse Binding pKi = 8.7 8.7 1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
CHEMBL78535 415 None 10 Mouse Binding pKi = 8.7 8.7 1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm0200815
802 415 None 10 Human Binding pKi = 8.7 8.7 -1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
804 415 None 10 Human Binding pKi = 8.7 8.7 -1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
9574343 415 None 10 Human Binding pKi = 8.7 8.7 -1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
CHEMBL78535 415 None 10 Human Binding pKi = 8.7 8.7 -1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 10.1021/jm030265z
5495589 115489 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL335120 115489 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1021/jm030265z
3009355 3987 None 26 Human Binding pKi = 8.7 8.7 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
807 3987 None 26 Human Binding pKi = 8.7 8.7 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
CHEMBL82301 3987 None 26 Human Binding pKi = 8.7 8.7 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
DB06652 3987 None 26 Human Binding pKi = 8.7 8.7 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 10.1016/s0960-894x(02)01063-6
5495589 115489 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL335120 115489 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
6532433 33489 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 541 6 0 6 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL142021 33489 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 541 6 0 6 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
5482299 120173 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 541 6 0 6 5.0 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL351625 120173 None 1 Human Binding pKi = 8.7 8.7 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 541 6 0 6 5.0 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
464036 9744 None 4 Human Binding pKi = 8.6 8.6 1174 2
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL113436 9744 None 4 Human Binding pKi = 8.6 8.6 1174 2
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
464036 9744 None 4 Human Binding pKi = 8.6 8.6 1174 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL113436 9744 None 4 Human Binding pKi = 8.6 8.6 1174 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1ccnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
6533779 28870 None 1 Human Binding pKi = 8.6 8.6 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1021/jm030265z
CHEMBL137934 28870 None 1 Human Binding pKi = 8.6 8.6 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 540 6 0 5 5.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1021/jm030265z
CHEMBL5071060 214249 None 0 Rhesus macaque Binding pKi = 8.6 8.6 21 2
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay
ChEMBL None None None Cc1nnc(C(C)C)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1021/acs.jmedchem.1c00408
462395 115200 None 1 Human Binding pKi = 8.6 8.6 128 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
CHEMBL334470 115200 None 1 Human Binding pKi = 8.6 8.6 128 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00918-6
462395 115200 None 1 Human Binding pKi = 8.6 8.6 128 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
CHEMBL334470 115200 None 1 Human Binding pKi = 8.6 8.6 128 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 558 4 0 4 5.4 C[C@H]1CN(C2(C)CCN(C(=O)c3c(Cl)c[n+]([O-])cc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
462902 119851 None 1 Human Binding pKi = 7.7 7.7 8 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 460 4 0 6 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C#N)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL348667 119851 None 1 Human Binding pKi = 7.7 7.7 8 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 460 4 0 6 3.7 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C#N)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
483744 9626 None 2 Human Binding pKi = 7.7 7.7 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL112659 9626 None 2 Human Binding pKi = 7.7 7.7 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
9579332 5284 None 0 Mouse Binding pKi = 7.7 7.7 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 7 0 7 3.5 CCO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106558 5284 None 0 Mouse Binding pKi = 7.7 7.7 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 7 0 7 3.5 CCO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
483744 9626 None 2 Human Binding pKi = 7.7 7.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL112659 9626 None 2 Human Binding pKi = 7.7 7.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496119 29258 None 1 Human Binding pKi = 7.7 7.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 7 0 7 3.5 CCO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138263 29258 None 1 Human Binding pKi = 7.7 7.7 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 7 0 7 3.5 CCO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
71718331 87826 None 0 Human Binding pKi = 6.7 6.7 -208 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 663 8 2 8 5.7 Cc1c(NC[C@H]2CCC[C@@H](c3ccc(C(F)(F)F)cc3)O2)nc(C2CCOCC2)nc1C(=O)N1CCC(N[C@H]2CCOC[C@H]2F)CC1 10.1021/ml400055e
CHEMBL2338391 87826 None 0 Human Binding pKi = 6.7 6.7 -208 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 663 8 2 8 5.7 Cc1c(NC[C@H]2CCC[C@@H](c3ccc(C(F)(F)F)cc3)O2)nc(C2CCOCC2)nc1C(=O)N1CCC(N[C@H]2CCOC[C@H]2F)CC1 10.1021/ml400055e
9827221 109700 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL322817 109700 None 0 Human Binding pKi = 7.6 7.6 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 497 4 0 3 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Br)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
5495579 56279 None 1 Human Binding pKi = 7.6 7.6 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL162946 56279 None 1 Human Binding pKi = 7.6 7.6 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 540 6 0 5 5.6 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cncc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
461838 203646 None 1 Human Binding pKi = 6.6 6.6 1 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 611 6 0 7 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3F)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
CHEMBL67281 203646 None 1 Human Binding pKi = 6.6 6.6 1 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 611 6 0 7 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(F)cccc3F)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
89702731 109394 None 0 Rhesus macaque Binding pKi = 6.6 6.6 -4 3
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
CHEMBL3219777 109394 None 0 Rhesus macaque Binding pKi = 6.6 6.6 -4 3
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1039/c3md00080j
162650661 180147 None 0 Rhesus macaque Binding pKi = 6.6 6.6 -74 2
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
CHEMBL4748891 180147 None 0 Rhesus macaque Binding pKi = 6.6 6.6 -74 2
Displacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysisDisplacement of [125I]MIP-1alpha from CCR5 receptor in rhesus monkey membrane incubated for 120 mins by liquid scintillation counting analysis
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1[C@@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 10.1016/j.bmc.2016.09.059
89702731 109394 None 0 Human Binding pKi = 6.6 6.6 -4 3
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
CHEMBL3219777 109394 None 0 Human Binding pKi = 6.6 6.6 -4 3
Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.Radioligand Binding Assay: Afterwards, the pharmacological profile of bivalent ligand 1 at the chemokine receptor CCR5 was characterized similarly. The competitive radioligand binding assay was conducted in CCR5 rhesus macaque membrane preparations from Chem-1 cells. Monovalent ligand 3 and compound 4, an analogue of maraviroc, were tested along under the same condition. Introduction of the 4-NH2 group onto the phenyl ring of maraviroc, as seen in compound 4, caused approximately 65-fold decrease in the binding affinity, compared to maraviroc. The decrease of the binding affinity was even more profound for bivalent ligand 1 and monovalent ligand 3, as their Ki values dropped to submicromolar range, respectively.
ChEMBL 1197 28 7 15 6.6 Cc1nnc(C(C)C)n1C1CC2CCC(C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccc(NC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)cc1 nan
9579329 5200 None 0 Mouse Binding pKi = 7.6 7.6 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 5 0 5 4.3 CO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106099 5200 None 0 Mouse Binding pKi = 7.6 7.6 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 498 5 0 5 4.3 CO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496116 29124 None 1 Human Binding pKi = 7.6 7.6 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 5 0 5 4.3 CO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138143 29124 None 1 Human Binding pKi = 7.6 7.6 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 498 5 0 5 4.3 CO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
5479845 9645 None 1 Human Binding pKi = 7.6 7.6 3 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL112760 9645 None 1 Human Binding pKi = 7.6 7.6 3 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
511304 5388 None 1 Mouse Binding pKi = 7.6 7.6 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL107092 5388 None 1 Mouse Binding pKi = 7.6 7.6 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
5479845 9645 None 1 Mouse Binding pKi = 7.6 7.6 -3 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL112760 9645 None 1 Mouse Binding pKi = 7.6 7.6 -3 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511304 5388 None 1 Human Binding pKi = 7.6 7.6 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL107092 5388 None 1 Human Binding pKi = 7.6 7.6 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 472 4 0 2 6.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(C(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
5479845 9645 None 1 Human Binding pKi = 7.6 7.6 3 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL112760 9645 None 1 Human Binding pKi = 7.6 7.6 3 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 525 5 0 4 5.8 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5495595 30428 None 1 Human Binding pKi = 7.6 7.6 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL139246 30428 None 1 Human Binding pKi = 7.6 7.6 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1021/jm030265z
5495595 30428 None 1 Human Binding pKi = 7.6 7.6 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL139246 30428 None 1 Human Binding pKi = 7.6 7.6 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 581 7 0 6 5.9 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C4CC4)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
9579318 169842 None 0 Mouse Binding pKi = 7.6 7.6 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 6 0 5 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm0200815
CHEMBL443999 169842 None 0 Mouse Binding pKi = 7.6 7.6 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 6 0 5 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm0200815
5496105 28970 None 1 Human Binding pKi = 7.6 7.6 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 6 0 5 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL138028 28970 None 1 Human Binding pKi = 7.6 7.6 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 6 0 5 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3cccnc3C)CC2)CC1 10.1021/jm030265z
11069824 110670 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 419 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccccc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL325957 110670 None 0 Human Binding pKi = 6.6 6.6 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 419 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccccc3)[C@@H](C)C2)CC1 10.1021/jm0155401
456293 204056 None 1 Human Binding pKi = 7.6 7.6 17 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL70010 204056 None 1 Human Binding pKi = 7.6 7.6 17 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 603 6 0 7 5.2 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
11079978 9179 None 0 Mouse Binding pKi = 6.6 6.6 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 404 4 0 2 5.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccccc3)CC2)CC1 10.1021/jm0200815
CHEMBL110270 9179 None 0 Mouse Binding pKi = 6.6 6.6 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 404 4 0 2 5.3 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccccc3)CC2)CC1 10.1021/jm0200815
457672 7221 None 1 Human Binding pKi = 7.5 7.5 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL108569 7221 None 1 Human Binding pKi = 7.5 7.5 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
457672 7221 None 1 Mouse Binding pKi = 7.5 7.5 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL108569 7221 None 1 Mouse Binding pKi = 7.5 7.5 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
457672 7221 None 1 Human Binding pKi = 7.5 7.5 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL108569 7221 None 1 Human Binding pKi = 7.5 7.5 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 484 4 0 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Oc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
483747 105407 None 3 Human Binding pKi = 8.5 8.5 177 4
Ability of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL311795 105407 None 3 Human Binding pKi = 8.5 8.5 177 4
Ability of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility of compound to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
484578 9690 None 2 Human Binding pKi = 8.5 8.5 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL113072 9690 None 2 Human Binding pKi = 8.5 8.5 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
9579312 109144 None 0 Mouse Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 6 0 4 6.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm0200815
CHEMBL321413 109144 None 0 Mouse Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 6 0 4 6.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm0200815
484578 9690 None 2 Human Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL113072 9690 None 2 Human Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 5 0 5 4.5 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(S(C)(=O)=O)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
483747 105407 None 3 Human Binding pKi = 8.5 8.5 177 4
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL311795 105407 None 3 Human Binding pKi = 8.5 8.5 177 4
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 0 5 4.9 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496099 165252 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 6 0 4 6.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm030265z
CHEMBL423000 165252 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 6 0 4 6.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(F)cccc3C(F)(F)F)CC2)CC1 10.1021/jm030265z
5495590 31708 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140552 31708 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1021/jm030265z
5495590 31708 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140552 31708 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 609 6 0 6 6.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(F)(F)F)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL5074744 214327 None 0 Rhesus macaque Binding pKi = 8.5 8.5 1 2
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
5495588 32157 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL140912 32157 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495588 32157 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140912 32157 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 555 6 0 6 5.4 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
9574358 5145 None 0 Human Binding pKi = 8.5 8.5 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm015526o
CHEMBL105784 5145 None 0 Human Binding pKi = 8.5 8.5 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm015526o
9574358 5145 None 0 Mouse Binding pKi = 8.5 8.5 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm0200815
CHEMBL105784 5145 None 0 Mouse Binding pKi = 8.5 8.5 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 5 1 5 5.4 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm0200815
5479842 116715 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 5 1 5 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm030265z
CHEMBL337340 116715 None 1 Human Binding pKi = 8.5 8.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 5 1 5 5.4 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CC1 10.1021/jm030265z
9579330 5280 None 0 Mouse Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 6 0 5 5.1 CCO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106533 5280 None 0 Mouse Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 546 6 0 5 5.1 CCO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496117 96412 None 1 Human Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 6 0 5 5.1 CCO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL261950 96412 None 1 Human Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 546 6 0 5 5.1 CCO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
456647 10213 None 2 Human Binding pKi = 7.5 7.5 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL116008 10213 None 2 Human Binding pKi = 7.5 7.5 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
9579334 5975 None 0 Mouse Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 6 0 5 4.2 CCO/N=C(\c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL107999 5975 None 0 Mouse Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 6 0 5 4.2 CCO/N=C(\c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
9579328 168090 None 0 Mouse Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 7 3.1 CO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL432636 168090 None 0 Mouse Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 542 6 0 7 3.1 CO/N=C(\c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
456647 10213 None 2 Human Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL116008 10213 None 2 Human Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496115 29710 None 1 Human Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 7 3.1 CO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138655 29710 None 1 Human Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 542 6 0 7 3.1 CO/N=C(/c1ccc(S(C)(=O)=O)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
5496121 32696 None 1 Human Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 6 0 5 4.2 CCO/N=C(/c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL141345 32696 None 1 Human Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 6 0 5 4.2 CCO/N=C(/c1ccc(F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
73345281 89243 None 0 Human Binding pKi = 4.5 4.5 - 1
Inhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cellsInhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cells
ChEMBL 942 8 10 19 -0.6 C[C@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)C5=C[C@H](O)C67C(=O)O[C@@](C)(C8CCC(C)(C)O8)[C@@]6(O)CC[C@@]7(C)C5CCC4C3(C)C)OC[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 10.1016/s0960-894x(02)00599-1
CHEMBL2367888 89243 None 0 Human Binding pKi = 4.5 4.5 - 1
Inhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cellsInhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cells
ChEMBL 942 8 10 19 -0.6 C[C@H]1O[C@@H](O[C@H]2[C@H](O[C@H]3CC[C@]4(C)C5=C[C@H](O)C67C(=O)O[C@@](C)(C8CCC(C)(C)O8)[C@@]6(O)CC[C@@]7(C)C5CCC4C3(C)C)OC[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 10.1016/s0960-894x(02)00599-1
455656 204008 None 1 Human Binding pKi = 7.5 7.5 3 2
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cellsAbility to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cells
ChEMBL 604 6 1 8 4.5 Cc1cccc(N)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL69670 204008 None 1 Human Binding pKi = 7.5 7.5 3 2
Ability to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cellsAbility to inhibit [125I]-labeled RANTES binding to C-C chemokine receptor type 5 expressed in membrane preparation of CHO cells
ChEMBL 604 6 1 8 4.5 Cc1cccc(N)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
71717723 87827 None 0 Human Binding pKi = 7.5 7.5 -51 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 525 7 2 7 4.3 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(CF)nc(Nc3ccc(Cl)c(Cl)c3)c2C)CC1 10.1021/ml400055e
CHEMBL2338392 87827 None 0 Human Binding pKi = 7.5 7.5 -51 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 525 7 2 7 4.3 CO[C@@H]1COCC[C@@H]1NC1CCN(C(=O)c2nc(CF)nc(Nc3ccc(Cl)c(Cl)c3)c2C)CC1 10.1021/ml400055e
5495593 119091 None 1 Human Binding pKi = 6.5 6.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL342706 119091 None 1 Human Binding pKi = 6.5 6.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1021/jm030265z
5495593 119091 None 1 Human Binding pKi = 6.5 6.5 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL342706 119091 None 1 Human Binding pKi = 6.5 6.5 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 634 8 1 8 4.4 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NS(C)(=O)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
455657 204003 None 1 Human Binding pKi = 7.5 7.5 3 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 624 6 1 8 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
CHEMBL69642 204003 None 1 Human Binding pKi = 7.5 7.5 3 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 624 6 1 8 4.9 C[C@H]1CN(C2CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
9579315 5143 None 0 Mouse Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL105779 5143 None 0 Mouse Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511303 5259 None 1 Mouse Binding pKi = 7.5 7.5 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106406 5259 None 1 Mouse Binding pKi = 7.5 7.5 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0200815
9579316 5324 None 0 Mouse Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL106790 5324 None 0 Mouse Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511307 5371 None 1 Mouse Binding pKi = 7.5 7.5 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106982 5371 None 1 Mouse Binding pKi = 7.5 7.5 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm0200815
511303 5259 None 1 Human Binding pKi = 7.5 7.5 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106406 5259 None 1 Human Binding pKi = 7.5 7.5 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 530 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
511307 5371 None 1 Human Binding pKi = 7.5 7.5 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106982 5371 None 1 Human Binding pKi = 7.5 7.5 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 5 0 4 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(S(C)(=O)=O)cc3)CC2)CC1 10.1021/jm030265z
5496102 33226 None 1 Human Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL141802 33226 None 1 Human Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 597 8 0 6 5.8 CCOC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
5496103 118769 None 1 Human Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL341928 118769 None 1 Human Binding pKi = 7.5 7.5 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 582 7 1 5 4.9 CNC(=O)CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
474465 203069 None 2 Human Binding pKi = 6.5 6.5 1 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 6 0 5 5.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL63757 203069 None 2 Human Binding pKi = 6.5 6.5 1 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 525 6 0 5 5.0 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
511297 5230 None 1 Human Binding pKi = 6.4 6.4 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106264 5230 None 1 Human Binding pKi = 6.4 6.4 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm030265z
511297 5230 None 1 Mouse Binding pKi = 6.4 6.4 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106264 5230 None 1 Mouse Binding pKi = 6.4 6.4 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 480 5 0 2 6.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(-c4ccccc4)cc3)CC2)CC1 10.1021/jm0200815
474188 31647 None 2 Human Binding pKi = 7.4 7.4 28 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL140490 31647 None 2 Human Binding pKi = 7.4 7.4 28 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
474188 31647 None 2 Human Binding pKi = 7.4 7.4 28 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL140490 31647 None 2 Human Binding pKi = 7.4 7.4 28 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 1 6 4.5 Cc1nc(N)nc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
9579314 7887 None 0 Mouse Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL109008 7887 None 0 Mouse Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
5496101 30120 None 1 Human Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL138975 30120 None 1 Human Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 553 6 0 4 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
9579331 107453 None 0 Mouse Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 562 7 0 6 5.0 CCO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL318311 107453 None 0 Mouse Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 562 7 0 6 5.0 CCO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496118 29270 None 1 Human Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 562 7 0 6 5.0 CCO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL138274 29270 None 1 Human Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 562 7 0 6 5.0 CCO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
9574360 8106 None 0 Human Binding pKi = 8.4 8.4 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm015526o
CHEMBL109158 8106 None 0 Human Binding pKi = 8.4 8.4 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm015526o
9574360 8106 None 0 Mouse Binding pKi = 8.4 8.4 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm0200815
CHEMBL109158 8106 None 0 Mouse Binding pKi = 8.4 8.4 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 526 5 1 5 5.1 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm0200815
5479852 30178 None 1 Human Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 1 5 5.1 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm030265z
CHEMBL139029 30178 None 1 Human Binding pKi = 8.4 8.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 526 5 1 5 5.1 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3N)CC2)CC1 10.1021/jm030265z
5495583 32509 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 0 6 4.6 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
CHEMBL141202 32509 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 527 5 0 6 4.6 CO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1021/jm030265z
9579117 54977 None 0 Human Binding pKi = 8.3 8.3 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 527 5 0 6 4.6 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL161587 54977 None 0 Human Binding pKi = 8.3 8.3 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 527 5 0 6 4.6 CO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL5094690 215509 None 0 Rhesus macaque Binding pKi = 7.4 7.4 - 1
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells by competitive radioligand binding assay
ChEMBL None None None CNC(=O)COCC(=O)NCCCCCCCNC(=O)COCC(=O)NCCc1nnc(C(C)C)n1[C@@H]1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
9579321 9244 None 0 Mouse Binding pKi = 7.4 7.4 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm0200815
CHEMBL110730 9244 None 0 Mouse Binding pKi = 7.4 7.4 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm0200815
5496108 29991 None 1 Human Binding pKi = 7.4 7.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm030265z
CHEMBL138879 29991 None 1 Human Binding pKi = 7.4 7.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(C)nc3O)CC2)CC1 10.1021/jm030265z
5495594 30845 None 1 Human Binding pKi = 7.4 7.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL139701 30845 None 1 Human Binding pKi = 7.4 7.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1021/jm030265z
5495594 30845 None 1 Human Binding pKi = 7.4 7.4 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL139701 30845 None 1 Human Binding pKi = 7.4 7.4 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 583 7 0 6 6.1 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(C(C)C)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
456611 203552 None 1 Human Binding pKi = 7.4 7.4 - 1
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL66623 203552 None 1 Human Binding pKi = 7.4 7.4 - 1
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 5 5.4 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(Cc4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
461546 9479 None 1 Human Binding pKi = 6.4 6.4 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
CHEMBL111982 9479 None 1 Human Binding pKi = 6.4 6.4 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
461546 9479 None 1 Human Binding pKi = 6.4 6.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL111982 9479 None 1 Human Binding pKi = 6.4 6.4 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 517 4 0 3 4.3 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
463517 203700 None 1 Human Binding pKi = 6.4 6.4 -436 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL67563 203700 None 1 Human Binding pKi = 6.4 6.4 -436 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.8 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)CC2)CC1 10.1016/s0960-894x(01)00381-x
461871 161767 None 1 Human Binding pKi = 7.4 7.4 - 1
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 543 6 0 3 6.9 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4cccc(Cl)c4)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL413972 161767 None 1 Human Binding pKi = 7.4 7.4 - 1
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 543 6 0 3 6.9 Cc1cccc(C)c1C(=O)N1CCC(N2CCN([C@@H](C)c3ccc(Cc4cccc(Cl)c4)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
503637 56345 None 1 Human Binding pKi = 7.3 7.3 - 1
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 56345 None 1 Human Binding pKi = 7.3 7.3 - 1
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
5479843 113054 None 1 Human Binding pKi = 7.3 7.3 4 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
CHEMBL331140 113054 None 1 Human Binding pKi = 7.3 7.3 4 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm015526o
5479843 113054 None 1 Mouse Binding pKi = 7.3 7.3 -4 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL331140 113054 None 1 Mouse Binding pKi = 7.3 7.3 -4 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
5479843 113054 None 1 Human Binding pKi = 7.3 7.3 4 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL331140 113054 None 1 Human Binding pKi = 7.3 7.3 4 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 539 6 0 4 6.2 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
462772 102309 None 1 Human Binding pKi = 7.3 7.3 5 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 643 6 0 7 5.9 C[C@H]1CN(C2CCN(C(=O)c3c(Cl)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
CHEMBL303503 102309 None 1 Human Binding pKi = 7.3 7.3 5 2
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 643 6 0 7 5.9 C[C@H]1CN(C2CCN(C(=O)c3c(Cl)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(=O)(=O)c2ccc3c(c2)OCO3)cc1 10.1016/s0960-894x(01)00381-x
484577 9481 None 2 Human Binding pKi = 8.3 8.3 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL111998 9481 None 2 Human Binding pKi = 8.3 8.3 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
484579 9685 None 2 Human Binding pKi = 8.3 8.3 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm0155401
CHEMBL113042 9685 None 2 Human Binding pKi = 8.3 8.3 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm0155401
456323 9701 None 1 Human Binding pKi = 8.3 8.3 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm0155401
CHEMBL113154 9701 None 1 Human Binding pKi = 8.3 8.3 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 580 4 1 4 5.3 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(I)cc1 10.1021/jm0155401
456372 10136 None 1 Human Binding pKi = 8.3 8.3 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL115716 10136 None 1 Human Binding pKi = 8.3 8.3 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
461327 110559 None 1 Human Binding pKi = 8.3 8.3 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm0155401
CHEMBL325276 110559 None 1 Human Binding pKi = 8.3 8.3 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm0155401
484577 9481 None 2 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL111998 9481 None 2 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 503 4 1 4 5.5 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
484579 9685 None 2 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm030265z
CHEMBL113042 9685 None 2 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 1 6 4.1 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(S(C)(=O)=O)cc1 10.1021/jm030265z
456372 10136 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL115716 10136 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 559 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
461327 110559 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
CHEMBL325276 110559 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 522 4 1 4 5.7 C[C@H]1CN(C2(C)CCN(C(=O)c3c(N)cccc3Cl)CC2)CCN1[C@@H](C)c1ccc(C(F)(F)F)cc1 10.1021/jm030265z
503637 56345 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 56345 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
462573 29527 None 1 Human Binding pKi = 8.3 8.3 316 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL138502 29527 None 1 Human Binding pKi = 8.3 8.3 316 2
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
462573 29527 None 1 Human Binding pKi = 8.3 8.3 316 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL138502 29527 None 1 Human Binding pKi = 8.3 8.3 316 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 502 4 0 4 5.5 Cc1cncc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
9579326 108602 None 0 Mouse Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 532 5 0 5 4.7 CO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL320502 108602 None 0 Mouse Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 532 5 0 5 4.7 CO/N=C(\c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496113 32646 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 0 5 4.7 CO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL141301 32646 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 532 5 0 5 4.7 CO/N=C(/c1ccc(C(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
5495596 119241 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL343520 119241 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1021/jm030265z
5495596 119241 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL343520 119241 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 571 7 0 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(OC)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
9579333 163426 None 0 Mouse Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 512 6 0 5 4.7 CCO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL419735 163426 None 0 Mouse Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 512 6 0 5 4.7 CCO/N=C(\c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496120 119285 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 512 6 0 5 4.7 CCO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL343826 119285 None 1 Human Binding pKi = 8.3 8.3 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 512 6 0 5 4.7 CCO/N=C(/c1ccc(Cl)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL5089300 215199 None 0 Rhesus macaque Binding pKi = 8.2 8.2 1 2
Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assayDisplacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay
ChEMBL None None None CC(C)c1nnc(CCNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)N[C@@H]2CC[C@@]3(O)[C@H]4Cc5ccc(O)c6c5[C@@]3(CCN4CC3CC3)[C@H]2O6)n1C1C[C@H]2CC[C@@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)c1ccccc1 10.1021/acs.jmedchem.1c00408
5495591 33083 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL141683 33083 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1021/jm030265z
5495591 33083 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL141683 33083 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 1 7 4.6 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(N)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
71719547 87828 None 0 Human Binding pKi = 7.3 7.3 -50 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 660 8 2 9 5.8 Cc1cc(-c2nc(NC[C@H]3CCC[C@@H](c4ccc(C(F)(F)F)cc4)O3)c(C)c(C(=O)N3CCC(N[C@@H]4CCOC[C@@H]4F)CC3)n2)no1 10.1021/ml400055e
CHEMBL2338393 87828 None 0 Human Binding pKi = 7.3 7.3 -50 2
Displacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysisDisplacement of [125I]RANTES from human CCR5 expressed in CHO cell membranes coexpressing Gal6 after 6 hrs by scintillation counting analysis
ChEMBL 660 8 2 9 5.8 Cc1cc(-c2nc(NC[C@H]3CCC[C@@H](c4ccc(C(F)(F)F)cc4)O3)c(C)c(C(=O)N3CCC(N[C@@H]4CCOC[C@@H]4F)CC3)n2)no1 10.1021/ml400055e
CHEMBL2367887 209584 None 0 Human Binding pKi = 5.3 5.3 - 1
Inhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cellsInhibitory activity against human CCR5 chemokine receptor (CCR5) expressed in CHO cells
ChEMBL None None None COC1[C@@H](O)C(OC2[C@@H](O)[C@H](O[C@@H]3[C@@H](C)O[C@@H](O[C@H]4[C@H](O[C@H]5CC[C@]6(C)C7=C[C@H](O)C89C(=O)O[C@@](C)(CCCC(C)C)C8CC[C@@]9(C)C7CCC6C5(C)C)OC[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](OC6O[C@H](CO)[C@@H](O)[C@H](OC)[C@H]6O)[C@H]5O)[C@@H]4O)[C@H](O)[C@H]3O)O[C@H](CO)[C@H]2O)O[C@H](CO)[C@H]1O 10.1016/s0960-894x(02)00599-1
457671 5216 None 1 Human Binding pKi = 7.3 7.3 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL106209 5216 None 1 Human Binding pKi = 7.3 7.3 1 2
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
457671 5216 None 1 Mouse Binding pKi = 7.3 7.3 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106209 5216 None 1 Mouse Binding pKi = 7.3 7.3 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
457671 5216 None 1 Human Binding pKi = 7.3 7.3 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106209 5216 None 1 Human Binding pKi = 7.3 7.3 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 3 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(=O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
511305 107324 None 1 Mouse Binding pKi = 7.3 7.3 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL317476 107324 None 1 Mouse Binding pKi = 7.3 7.3 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm0200815
511305 107324 None 1 Human Binding pKi = 7.3 7.3 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL317476 107324 None 1 Human Binding pKi = 7.3 7.3 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 488 5 0 3 6.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(OC(F)(F)F)cc3)CC2)CC1 10.1021/jm030265z
457875 5227 None 1 Mouse Binding pKi = 7.2 7.2 1 3
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106247 5227 None 1 Mouse Binding pKi = 7.2 7.2 1 3
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
457875 5227 None 1 Human Binding pKi = 7.2 7.2 -1 3
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106247 5227 None 1 Human Binding pKi = 7.2 7.2 -1 3
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
483741 33490 None 2 Human Binding pKi = 6.2 6.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 504 4 0 2 6.6 CC1(N2CCC(Cc3ccc(Br)cc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm030265z
CHEMBL142022 33490 None 2 Human Binding pKi = 6.2 6.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 504 4 0 2 6.6 CC1(N2CCC(Cc3ccc(Br)cc3)CC2)CCN(C(=O)c2cccc3ccccc23)CC1 10.1021/jm030265z
511308 7659 None 1 Mouse Binding pKi = 6.2 6.2 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL108845 7659 None 1 Mouse Binding pKi = 6.2 6.2 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
511308 7659 None 1 Human Binding pKi = 6.2 6.2 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL108845 7659 None 1 Human Binding pKi = 6.2 6.2 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 446 5 0 3 5.5 CC(=O)c1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
5495592 31343 None 1 Human Binding pKi = 7.2 7.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL140201 31343 None 1 Human Binding pKi = 7.2 7.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1021/jm030265z
5495592 31343 None 1 Human Binding pKi = 7.2 7.2 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL140201 31343 None 1 Human Binding pKi = 7.2 7.2 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 598 7 1 7 5.0 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)nc(NC(C)=O)nc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
456298 9787 None 1 Human Binding pKi = 7.2 7.2 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
CHEMBL113648 9787 None 1 Human Binding pKi = 7.2 7.2 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm0155401
44337265 5273 None 0 Mouse Binding pKi = 7.2 7.2 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 555 7 1 5 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OCCO)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106507 5273 None 0 Mouse Binding pKi = 7.2 7.2 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 555 7 1 5 5.2 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OCCO)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
511299 9278 None 1 Mouse Binding pKi = 7.2 7.2 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL110871 9278 None 1 Mouse Binding pKi = 7.2 7.2 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
511299 9278 None 1 Human Binding pKi = 7.2 7.2 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL110871 9278 None 1 Human Binding pKi = 7.2 7.2 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 496 4 0 2 6.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(C(C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
456298 9787 None 1 Human Binding pKi = 7.2 7.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL113648 9787 None 1 Human Binding pKi = 7.2 7.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 531 4 0 3 4.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)CC2)CC1 10.1021/jm030265z
3497 1180 None 25 Human Binding pKi = 7.2 7.2 -2 3
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
5311123 1180 None 25 Human Binding pKi = 7.2 7.2 -2 3
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
CHEMBL1628706 1180 None 25 Human Binding pKi = 7.2 7.2 -2 3
Binding affinity to CCR5Binding affinity to CCR5
ChEMBL 482 11 4 6 2.5 O[C@H]([C@@H](NC(=O)c1cnc2c(n1)cccc2)Cc1cccc(c1)F)C[C@H](C(=O)N)CCC(O)(C)C 10.1021/jm300682j
457875 5227 None 1 Human Binding pKi = 7.2 7.2 -1 3
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL106247 5227 None 1 Human Binding pKi = 7.2 7.2 -1 3
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
10961907 9264 None 0 Mouse Binding pKi = 7.2 7.2 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3cccc(Br)c3)CC2)CC1 10.1021/jm0200815
CHEMBL110809 9264 None 0 Mouse Binding pKi = 7.2 7.2 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 482 4 0 2 6.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3cccc(Br)c3)CC2)CC1 10.1021/jm0200815
511294 5236 None 1 Mouse Binding pKi = 7.2 7.2 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106299 5236 None 1 Mouse Binding pKi = 7.2 7.2 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm0200815
511294 5236 None 1 Human Binding pKi = 7.2 7.2 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL106299 5236 None 1 Human Binding pKi = 7.2 7.2 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 438 4 0 2 5.9 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1021/jm030265z
511332 109626 None 5 Human Binding pKi = 8.2 8.2 35 3
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
CHEMBL322251 109626 None 5 Human Binding pKi = 8.2 8.2 35 3
Ability to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cellsAbility to inhibit [125I]-labeled RANTES binding to the CCR5 receptor expressed in membrane preparations from CHO cells
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(02)00918-6
511332 109626 None 5 Human Binding pKi = 8.2 8.2 35 3
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL322251 109626 None 5 Human Binding pKi = 8.2 8.2 35 3
Binding affinity at C-C chemokine receptor type 5Binding affinity at C-C chemokine receptor type 5
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
456375 10095 None 1 Human Binding pKi = 8.2 8.2 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL115487 10095 None 1 Human Binding pKi = 8.2 8.2 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 501 4 0 3 6.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
457871 100721 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
CHEMBL292625 100721 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to C-C chemokine receptor type 5Inhibition of RANTES binding to C-C chemokine receptor type 5
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm015526o
9579320 9250 None 0 Mouse Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm0200815
CHEMBL110757 9250 None 0 Mouse Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 556 6 1 6 5.3 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm0200815
457871 100721 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL292625 100721 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 483 4 1 3 5.6 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(Nc3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
511332 109626 None 5 Human Binding pKi = 8.2 8.2 35 3
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL322251 109626 None 5 Human Binding pKi = 8.2 8.2 35 3
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 518 4 0 4 4.7 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(C(F)(F)F)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
462409 110689 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL326020 110689 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 561 4 1 4 5.1 Cc1cccc(O)c1C(=O)N1CCC(C)(N2CCN([C@@H](C)c3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5496107 116534 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm030265z
CHEMBL336246 116534 None 1 Human Binding pKi = 8.2 8.2 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 1 6 5.3 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc(O)nc3C)CC2)CC1 10.1021/jm030265z
9579327 5329 None 0 Mouse Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 548 6 0 6 4.6 CO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
CHEMBL106813 5329 None 0 Mouse Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 548 6 0 6 4.6 CO/N=C(\c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm0200815
5496114 118771 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 548 6 0 6 4.6 CO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
CHEMBL341945 118771 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 548 6 0 6 4.6 CO/N=C(/c1ccc(OC(F)(F)F)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cc[n+]([O-])c3C)CC2)CC1 10.1021/jm030265z
463502 203993 None 1 Human Binding pKi = 7.1 7.1 - 1
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
CHEMBL69581 203993 None 1 Human Binding pKi = 7.1 7.1 - 1
Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5Inhibition of [125I]-labeled RANTES binding to C-C chemokine receptor type 5
ChEMBL 589 6 0 7 4.7 Cc1cccc(C)c1C(=O)N1CCC(N2CCN(Cc3ccc(S(=O)(=O)c4ccc5c(c4)OCO5)cc3)[C@@H](C)C2)CC1 10.1016/s0960-894x(01)00381-x
9579311 5265 None 0 Mouse Binding pKi = 7.1 7.1 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL106468 5265 None 0 Mouse Binding pKi = 7.1 7.1 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
5496098 118979 None 1 Human Binding pKi = 7.1 7.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL342452 118979 None 1 Human Binding pKi = 7.1 7.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 511 4 1 4 5.7 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\O)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
484581 110597 None 2 Human Binding pKi = 8.1 8.1 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
CHEMBL325556 110597 None 2 Human Binding pKi = 8.1 8.1 - 1
Binding affinity towards C-C chemokine receptor type 5Binding affinity towards C-C chemokine receptor type 5
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm0155401
511309 5400 None 1 Mouse Binding pKi = 8.1 8.1 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
CHEMBL107154 5400 None 1 Mouse Binding pKi = 8.1 8.1 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm0200815
511309 5400 None 1 Human Binding pKi = 8.1 8.1 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
CHEMBL107154 5400 None 1 Human Binding pKi = 8.1 8.1 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 494 4 0 2 6.5 C=C(c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)cccc3C)CC2)CC1 10.1021/jm030265z
484581 110597 None 2 Human Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
CHEMBL325556 110597 None 2 Human Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 545 4 0 3 5.1 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCN(Cc3ccc(I)cc3)[C@@H](C)C2)CC1 10.1021/jm030265z
5495586 118731 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL341758 118731 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
5495586 118731 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL341758 118731 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 569 7 0 6 5.6 Cc1ncnc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OCC(C)C)c3ccc(Br)cc3)CC2)CC1 10.1016/s0960-894x(02)01063-6
6533780 28778 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1021/jm030265z
CHEMBL137856 28778 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 556 6 0 5 4.8 CCO/N=C(/c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1021/jm030265z
5495580 55068 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
CHEMBL161664 55068 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of [125I]RANTES binding to CCR5 receptor.Inhibition of [125I]RANTES binding to CCR5 receptor.
ChEMBL 556 6 0 5 4.8 CCO/N=C(\c1ccc(Br)cc1)C1CCN(C2(C)CCN(C(=O)c3c(C)c[n+]([O-])cc3C)CC2)CC1 10.1016/s0960-894x(02)01063-6
2600 3777 None 74 Human Binding pKi = 6.1 6.1 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
2608 3777 None 74 Human Binding pKi = 6.1 6.1 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
5405 3777 None 74 Human Binding pKi = 6.1 6.1 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
CHEMBL17157 3777 None 74 Human Binding pKi = 6.1 6.1 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
DB00342 3777 None 74 Human Binding pKi = 6.1 6.1 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
ChEMBL 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O nan
511296 9206 None 1 Mouse Binding pKi = 7.1 7.1 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
CHEMBL110463 9206 None 1 Mouse Binding pKi = 7.1 7.1 -1 2
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm0200815
511296 9206 None 1 Human Binding pKi = 7.1 7.1 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
CHEMBL110463 9206 None 1 Human Binding pKi = 7.1 7.1 1 2
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 450 5 0 3 6.0 CSc1ccc(CC2CCN(C3(C)CCN(C(=O)c4c(C)cccc4C)CC3)CC2)cc1 10.1021/jm030265z
9579313 163326 None 0 Mouse Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
CHEMBL418997 163326 None 0 Mouse Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cellsInhibition of RANTES binding to Chemokine receptor type 5 receptor from NIH 3T3 cells
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N/OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm0200815
5496100 116720 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
CHEMBL337364 116720 None 1 Human Binding pKi = 8.1 8.1 - 1
Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)Inhibition of RANTES binding to the human C-C chemokine receptor type 5 (CCR5)
ChEMBL 567 5 0 4 7.0 Cc1cccc(C)c1C(=O)N1CCC(C)(N2CCC(/C(=N\OC(C)(C)C)c3ccc(Br)cc3)CC2)CC1 10.1021/jm030265z
503637 56345 None 1 Human Binding pKi = 7.0 7.0 - 1
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 56345 None 1 Human Binding pKi = 7.0 7.0 - 1
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
503637 56345 None 1 Human Binding pKi = 7.0 7.0 - 1
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
CHEMBL163078 56345 None 1 Human Binding pKi = 7.0 7.0 - 1
Inhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assayInhibitory activity against CCR5 receptor in CHO cell membranes was determined using radio-ligand [125I]-RANTES binding assay
ChEMBL 331 2 0 3 2.4 Cc1cc[n+]([O-])c(C)c1C(=O)N1CCC(C)(N2CCCCC2)CC1 10.1016/s0960-894x(02)01062-4
3002977 2458 None 71 Mouse Binding pIC50 = 8.1 8.1 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
803 2458 None 71 Mouse Binding pIC50 = 8.1 8.1 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
806 2458 None 71 Mouse Binding pIC50 = 8.1 8.1 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL1201187 2458 None 71 Mouse Binding pIC50 = 8.1 8.1 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL256907 2458 None 71 Mouse Binding pIC50 = 8.1 8.1 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL584744 2458 None 71 Mouse Binding pIC50 = 8.1 8.1 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
DB04835 2458 None 71 Mouse Binding pIC50 = 8.1 8.1 - 2
Displacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hrDisplacement of [125I]-RANTES from CCR5 in mouse NIH/3T3 cells after 1 hr
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
11598 672 None 9 Human Binding pIC50 = 6.1 6.1 - 1
Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5
Guide to Pharmacology 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 30891130
23725177 672 None 9 Human Binding pIC50 = 6.1 6.1 - 1
Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5
Guide to Pharmacology 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 30891130
CHEMBL4442783 672 None 9 Human Binding pIC50 = 6.1 6.1 - 1
Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5Antagonism of MIP-1β binding to HT1080 cells stably expressing CCR5
Guide to Pharmacology 506 6 2 6 3.4 CC(=O)N[C@@H]1C[C@@H](CC[C@@H]1N1CC[C@@H](C1=O)Nc1ncnc2c1cc(cc2)C(F)(F)F)N(C(C)C)C 30891130
11614352 550 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cells
Guide to Pharmacology 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 22266038
7686 550 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cells
Guide to Pharmacology 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 22266038
CHEMBL1951914 550 None 1 Human Binding pIC50 = 9.6 9.6 - 0
Displacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cellsDisplacement of [125I]MIP-1α from human recombinant CCR5 expressed in CHO cells
Guide to Pharmacology 639 11 0 6 4.1 CCN(C(=O)Cc1ccc(cc1)S(=O)(=O)C)C1CCN(CC1)CC[C@@H](c1cc(F)cc(c1)F)C1CCN(CC1)S(=O)(=O)C 22266038
10416 1877 None 30 Human Binding pIC50 = 5.2 5.2 - 1
IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.
Guide to Pharmacology 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 23409871
46861584 1877 None 30 Human Binding pIC50 = 5.2 5.2 - 1
IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.
Guide to Pharmacology 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 23409871
CHEMBL2018969 1877 None 30 Human Binding pIC50 = 5.2 5.2 - 1
IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.IC50 determined in a GTPγS binding assay using membranes from CHO cells expressing recombinant CCR5 receptor.
Guide to Pharmacology 548 9 3 8 4.0 COc1cccc2c1c(nn2Cc1cccc(c1)CNC(=O)C(O)(C)C)NS(=O)(=O)c1ccc(s1)Cl 23409871
3002977 2458 None 71 Human Binding pKd = 8.1 8.1 -3 2
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
803 2458 None 71 Human Binding pKd = 8.1 8.1 -3 2
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
806 2458 None 71 Human Binding pKd = 8.1 8.1 -3 2
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL1201187 2458 None 71 Human Binding pKd = 8.1 8.1 -3 2
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL256907 2458 None 71 Human Binding pKd = 8.1 8.1 -3 2
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL584744 2458 None 71 Human Binding pKd = 8.1 8.1 -3 2
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
DB04835 2458 None 71 Human Binding pKd = 8.1 8.1 -3 2
Binding affinity to CCR5Binding affinity to CCR5
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
1638 2722 None 38 Mouse Binding pKd = 8.1 8.1 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
1676 2722 None 38 Mouse Binding pKd = 8.1 8.1 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
1878 2722 None 38 Mouse Binding pKd = 8.1 8.1 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
5284596 2722 None 38 Mouse Binding pKd = 8.1 8.1 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
CHEMBL80 2722 None 38 Mouse Binding pKd = 8.1 8.1 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
DB01183 2722 None 38 Mouse Binding pKd = 8.1 8.1 -6 17
Binding affinity to CCR5 in NY1DD transgenic mouse brain membraneBinding affinity to CCR5 in NY1DD transgenic mouse brain membrane
Drug Central 327 2 2 5 1.3 C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O None
802 415 None 10 Human Binding pKd None 8.9 8.9 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
804 415 None 10 Human Binding pKd None 8.9 8.9 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
9574343 415 None 10 Human Binding pKd None 8.9 8.9 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
CHEMBL78535 415 None 10 Human Binding pKd None 8.9 8.9 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
3002977 2458 None 71 Human Binding pKd None 9.1 9.1 -3 2
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
803 2458 None 71 Human Binding pKd None 9.1 9.1 -3 2
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
806 2458 None 71 Human Binding pKd None 9.1 9.1 -3 2
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL1201187 2458 None 71 Human Binding pKd None 9.1 9.1 -3 2
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL256907 2458 None 71 Human Binding pKd None 9.1 9.1 -3 2
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
CHEMBL584744 2458 None 71 Human Binding pKd None 9.1 9.1 -3 2
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
DB04835 2458 None 71 Human Binding pKd None 9.1 9.1 -3 2
UnclassifiedUnclassified
Guide to Pharmacology 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C 16298345
3117 207839 None 103 Human Binding pKi = 8.3 8.3 -8 16
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
CHEMBL964 207839 None 103 Human Binding pKi = 8.3 8.3 -8 16
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 296 4 0 4 3.6 CCN(CC)C(=S)SSC(=S)N(CC)CC None
2600 3777 None 74 Human Binding pKi = 8.2 8.2 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
2608 3777 None 74 Human Binding pKi = 8.2 8.2 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
5405 3777 None 74 Human Binding pKi = 8.2 8.2 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
CHEMBL17157 3777 None 74 Human Binding pKi = 8.2 8.2 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
DB00342 3777 None 74 Human Binding pKi = 8.2 8.2 -5 13
DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)
Drug Central 471 8 2 3 6.4 OC(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)C(c1ccccc1)(c1ccccc1)O None
3002977 2458 None 71 Rhesus macaque Binding pKi = 8.0 8.0 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
803 2458 None 71 Rhesus macaque Binding pKi = 8.0 8.0 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
806 2458 None 71 Rhesus macaque Binding pKi = 8.0 8.0 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL1201187 2458 None 71 Rhesus macaque Binding pKi = 8.0 8.0 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL256907 2458 None 71 Rhesus macaque Binding pKi = 8.0 8.0 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
CHEMBL584744 2458 None 71 Rhesus macaque Binding pKi = 8.0 8.0 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
DB04835 2458 None 71 Rhesus macaque Binding pKi = 8.0 8.0 3 2
Displacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysisDisplacement of [125I]-MIP-1alpha from CCR5 in rhesus monkey Chem-1 cell membranes after 120 mins by liquid scintillation counting analysis
Drug Central 513 8 1 5 6.0 O=C(C1CCC(CC1)(F)F)N[C@H](c1ccccc1)CCN1[C@@H]2CC[C@H]1CC(C2)n1c(C)nnc1C(C)C None
753 828 None 0 Human Binding pKi = 7.2 7.2 -1 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
771 835 None 0 Human Binding pKi = 7.5 7.5 -1 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
759 866 None 0 Human Binding pKi = 7.5 7.5 -25 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
183790 3740 None 11 Human Binding pKi = 7.5 7.5 6 2
UnclassifiedUnclassified
Guide to Pharmacology 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 16476734
783 3740 None 11 Human Binding pKi = 7.5 7.5 6 2
UnclassifiedUnclassified
Guide to Pharmacology 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 16476734
CHEMBL1178786 3740 None 11 Human Binding pKi = 7.5 7.5 6 2
UnclassifiedUnclassified
Guide to Pharmacology 495 6 1 2 6.8 Cc1ccc(cc1)c1ccc2c(c1)C=C(CCC2)C(=O)Nc1ccc(cc1)C[N+](C1CCOCC1)(C)C 16476734
802 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
802 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
802 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
804 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
804 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
804 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
9574343 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
9574343 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
9574343 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
CHEMBL78535 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 11585437
CHEMBL78535 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16304152
CHEMBL78535 415 None 10 Human Binding pKi = 8.3 8.3 -1 2
UnclassifiedUnclassified
Guide to Pharmacology 556 6 0 5 4.8 CCO/N=C(\c1ccc(cc1)Br)/C1CCN(CC1)C1(C)CCN(CC1)C(=O)c1c(C)cc[n+](c1C)[O-] 16476734
756 857 None 0 Human Binding pKi = 8.5 8.5 -3 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11170631
756 857 None 0 Human Binding pKi = 8.5 8.5 -3 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
756 857 None 0 Human Binding pKi = 8.5 8.5 -3 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
3001322 443 None 23 Human Binding pKi = 8.5 8.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
805 443 None 23 Human Binding pKi = 8.5 8.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
CHEMBL1255794 443 None 23 Human Binding pKi = 8.5 8.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
DB06497 443 None 23 Human Binding pKi = 8.5 8.5 - 1
UnclassifiedUnclassified
Guide to Pharmacology 577 10 3 6 4.6 CCCCN1C(=O)[C@H](NC(=O)C21CCN(CC2)Cc1ccc(cc1)Oc1ccc(cc1)C(=O)O)[C@@H](C1CCCCC1)O 16476734
3009355 3987 None 26 Human Binding pKi = 9.1 9.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
807 3987 None 26 Human Binding pKi = 9.1 9.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
CHEMBL82301 3987 None 26 Human Binding pKi = 9.1 9.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
DB06652 3987 None 26 Human Binding pKi = 9.1 9.1 - 1
UnclassifiedUnclassified
Guide to Pharmacology 533 6 0 6 4.5 COC[C@H](N1CCN(C[C@@H]1C)C1(C)CCN(CC1)C(=O)c1c(C)ncnc1C)c1ccc(cc1)C(F)(F)F 16304152
772 869 None 0 Human Binding pKi = 9.3 9.3 - 1
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
758 863 None 0 Human Binding pKi = 9.5 9.5 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10318947
758 863 None 0 Human Binding pKi = 9.5 9.5 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
758 863 None 0 Human Binding pKi = 9.5 9.5 3 4
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
757 862 None 0 Human Binding pKi = 9.5 9.5 112 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16298345
757 862 None 0 Human Binding pKi = 9.5 9.5 112 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730
760 1653 None 0 Human Binding pKi None 7.6 7.6 3 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11170631
752 709 None 0 Human Binding pKi None 7.7 7.7 -12 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 11170631
770 827 None 0 Human Binding pKi None 9.1 9.1 79 2
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9790730